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Abstract 
Background 
In Australia, one in every 139 women reaching 20 weeks gestation will have a stillborn 
baby. There is significant disparity in stillbirth rates within subgroups of the Australian 
population.  Among Aboriginal and Torres Strait Islander (Indigenous) women, the stillbirth 
rate is one in every 93 women reaching 20 weeks gestation. Unfortunately, there has been 
no reduction in the national stillbirth rates over the past two decades and nearly a third are 
‘unexplained’.  The ability to identify women at increased risk of stillbirth is an important 
and challenging priority.  At present in Australia, there is a paucity of high quality data on 
causes and contributing factors to stillbirth.  Furthermore, inconsistent approaches to 
investigation and classification affect the quality of data on causes of death and hamper 
the development of effective interventions to prevent stillbirth.  
 
Aims 
The primary aim of this Thesis is to describe the epidemiology of stillbirth within the 
Australian context. This aim was addressed by: 
 Examining trends in stillbirth by clinical classification of cause of death, Indigenous 
status and gestational age, to identify focal areas for preventive efforts  
 Assessing gestational age specific risk of stillbirth associated with four important 
contributors (diabetes, hypertension, antepartum haemorrhage and small-for-
gestational age) to higher stillbirth rates among Indigenous women in order to 
identify periods of increased risk  
 Developing and validating a statistical model to predict the risk of antepartum 
stillbirth at term (≥37 weeks) using maternal and pregnancy factors as a potential 
decision-making aid for clinicians and women  
 Assessing consistency in application of the Perinatal Society of Australia and New 
Zealand Perinatal Death Classification system between hospital committees and an 
independent expert panel, to identify areas for quality improvement  
 Determining maternal and pregnancy factors associated with parental consent to 
autopsy following stillbirth and explore parents’ views and experiences of the 
autopsy consent process to inform clinical practice  
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Methods and Results 
Data for 1995-2011 (n=881,211 singleton births) from the Queensland Perinatal Data 
Collection was analysed to address the first three aims.  Stillbirth trends analysis found 
consistently higher rates of stillbirth among Indigenous women, however, the gap in 
stillbirth rates had narrowed.  Gestational age specific stillbirth risk analysis found disparity 
in the magnitude of stillbirth risk for pre-existing diabetes and small-for-gestational age 
between Indigenous and non-Indigenous women.  Despite strong association between 
maternal clinical factors and antepartum stillbirth risk, the prediction model had a poor 
ability to predict stillbirth risk at term.  
Consistency in application of the perinatal death classification system was assessed by 
calculating agreement.  A substantial level of agreement was found between hospital 
committee and expert panel review of a cohort of 217 stillbirth cases, however, low levels 
of agreement were found for the categories of antepartum haemorrhage and fetal growth 
restriction.   
 
Parents’ lived experiences were explored using mixed methods. The study identified 
maternal and pregnancy characteristics associated with consent or decline of autopsy 
following stillbirth; likewise the in-depth interviews revealed that the autopsy consenting 
process was part of a larger bereavement journey for parents.  Parents expected 
healthcare professionals to have an appreciation for their loss and provide bereavement 
care in a sensitive and respectful manner. 
 
Conclusions  
These studies highlight the need for early detection and management of pre-existing 
medical conditions as well as improving equitable access to high quality antenatal care.  
Of continued concern are stillbirths which remain unexplained after investigation.  
Numerous factors influence parents’ decision making around stillbirth autopsy and 
sensitivity and respectfulness in particular on the part of healthcare providers is essential.  
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Chapter 1 
Literature Review 
 
1.1 Definition 
Stillbirth within Australia is widely defined across birth registration and perinatal death 
collections as “a fetal death prior to the complete expulsion or extraction from its mother of 
a product of conception of 20 or more completed weeks of gestation or of 400 grams or 
more birthweight.  The death is indicated by the fact that after such separation the fetus 
does not breathe or show any other evidence of life, such as beating of the heart, pulsation 
of the umbilical cord, or definite movement of voluntary muscles” [1].  However, the 
statutory definition of stillbirth in South Australia excludes induced terminations of 
pregnancy [2].  Furthermore, where information is missing on gestational age and 
birthweight, there are slight differences in application of the rules in relation to reporting 
across states and territories [3]. In Australian reports pertaining to perinatal deaths, the 
terms fetal death and stillbirth are used synonymously.  However, the term fetal death is a 
broader term encompassing fetal deaths at earlier gestational ages than stillbirth, where 
the birth is not recognised [4].  Stillbirth is the preferred term [5]. 
Stillbirths can be further classified into antepartum stillbirths, which are deaths occurring 
before the onset of labour, and intrapartum stillbirths, which are deaths occurring after the 
onset of labour but before birth [6].  Stillbirths can also be classified by gestational age.  
Early gestation stillbirths refer to deaths occurring at less than 28 weeks gestation and late 
gestation stillbirths refer to deaths at 28 weeks gestation or more [7, 8]. The legal 
requirements for registration and reporting of stillbirth vary widely within and between 
countries [9].  Nevertheless, the World Health Organisation (WHO) recommends a 
definition of at least 500g birthweight or 22 weeks gestation for national reporting and at 
least 1000g or 28 weeks gestation for international comparisons [10]. For the purposes of 
these studies, the Australian legal definition of stillbirth (at least 400g or at least 20 weeks 
gestation) will be used.   
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1.2 Stillbirth: the global picture 
Stillbirth is a significant but under-appreciated public health issue globally.  It is estimated 
that nearly 3 million stillbirths occur during the third trimester of pregnancy each year [11].  
In 2012, compared with the leading global causes of death in all age categories, stillbirth 
during the third trimester ranked 5th ahead of lung cancer related deaths (1.6 million each 
year), HIV/AIDS-related deaths (1.5 million each year) and diarrhoeal disease (1.5 million 
each year) [12]. The majority (98%) of stillbirths occur in low and middle income countries, 
and nearly three quarters occur in South Asia and Sub-Saharan Africa [11]. 
Underreporting of stillbirths is an important issue in many developing countries as nearly 
half of all births occur at home [11]. Therefore, assessments of the number of stillbirths in 
the most affected countries are likely to be an underestimate. 
Despite the magnitude of this issue, there had been little political impetus for preventive 
action. Stillbirths were severely under-represented in the global health policy agenda. This 
is evidenced by the lack of its inclusion in the Millennium Development Goals (MDGs), or 
as an indicator in the Countdown to 2015 monitoring process or in the Global Burden of 
Disease estimates [11, 13].  There was very little research, programmatic or policy 
attention devoted to stillbirth prevention in low and middle income countries [14] and most 
government departments in these countries did not count stillbirths [13]. The Lancet Series 
on Stillbirths published in 2011 focussed global attention on stillbirths; and the Every 
Newborn action plan was launched in May 2014 to prioritise newborn deaths and stillbirths 
by strengthening the newborn health components in existing health sector strategies 
relating to reproductive, maternal and child health [15].  A goal within the action plan is to 
reduce all national stillbirth rates to 10 or less per 1000 by 2035 and close equity gaps 
within countries [15].  
 
1.2.1 Stillbirth rates in low and middle income countries (LMICs) 
Comparison of stillbirth rate estimates between 1995 and 2008 suggest there have been 
decreases in the rate of stillbirth in many low and middle income countries but the rate of 
decrease has not been uniform across countries or regions [16]. Cuba, Sri Lanka, 
Malaysia and Mexico made substantial reductions in national stillbirth rates and China 
achieved a two-thirds reduction in national stillbirth rates [11].  There has been limited 
information on how these reductions were achieved. Family planning and increased inter-
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pregnancy interval have been implicated in the reductions seen in China [17] and anti-
helminthic interventions and its impact on maternal nutrition have been suggested for 
reductions in Sri Lanka [18]. 
Variations in stillbirth rates were observed between rural and urban populations within 
many low and middle income countries.  In South Asia and Sub-Saharan Africa, with 
predominantly rural populations, two-thirds of stillbirths occur in rural areas [11].  
Disparities in stillbirth rates between urban and rural populations also mirror disparities in 
rates of skilled attendance at birth and caesarean section delivery [11]. In Africa and South 
Asia, women living in rural areas had 50% lower rates of skilled attendance at birth 
compared with women living in urban areas.  Similarly, there were higher rates of birth by 
caesarean section in urban areas in South Asia and Africa, 14% and 5% respectively 
compared with rural areas which had rates of 5% and 1%, respectively [11].  Up to a 
reported 70% of stillbirths occurring in low and middle income countries are intrapartum 
deaths associated with obstetric emergencies [13]. This suggests that improved care 
around the time of delivery may have a significant effect on stillbirth rates in LMIC settings. 
 
1.2.2 Stillbirth rates in high income countries (HICs) 
Despite the lack of attention to stillbirth prevention in policies and programs, there have 
been significant declines in the rate of stillbirths in high income countries (HICs) [13]. In a 
study of stillbirth rates in eleven European countries, a similar pattern of decline was 
observed between the countries [19]. This decline in stillbirth rates has been attributed to 
antenatal care, admission to hospital for delivery, use of caesarean section for fetal 
distress – all of which were introduced after 1935-40 [13]. However, the rate of decline in 
stillbirth rates in many HICs has slowed or stalled over the past two decades [13].  
 
Historical trends in type of stillbirth 
There have been variations in the rate of reduction of different types of stillbirth. In high 
income countries, stillbirths at term or during birth (intrapartum) have been significantly 
reduced to less than 15% of all stillbirths [13, 19].  Reductions in intrapartum stillbirth rates 
were achieved as a result of effective birth attendants supported by skilled obstetricians, 
advancements in medical technology and the advent of specialised neonatal intensive 
care units (NICU) [19]. The recent slow decline in stillbirth rates has been attributed to little 
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or no reduction in the rate of antepartum stillbirths. There has been an increase in the 
proportion of preterm births as a result of increased induction of labour in pregnancies 
thought to be at increased risk of antepartum death [20].  Antepartum and preterm-related 
stillbirths now make up the majority of stillbirths in high income countries [13], suggesting 
the need for increased attention to understanding the aetiologies of antepartum and 
preterm-related stillbirth.   
 
International comparison of national stillbirth rates 
Using the WHO stillbirth definition for international comparison (≥1000g or 28 weeks 
gestation), 193 countries were ranked by national stillbirth rates (see Table 1.1). Finland 
had the lowest stillbirth rate (2.0 per 1000 total births) and Pakistan had the highest 
estimated stillbirth rates with 46.1 per 1000 total births. Australia was ranked 15th with 2.9 
per 1000 total births [21]. However, within countries there is wide variation in stillbirth 
rates.  In Australia, stillbirth rates among Indigenous Australians were nearly twice that of 
non-Indigenous Australians.  Using the WHO definition for international comparison, 
Indigenous Australians would be ranked 56th after Malaysia with a rate of 6.0/1000 total 
births [22] (see Table 1.1).  
 
Table 1.1: Selected country stillbirth rate estimates per 1000 total births, 2009 
Rank Country Total births Total stillbirths 
Stillbirth rate 
per 1000 births 
1 Finland 59,540 120 2.0 
15 Australia 270,360 780 2.9 
17 USA 4,425,800 13,070 3.0 
26 Canada 359,280 1,180 3.3 
33 United Kingdom 751,370 2,630 3.5 
34 New Zealand 58,790 210 3.5 
55 Malaysia 553,410 3,290 5.9 
82 China 18,500,000 182,150 9.8 
154 India 27,400,000 605,230 22.1 
193 Pakistan 5,667,980 264,550 46.7 
Source: World Health Organization, Save the Children. Stillbirths: The Invisible Public Health Problem (press 
release). 2011. http://www.who.int/pmnch/media/news/2011/20110414_stillbirths_pressrelease.pdf. 
(accessed 24/02/2013) 
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1.3 Stillbirth: the Australian picture 
1.3.1 Rates and trends 
There were significant reductions in stillbirth rates during the 1970s and 1980s, however, 
this reduction has slowed over the past 20 years and rates may be slowly increasing 
(Figure 1.1). Reductions in stillbirth rates have been more modest than those seen in 
perinatal mortality rates and over the past two decades have remained steady at about 
7.4/1000 total births [23].  This equates to more than 2000 stillbirths each year.  Data from 
the National Perinatal Data Collection indicate that during the 1970s to 1980s there was a 
higher rate of decline in intrapartum deaths compared with antepartum deaths with a 
trough in 1994  (see Figure 1.2). From 1991 to 2009 there were increases in the rate of 
extremely preterm stillbirths [4]. 
 
 
Figure 1.1: Trends in national stillbirth rate, Australia, 1973-2012 
Data for the years 1973-1989 were from the Australian Bureau of Statistics (ABS) using the definition of fetal 
death of at least 22 weeks gestation or birthweight of at least 500g. Data for the years 1990 and onwards 
were from the National Perinatal Statistics Unit using the definition of fetal death of at least 20 weeks 
gestation or birthweight of at least 400g.  Source: Australia’s mothers and babies report 1992 to 2012  
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Figure 1.2: Trends in type of stillbirth, Australia, 1973-1996 
Data is from the Australian Bureau of Statistics using the definition of fetal death of at least 22 weeks 
gestation or at least 500g birthweight.  Source: Australia’s mothers and babies reports 1992 to1996  
 
 
1.3.2 Disparity in stillbirth rates 
In the Australian obstetric population, disparity in stillbirth rates has been reported for a 
number of subgroups including teenage women [24] and women born in South Asia [25]. 
However, the focus of this Thesis is on disparity between Indigenous and non-Indigenous 
women in Australia.  There is continued disproportionate disadvantage among Indigenous 
Australians in relation to education attainment, employment and ill health [26].  Life 
expectancy for Indigenous Australian men and women is lower than values for indigenous 
populations in New Zealand (Māori), Hawai’i (Kanaka Maoli) and Micronesia [27]. 
Furthermore, worse reproductive health outcomes have been reported for Indigenous 
women, for example higher rates of low birthweight (11.8% versus 6.0%), preterm birth 
(14.3% vs 8.3%) and perinatal mortality (14.9 vs 9.4 per 1000 births) compared to their 
non-Indigenous counterparts [24].   
In 2012, Indigenous women made up 4.0% of women giving birth in Australia [24]. The 
stillbirth rates for Indigenous and non-Indigenous women in Australia were 10.8/1000 
births and 7.1/1000 births, respectively [24].  Examining historical trends, it appears the 
gap is reducing somewhat between Indigenous and non-Indigenous stillbirth rates (see 
Figure 1.3).  Indigenous women also have higher rates of risk factors known to be 
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associated with stillbirth, including maternal obesity, smoking and alcohol consumption, 
diabetes and lower rates of adequate antenatal care [23].  It is suggested that maternal 
behaviours, genetics, physical and social environment, access to and quality of health care 
may be at the core of this disparity [28]. The excess mortality in Indigenous births may be 
due mainly to low birthweight and preterm birth and these should be priority areas for 
primary health care [29]. 
 
Figure 1.3: Trends in stillbirth rate by maternal race, Australia, 1991-2012 
Data are from the National Perinatal Statistics Unit using the definition of fetal death of at least 20 weeks 
gestation or at least 400g birthweight.  Source: Australia’s mothers and babies report 1992 to 2012. 
 
 
1.3.3 Risk Factors for stillbirth 
Several factors have been identified to be associated with increased risk of stillbirth. 
Scientific inquiry into risk factors for stillbirth is important for uncovering possible aetiologic 
pathways as well as suggesting areas for primary prevention.  In this review, discussion 
will be limited to potentially modifiable risk factors and factors for which data are available 
in the state perinatal data collections. 
 
The risk factors to be examined include maternal (age, overweight and obesity, maternal 
place of birth, socioeconomic status, geographic location, smoking, alcohol and substance 
use), medical and obstetric factors (diabetes, hypertension, antenatal care, parity and 
assisted reproductive technology). 
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1.3.3.1 Maternal Factors 
Maternal age  
Women at the extremes of reproductive age are at increased risk of stillbirth and other 
adverse pregnancy outcomes [30].  From 1991 to 2010, the mean age of women giving 
birth in Australia increased 7.5% [23]. The proportion of teenage mothers (aged less than 
20 years old) was stable around 3.9%, a slight decrease from 5.0% in 2001 [23]. In 2012, 
the rate of stillbirth among women younger than 20 years and women aged 40 years or 
older was 12.6/1000 and 11.7/1000 respectively compared with the overall rate of 
7.2/1000 total births [24].  
Data from the National Perinatal Data Collection indicate differences in the age profile of 
Indigenous compared with non-Indigenous mothers. More Indigenous mothers birthed at a 
younger age; mean maternal age for Indigenous mothers in 2012 was 25.2 years 
compared with non-Indigenous (30.3 years) [24]. A higher proportion of Indigenous 
mothers were teenagers compared with non-Indigenous mothers – 18.6% versus 3.0% 
and conversely, 8.9% of Indigenous mothers were aged 35 years or older compared with 
23.0% of non-Indigenous mothers [24]. 
There is conflicting evidence on the association between young maternal age (defined as 
less than 20 years old) and stillbirth. Bateman and Simpson reported an increased risk of 
stillbirth after adjusting for medical and obstetric predisposing factors (adjusted OR 1.11, 
95% CI 1.08-1.14)[30] while Chandra reported no effect of maternal age on perinatal 
mortality for teenage mothers; however, there was an increased risk of low birth weight 
and growth restriction [31]. A meta-analysis of six studies on young maternal age found no 
association with stillbirth [32].   
However, two studies on very young maternal age (defined as less than 15 years old) 
reported significantly increased risk of stillbirth. Salihu and colleagues reported adjusted 
odds ratio of 1.57 (95% CI 1.49 – 1.66) [33] and Wilson et al reported adjusted hazard 
ratio of 2.6 (95% CI 2.1 – 3.3) [34]. It has been hypothesised that the increased risk of 
stillbirth in young mothers is due to biological immaturity [34, 35] and social disadvantage 
[34].  This hypothesis is supported by findings that compared to women aged 20-24 years 
old, there was a higher risk of intrapartum stillbirth in mothers aged less than 15 years 
(adjusted HR 4.3, 95% CI 4.0-4.7) and 15-19 years (adjusted HR 1.5, 95% CI 1.2-1.8) [34]. 
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In Australia, there has been a trend towards delayed childbearing.  The proportion of 
mothers aged over 35 years increased from 16.3% in 1999 to 22.4% in 2012 [23, 24]. The 
proportion of women aged 40 years or older giving birth increased from 2.9% in 2001 to 
4.3% in 2012 [23, 24]. Women aged 45 years or older made up 0.2% of women giving 
birth in Australia in 2012 [24].  
Advanced maternal age (older than 35 years) is associated with a 65% increase in odds of 
stillbirth and the risk increases with increasing age. Compared with women aged less than 
35 years, the odds of stillbirth were: 35-39 years (adjusted OR 1.46, 95% CI 1.22-1.73), 
40-44 years (adjusted OR 1.82 95% CI 1.43-2.31), older than 45 years (adjusted OR 2.85 
95% CI 1.86-4.36) and older than 50 years (adjusted OR 2.20 95% CI 1.01-4.75)[32].  
While higher stillbirth rates are reported for women aged 40 years or older in Australia, 
between 1991 and 2009, the stillbirth rate among these women decreased from 12.7/1000 
to 10.6/1000 [4]. 
It has been suggested that the mechanism behind the increased risk of stillbirth may be 
related to the direct effect of maternal aging which manifests as low utero-placental 
perfusion as a result of poor uterine vasculature [35, 36]. It has also been suggested that 
the association between older maternal age and the increased risk of chronic disease 
(such as diabetes and hypertensive disorders) and other medical or obstetric 
complications may be another pathway ultimately leading to stillbirth [36]. 
 
Overweight and obesity 
Obesity is a significant health issue during pregnancy and is associated with increased risk 
of maternal, antenatal, peripartum and neonatal complications [23, 37]. Overweight and 
obesity is measured using the Body Mass Index (BMI), which is a ratio of body weight to 
height and is classified according to World Health Organisation (WHO) recommendations 
outlined in Table 1.2 [38].  
It is estimated that up to one third of pregnant women in Australia are overweight or obese 
[24, 39]. Data from the National Perinatal Data Collection indicates that 22.4% of mothers 
were classified as obese at the time of conception, and a higher proportion of Indigenous 
mothers were obese compared to non-Indigenous mothers (29.1% versus 21.8%) [23, 37].  
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Table 1.2: BMI classification according to World Health Organisation (WHO)  
Classification BMI cut points 
Underweight Less than 18.5 kg/m2 
Normal range 18.5 – 24.9 kg/m2 
Overweight 25 – 29.9 kg/m2 
Obese I 30 – 34.9 kg/m2 
Obese II 35 – 39.9 kg/m2 
Obese III ≥ 40 kg/m2 
Source: World Health Organization. Obesity and overweight. Fact sheet No. 311. 2012. 
www.who.int/topics/obesity (accessed 24/02/2013) 
 
Women who are obese are at increased risk of thromboembolism, gestational diabetes, 
pre-eclampsia, post partum haemorrhage, wound infection and caesarean section delivery 
[23]. Outcomes for babies born to mothers who are obese include increased risk of 
congenital anomalies, stillbirth and neonatal death [23]. Pregnancy complications of 
maternal obesity are related to pre-conception obesity and excessive weight gain during 
pregnancy.   
Maternal pre-conception obesity is associated with an increased risk of stillbirth [40]. A 
recent meta-analysis reported a 23% increase in the odds of stillbirth (OR 1.23 95%CI 
1.09-1.38) associated with a maternal BMI of 25-30 kg/m2; and a 63% increase in the odds 
of stillbirth (OR 1.63 95% CI 1.35-1.95) associated with a BMI of >30 kg/m2 [32]. Similarly, 
a population-based retrospective cohort study found increasing risk of stillbirth with 
increasing BMI and attributed about 25% of stillbirths between 37 and 42 weeks to 
maternal obesity [41]. Furthermore, an interpregnancy weight gain of 4 units in body mass 
index is associated with a 55% increase in risk of stillbirth [42].While maternal obesity has 
been identified as a leading modifiable risk factor for stillbirth, the mechanism to explain 
the association is not clear [40].  Inadequate placental function has been implicated as a 
possible mechanism [43]. 
Guidelines issued in 2009 by the Institute of Medicine recommend total weight gain 
according to pre-pregnancy BMI as follows: Underweight 12.7-18.1kg, Normal 11.3-
15.9kg, Overweight 6.8-11.3kg, and Obese (all classes) 5.0-9.1kg [44]. Using these 
recommendations, inadequate gestational weight gain is associated with increased risk of 
preterm birth and small-for-gestational age, while excessive gestational weight gain is 
associated with increased risk of pregnancy-induced hypertension, caesarean section 
delivery, large-for-gestational age and macrosomia [45]. However, there is uncertainty 
around appropriate gestational weight gain targets for women who are obese pre-
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pregnancy [46].  Evidence shows that diet or exercise or both can reduce the risk of 
excessive weight gain, but more studies are needed to establish safe levels of exercise 
during pregnancy [47] and it is unclear how best to implement guidelines on gestational 
weight gain, physical activity and nutrition [48]. There is little high level evidence for best 
practice management of obesity (BMI > 30 kg/m2) during pregnancy and current clinical 
practice guidelines are based on consensus [37]. 
 
Maternal place of birth 
There is some indication that there might be differences in the rate of stillbirth between 
Australian born and overseas born mothers. Data from the National Perinatal Data 
Collection from 2006 to 2012 indicate that the rate among overseas born mothers may be 
higher (see Figure 1.4). In 2010, 28.1% of mothers birthing in Australia were born 
overseas and one in ten (12.7%) was born in an Asian country [23]. Overseas born women 
birthing in Australia have a 13% increased risk of stillbirth [49]. In a recent Victorian study, 
Drysdale and colleagues reported an increased risk of late antepartum stillbirth among 
women born in South Asia (adjusted OR 2.5, 95% CI 1.3-5.1) [25].  This population had 
lower rates of smoking, hypertension and mean BMI but higher rates of diabetes and low 
birthweight; however, these risk factors did not fully explain the difference in stillbirth risk 
suggesting that different aetiological factors may be at work in this population [25]. 
 
Figure 1.4: Fetal death rates by maternal place of birth, Australia, 2006-2012 
Source: Australia’s mothers and babies reports 2006-2012 
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Socioeconomic status (SES) 
Socioeconomic status is a combined measure based on income, education and 
occupation. It can be defined at the individual or community level. Observational studies 
have demonstrated an association between stillbirth and socioeconomic status.  In a meta-
analysis by Flenady and colleagues, low socioeconomic status was associated with a 20% 
increased risk of stillbirth, with an associated population attributable fraction of 9% in high 
income countries [32]. 
In a number of studies assessing the relationship between low socioeconomic status and 
adverse pregnancy outcomes, individual level factors relating to socioeconomic status 
(such as maternal education, household income) were found to be stronger and 
independent predictors of stillbirth than community level SES indicators (eg neighbourhood 
SES) [50, 51]. 
It has been hypothesised that low socioeconomic status affects stillbirth through health risk 
behaviour associated with low socioeconomic status such as smoking or pre pregnancy 
obesity [50]. In a Canadian study that reported an increased risk of stillbirth with low 
socioeconomic status after controlling for individual SES factors; there was an 18.5% 
reduction in the estimate of odds ratio (from adjusted OR 3.31 to 2.79) for low SES and 
stillbirth when adjustment was made for smoking [50]. 
 
Geographic location (Remoteness) 
In Australia, remoteness is a measure classifying the distance of a geographic location to 
the nearest urban centre [52].  The distribution of remoteness varies with states and 
territories. In 2012, overall 71.5% of women birthing in Australia resided in major cities 
(ranging from 61.5% in Queensland to 99.8% in Australian Capital Territory); 27.9% 
resided in regional areas (ranging from 0.2% in Australian Capital Territory to 98.1% in 
Tasmania) and 2.6% in remote or very remote areas (ranging from 0.1% in Victoria to 
46.2% in Northern Territory) [24].  Furthermore, there are differences in the residential 
distribution of women giving birth by Indigenous status. In 2012, the majority (73.3%) of 
non-Indigenous mothers resided in major cities compared with 30.6% of Indigenous 
mothers.  Conversely, 24.1% of Indigenous mothers lived in remote or very remote areas 
compared with 1.8% of non-Indigenous mothers [24]. 
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Two studies from NSW have found increased risk of stillbirth with rural or regional 
residence compared with residence in urban areas [53, 54].  Abdel-Latif and colleagues 
reported an unadjusted odds ratio of 1.20 (95% CI 1.09-1.32)[54]. Roberts et al found a 
not statistically significant association between stillbirth and remote residence (crude OR 
1.55) for Indigenous women and an increased risk of stillbirth for non-Indigenous women 
living in remote areas (crude OR 1.66, p <0.001) [53]. Whereas both analyses did not 
adjust for maternal and pregnancy factors; the descriptive characteristics of the 
populations indicate relative socioeconomic disadvantage and suboptimal maternity 
services. 
 
Maternal smoking 
Maternal smoking is an important modifiable risk factors for adverse pregnancy outcomes, 
and is associated with maternal, fetal and infant morbidity and mortality [55]. Smoking 
during pregnancy is associated with intrauterine growth restriction, placenta praevia, 
placental abruption, decreased maternal thyroid function, preterm premature rupture of 
membrane, low birthweight, preterm birth, babies that are small for gestational age and 
perinatal mortality [55-57]. Infants born to mothers who smoke are at increased risk of 
sudden infant death syndrome (SIDS), asthma, infantile colic and childhood obesity [55, 
58].  
Maternal smoking is associated with an increased risk of stillbirth, and the risk increases in 
a dose-dependent fashion [59].  Recent meta-analyses have estimated increased odds of 
36-47% for stillbirth associated with any smoking [32, 60]; and there may be a dose-
response effect with odds of stillbirth increasing with higher daily cigarette consumption 
[60].   It has been suggested that maternal cigarette smoking increases the risk of fetal 
death through fetal growth restriction and placental abruption [20]. Interestingly, there have 
been reports that smoking has a protective effect on pregnancy-induced hypertension [61]. 
In 2012, it is estimated that 12.5% of women smoked during pregnancy, a 14% decrease 
from rates in 2009 [24]. Smoking rates are particularly high among teenage and 
Indigenous mothers. Teenage mothers made up 10.2% of mothers who smoked and 
34.9% of teenage mothers smoked during pregnancy [24].  An estimated 48.1% of 
Indigenous mothers smoked during pregnancy compared with 10.7% of non-Indigenous 
mothers [24] . The proportion of mothers who smoked increased with increasing levels of 
socioeconomic disadvantage but there was little variation in smoking rates across age 
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groups of Indigenous women [56]. It has been estimated that 6.2% of stillbirths in Australia 
could be averted by prevention of smoking during pregnancy, and among Indigenous 
women this proportion is estimated at 20% [32].  
There is evidence of stillbirth risk reduction with smoking cessation during pregnancy. A 
UK study found similar rates of stillbirth among non-smokers and women who quit smoking 
by four months gestation [62], and more recently smoking cessation by 15 weeks gestation 
was associated with reduced risk of small-for-gestational age and spontaneous preterm 
birth [63]. Smoking cessation prior to the third trimester has been reported to reduce much 
of the reduction in birthweight associated with smoking [55] and there is high level 
evidence to support the effectiveness of smoking cessation interventions for pregnant 
women in reducing smoking, preterm birth and low birthweight rates [64-66].  
Nevertheless, there are high rates of relapse during pregnancy and post-delivery [66]. In 
2012, 21.1% of women quit smoking during pregnancy, however, the quit rate was lower 
among Indigenous women (11.6% versus 22.9%) [24].  This highlights the need for policy 
and guidelines to incorporate smoking cessation interventions tailored and targeted at 
Indigenous women into routine antenatal care. Smoke-free legislation was associated with 
reduced risk of preterm birth which could impact perinatal mortality [67] 
 
Alcohol Use 
Alcohol is considered a teratogen and fetal exposure to alcohol is associated with 
placental dysfunction, decreased placental size, impaired blood flow and nutrient transport, 
endocrine changes, increased rates of stillbirth and abruption, umbilical cord 
vasoconstriction and low birthweight [68]. Maternal alcohol consumption increases the risk 
of placental abruption as well as the toxic effects on the fetus, including birth defects and 
neurodevelopmental disorders [20]. High level and frequent intake of alcohol during 
pregnancy has been associated with increased risk of miscarriage, stillbirth and preterm 
birth [10]. 
Although there is evidence that women reduce alcohol consumption once they become 
aware of their pregnancy [69], a national survey on alcohol consumption during pregnancy 
estimated that up to 47% of women drank during pregnancy [70]. A Western Australian 
study found that 59% of women drank during pregnancy, and of these women 15% drank 
above the NHMRC recommended guidelines (no more than 7 standard drinks per week or 
no more than 2 standard drinks per day) during the first trimester [70]. A further 14% 
15 
reported drinking more than 5 standard drinks on a typical occasion prior to pregnancy 
[70]. This is particularly significant for possible fetal alcohol exposure during early 
pregnancy, before the mother is aware of her pregnancy. Among Indigenous women, it 
has been reported that 19-44% consume alcohol during pregnancy and a further 10-19% 
consumed alcohol at harmful levels [70]. 
At present, there is uncertainty about whether the effects of fetal alcohol exposure is dose 
dependent and if there is a threshold above which adverse effects occur [70].  Systematic 
reviews have found inconclusive evidence of the adverse effects of antenatal alcohol 
exposure at low to moderate levels (up to 83g per week) [71, 72]. Some studies have 
reported adverse effects on fetal neurodevelopmental outcomes [73] and increased risk of 
stillbirth with antenatal binge drinking [74]. A review of the adverse effects of smoking and 
drinking during pregnancy found a synergistic effect of these two factors on adverse 
pregnancy outcomes such as preterm labour, low birthweight and growth restriction [75]. 
As a result, Australian national guidelines are based on the safest option of no drinking 
during pregnancy [70, 76]. However, it has been shown that up to 72% of pregnant women 
do not comply with these guidelines [77]. 
 
Substance Use 
Substance use includes the use of illicit substances such as heroin, methamphetamines, 
marijuana and the abuse of licit substances such as paint or petrol. Reports from the 
National Drug Strategy Household Survey indicate that 7% of pregnant women used 
marijuana/cannabis, 8% used any illicit drug and 4% used an illicit drug other than 
cannabis in 2001 [78]. Polydrug use is common among women with substance abuse 
issues [79]. Data on prevalence of substance use is based on self-report and it has been 
shown that pregnant women are particularly reluctant to disclose a history of substance 
use [79, 80]. 
Studies have shown that women with substance use issues also had increased risk of 
other risk factors for adverse pregnancy outcomes such as later presentation to antenatal 
care, fewer antenatal visits, one or more sexually transmitted infections during pregnancy 
[81], lower education level and lower household income [82].  
Researchers have proposed that adverse pregnancy outcomes associated with substance 
use may be due to a number of factors including the teratogenic effect on the developing 
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fetus, drug withdrawal or toxicity or the associated maternal lifestyle and health issues 
[79]. 
Many reports on the association with stillbirth have looked at illicit drug or substance use 
as a group.  In a meta-analysis by Flenady and colleagues, there was a nearly two fold 
increase in odds of stillbirth associated with illicit drug use (adjusted OR 1.9, 95% CI 1.2-
3.0) and it was estimated that 2.1% of stillbirths in high income countries could be averted 
by addressing maternal illicit drug use [32]. However, attempts to assess the effect of 
specific drugs or class of drugs on stillbirth have been challenged by difficulties in 
separating the role of the drug from that of the lifestyle associated with abusive behaviour 
[81, 83]. 
An interesting finding by Pinto and colleagues was the low incidence of pre-eclampsia 
among drug users after controlling for parity and smoking [84].  This is a similar finding to 
the low incidence of pregnancy induced hypertension observed among smokers, and may 
suggest some common aetiologic effect between illicit drug use and smoking. 
 
1.3.3.2 Medical and Obstetric Factors 
Diabetes 
Diabetes is a metabolic disorder of multiple aetiology which results in chronic 
hyperglycaemia and disturbances in the metabolism of carbohydrates, fats and protein 
from insulin secretion, insulin action or both [85]. The effects of diabetes are long term 
damage, dysfunction and failure of various organs (including effects on the developing 
baby) [85].  Glucose intolerance is determined by measuring plasma or blood glucose 
concentration (see Table 1.3 and 1.4). 
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Table 1.3: WHO recommended diagnostic criteria for diabetes and other categories 
of hyperglycaemia 
 Glucose Concentration (mmol/l) 
 Whole blood Plasma 
 Venous Capillary Venous Capillary 
Diabetes Mellitus 
Fasting or ≥ 6.1 ≥ 6.1 ≥ 7.0 ≥ 7.0 
2 hour post glucose load or both ≥ 10.0 ≥ 11.1 ≥ 11.1 ≥ 12.2 
Impaired glucose tolerance 
Fasting and < 6.1 < 6.1 < 7.0 < 7.0 
2 hour post glucose load ≥6.7 to <10.0 ≥7.8 to <11.1 ≥7.8 to <11.1 ≥ 8.9 to <12.2 
Impaired fasting glycaemia 
Fasting ≥5.6 to <6.1 ≥5.6 to <6.1 ≥ 6.1 to <7.0 ≥6.1 to <7.0 
2 hour < 6.7 < 7.8 < 7.8 < 8.9 
Source: Alberti K, Zimmet P, for the WHO consultation. Definition, Diagnosis and Classification of Diabetes 
Mellitus and its Complication - Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of 
a WHO Consultation. Diabetic Medicine 1998; 15: 539-53. 
 
Table 1.4: Australasian Diabetes in Pregnancy Society (ADIPS) revised diagnostic 
criteria for gestational diabetes mellitus 
Capillary plasma glucose levels 
Fasting glucose ≥ 5.1 mmol/l 
1 hour glucose ≥ 10.0 mmol/l 
2 hour glucose ≥ 8.5 mmol/l 
Glycated haemoglobin (HbA1c) ≥ 6.5%* 
* Glycated or glycosylated haemoglobin reflects average plasma glucose levels over an extended period of 
time 
Source: Nankervis A, McIntyre HD, Moses R, Ross GP, Callaway L, Porter C, et al. Australasian Diabetes In 
Pregnancy Society (ADIPS) Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes 
Mellitus in Australia. 2013. 
 
Gestational diabetes (GDM) is carbohydrate intolerance resulting in hyperglycaemia of 
variable severity which is first recognised during pregnancy [9]. It was estimated that 
gestational diabetes affected 4.8-10.3% of pregnancies across various states and 
territories in Australia in 2012 [24]; and that GDM rates are higher among Indigenous 
women [86, 87]. Risk factors for gestational diabetes include previous GDM, ethnicity 
(Asian including Indian, Aboriginal, Pacific Islander, Maori, Middle Eastern, non-white 
African), maternal age ≥ 40 years, family history of diabetes, obesity (BMI > 35kg/m2), 
previous macrosomia (defined as birthweight > 4500g), polycystic ovarian syndrome and 
medications including corticosteroids and antipsychotics [9]. 
The incidence of stillbirth among women with diabetes has decreased dramatically with 
improved care [88]. However, pre-existing diabetes is associated with a three-fold increase 
in the odds of stillbirth [32]. An increase in risk was not found for gestational diabetes [32]. 
Pre-existing diabetes complicated 0.6-1.7% of pregnancies across Australian states and 
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territories in 2012 [24]; and pregnant Indigenous women have been reported to have 
higher rates of pre-existing diabetes than their non-Indigenous counterparts [89] . Obesity 
is associated with Type 2 diabetes and gestational diabetes and the prevalence of these 
conditions is increasing [90].  In diabetes-associated stillbirths, it has been proposed that 
the mechanism leading to mortality begins with hyperglycaemia which leads to fetal 
anaerobic metabolism with hypoxia and acidosis [88]. There is evidence of differences in 
pregnancy outcomes by ethnicity among women with gestational diabetes, for example, 
compared to Caucasian women, African American women had higher risk of caesarean 
delivery and intrauterine fetal death, while Asian women had decreased risk of 
macrosomia (birthweight >4000g) [91].  
Many national guidelines on the screening, diagnosis and management of gestational 
diabetes were updated since publication of results from the Hyperglycaemia and Adverse 
Pregnancy Outcome (HAPO) study which found strong correlation between increasing 
maternal glucose levels at 24-32 weeks gestation and adverse maternal and fetal 
outcomes [92]. However, there is controversy around the screening and management of 
women with diabetes during pregnancy. Pre-pregnancy counselling has been found to 
significantly lower the risk of major congenital anomalies associated with diabetes during 
pregnancy (RR 0.36, 95% CI 0.22-0.59; absolute risk 2.1% versus 6.5%) [9].  Interventions 
to reduce adverse pregnancy outcomes associated with diabetes during pregnancy 
include folate supplementation, ceasing of oral hypoglycaemics and moving women onto 
insulin and screening for diabetes complications. Glycaemic control is a major objective of 
antenatal care for women with diabetes during pregnancy [93]. 
 
Hypertension 
Hypertension is one of the most common medical conditions occurring during pregnancy 
[94]. It is defined as a systolic blood pressure of ≥ 140 mmHg and/or a diastolic blood 
pressure of ≥ 90mmHg. Severe hypertension in pregnancy is defined as a systolic blood 
pressure of ≥ 170mmHg and/or a diastolic BP of ≥ 110 mmHg [94]. Hypertension in 
pregnancy is classified as pre-eclampsia/eclampsia, gestational hypertension, chronic 
hypertension and pre-eclampsia superimposed on chronic hypertension (see Table 1.5) 
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Table 1.5: Classification and definitions of hypertensive conditions during 
pregnancy 
Classification Definition 
Pre-eclampsia / 
Eclampsia 
Hypertension + Involvement of one or more organ systems 
and/or the fetus 
Renal, haematological, liver, neurological, pulmonary oedema, 
Intrauterine growth restriction, placental abruption 
Gestational 
hypertension 
New onset of hypertension 
After 20 weeks gestation 
No additional features of pre-eclampsia 
Resolves within 3 months post-partum 
Chronic Hypertension 
Essential 
 
 
 
Secondary 
Pre-existing hypertension 
BP ≥ 140/90 pre conception or prior to 20 weeks gestation 
without underlying cause 
BP < 140/90 entering pregnancy on antihypertensives 
 
Hypertension due to chronic kidney disease, renal artery 
stenosis, systemic disease with renal involvement, endocrine 
disorders, coarctation of the aorta 
Pre-eclampsia 
superimposed on 
chronic hypertension 
Pre-existing hypertension 
With systemic features of pre-eclampsia 
After 20 weeks gestation 
Source: Queensland Maternity and Neonatal Clinical Guidelines Program. Hypertensive disorders of 
pregnancy. Document No. MN10.13-V3-R15: Queensland Health, 2010. 
 
The risk factors for pre-eclampsia include: a history of pre-eclampsia (either family history 
or in a previous pregnancy), adverse pregnancy outcome in a previous pregnancy 
(placental abruption, fetal growth restriction, fetal death), nulliparity, interdelivery interval > 
10 years, pre-exisiting medical condition (chronic hypertension, pre-existing or gestational 
diabetes, renal disease or thrombophilia), maternal age ≥ 40 years, BMI > 35kg/m2, 
multiple pregnancy and gestational trophoblastic disease [94-96].  In 2012, pregnancy 
induced hypertension complicated 2-7% of pregnancies; while pre-existing hypertension 
affected 0.6-1.3% of pregnancies across the various states and territories [24]. 
Hypertension is associated with increased odds of stillbirth. A recent systematic review 
and meta-analysis by Flenady and colleagues found the risk of stillbirth varied with 
classification of hypertensive disorder. The reported odds ratios were gestational 
hypertension (OR 1.33, 95% CI 1.14-1.58), pre-existing hypertension (OR 2.58, 95% CI 
2.13-3.13), pre-eclampsia (OR 1.6, 95% CI 1.1-2.2), severe pre-eclampsia (OR 3.10, 95% 
CI 2.40-4.0) and eclampsia (OR 2.2 95%, CI 1.5-3.2)[32].  It should be noted that the 
estimate for severe pre-eclampsia was based on one study and so the result should be 
interpreted cautiously.   
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Studies have shown that the risk of hypertension and pre-eclampsia vary with ethnic 
background [96] and pregnant women from ethnic minority groups in the US, UK and 
Netherlands had higher blood pressure than Caucasian women [97]. Women of African 
descent appear to have an excess risk of stillbirth due to pre-eclampsia [96, 98].  However, 
little is known about the underlying mechanism explaining these differences [97].  It has 
been suggested that socioeconomic factors may play a role, however, recent studies have 
found that education and lifestyle factors did not explain these differences [97].  
Paradoxically, smoking has been found to decrease the risk of pre-eclampsia, however, 
smokers with pre-eclampsia have increased risk of adverse pregnancy outcomes [61, 99]. 
Major objectives of antenatal care for women with hypertensive disorder during pregnancy 
are: to control blood pressure, diagnose pre-eclampsia early, prevent eclampsia and 
optimise birth outcomes for the mother and infant [94]. 
 
Antenatal Care 
Antenatal care involves the monitoring and management of women during pregnancy to 
prevent complications and optimise healthy outcomes for the mother and infant [20].  The 
World Health Organisation recommends at least four antenatal care visits. Studies have 
shown that antenatal care attendance is associated with improved perinatal and maternal 
outcomes [9], however it is unclear what specific components of antenatal care are 
associated with decreased risk of stillbirth [100].  
Data on antenatal visit from six Australian states and territories indicates that at least 
99.1% of women in these areas had one visit; 94.9% had five or more visits and 0.1% had 
no visits [24]. There were differences between Indigenous and non-Indigenous women 
with regards to attending antenatal care. Eighty five per cent of Indigenous women who 
birthed at 32 weeks or more had at least five antenatal care visits compared with 95.9% of 
non-Indigenous mothers [24]. 
Inadequate antenatal care has been associated with increased risk of preterm birth [101] 
and stillbirth [32]. National estimates indicate that nearly 12% of pregnant women in 2010 
did not begin antenatal care until after 20 weeks gestation [23]. A case control study from 
New Zealand reported a two-fold increase in the odds of late stillbirth with attendance of 
less than 50% of the recommended number of antenatal care visits (adjusted OR 2.68, 
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95% CI 1.04-6.90) after adjusting for maternal age, BMI, ethnicity, smoking, parity, SES 
and medical and obstetric history [100].  
No antenatal care is associated with a three-fold increase in the odds of stillbirth (adjusted 
OR 3.30 95% CI 3.10-3.60) [32]. Women not accessing antenatal care were more likely to 
be from the most disadvantaged and marginalised groups in society.  Studies indicate that 
these women were more likely to be highly parous [102, 103]; less highly educated [103], 
more likely to have used alcohol [102], tobacco [103] or abuse substances [103]. Preterm 
labour, preterm birth, babies with low birthweight, babies with low apgar score and post-
partum haemorrhage were more common among this group of women [102, 103]. 
 
Gravidity and Parity 
Gravidity refers to the number of times a woman has been pregnant, while parity refers to 
the number of times a woman has given birth at a specified gestational age, regardless of 
birth outcome and counting multiple births (for example twin or triplets) as one birth. 
Nulligravidity is associated with preterm birth [104]; while stillbirth, small-for-gestational 
age and caesarean section delivery in a previous pregnancy is associated with stillbirth in 
a subsequent pregnancy [105-107].  Primiparity is associated with increased risk of 
stillbirth compared with multiparity (having at least one previous pregnancy) [9]. Primiparity 
is associated with a 42% increase in odds of stillbirth (OR 1.42, 95% CI 1.33-1.51), and it 
was estimated that 14.5% of stillbirths in Australia were associated with primiparity [32].  In 
Australia, as in other high income countries, there is a trend towards delayed childbearing 
and the proportion of older primiparous women is increasing. Of all first time mothers, 
13.9% were aged 35 years or older in 2008, compared with 10.7% in 2001 [91]. Evidence 
indicates that stillbirth risk among older primiparous women is greater than that in 
primiparous women less than 35 years [32], with reported adjusted OR for older 
primiparous women ranging from 1.68 to 3.60 [32].  Grandmultiparous women (having 5 or 
more previous births) reportedly have higher rates of anaemia, malpresentation, 
obstructed labour, placenta praevia and abruption [108-111]. However, there are mixed 
results on the effect of high parity on perinatal outcomes [112]. 
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Assisted Reproductive Technology (ART) 
Assisted reproductive technology is defined as a range of procedures carried out to 
circumvent infertility including in vitro fertilisation (IVF), embryo transfer (ET), gamete 
intrafallopian transfer (GIFT) and artificial insemination (AI) [113]. The number of ART 
procedures performed in Australia has increased at a rate of over 10% per year [114]. In 
Australia, it is estimated that 3.3% of children were conceived through ART [114].  
Studies have shown that ART is associated with low birthweight, preterm birth, small for 
gestational age and birth defects [115-118]; and a two-fold  risk in perinatal mortality has 
been reported for singleton births conceived by ART compared with spontaneously 
conceived singleton births [115].  With the trend towards delayed childbearing a 
considerable proportion of older mothers are conceiving through ART. In 2012, the 
average age of women undergoing ART was 34.3 years compared with 29.8 years for 
women not undergoing ART [24]; similarly, 58.1% of women undergoing ART were having 
their first baby [24]. Also, the proportion of women undergoing autologous cycles who were 
aged 40 years or more increased from 22.8% in 2007 to 26.5% in 2011 [119]. In recent 
years there has been a decrease in multiple births among women undergoing ART as a 
result of clinical shift towards single embryo transfers [119]. 
A number of studies have proposed that the increased risk of stillbirth observed in women 
undergoing ART may be due to factors related to infertility [118] or fertility treatment [120]. 
 
1.3.4 Data for Stillbirth Prevention 
Accurate cause of death information is important not only for developing effective 
prevention strategies for stillbirth [121], but it is vital for parents faced with the loss of a 
baby. Having an accurate cause of death helps parents understand the circumstances 
surrounding the death of their baby; and aids in counselling regarding the risk of 
recurrence in future pregnancies [122, 123].  The quality of data for stillbirth prevention 
strategies is influenced by the quality and comprehensiveness of investigations 
undertaken to uncover cause of death, the characteristics of the classification system and 
its ability to retain useful information and consistent application of the classification system 
over time.  
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1.3.4.1 Investigation of stillbirth 
Autopsy is currently the gold standard investigation for determining cause of death 
following perinatal death [124, 125]. Autopsy findings have been shown to change the 
primary diagnosis of cause of death in 9-34% of stillbirth cases and confirm diagnosis in 
49-58% of cases, while placental histology alone or maternal blood tests provide 
information for classification of stillbirth in 47% and less than 15% of stillbirth cases, 
respectively [126].  However, perinatal and stillbirth autopsy rates have been decreasing in 
many high income countries [127].  Perinatal autopsy rates in Queensland have decreased 
by 50% over the period 1997 to 2003 and are currently around 30% [128]. This is well 
below the recommendation of 75% by the Royal College of Pathologists [129]. In this 
atmosphere of declining perinatal autopsy rates, a substantial proportion of stillbirths 
(about 30%) are ‘unexplained’ [130]; and at gestational ages approaching term this 
proportion increases to around 60%  [131]. It has been argued that many of these 
stillbirths are under-investigated rather than unexplained [126]. 
The reasons for the decline in perinatal and stillbirth autopsy rates are varied and 
multifaceted, however parental consent has been identified as a major factor [132]. The 
process of counselling and consent for autopsy is a difficult and intrusive process for 
clinicians and parents. It requires parents to gain an understanding of detailed consent 
procedures in a state of acute grief.  Reasons identified for parents declining autopsy have 
been given as: 1) fear of additional suffering and mutilation of the baby, 2) belief that the 
pre-delivery ultrasound provides sufficient information, 3) health professionals not 
providing an adequate explanation for the need for autopsy, 4) failure by health 
professionals to offer options to autopsy in post mortem examination, and 5) lack of 
understanding of cultural and religious influences on parent’s decisions [133]. The most 
common reasons for parents to request an autopsy was to find the cause of the baby’s 
death; altruism was also highly ranked [126, 134].  
Studies have shown that the attitude of staff towards perinatal autopsy has an important 
influence on parental decision-making regarding consent for autopsy.  Typically, the 
medical consultant approaches parents for consent, but midwives, nurses, social workers 
and pathologists often can provide information to parents to assist in decision making. A 
study found that while perinatal pathologist were the most knowledgeable about the 
autopsy procedure and its efficacy in determining the cause of death, they were less likely 
to meet the bereaved parents [126]. One Australian study showed that while midwives and 
neonatal nurses were reluctant to seek consent, obstetricians and neonatologists viewed 
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nurses and midwives as influential on parent’s decisions around autopsy [135]. Studies 
from USA, UK and Japan reported that nurses and midwives felt ill-equipped to deal with 
grieving parents and highlighted lack of experience, communication skills, confidence and 
competence to provide sensitive care [136]. Studies examining staff attitude towards 
perinatal autopsy have highlighted that clinicians feel inadequate talking to parents about 
autopsy, and they may avoid discussing about autopsy to spare parents additional distress 
[137, 138]. 
Other factors that have been identified which affect clinicians’ willingness to approach 
parents for autopsy consent include: low gestational age at death [135, 139], the 
professional discipline of the clinician and their level of seniority [140], ambivalence about 
the value of autopsy [141], and lack of technical understanding of autopsy procedures 
[142].  Parents may regret their decision about autopsy as a result of poor communication 
or inadequate information [143]. A study found that 52% of bereaved parents reported a 
poor understanding of events surrounding the stillbirth and 71% were dissatisfied with 
information they were given [144]. Twice as many parents who declined an autopsy later 
regretted their decision compared to those who agreed to an autopsy (34.4% versus 
17.4%) [134]. Numerous studies have highlighted the need for specific training around 
communication with bereaved parents following a perinatal death [145, 146]. Furthermore, 
studies have demonstrated that the role of health professionals in handling the death and 
the interaction with bereaved persons can influence the intensity of grief; and skilled, 
sensitive and caring treatment in the time around the death of the unborn baby can 
positively impact the grief experience for parents [124].  
There is guidance within the PSANZ Clinical Practice Guideline for Perinatal Mortality for 
clinicians in communicating with parents regarding the autopsy consent process, including 
a brochure for parents explaining perinatal autopsy and also to guide health care 
professionals in counselling about autopsy [124].  However, there is limited understanding 
about how the interactions between health care providers and parents impact on parent’s 
perception of care and the decision making process about investigation into the cause of 
death [144]. 
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1.3.4.2 Classification of cause of death 
The value of a death classification system is using available information to establish the 
likely cause of death which is important for developing strategies for prevention and for 
monitoring the impact of such strategies [121, 147, 148]. More specifically, classification of 
stillbirth helps to identify groups for closer investigation and ongoing monitoring, policy 
development for prevention and health service utilisation [148]. Currently there are more 
than 81 classification systems in use for stillbirth but none is universally accepted [149].  
Furthermore, there is no agreement on the features of an ideal classification system, 
although there has been work towards consensus on some important elements of a good 
classification system [150, 151]. Some of these elements include: ease of use, uniform 
definitions, clear guidelines and a well-defined structure to ensure that the system is 
applied unambiguously and consistently [147, 150], good inter-rater agreement, 
reproducibility, and the ability to amend the system for future research developments [147, 
150]. The ability to explain the underlying cause of death is another important element 
[152]. However, assigning a cause of stillbirth is a complex undertaking that involves 
processes and interactions between the mother, baby and placenta.  Therefore, complete 
evaluation is needed to provide pathologic, clinical and diagnostic data. There is a degree 
of uncertainty about what specific condition caused death due to a lack of sufficient 
knowledge about disease states and normal fetal physiology [147]. At present, efforts are 
underway to identify features of an international classification system to be used in low, 
middle and high income settings which will be aligned with the International Classification 
of Disease (ICD) [149]. 
The ICD is used internationally to classify health conditions and diseases for epidemiology, 
health management and clinical purposes [153], however it does not consistently treat the 
baby, umbilical cord, placenta and membranes as separate entities for which codes can be 
assigned [151]. The result is significant loss of information requiring supplementation to 
retain important information [151, 154]. Furthermore, the ICD contains a large number of 
categories that are not relevant to stillbirth [155]. As a result of these deficiencies, a 
number of classification systems have been developed. There is currently work being 
undertaken to apply the current ICD10 to perinatal mortality (ICD-Perinatal Mortality); and 
concurrently, the 11th revisions to ICD are underway [156]. This presents an opportunity to 
provide feedback to alter existing ICD codes. 
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1.3.4.3 PSANZ-PDC 
The classification system for stillbirth currently used across much of Australia is the 
Perinatal Society of Australia and New Zealand (PSANZ) Perinatal Death Classification 
(PDC). The major categories are outlined in Table 2.7. The PSANZ-PDC system was 
developed following the PSANZ annual conference in 2000, as Australian states were 
using different systems at that point [157], making monitoring of trends difficult. As will be 
outlined below, PSANZ-PDC has many of the elements described in the preceding 
section.  
The PSANZ-PDC is similar to the Aberdeen system in that it identifies antecedent obstetric 
factors that initiated the chain of events leading to perinatal death.  It is based on clinical 
and autopsy findings, including placental pathology [147, 157]. It uses a hierarchical 
structure in descending order for the major categories; whereby primary conditions are 
assigned based on the order of categories, with categories closer to the top of the list 
taking precedence. It has been argued that hierarchical systems are easier to use because 
of the structured and consistent approach to classification, especially where there are 
competing conditions [154]; however, it has also been argued that erroneous results are 
produced when classification to a less important condition occurs because of the relatively 
higher position of that condition on the list of conditions [151]. 
PSANZ-PDC has been shown to be relatively easy to use, has specific definitions and 
guidelines which are linked to the Australian national birthweight/gestation percentile 
charts [157].  It has the provision to expand classifications and it considers the obstetric 
and fetal/neonatal factors and can be used to classify stillbirths and neonatal deaths [157].   
PSANZ-PDC has been validated with high reliability when used with the PSANZ perinatal 
mortality audit guidelines. A national study found 83% agreement for stillbirths and 87% 
agreement for neonatal deaths with three classifiers using the PSANZ-PDC; reported 
kappas ranged from 0.83-0.95, p<0.01 [64].  An international study evaluating the 
performance of six classification systems (Amended Aberdeen, Extended Wigglesworth, 
PSANZ-PDC, ReCoDe, Tulip and CODAC) according to: ability to retain important 
information, ease of use, inter-observer agreement and proportion of unexplained stillbirths 
found PSANZ-PDC achieved the second highest score for retention of information and 
ease of use [155].  Both Aberdeen and Wigglesworth had unsatisfactory scores for 
retention of information. PSANZ-PDC had good inter-observer agreement with an overall 
kappa of 0.63.  CODAC and ReCoDe also had good agreement with overall kappas of 
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0.65 and 0.51, respectively.  Aberdeen and Wigglesworth had poor inter-observer 
agreement with reported kappas of 0.35 and 0.25, respectively [155].  The rates of 
unexplained stillbirth obtained using the six classification systems ranged from 9.5% to 
50.2%.  Aberdeen and Wigglesworth had unexplained rates of 44.3% and 50.2%, CODAC 
and Tulip had rates of 9.5% and 10.2%, PSANZ-PDC and ReCoDe had rates of 15.4% 
and 13.8% [155]. 
The PSANZ PDC has been highlighted as being useful for surveillance of cause of 
perinatal death, identifying the main cause of death for preventative strategies, 
investigating cause of death by gestational age or birthweight groups including aetiology 
and for facilitating studies on specific causes of death [157]. 
 
1.3.4.4 Application of the PSANZ PDC system 
The PSANZ Clinical Practice Guideline for Perinatal Mortality was developed with the aim 
of ensuring a systematic and high quality approach to investigation and classification of 
stillbirth [124].  However, uptake of the guidelines has been poor [158].  Limited evidence 
base for the stillbirth investigation protocol and lack of an adequate implementation plan at 
the initial release of the guidelines may have played a role in the poor uptake [158]. To 
address the issue of implementation, an education program (IMPROVE) was developed by 
the Australia and New Zealand Stillbirth Alliance and PSANZ Perinatal Mortality Group to 
assist with implementation [159]. 
While the PSANZ Clinical Practice Guideline for Perinatal Mortality provides detailed 
guidance on classifying perinatal death, variations in the reported categories of PSANZ-
PDC across Australia has raised concerns about the quality of data on causes of stillbirth.  
Data from six Australian states and territories show wide variation in the leading causes of 
stillbirth by jurisdiction (see Table 1.6). Variations in reported cause of death may be due 
to jurisdictional differences in the application of the PSANZ-PDC system [24].  
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Table 1.6: Variation in leading categories of stillbirth using PSANZ-PDC from six 
Australian states and territories, 2012 
PSANZ PDC Category Mean (%) Range (%) 
Congenital abnormality 29.1 17.4 – 36.4 
Spontaneous preterm 16.5 7.2 – 23.6 
Unexplained antepartum death 15.2 8.0 – 25.3 
Source: Hilder, L., Z. Zhichao, M. Parker, S. Jahan, and G. Chambers, Australia's mothers and babies 2012. 
Perinatal statistics series no. 30. Cat. no. PER 69. 2014, AIHW: Canberra. 
 
Currently, a number of models are employed in the multidisciplinary review and 
classification of stillbirths including hospital-based and centralised state-wide reviews [124, 
160]. It has been argued that reviews should be hospital-based as there is potentially 
increased access to clinical information than review at statewide level [160]. However, 
there may be limited expertise in perinatal mortality audit at smaller maternity centres 
requiring aggregation of cases between maternity centres.  A study carried out in New 
South Wales assessed agreement between hospital review and expert panel review and 
found the level of agreement to be low [131].  The low level of agreement was attributed to 
lack of familiarity on the part of the hospital review panels with the PSANZ perinatal 
mortality audit guidelines [131].  To our knowledge, no assessments in consistency of 
application of the PSANZ PDC system have been undertaken since the introduction of the 
IMPROVE education program. 
 
1.4 Research aims and specific objectives 
In high income countries such as Australia, it has been highlighted that further 
improvements in stillbirth rates can be achieved.  Addressing inequity and lifestyle factors, 
the need for high quality data on stillbirths and detection and management of women at 
increased risk of stillbirth have been suggested as ways of accomplishing this [28]. This 
Thesis aims to describe the epidemiology of stillbirth within the Australian context and 
contribute to improving the quality of data through appropriate investigation of stillbirths. 
 
The specific objectives are to: 
1. Examine trends in stillbirth by clinical classification of cause of death, Indigenous 
status and gestational age, to identify focal areas for preventive efforts (Chapter 3) 
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2. Assess gestational age specific risk of stillbirth associated with four important 
contributors (diabetes, hypertension, antepartum haemorrhage and small-for-
gestational age) to higher stillbirth rates among Indigenous women in order to 
identify periods of increased risk (Chapter 4) 
3. Develop and validate a statistical model to predict the risk of antepartum stillbirth at 
term (≥37 weeks) using maternal and pregnancy factors as a potential decision-
making aid for clinicians and women (Chapter 5) 
4. Assess consistency in application of the Perinatal Society of Australia and New 
Zealand Perinatal Death Classification system between hospital committees and an 
independent expert panel, to identify areas for quality improvement (Chapter 6) 
5. Determine maternal and pregnancy factors associated with parental consent to 
autopsy following stillbirth and explore parents’ views and experiences of the 
autopsy consent process to inform clinical practice (Chapter 7) 
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Chapter 2 
Data Management for Queensland perinatal data 
This chapter describes the data management procedures carried out on the Queensland 
perinatal data utilised in various investigations within this Thesis.  Queensland perinatal 
data was utilised for the following investigations:  
 Stillbirth trends analysis (Chapter 3) 
 Gestational age specific stillbirth risk analysis (Chapter 4) 
 Term antepartum stillbirth risk prediction (Chapter 5) 
 Predictors of autopsy following stillbirth (Chapter 7) 
 
The data management procedures are described here to avoid repetition within the 
respective chapters.  Section 2.1 of this chapter describes the data source and range of 
variables obtained while Section 2.2 outlines the data cleaning and management 
procedures. Section 2.3 concludes this chapter with some reflections on the quality of the 
Queensland perinatal data. 
 
2.1 Data Source and Variables  
Data was obtained from the Queensland Perinatal Data Collection (QPDC). The QPDC 
was started in November 1986 under state legislation Part II of the Health Act 1937 
requiring perinatal data to be provided to the Chief Executive of Queensland Health for 
every baby born in Queensland. This data source was particularly useful for as it was the 
most extensive collection of maternal demographic, pregnancy outcomes and clinical 
classification of cause of death data available on a population level within Queensland.  
Data was requested for births in Queensland during the period 1994 to 2011.  The study 
period was chosen to maximise the number of years with consistent data collection; and 
2011 was the most recent year of data available at the time of data request. Analysis was 
restricted to singleton births because of the differences in the type and distribution of 
causes of death between singleton and multiple pregnancies [3].   
Data was collected via the Queensland Perinatal Data Collection form (MR63D), the 
Perinatal Online Application or via electronic extracts from the hospital electronic records.  
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Data was provided to the QPDC by all public and private hospitals, private midwives and 
medical practitioners involved in the delivery of babies outside hospital.  However, the 
completeness of data from births outside hospital is unknown.  The scope of information 
requested included maternal demographic, medical, obstetric and birth outcome 
information.  Data checks were performed by the Queensland Health Statistics Unit to 
validate information received by the QPDC and queries were directed back to the hospital 
or independent healthcare practitioner who submitted the data [161]. Although validation 
studies are yet to be performed on the perinatal data from Queensland, data audits 
completed in other Australian states using state-based perinatal data collections show that 
misclassification (i.e. false positive and false negatives) are generally <5% for coding of 
conditions such as diabetes, hypertensive disorders and antepartum haemorrhage [162]. 
Birth outcome information requested included maternal, fetal and underlying cause of 
perinatal death using ICD codes as well as the antecedent causes of perinatal mortality 
using the Perinatal Society of Australia and New Zealand Perinatal Death Classification 
(PSANZ-PDC). Antecedent cause of perinatal death available from the QPDC dataset was 
assigned by the Perinatal Mortality sub-committee of the Queensland Maternal and 
Perinatal Quality Council.  This was a multidisciplinary perinatal mortality review committee 
which systematically assigned clinical classification of cause of death as part of routine 
procedure.  The sub-committee undertook review of all perinatal death in the state using 
confidential case summaries, autopsy, placental and other pathology reports, medical 
certificates of cause of perinatal death, and QPDC data forms [163].  
 
2.1.1 Ethics and Data Custodian approvals 
Non-identifiable routinely collected data from the QPDC were utilised for this study.  Ethics 
approval was obtained from the Queensland Health Central Office (Ref: 
HREC/05/QHC/009) and University of Queensland School of Population Health Human 
Research Ethics Committees (Ref: II180313).  In addition, approval was obtained from the 
Director General for access to and use of confidential information under Section 284 of the 
Public Health Act 2005 (Ref: RD004800) (See Appendix A). 
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2.2 Data Management 
Data were obtained on maternal, medical and obstetric and birth outcome variables from 
the QPDC. Data were supplied in five separate zipped and password protected ASCII 
comma delimited text files (see Table 2.1 below).  Outlined in this section are the data 
management procedures undertaken for each group of variables.  
Table 2.1: Details of data files from the Queensland Perinatal Data Collection, 1994-
2011 
Filename File 
Type 
n Comments 
peri9411 .dat 928,313 Main dataset, one observation per pregnancy 
medic_cond .dat 255,516 Pre-existing maternal medical conditions, multiple 
entries relating to a pregnancy permitted 
deliv_cmplc .dat 1,071,431 Delivery complications, multiple entries relating to a 
pregnancy permitted 
preg_cmplc .dat 820,706 Maternal conditions arising as a result of pregnancy, 
multiple entries relating to a pregnancy permitted 
cong_anom .dat 51,511 Congenital anomalies, multiple entries relating to a 
pregnancy permitted 
 
2.2.1 Maternal Variables 
Maternal variables included: 
 Age 
 Maternal Indigenous status 
 Marital status 
 Smoking status 
 Alcohol and substance use status 
 Postcode of usual residence 
 Socioeconomic status 
 Geographic location 
 Maternal region of birth 
 
 
Maternal age 
Data on maternal age were provided in categories starting with “Less than 18 years” and 
increasing in two year blocks up to “45 years or older”.  These were re-categorised as: 
“Less than 18 years”, “19-24 years”, “25-30 years”, “31-34 years” and “35+ years”. This 
was to adequately separate lower and higher risk maternal age groups and for 
comparability with other studies. 
  
33 
Maternal Indigenous status 
Maternal Indigenous status was based on maternal self-identification as Aboriginal and/or 
Torres Strait Islander during clinical interview.  Classification as ‘non-Indigenous’ referred 
to women who identified as neither Aboriginal nor Torres Strait Islander.  A national 
assessment of the quality of reporting of Indigenous status in perinatal data over the 
period 1991-2004 found data from the QPDC to be suitable for trend analyses from 1991 
onwards [56].  
 
Marital status 
Marital status was categorised as “Married/defacto”, “Never married”, “Divorced”, 
“Separated” or “Widowed”.  These categories were collapsed into two groups: “Domestic 
partner” (married/defacto) and “No domestic partner” (never married, divorced or 
widowed). 
 
Smoking status 
Smoking status was based on maternal self-report and referred to any smoking during 
pregnancy (yes or no).  Consistent data collection commenced in July 2005.  
 
Alcohol and Substance Use 
Alcohol use was based on the presence of the diagnostic codes 291, 303, 305.0 (ICD9) or 
F10 (ICD10AM) in maternal hospital records while substance use was based on the 
presence of the diagnostic codes 291-292 or 303-305 (ICD9) or F10-F19 (ICD10AM). It 
should be noted that the coding for substance use status includes alcohol use. The 
prevalence of alcohol use within this population was 0.05%, well below national reports 
which ranged from 47% to 59% [70]. Whereas the prevalence of substance use was 0.6% 
compared with reports of around 8% nationally [78]; furthermore a prevalence of 0.8% has 
been reported among the obstetric population in South Australia using hospital records 
[164]. While it has been reported that pregnant women are reluctant to disclose a history of 
substance use [80, 164], the magnitude of difference in prevalence of alcohol use between 
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this population and national reports led us to conclude that the data on alcohol use were 
not reliable and it was not used in subsequent analyses. 
 
Postcode of maternal usual residence 
Postcode of usual residence was used to derive measures of socioeconomic status and 
geographic location. 
 
Socioeconomic status 
Socioeconomic status was derived from the postcode of maternal usual place of 
residence.  The postcode was mapped to the Australian Bureau of Statistics’ Index of 
Relative Socio-economic Disadvantage (IRSD), which is a summary measure allowing the 
ranking of geographic areas in Australia according to social and economic wellbeing [165].  
The IRSD was derived from census data on income, educational attainment, employment, 
measures of material and social resources and the ability to participate in society [165]. 
This index was chosen specifically because of the interest in the effect of socioeconomic 
disadvantage on stillbirth and the need for a broad measure of disadvantage rather than a 
specific measure such as income alone.   
Data on IRSD were published every five years from 1991.  Publications between 1991 and 
2001 did not include explicit listings of deciles of IRSD by postcode, therefore, this 
measure was calculated from the data provided.  Contained in these publications were 
listings of: absolute disadvantage scores for each census collection district, population size 
within each collection district, and listing of the collection districts within each postcode 
area.  Collection districts were the smallest unit of census data collection and were roughly 
equivalent to 250 households in an urban setting or a group of suburban blocks [165].  
Postcode areas were developed by the ABS and matched to postcodes as closely as 
possible [165].   
To obtain decile ranks for each postcode, the population-weighted average disadvantage 
score and percentile rank were calculated (see below). Data from 1991 and 1996 were 
manipulated using Steps 1 and 2.  Data from 2001 were manipulated using Step 2 only.  
Decile ranks were applied to the corresponding study periods, eg decile ranks calculated 
from the 2001 publication were applied to study data from 2001 to 2005.  IRSD could not 
35 
be determined for 80 unique postcodes.  The reasons for this were: few (10 or less) people 
living or working in the area, low response rates to census questions on occupation, labour 
and education, and classification of the area as prison, offshore, shipping or migratory 
area [165]. 
For the purpose of this study, decile ranks were coded into three categories: lowest ranked 
20%, middle 60% and top ranked 20%. Socioeconomic disadvantage was defined as 
residing in an area with a postcode classified in the lowest ranked 20%.   
 
Figure 2.1: Calculation of decile rankings for IRSD data published between 1991 and 
2001 
Step 1: Calculation of population-weighted disadvantage score for each collection 
district 
 
𝑺𝒄𝒐𝒓𝒆 𝒇𝒐𝒓 𝒆𝒂𝒄𝒉 𝒄𝒐𝒍𝒍𝒆𝒄𝒕𝒊𝒐𝒏 𝒅𝒊𝒔𝒕𝒓𝒊𝒄𝒕 𝒊𝒏 𝒑𝒐𝒔𝒕𝒄𝒐𝒅𝒆 × 𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒊𝒏 𝒄𝒐𝒍𝒍𝒆𝒄𝒕𝒊𝒐𝒏 𝒅𝒊𝒔𝒕𝒓𝒊𝒄𝒕
𝒑𝒐𝒑𝒖𝒍𝒂𝒕𝒊𝒐𝒏 𝒊𝒏 𝒆𝒂𝒄𝒉 𝒑𝒐𝒔𝒕𝒄𝒐𝒅𝒆
 
 
Step 2: Calculation of decile rank for each postal area 
 
 
Geographic location 
Geographic location, in terms of remoteness, was derived by mapping postal areas (POA) 
from postcode of maternal usual place of residence to the Australian Standard 
Geographical Classification (ASGC) Remoteness Areas.  This allowed for the classification 
of geographic areas by their physical road distance to the nearest urban centre using the 
Accessibility/Remoteness Index of Australia (ARIA) [52].   
Geographic areas were classified as: major cities (ARIA 0 to 0.2), inner regional (ARIA 
>0.2 to ≤2.4), outer regional (ARIA >2.4 to ≤5.92), remote (>5.92 to ≤10.53) and very 
remote (ARIA >10.53).  In the event of a postal area falling within two or more geographic 
area classifications, the classification applied was the one with the largest proportion of 
that postcode.  For example:  The postal area 4133 is listed as 87.3% major cities and 
12.7% inner regional and would be classified as major cities.  For the analyses, the five 
Sum of population-
weighted 
disadvantage score for 
all collection districts 
in each postcode 
Order disadvantage 
scores for all 
postcodes from lowest 
to highest 
Calculate cut-offs for 
deciles 
Assign deciiles to 
postcodes based on 
disadvantage scores 
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categories of geographic areas were collapsed to three: Urban (major cities), Regional 
(inner and outer regional) and Remote (remote and very remote).   
Remoteness data linked to postal areas were available from the ABS for 2006 only; data 
available for earlier time periods were linked to other measures such as SLA but not postal 
areas.  As a result, data from 2006 were applied to the entirety of the study period.  A 
potential consequence of this may be misclassification of urban and regional areas in 
earlier parts of the study period, if there has been increased urbanisation over the study 
period.  It is unlikely to affect classification of remoteness in later parts of the study period.  
Issue was raised about the analyses of variables derived from the ABS remoteness 
structure and socioeconomic index for areas (which includes IRSD) – as these are derived 
from similar census data items.  This issue was explored in the course of the Gestational 
age specific stillbirth risk analysis (Chapter 4) as it was important to assess the effect of 
geographic location on the risk of stillbirth; and socioeconomic status (as defined using the 
IRSD) was an important potential confounder.  The association between these variables 
and with stillbirth was explored using multivariate analysis.  It was found that the standard 
errors in the models were not particularly larger with either or neither of the variables 
“socioeconomic status” and “geographic location” in the models; as well the effect 
estimates for stillbirth were stable in terms of magnitude and direction of effect with either 
or neither of these variables in the multivariate models.  It was also noted that the measure 
IRSD published in 2006 was derived from data that included Indigenous status.  This was 
another reason for stratification of the analysis in the Gestational age specific stillbirth risk 
analysis (Chapter 4) by Indigenous status. 
 
Maternal region of birth 
Maternal region of birth was derived from maternal country of birth. Country of birth 
classification was based on the Australian Bureau of Statistics’ Standard classification of 
countries, which underwent a number of revisions over the study period (Table 2.2). 
Countries were grouped using the United Nations Geographic regions.  These groups 
were further collapsed based on frequency into the following nine categories: Africa, 
Americas and Caribbean, East Asia, South East Asia, Asia (Other), Europe, Australia and 
New Zealand, Oceania (excluding Australia and New Zealand) and Other. 
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Table 2.2: Details of classification of maternal region of birth, 1994-2011 
Study Period Classification Comments 
Jan 1986 - June 1994 Country of birth code list Country and region level 
coding, 90 codes 
July 1994 – June 2001 Australian Standard 
Classification of Countries for 
Social Statistics (ASCCSS) 
Country level coding, 280 
codes 
July 2001 – June 2004 Standard Australian 
Classification of countries - 
Version 1 (V1_SACC) 
Country level coding, 249 
codes 
July 2004 – current Standard Australian 
Classification of countries - 
Version 2 (V2_SACC) 
Country level coding, 253 
codes 
 
 
2.2.2 Medical and Obstetric Variables 
Medical and obstetric variables included: 
 Accommodation status 
 Primigravidity 
 Use of assisted conception 
techniques 
 Number of antenatal care visits 
 Congenital anomalies 
 
 Pre-existing diabetes 
 Pre-existing hypertension 
 Antepartum haemorrhage, 
Gestational Diabetes, Pregnancy 
Induced Hypertension and Pre-
eclampsia/Eclampsia 
 
Hospital accommodation Status 
Hospital accommodation status was defined as the type of ward accommodation elected 
regardless of method of payment for admission. Hospital accommodation status was 
classified as ‘Public’ or ‘Private’. 
 
Primigravidity 
Primigravidity was defined as having no previous pregnancy (excluding the current 
pregnancy).  
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Use of assisted conception techniques 
Use of assisted conception techniques referred to whether pregnancy was achieved using 
any of the following methods: artificial insemination (AIH/AID), ovulation induction, in-vitro 
fertilisation (IVF), gamete intra fallopian transfer (GIFT), intracytoplasmic sperm injection 
(ICSI) or other methods such as assisted hatching or blastocyst culture. 
 
Number of antenatal care visits 
Number of antenatal care visits was collected in two categories: “Less than 2 visits” and “2 
or more visits” prior to mid-1998.  This was changed from July 1998 and data was 
collected in four categories: “Less than 2”, “2 to 4”, “5 to 7” and “8 or more” visits.  Data 
were not available on the gestational age at initiation of antenatal care visits prior to July 
2009, therefore, adequacy of antenatal care index could not be derived for the majority of 
the study period.  However, attending less than 2 antenatal care visits was used as a 
proxy for inadequate antenatal care in models adjusted for gestational age.  This was to 
ensure that bias was not introduced for stillbirths occurring at very young gestational ages 
where the mother may have only had an opportunity to attend one antenatal care visit. 
 
Congenital anomalies  
Data on congenital anomalies were extracted from the supplementary dataset 
‘cong_anom.dat’. This dataset allowed for multiple entries relating to a specific 
pregnancy. Congenital anomalies were coded using the British Paediatric Association 
Classification of Disease extension to the International Classification of Disease (ICD) 
codes 740-759 (9th edition) and Q00-Q99 (10th edition Australian modification).  
 
Antepartum haemorrhage, Gestational Diabetes, Pregnancy Induced Hypertension and 
Pre-eclampsia/Eclampsia 
Data on antepartum haemorrhage, diabetes (pre-existing and gestational) and 
hypertension (essential, pregnancy induced and pre-eclampsia/eclampsia) were extracted 
from supplementary datasets ‘medic_cond.dat’ and ‘preg_cmplc.dat’.  These 
supplementary datasets were set up to allow multiple entries for each pregnancy.  Data 
extraction involved extracting all occurrences of the ICD9 and ICD10 codes associated 
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with each condition of interest (see Table 2.3) and using each woman’s unique study 
number (duplicate entries were dropped) to merge the data with the main dataset.  Within 
the main dataset, entries with missing data for the maternal condition/pregnancy 
complication were coded as not having the condition/complication.  The proportion of 
women with antepartum haemorrhage or hypertensive disorders was consistent 
throughout the data collection period.  However, the ascertainment of pre-existing and 
gestational diabetes increased dramatically to coincide with the introduction of ICD10AM 
for classification of maternal conditions and pregnancy complication. 
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Table 2.3: International Classification of Disease (ICD) codes for selected maternal 
conditions and pregnancy complications 
Condition Sub-categories 
ICD9 
codes 
ICD10 AM 
codes 
Data 
Collection 
period 
Antepartum 
haemorrhage 
Placenta praevia with 
haemorrhage, placental 
abruption, antepartum 
haemorrhage not elsewhere 
classified 
641.1, 
641.2, 
641.3, 
641.8, 
641.9 
O44.1 
O45 
O46 
1994-2011 
Gestational 
diabetes* 
Gestational diabetes 
648.0 
O24.4 
July 1999 - 
2011 
Unspecified O24.9 
July 1999 - 
2011 
Pre-existing 
diabetes*  
Type I 
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O24.0, E10 
July 1999 - 
2011 
Type II E11, O24.1 
July 1999 - 
2011 
Unspecified E14, O24.3 
July 1999 - 
2011 
Other specified (malnutrition 
related) 
O24.2, E13 
July 1999 - 
2011 
Essential 
hypertension 
 
Pre-existing hypertension 
complicating pregnancy 
401.0 
401.1 
642.0 
642.00 
642.01 
O10.0 
O10.1 
O10.2 
O10.3 
I10 
I11 
I12 
I13 
1994-2011 
Secondary hypertension 642.1 
O10.4 
I15 
1994-2011 
Unspecified/Other 
401.9 
642.2 
O10.9 1994-2011 
Superimposed with pre-
eclampsia 
642.7 O11 1994-2011 
Pregnancy 
Induced 
hypertension 
Gestational hypertension or 
transient hypertension of 
pregnancy or other unspecified 
hypertension complicating 
pregnancy 
642.3 
642.9 
O13 
O16 
1994-2011 
Pre-
eclampsia 
and 
Eclampsia 
Pre-eclampsia 
642.4 
642.5 
O14.0 
O14.1 
O14.9 
1994-2011 
Eclampsia 642.6 
O15.0 
O15.1 
O15.2 
O15.9 
1994-2011 
* Level of detail provided for ICD9 codes did not allow for identification of type of diabetes mellitus (ie 
whether Type I or II).     ^ British Paediatric Association Classification of Disease extension to ICD9 and 
ICD10 used 
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2.2.3 Birth Outcome Variables 
Birth outcome variables included: 
 Gestational age at birth 
 Birthweight 
 Baby’s sex 
 Small for gestational age (SGA) and 
large for gestational age (LGA) 
 
 Birth status (stillbirth or livebirth) 
 Type of perinatal death (antepartum, 
intrapartum, unknown stillbirth, 
neonatal) 
 Clinical classification of stillbirth 
 Post-mortem/autopsy 
 
Gestational age at birth 
Gestational age was determined by clinical assessment after birth and given in completed 
weeks.  Births eligible for registration in the QPDC were all livebirths and stillbirths of at 
least 20 weeks gestation and/or 400 grams birthweight.  The QPDC also included 
livebirths that were less than 20 weeks gestation and also less than 400 grams 
birthweight.  However, these were excluded from analyses, as they were not within the 
population of interest. 
 
Birthweight 
Birthweight was measured after birth and given to the nearest gram.  Births eligible for 
registration in the QPDC were all livebirths and stillbirths of at least 20 weeks gestation 
and/or 400 grams birthweight.  The QPDC also included livebirths that were less than 400 
grams birthweight and also less than 20 weeks gestation.  However, these were excluded 
from analyses, as they were not within the population of interest. 
 
Baby’s sex 
Baby’s sex was classified as “Male”, “Female” and “Indeterminate”.  
 
Small for gestational age (SGA) and Large for gestational age (LGA) 
Small for gestational age was defined as having a birthweight less than the 10th population 
centile by gestational age, plurality and gender of the infant (Table 2.4). The population 
birthweight percentiles used were those published by Dobbins and colleagues [166] as 
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they were derived from population data arising from a similar period as our data (1998-
2007).  Large for gestational age was defined as having a birthweight more than the 90th 
population centile by gestational age, plurality and gender of the baby (Table 2.4). 
 
Table 2.4: Birthweight percentile values (grams) for live singleton births (female and 
male), 1998-2007 
Gestational 
age 
(weeks) 
Birthweight percentile (grams) 
Female Male 
3rd 10th 90th 3rd 10th 90th 
20 210 265 410 248 273 430 
21 250 300 470 290 335 500 
22 325 400 560 370 410 600 
23 375 445 660 450 500 700 
24 430 520 754 470 550 810 
25 470 559 884 505 620 944 
26 490 594 1026 576 680 1078 
27 568 675 1175 605 752 1250 
28 622 764 1347 680 844 1395 
29 712 870 1494 782 964 1620 
30 870 1030 1715 900 1091 1800 
31 1000 1190 1948 1055 1270 2028 
32 1140 1348 2170 1214 1430 2270 
33 1330 1560 2450 1381 1638 2560 
34 1525 1764 2705 1580 1860 2810 
35 1710 1980 2995 1795 2080 3095 
36 1940 2198 3250 2015 2295 3360 
37 2175 2430 3545 2265 2540 3670 
38 2440 2690 3770 2540 2800 3910 
39 2600 2830 3890 2700 2950 4040 
40 2740 2975 4030 2840 3090 4195 
41 2855 3090 4170 2970 3220 4340 
42 2850 3110 4240 2980 3250 4430 
43 2800 3010 4210 2782 3085 4470 
44 - 3070 4230 - 3110 4415 
Source: Dobbins TA, Sullivan EA, Roberts CL, Simpson JM. Australian national birthweight percentiles by 
sex and gestational age, 1998-2007. Med J Aust. 2012; 197(5): 291-4. 
 
Birth Status 
Birth status was defined as whether the baby was born alive or not.  Stillbirth was defined 
as a baby born with no evidence of life (for example: does not breathe, no heartbeat, no 
pulsing of umbilical cord or movement of voluntary muscles) at 20 weeks gestation or older 
or 400grams birthweight or more.   
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Type of perinatal death 
The type of perinatal death was indicated using one of five categories and these were 
coded accordingly (see Table 2.5 below).   
 
Table 2.5: Categories and coding for type of perinatal death 
Categories Coding 1 Coding 2 
Before labour commenced Antepartum 
stillbirth 
stillbirth 
During labour, before delivery Intrapartum 
stillbirth 
stillbirth 
Before delivery, but not known if before or during 
labour 
Unknown stillbirth stillbirth 
After delivery Neonatal death neonatal death 
Not known if before or after delivery Perinatal death perinatal death 
 
Clinical Classification of stillbirth 
Stillbirth was classified according to the Perinatal Society of Australia and New Zealand 
Perinatal Death Classification (PSANZ-PDC) [124], which has been in use since 2004.  
Over the study period, there were four predecessors to the PSANZ-PDC in use. The 
classification system in use in Queensland around the start of the study period was the 
Queensland Council on Obstetric and Paediatric Mortality and Morbidity (QCOPMM) 
based on the Whitfield classification system [167] with the category “Other Specific 
Obstetric conditions”.  This additional category included fetomaternal haemorrhage and 
idiopathic hydrops, which would have been classified as “Other” under the Whitfield 
system.  The aim of the QCOPMM was to identify the primary maternal and/or fetal factors 
leading to perinatal death [157].  The QCOPMM system was further refined to identify 
important sub-categories obscured by the Whitfield classification system.  The new system 
was developed by the QCOPMM was renamed the Queensland Council Perinatal Mortality 
Classification (QCPMC).  In 2000, following the Perinatal Society of Australia and New 
Zealand annual conference, there was consensus to develop uniform classification system 
for use across Australia and New Zealand.  Developed by representatives from South 
Australia and Queensland, this system was named ANZACPM and was the immediate 
predecessor of the PSANZ-PDC.   
The PSANZ-PDC system aims to identify the single most important maternal or fetal factor 
which initiated the chain of events leading to perinatal death [124]. The classification 
system consists of eleven main categories and 67 major subcategories and is meant to be 
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applied using a hierarchical approach although this can be overridden depending on the 
scenario.  These classification systems were mapped to the current PSANZ-PDC [124].  In 
mapping categories across the classification systems, most major categories were 
mapped without problems.  However, there were differences in the definition of sub-
categories within the major categories of idiopathic preterm birth and unexplained 
antepartum fetal death. This did not allow sub-categories to be mapped across the entire 
time period, so wider categories were used.  Table 2.6 shows the distribution of stillbirths 
across the main categories of the classification systems in use over the study period.  
Table 2.7 shows the detailed categories and descriptions of the PSANZ PDC. 
 
Table 2.6: Classification systems and their main categories in use in Queensland, 
1995-2011 
Category PSANZ-PDC 
(2004-2011) 
ANZACPM 
(2000-2003) 
QCPMC 
(1997-1999) 
QCOPMM 
(1994-1996) 
1 Congenital abnormality 718 (25.3) 231 (20.0) 159 (20.7) 105 (18.4) 
2 Perinatal infection 75 (2.6) 31 (2.7) 38 (4.9) 39 (6.8) 
3 Hypertension 81 (2.9) 30 (2.6) 70 (9.1) 25 (4.4) 
4 Antepartum 
haemorrhage 
196 (6.9) 89 (7.7) 90 (11.7) 55 (9.6) 
5 Maternal conditions 81 (2.9) 49 (4.2) 20 (2.6) 30 (5.3) 
6 Specific perinatal 
conditions 
140 (4.9) 80 (6.9) 37 (4.8) 20 (3.5) 
7 Hypoxic peripartum 
death  
54 (1.9) 27 (2.3) 16 (2.1) 12 (2.1) 
8 Fetal Growth Restriction 146 (5.1) 61 (5.3) 25 (3.3) 19 (3.3) 
9 Spontaneous preterm 395 (13.9) 149 (12.9) 100 (13.0) 67 (11.8) 
10 Unexplained 
antepartum death 
896 (31.6) 405 (35.0) 206 (26.8) 194 (34.0) 
11 No obstetric antecedent 54 (1.9) 4 (0.3) 7 (0.9) 4 (0.7) 
Total 2836 (100.0) 1156 (100.0) 768 (100.0) 570 (100.0) 
QCOPMM = Queensland Council on Obstetric and Paediatric Morbidity and Mortality;  QCPMC = 
Queensland Council Perinatal Mortality Classification; ANZACPM = Australia and New Zealand Antecedent 
Classification of Perinatal Death; PSANZ-PDC = Perinatal Society of Australia and New Zealand Perinatal 
Death Classification 
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Table 2.7: Categories and description of the Perinatal Society of Australia and New 
Zealand Perinatal Death Classification (PSANZ-PDC)  
Main Category Description and main sub-categories 
1 Congenital abnormality 
     (including terminations 
for congenital abnormality) 
Includes all major fetal abnormalities and is the only category which 
strictly overrides all other categories.  Major subcategories: central 
nervous system, cardiovascular system, urinary system, 
gastrointestinal system, chromosomal, metabolic, multiple/non-
chromosomal syndromes, other congenital abnormality 
(musculoskeletal, respiratory, diaphragmatic hernia, haematological, 
tumours, other specified congenital abnormality) and unspecified 
congenital abnormality. 
2 Perinatal Infection Identifies all primary infections preterm and secondary infections in 
term births based on laboratory evidence. Major subcategories:  
bacterial, viral, protozoal, fungal, other specified organism, other 
unspecified organism 
3 Hypertension Includes deaths where hypertensive disorder is considered the 
initiating factor in the events leading to perinatal death. Major 
subcategories: chronic hypertension (essential, secondary, 
unspecified), gestational hypertension, pre-eclampsia, pre-eclampsia 
superimposed on chronic hypertension, unspecified hypertension 
4 Antepartum 
haemorrhage (APH) 
Identifies all perinatal deaths where the primary factor leading to 
death was an antepartum haemorrhage. Major subcategories:  
placental abruption, placenta praevia, vasa praevia, other APH, APH 
of undetermined origin 
5 Maternal conditions Identifies all perinatal deaths attributed to any medical or surgical 
disorder in the mother, its complications or treatment, excluding 
hypertension. Major subcategories: Termination of pregnancy for 
maternal psychosocial indications, Diabetes / Gestational Diabetes, 
Maternal injury, Maternal sepsis, Antiphospholipid syndrome, 
Obstetric cholestasis, Other specified maternal conditions 
6 Specified perinatal 
conditions 
Includes deaths of normally formed, appropriately grown babies in 
which the specific perinatal condition was a major contributing factor 
to perinatal death. Major subcategories: Twin-twin transfusion, 
Fetomaternal haemorrhage, Antepartum cord complications, Uterine 
abnormalities (including cervical incompetence), Birth trauma, 
Alloimmune disease, Idiopathic hydrops, Other specific perinatal 
conditions, Unspecified perinatal conditions 
7 Hypoxic peripartum 
death 
     (typically infants of >24 
weeks gestation or >600g 
birthweight) 
Identifies perinatal deaths, usually of > 24 weeks gestation or 600g 
birthweight, due to intrapartum events.  Major subcategories:  With 
intrapartum complications, Evidence of non-reassuring fetal status in 
a normally grown infant, No intrapartum complications and no 
evidence of non-reassuring fetal status, Unspecified hypoxic 
peripartum death 
8 Fetal Growth Restriction 
(FGR) 
Includes all death of babies with birthweight less than 10th percentile 
for gestational age for livebirths or non-macerated stillbirths, or all 
perinatal deaths with antenatal evidence of fetal growth restriction or 
growth arrest before death or FGR determined at autopsy. Major 
subcategories:  With evidence of reduced vascular perfusion on 
Doppler studies and/or placental histopathology, With chronic villitis, 
No placental pathology, No examination of placenta, Other specified 
placental pathology, Unspecified or not known whether placenta 
examined. 
9 Spontaneous preterm 
     (<37 weeks gestation)* 
Identifies perinatal deaths of normally formed, appropriately grown 
babies born before 37 weeks’ gestation, following spontaneous onset 
of preterm labour or rupture of membranes, irrespective of mode of 
delivery.  Major subcategories: Spontaneous preterm with intact 
46 
Main Category Description and main sub-categories 
membranes or membrane rupture <24 hours before delivery, 
Spontaneous preterm with membrane rupture ≥24 hours before 
delivery, Spontaneous preterm with membrane rupture of unknown 
duration before delivery. Further subdivisions within major 
subcategories: with chorioamnionitis on placental histopathology, 
without chorioamnionitis on placental histopathology, with clinical 
evidence of chorioamnionitis - no examination of placenta, No clinical 
signs of chorioamnionitis – no examination of placenta, Unspecified 
or not known whether placenta examined.* 
10 Unexplained 
antepartum death 
Identifies normally formed babies who died before the onset of labour 
without any predisposing conditions which were likely to have caused 
death.  Perinatal autopsy is not required for this category. Major 
subcategories: With evidence if reduced vascular perfusion on 
Doppler studies and/or placental histopathology, With chronic villitis, 
No placental pathology, No examination of placenta, Other specified 
placental pathology, Unspecified or not known whether placenta 
examined. 
11 No obstetric 
antecedent 
Stillbirths with no obstetric contributing factors and other unknown or 
unspecified causes of death.  Major subcategories:  Sudden Infant 
Death Syndrome (SIDS), Postnatally acquired infection, Accidental 
asphyxiation, Other accident, poisoning or violence (postnatal), Other 
specified, Unknown/Undetermined 
* The duration of membrane rupture with or without secondary chorioamnionitis was only consistently 
captured as subcategory from 2000 onwards.  PSANZ Clinical Practice Guidelines for Perinatal Mortality 
including the PSANZ PDC is available at: www.stillbirthalliance.org.au/guideline1.htm 
 
Terminations of pregnancy 
Data on stillbirths as a result of termination of pregnancy for maternal psychosocial 
reasons was systematically collected over the data collection period. Data was not 
available on stillbirths resulting from terminations of pregnancy for maternal and fetal 
reasons other than maternal psychosocial reasons within the QPDC.   
Provision was made for classification of stillbirths as a result of termination of pregnancy 
due to congenital anomaly from 2009 [124], however, data was available only for 2009 
(partial) and 2010 (complete).  Data from 2010 indicated that 6.7% and 14.4% of stillbirths 
among Indigenous and non-Indigenous women were terminations of pregnancy for 
congenital anomalies, respectively.  Among Indigenous women, this consisted of urinary 
(3.3%) and central nervous system (3.3%) anomalies.  Among non-Indigenous, 
terminations for congenital anomaly included: central nervous system (4.2%), 
chromosomal (3.9%), cardiovascular system (3.6%), urinary system (1.2%), multiple/non-
chromosomal (0.6%), unspecified anomaly (0.6%) and musculoskeletal (0.3%). Available 
details of terminations of pregnancy due to congenital anomaly for 2009 are shown in 
Table 2.8 below. 
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Table 2.8: Trends in stillbirths as a result of termination of pregnancy due to 
congenital anomaly, by Indigenous status, Queensland, 2009-2011 
Type of 
congenital anomaly 
Indigenous Non-Indigenous 
Percentage of all stillbirths 
2009 
(n=34) 
2010 
(n=30) 
2011 
(n=34) 
2009 
(n=377) 
2010 
(n=333) 
2011 
(n=329) 
Central nervous system 0.0 3.3 - 0.8 4.2 - 
Cardiovascular system 0.0 0.0 - 0.3 3.6 - 
Urinary system 0.0 3.3 - 0.0 1.2 - 
Chromosomal 0.0 0.0 - 0.5 3.9 - 
Multiple/non-chromosomal 0.0 0.0 - 0.0 0.6 - 
Musculoskeletal 0.0 0.0 - 0.0 0.3 - 
Unspecified congenital anomaly 0.0 0.0 - 0.0 0.6 - 
- no reports of stillbirths as a result of termination of pregnancy due to congenital anomaly for 2011 
 
Autopsy 
Data was obtained on whether or not an autopsy was conducted.  Data was classified as 
“No”, “Yes”, “Under Investigation” or “unknown”.  The category “Under Investigation” was 
re-classified as “Yes”. Complete ascertainment of autopsy status was available from mid 
2000. Prior to this time, the rate of missing data ranged from 30.4% in 1994 decreasing to 
6.9% in 1999. 
 
2.3 Reflection on data quality 
Data from the QPDC was utilised for the population based studies within this Thesis 
instead of data from the Australian Bureau of Statistics (ABS) for a number of reasons 
relating to data accuracy and completeness.   
 
Data Accuracy 
In Australia, perinatal data from the ABS is obtained from death certificates. Typically, 
death certificates are completed before many stillbirth investigations are performed, as a 
result, the cause of death given on the death certificate may not reflect the cause of death 
found after investigation.  It is estimated that up to 40% of cause of death information on 
stillbirth death certificates are incorrect [168].  In contrast, the QPDC contains clinical 
classification of cause of death obtained through expert review of each stillbirth. 
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Data completeness 
The QPDC is the most comprehensive collection of population based perinatal data 
available in Queensland; and data from the QPDC is provided to the Australian Institute of 
Health and Welfare for national reporting of perinatal statistics [169].  There is around 
2.7% underreporting of births in ABS data compared with the QPDC [170].  The QPDC 
also compares favourably with perinatal data collections used for reporting in other high 
income countries.  In USA, there was evidence of underreporting of fetal deaths 
particularly around the lower limits of gestational age [171], while in England, up to 8% of 
stillbirths were missing from CEMACE data compared with death registration data [172].   
In relation to missing data, the QPDC was again comparable to data collections used in 
other high income countries.  As shown in Table 2.9, the proportion of missing data for a 
number of important variables such as gestational age, birthweight and maternal 
ethnicity/Indigenous status was comparatively low during the data collection period (1994-
2011).  Although the proportion of missing data has subsequently reduced for USA [171]. It 
was also interesting to note that the proportion of missing data was higher among stillbirths 
than live births for both the QPDC and National Centre for Health Statistics (NCHS). 
Table 2.9: Proportion of missing data for population based perinatal data collections 
in Australia, England and USA. 
Characteristics Australia 
(QPDC) 
1994-2011 
England 
CMACE 
2011 
USA 
NCHS Vital Statistics 
2006  
Gestational age 0.01% (all births) 
0.15% (stillbirth) 
0.01% (live births) 
3% (all births)  
2.09% (stillbirth) 
0.60% (live births) 
Birthweight 0.01% (all births) 
0.71% (stillbirth) 
0.01% (livebirths) 
19% (all births)  
9.88% (stillbirth) 
0.03% (live births) 
Ethnicity/ 
Indigenous status 
0.03% (all births) 
1.6% (stillbirths) 
0.02% (live births) 
6% (all births)  
5.22% (stillbirth) 
0.71% (live births) 
Source: Australian estimates from QPDC (Queensland Perinatal Data Collection. Estimates for England from  
Healthcare Quality Improvement Partnership (HQIP). Report on the Data for Perinatal Deaths which 
occurred in England 2010, 2011 and 2012. 2013  10/09/2015]; Available from: 
www.hqip.org.uk/assets/Downloads/Report-on-2010-2011-2012-perinatal-mortality-data-FINAL.pdf.  
Estimates for USA from MacDorman, M.F., S. Kirmeyer, E.C. Wilson, and et al., Fetal and perinatal mortality, 
United States, 2006. . National Vital Statistics Reports, 2012. 60(8). 
 
Data quality issues relating to the individual variables used for analyses in this Thesis are 
outlined in Section 2.2.  However, some key issues and their implications are highlighted 
here. 
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 Within the population dataset supplied, it was not possible to identify women who 
had subsequent pregnancies over the data period of 1994-2011; as a result, 
adjustments could not be made in the multivariate analyses for correlations 
between pregnancies at different periods.  This may result in overly optimistic 
estimates of the true associations between maternal factors and stillbirth.  However, 
the magnitudes of associations found in our results have been comparable to 
estimates from other studies. 
 Maternal age was provided as categorical data in two year intervals with truncation 
of categories at the extremes of maternal age (e.g. Less than 18 years, and 45 
years and older).  As a result, nuanced assessment of the effects of maternal age 
was limited. 
 Ascertainment of alcohol use during pregnancy was unreliable and as a result could 
not be used in analyses 
 Number of antenatal care visits was provided as categorical data (e.g. Less than 2, 
2-4, 5-7 and 8 or more), and gestational age at initiation of first antenatal care visit 
was unavailable at the time of data request.  As a result, the composite measure of 
adequacy of antenatal care utilisation could not be derived nor its effects on stillbirth 
risk adequately assessed.  However, the number of antenatal care visits was 
always adjusted for gestational age in multivariate analyses. 
 Over the data collection period, increases in the ascertainment rate of 
characteristics such as smoking (data collection commenced mid 2005) and 
diabetes (improved ascertainment with introduction of ICD10-AM in mid 2000) were 
observed.  As a result, analyses were restricted to study periods after mid 2005 to 
reduce bias from missing data.  
Data from the QPDC was comparable to data from other Australian states and territories. 
Presented in Table 2.10 are data on selected maternal and pregnancy factors for 2011.  
Queensland had the second highest proportion of Indigenous mother giving birth after the 
Northern Territory.  The stillbirth rate for Queensland was comparable to other Australian 
jurisdictions; however, it should be noted that the majority of terminations for maternal 
psychosocial reasons were performed in Victoria and the rate for Western Australia 
included late terminations of pregnancy [3]. 
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Table 2.10: Selected maternal characteristics showing similarity across data sources 
Characteristics 
New 
South 
Wales 
Victoria Queensland 
Western 
Australia 
South 
Australia 
Tasmania 
Australian 
Capital 
Territory 
Northern 
Territory 
National 
Maternal age less than 
20 years (%) 
3.2 2.5 5.1 4.3 4.0 6.1 2.3 9.3 3.7 
Maternal age of 35 years 
or older (%) 
23.7 24.8 19.9 20.9 20.6 18.6 25.6 16.1 22.6 
Public patient (%) 74.3 71.8 70.1 59.1 74.1 66.0 70.4 80.4 71.0 
Indigenous (%) 3.1 1.3 6.0 5.3 3.5 4.7 1.8 36.5 3.9 
Smoker (%) 11.2 12.2 16.1 12.1 17.0 18.4 10.0 26.0 13.2 
Pre-existing hypertension 
(rate per 1000 women) 
8.2 - 5.8 11.5 11.8 14.5 14.3 13.9 - 
Pregnancy induced 
hypertension 
(rate per 1000 women) 
64.1 - 46.9 9.1 72.6 62.2 54.4 37.2 - 
Pre-existing diabetes 
(rate per 1000 women) 
6.4 - 6.0 7.2 6.9 10.9 8.4 18.1 - 
Gestational diabetes 
(rate per 1000 women) 
63.6 - 64.7 69.4 69.5 44.5 59.3 69.2 - 
Antepartum 
haemorrhage 
(rate per 1000 women) 
- - 25.5 35.2 32.9 21.7 55.5 13.4 - 
Stillbirth 
(rate per 1000 births) 
5.9 9.8 6.4 8.4 7.4 5.4 7.7 7.1 7.4 
Source: Li, Z., R. Zeki, L. Hilder, and A.E. Sullivan, Australia's mothers and babies 2011. Perinatal statistics series no. 28. Cat. no. Per 59. 2013, AIHW National 
Perinatal Epidemiology and Statistics Unit: Canberra. 
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Chapter 3 
Trends in stillbirth rates and causes by gestational age, geographic 
location and Indigenous status 
 
3.1 Introduction 
Stillbirth is devastating to families and remains a challenging problem globally, with an 
estimated 3 million deaths occurring during the third trimester of pregnancy each year [11]. 
Applying the standard lower gestational age definition used in many high income 
countries, the numbers of stillbirths are likely to be at least double this estimate [32].   
Despite significant reductions in stillbirth rates in high income countries over the past 50 
years, reduction has slowed in recent times [28].  National reports from Canada [173] and 
Australia [23, 174] indicate that stillbirth rates may be increasing.  In comparison, neonatal 
death rates in many of these countries have continued to decline.  Globally, between 1990 
and 2012, neonatal death rates fell by 2.0% while stillbirth rates fell by 1.0%  [175]. In 
Australia [174] and USA [176], neonatal death rates declined at a faster pace than 
stillbirths. Between 1990 and 2000, the fetal and neonatal death rates in USA declined by 
an average of 1.3% and 2.4% per year, respectively [176].  Likewise in Australia during the 
same period, fetal and neonatal death rates declined by an annual average rate of 1.0% 
and 4.5%, respectively [174, 177].  In Queensland during this period, fetal death rates 
increased by 0.14% per year while neonatal death rates decreased by 2.5% per year 
[178].  National reports on trends in stillbirth rates by gestational age group indicate that 
reductions in late gestation (≥28 weeks) stillbirth rates combined with increases in early 
gestation stillbirth rates may explain the relatively unchanged overall stillbirth rates 
observed in some high income countries [4, 179]. 
The need to address disparities that exist across different population groups was recently 
highlighted as a priority in high income countries [13].  In Australia, as in other high income 
countries, marked disparity in adverse pregnancy outcomes such as stillbirth between 
Indigenous and non-Indigenous populations are evident [23, 180].  A number of factors 
including genetics, physical and social environment, maternal behaviour and access to 
and quality of health care have been suggested as contributing to this disparity [28, 181].  
Geographic location (regional or remote residence) has been identified as an important 
risk factor for stillbirth in the Australian context [54, 182].  
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The study of temporal trends in rates and underlying causes of death is important to 
gaining an understanding of the scope for further reductions in stillbirth rates and to direct 
further clinical and research efforts [183, 184].  The objective of this study was to assess 
the differences in stillbirth rates over time among Indigenous and non- Indigenous women 
based on their geographic location and gestational age to determine whether the gap was 
closing. Additionally, this study aimed to assess cause-specific stillbirth rates to determine 
where the greatest disparities lie in order to identify focal areas for preventive efforts. 
Presented in this chapter are findings from the Stillbirth trends analysis, a large population 
based study (n=881,211 births) assessing trends and disparity in stillbirth rates and 
causes among Indigenous and non-Indigenous women birthing in Queensland. Also 
presented are trends in a number of maternal, medical and obstetric factors. The analyses 
were stratified by geographic location and gestational age groups and two methods of 
gestational age-specific stillbirth rate calculation were utilised.   
Findings from this study were presented at the following conferences in 2014: Perinatal 
Society of Australia and New Zealand (PSANZ), International Stillbirth Alliance 
(ISA)/International Society for Prevention of Infant Death (ISPID) and Australian Society 
for Medical Research (ASMR) postgraduate student conference (Appendix G4, G5 and 
G6). In addition, the study was published in BJOG: An International Journal of Obstetrics 
and Gynaecology in September 2014 (Appendix E). 
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3.2 Methods 
Study Population 
The Stillbirth trends analysis was a population-based retrospective cohort study involving 
all singleton livebirths and stillbirths of at least 20 weeks gestation and/or at least 400 
grams birthweight occurring in Queensland between January 1995 and December 2011.  
During the study period, 881 654 singleton births were registered in Queensland.  Four 
hundred and forty three births were excluded from this study. Of these, 148 births were 
excluded from the analyses as these were terminations of pregnancy for maternal 
psychosocial reasons; maternal Indigenous status was unknown for 270 births and a 
further 25 births occurred at less than 20 weeks gestation and were also less than 400g 
birthweight (see Figure 3.1).   
 
 
 
 
 
 
 
 
 
Figure 3.1: Flowchart showing study population, Stillbirth trends analysis, 1995-
2011 
 
Power calculations 
Post-hoc power calculations were undertaken separately for the population of Indigenous 
and non-Indigenous women.  For Indigenous women, a sample size of 49,450 provided 
over 90% power to detect an odds ratio of 0.90 with confidence interval of 95% and an 
Eligible births 
881 654 singleton births 
Included births (99.95%) 
881 211 singleton births 
(incl 5425 stillbirths) 
Excluded births (443 – 0.05%) 
148 terminations of pregnancy for 
maternal psychosocial reasons 
270 births with unknown maternal 
Indigenous status 
25 less than 20 weeks gestation 
AND less than 400g birthweight 
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overall event proportion of 10.7/1000 ongoing pregnancies.  For non-Indigenous women, a 
sample size of 831 761 had over 99% power to detect an odds ratio of 1.04 with 96% 
confidence interval, with an overall event proportion of 5.9/1000 ongoing pregnancies. 
 
Statistical Analysis 
Data for this study was obtained from the Queensland Perinatal Data Collection (QPDC). 
Maternal demographic data included age, marital status, socioeconomic status and 
geographic location.  Pregnancy data included primigravidity, hospital accommodation, 
smoking, substance use, pregnancy complications, assisted conception and number of 
antenatal care visits. Pregnancy complications were defined as any conditions in the 
period immediately preceeding labour and delivery that were directly attributable to 
pregnancy and may have affected care and outcomes during the current pregnancy (ICD9 
codes 630-679 and ICD10AM codes O00-O99). Birth outcome data included baby’s sex, 
gestational age at birth, birthweight and stillbirth.  Data management was carried out as 
described in section 2.2.  All variables measured on a continuous scale were classified into 
categories and Chi square and Fisher’s exact tests were used to assess differences in 
proportions between Indigenous and non-Indigenous women. 
The primary outcome measure was crude stillbirth risk per 1000 ongoing pregnancies by 
gestational age and classification of stillbirth.  Two methods were employed in the 
calculation of stillbirth risk (Figure 3.2). The first method described by Feldman produced 
prospective stillbirth risk which is an indication risk at the gestational age window of 
interest and beyond [185]. The second method described by Yudkin gave an indication of 
stillbirth risk at the gestational age window of interest only [186]. There has been debate 
about the appropriateness of each of these methods for the calculation of stillbirth risk; 
with some researchers arguing that no one method is superior and the choice of method 
depends on the research question being addressed or the particular situation being 
studied [187].  For the purpose of this analysis, both methods were used as they are both 
commonly used methods and the results tell distinct but complementary stories. 
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Figure 3.2 Comparison of stillbirth risk calculation methods 
Prospective Stillbirth Risk 
Gestational age specific prospective stillbirth risk 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑖𝑙𝑙𝑏𝑖𝑟𝑡ℎ𝑠 𝑜𝑐𝑐𝑢𝑟𝑟𝑖𝑛𝑔 𝑎𝑡 𝑔𝑖𝑣𝑒𝑛 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒  𝑎𝑛𝑑 𝑜𝑙𝑑𝑒𝑟 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑛𝑔𝑜𝑖𝑛𝑔 𝑝𝑟𝑒𝑔𝑛𝑎𝑛𝑐𝑖𝑒𝑠 𝑎𝑡 𝑠𝑡𝑎𝑟𝑡 𝑜𝑓 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑤𝑖𝑛𝑑𝑜𝑤
× 1000 
 
Cause and gestational age specific prospective stillbirth risk 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑖𝑙𝑙𝑏𝑖𝑟𝑡ℎ𝑠 𝑎𝑡𝑡𝑟𝑖𝑏𝑢𝑡𝑒𝑑 𝑡𝑜 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑐𝑎𝑢𝑠𝑒 𝑜𝑐𝑐𝑢𝑟𝑟𝑖𝑛𝑔 𝑎𝑡 𝑔𝑖𝑣𝑒𝑛 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑎𝑛𝑑 𝑜𝑙𝑑𝑒𝑟
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑛𝑔𝑜𝑖𝑛𝑔 𝑝𝑟𝑒𝑔𝑛𝑎𝑛𝑐𝑖𝑒𝑠 𝑎𝑡 𝑠𝑡𝑎𝑟𝑡 𝑜𝑓 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑤𝑖𝑛𝑑𝑜𝑤
× 1000 
 
Stillbirth Risk 
Gestational age specific stillbirth risk 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑖𝑙𝑙𝑏𝑖𝑟𝑡ℎ𝑠 𝑜𝑐𝑐𝑢𝑟𝑟𝑖𝑛𝑔 𝑤𝑖𝑡ℎ𝑖𝑛 𝑔𝑖𝑣𝑒𝑛 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑤𝑖𝑛𝑑𝑜𝑤 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑛𝑔𝑜𝑖𝑛𝑔 𝑝𝑟𝑒𝑔𝑛𝑎𝑛𝑐𝑖𝑒𝑠 𝑎𝑡 𝑠𝑡𝑎𝑟𝑡 𝑜𝑓 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑤𝑖𝑛𝑑𝑜𝑤
× 1000 
 
Cause and gestational age specific stillbirth risk 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑡𝑖𝑙𝑙𝑏𝑖𝑟𝑡ℎ𝑠 𝑎𝑡𝑡𝑟𝑖𝑏𝑢𝑡𝑒𝑑 𝑡𝑜 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑐𝑎𝑢𝑠𝑒 𝑜𝑐𝑐𝑢𝑟𝑟𝑖𝑛𝑔 𝑤𝑖𝑡ℎ𝑖𝑛 𝑔𝑖𝑣𝑒𝑛 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑛𝑔𝑜𝑖𝑛𝑔 𝑝𝑟𝑒𝑔𝑛𝑎𝑛𝑐𝑖𝑒𝑠 𝑎𝑡 𝑠𝑡𝑎𝑟𝑡 𝑜𝑓 𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑔𝑒 𝑤𝑖𝑛𝑑𝑜𝑤
× 1000 
 
To assess changes in all-cause and gestational age-specific stillbirth risk, percentage 
differences were calculated in 2-3 year groupings and over the whole study period.  
Univariate Poisson regression involving time period was used to assess trends in rates of 
stillbirth and other sociodemographic and maternal characteristics.  Disparity in stillbirth 
risk was determined by calculating relative risk and 95% confidence intervals for 
Indigenous women compared with non-Indigenous women by geographic location, cause 
of stillbirth and gestational age grouping.   
Autopsy rates were calculated using the number of autopsies performed within a particular 
subgroup divided by the total number of stillbirths within that subgroup.  Autopsy rates 
were presented as percentages.  Relative risk and 95% confidence intervals for having an 
autopsy performed following a stillbirth were also estimated for Indigenous women 
compared with non-Indigenous women.  
Geographic location was classified as urban, regional or remote.  Cut points for gestational 
age groups were 24 weeks, 28 weeks and 37 weeks.  These groups were chosen to 
reflect the commencement of active clinical management (≥24 weeks), for international 
comparison (≥28 weeks) and to distinguish between preterm and term births (≥37 weeks). 
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All statistical analyses were performed using Stata 11.2 (StataCorp LP 2009, Texas, USA).  
Statistical significance was set at p<0.05.   
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3.3 Results 
Characteristics of Indigenous and non-Indigenous women 
A total of 881,211 births (including 5425 stillbirths) were included in these analyses.  Of 
these, 49,450 births were to Indigenous women and 831,761 births were to non-
Indigenous women.  The characteristics of the women by Indigenous status are presented 
in Table 3.1.  
There were significant differences between Indigenous and non-Indigenous women 
birthing in Queensland between 1995 and 2011. There was a higher proportion of 
Indigenous women aged 20 years or less (26.1% vs 8.0%, p<0.001) and conversely a 
higher proportion of non-Indigenous women aged 35 years or older (17.1% vs 8.1%, 
p<0.001). The rate of primigravidity was higher among non-Indigenous women (30.2% vs 
23.5%, p<0.001) while Indigenous women were more likely to have a preterm (<37 weeks 
gestation) birth (11.4% vs 6.4%, p<0.001).  A higher proportion of Indigenous women were 
in the lowest ranked quintile of socioeconomic disadvantage index (39.3% vs 16.1%, 
p<0.001) and Indigenous women were underrepresented among women who birthed as 
private patients (2.3% vs 30.7%, p<0.001). There were higher rates of smoking (53.0% vs 
16.8%, p<0.001) and substance use (1.6% vs 0.5%, p<0.001) among Indigenous women 
compared with non-Indigenous women. Non-Indigenous women were less likely to reside 
in regional or remote areas (39.5% vs 79.2%, p<0.001) and there were higher rates of 
pregnancy complications among non-Indigenous women (63.4% vs 61.6%, p<0.001). The 
most frequently coded pregnancy complications included: uterine scar from previous 
surgery, premature rupture of membranes, late/prolonged pregnancy and breech 
presentation.  There was no difference in the proportion of male babies (51.7% vs 51.5%, 
p=0.40). 
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Table 3.1: Characteristics of Indigenous and non-Indigenous women and babies, 
Queensland, 1995-2011 
Characteristics 
Indigenous 
n(%) 
Non-Indigenous 
n(%) 
p 
value 
All births 49 450 831 761  
Maternal age (years) 
     ≤ 20 12 888 (26.1) 66 171 (8.0)  
     21-34 32 577 (65.9) 623 301 (74.9) <0.001 
     ≥ 35 3 985 (8.1) 142 289 (17.1)  
Marital status 
     Partner 30 887 (62.5) 735 936 (88.5) <0.001 
     No Partner 18 545 (37.5) 95 727 (11.5)  
Primigravid 
     Yes 11 624 (23.5) 250 877 (30.2) <0.001 
Baby sexa 
     Male 25 548 (51.7) 428 092 (51.5) 0.38 
Gestational age at birth (weeks) 
     <24 weeks 355 (0.7) 2 646 (0.3)  
     24-27 weeks 386 (0.8) 2 701 (0.3)  
     28-36 weeks 4 913 (9.9) 48 605 (5.8) <0.001 
     37-41 weeks 43 044 (87.1) 767 101 (92.2)  
     42+ weeks 723 (1.5) 10 654 (1.3)  
Birthweight     
     Less than 10th centileb 7 995 (16.2) 76 024 (9.1) <0.001 
Socioeconomic status 
     Highest 20% 1 110 (2.3) 110 013 (13.3)  
     Middle 60% 28 727 (58.4) 585 074 (70.6) <0.001 
     Lowest 20% 19 340 (39.3) 133 460 (16.1)  
Accommodation status 
     Private 1 127 (2.3) 255 685 (30.7)  
     Public 48 322 (97.7) 576 056 (69.3) <0.001 
Smokerc 
     Yes 11 140 (53.0) 59 680 (16.8) <0.001 
Substance Use 
     Yes 785 (1.6) 4 514 (0.5) <0.001 
Pregnancy complicationsd 
     Yes 19 903 (61.6) 344 075 (63.4) <0.001 
Remoteness 
     Urban 10 281 (20.8) 503 085 (60.5)  
     Regional 28 820 (58.3) 306 402 (36.8) <0.001 
     Remote 10 347 (20.9) 22 255 (2.7)  
Stillbirth    
     Yes 527 (1.1) 4 898 (0.6) <0.001 
a
 Data was missing for 4 births and sex was indeterminate for 108 births (97 non-Indigenous and 11 
Indigenous).  
b
 Data on smoking was collected from July 2005, smoking status was unknown for 504 307 
births (28 404 Indigenous and 475 903 non-Indigenous births).  
c
 Australian population birthweight centile.  
d
 
pregnancy complication data consistently collected from July 2001 
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Temporal trends in characteristics of women by Indigenous status 
Indigenous women  
Between 1995 and 2011, stillbirth rates among Indigenous women decreased from 13.3 to 
9.1 per 1000 ongoing pregnancies (ptrend=0.014).  Concurrent with this trend of decreasing 
stillbirth rates were changes in a number of maternal sociodemographic and pregnancy 
factors (Table 3.2).  There were significant increases in the proportion of older mothers 
(aged 35 years or older) from 5.5% to 10.1% (ptrend<0.001), while the proportion of younger 
mothers (aged 20 years or younger) was stable around 26.1% (ptrend=0.402).  Decreases 
were observed in the proportion of Indigenous women who reported any smoking during 
pregnancy (from 54.2% to 51.9%, ptrend=0.015).  In contrast, there was a two-fold increase 
in the proportion of women who reported substance use during pregnancy (0.9% to 1.8%, 
ptrend<0.001).  There was evidence of increased affluence among Indigenous women 
during this period; there was an 8.6% increase in the proportion of women living in the 
highest ranked quintile (i.e. least disadvantaged) neighbourhoods and similarly an 82.4% 
decrease in the proportion of women living in the lowest ranked quintile (i.e. most 
disadvantaged) neighbourhoods. 
There was an increase in the rate of primigravidity among Indigenous women from 23.6% 
to 24.7% (ptrend=0.030), as well as an increase in the proportion of Indigenous women 
birthing as public patients (ptrend<0.001).  There was a 48.7% decline in the rate of 
inadequate antenatal care (defined as attending less than two antenatal care visits during 
pregnancy) from 7.8% in 1995-1997 to 4.0% in 2010-2011 (ptrend<0.001). There was no 
change in the proportion of Indigenous women using assisted conception technology 
(ptrend=0.066). 
There was an increase in the proportion of women with pregnancy complications from 
61.4% to 63.2% (ptrend<0.001).  There was no change in the proportion of male infants 
born (ptrend=0.416) or the proportion of preterm births (ptrend=0.973).  There was no change 
in the proportion of low or extremely low birthweight infants; but there was a decrease in 
the proportion of growth restricted infants (defined as birthweight less than the 10th 
population centile) (Table 3.2). 
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Table 3.2: Temporal trends in sociodemographic characteristics of Indigenous women and babies, Queensland, 1995-2011 
Characteristics 
1995-97 
% 
1998-00 
% 
2001-03 
% 
2004-06 
% 
2007-09 
% 
2010-11 
% 
Total 
% 
% 
difference 
ptrend 
Total births n=7498 n=8273 n=8182 n=8678 n=9758 n=7061 n=49450   
Maternal age 
       
  
     20 years or younger 27.2 25.1 26.4 25.8 25.8 26.2 26.1 -3.7 0.402 
     35 years or older 5.5 6.6 7.8 8.7 9.5 10.1 8.1 +83.6 <0.001 
Smoker - - - 54.2 53.2 51.9 53.0 -4.2 0.015 
Substance Use 0.9 1.1 2.3 1.6 1.8 1.8 1.6 +100.0 <0.001 
Socioeconomic status           
     Lowest ranked 20% 39.6 38.4 44.3 41.4 36.2 36.2 39.3 -8.6 <0.001 
     Highest ranked 20% 1.7 2.1 1.6 2.4 2.6 3.1 2.3 +82.4 <0.001 
Primigravidity 23.6 23.0 23.1 22.6 24.1 24.7 23.5 +4.7 0.030 
Assisted conception 0.8 0.4 0.4 0.4 0.4 0.6 0.5 -25.0 0.066 
Public patient 97.5 96.9 97.9 98.2 97.8 98.1 97.7 +0.6 <0.001 
Number of antenatal care visits          
     Less than 2 7.8 6.9 6.9 7.2 5.8 4.0 6.5 -48.7 <0.001 
     8 or more  - 47.0 48.5 46.2 47.9 51.5 48.1 +9.6 <0.001 
Pregnancy complication - - 61.4 60.9 61.1 63.2 61.6 +2.9 <0.001 
Male babies 51.5 51.2 51.9 51.5 51.9 52.0 51.7 +1.0 0.416 
Preterm birth 11.3 11.4 11.7 12.0 10.9 11.6 11.4 +2.7 0.973 
Birthweight          
     Extremely low (<1500g) 2.5 2.3 2.7 2.6 2.4 2.5 2.5 0.0 0.944 
     Low (<2500g) 10.8 10.5 11.2 11.0 10.3 10.8 10.8 0.0 0.636 
     Less than 10th population centile 17.0 16.1 17.3 16.5 15.2 15.1 16.2 -11.2 <0.001 
Stilbirth  
(rate per 1000 ongoing 
pregnancies) 
13.3 10.9 10.8 10.0 10.0 9.1 10.7 -31.6 0.014 
% difference = (rate (2010-11) minus rate (1995-97)) x 100 / rate (1995-97)     - Data unavailable 
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Non-Indigenous women 
Stillbirth rates among non-Indigenous women in Queensland remained steady at 5.9 per 
1000 ongoing pregnancies over the period 1995 to 2011.  There was a decrease in the 
proportion of younger mothers (aged 20 years or younger) from 9.0% to 6.9% 
(ptrend<0.001); concurrent with an increase in the proportion of older mothers (12.9% to 
20.4%, ptrend<0.001).  A decrease in the proportion of women who reported smoking during 
pregnancy was also observed (ptrend<0.001).  There was evidence of increased affluence 
among non-Indigenous women with an increase in the proportion of women who lived in 
the highest ranked quintile (least disadvantaged) neighbourhoods (9.5% to 16.8%, 
ptrend<0.001) and a decrease in the proportion of women who lived in the lowest ranked 
quintile (most disadvantaged) neighbourhoods (20.7% to 12.1%, ptrend<0.001). There was 
no change in the proportion of women who reported substance use during this period 
(ptrend=0.879).  There was no change in the proportion of primigravid women (ptrend=0.310) 
or the proportion of male babies born (ptrend=0.878).  However, there was an increase in 
the proportion of women who used assisted conception technologies (2.5% to 4.3%, 
ptrend<0.001).  There was also an increase in the proportion of women with preterm births 
(6.2% to 6.7%, ptrend<0.001).  There was no change in the proportion of low or very low 
birthweight infants; however, there was a decrease in the proportion of growth restricted 
infants (defined as birthweight less than the 10th population centile) from 10.2% to 8.5% 
(ptrend<0.001) (Table 3.3). 
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Table 3.3: Temporal trends in sociodemographic characteristics of non-Indigenous women and babies, Queensland, 1995-2011 
Characteristics 
1995-97 
% 
1998-00 
% 
2001-03 
% 
2004-06 
% 
2007-09 
% 
2010-11 
% 
Total 
% 
% 
difference 
ptrend 
Total births n=13282
7 
 
n=13349
2 
 
n=13606
7 
 
n=14867
9 
 
n=16765
5 
 
n=11304
1 
 
n=83176
1 
 
  
Maternal age          
     20 years or younger 9.0 8.5 8.4 7.6 7.3 6.9 8.0 -23.3 <0.001 
     35 years or older 12.9 14.6 16.1 18.3 20.1 20.4 17.1 +58.1 <0.001 
Smoker~ - - - 18.6 17.4 14.6 16.8 -21.5 <0.001 
Substance Use 0.4 0.6 0.8 0.5 0.5 0.5 0.5 +25.0 0.88 
Socioeconomic status           
     Lowest ranked 20% 20.7 19.9 18.5 15.7 10.7 12.1 16.1 -41.6 <0.001 
     Highest ranked 20% 9.5 11.1 11.5 13.5 16.8 16.8 13.3 +76.8 <0.001 
Primigravidity 30.3 30.2 30.2 30.1 30.0 30.3 30.2 0.0 0.31 
Assisted conception 2.5 2.2 2.7 3.2 3.6 4.3 3.1 +72.0 <0.001 
Public patient 72.0 72.8 67.3 67.2 68.1 68.6 69.3 -4.7 <0.001 
Number of antenatal care visits 
       
  
     Less than 2 1.5 1.1 1.0 0.9 0.8 0.5 1.0 -66.7 <0.001 
     8 or more* - 65.4 74.2 75.4 74.6 76.3 73.6 +16.7 <0.001 
Pregnancy complication - - 62.9 62.8 63.9 63.9 63.4 +1.6 <0.001 
Male babies 51.3 51.4 51.4 51.7 51.8 50.9 51.5 -0.8 0.88 
Preterm birth 6.2 6.3 6.4 6.7 6.7 6.7 6.5 +8.1 <0.001 
Birthweight          
     Extremely low (<1500g) 1.1 1.1 1.1 1.2 1.1 1.1 1.1 0.0 0.35 
     Low (<2500g) 5.0 5.1 5.0 5.2 5.0 5.0 5.0 0.0 0.59 
     Less than 10th population 
centile 10.2 9.6 9.1 8.9 8.6 8.5 9.1 
-16.7 <0.001 
Stillbirth (per 1000 births)^ 5.8 5.7 5.7 6.1 6.1 5.9 5.9 +1.7 0.26 
% difference = (rate (2010-11) minus rate (1995-97)) x 100 / rate (1995-97)      
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Maternal characteristics by Indigenous status and geographic location 
Table 3.4 shows the distribution of maternal characteristics by Indigenous status and 
geographic location and Table 3.5 shows the relative risk of each of these maternal 
characteristics for Indigenous women relative to non-Indigenous women. Stillbirth rates 
among Indigenous women varied significantly with geographic location.  Indigenous 
women living in urban areas had the lowest stillbirth rate (8.5/1000 ongoing pregnancies) 
compared with Indigenous women living in regional (10.8/1000) and remote areas 
(12.5/1000)(p=0.019).  In contrast, stillbirth rates among non-Indigenous women were not 
significantly different (p=0.070).  Stillbirth rates among non-Indigenous women living in 
urban, regional and remote areas were 5.8/1000, 6.1/1000 and 5.3/1000, respectively 
(Table 3.4).  Analyses of the distribution of sociodemographic characteristics for these 
women showed significant differences by geographic location. 
Among Indigenous and non-Indigenous women, there were higher proportions of younger 
(20 years or younger) mothers living in regional and remote areas and conversely, higher 
proportions of older (35 years or older) mothers living in urban areas.  Indigenous women 
were more than three-fold more likely to smoke during pregnancy (53.0% vs 16.8%, RR 
3.16, 95% CI 3.11-3.21).  For both groups of women, smoking rates were lowest for 
women living in urban areas (46.6% and 14.5% for Indigenous and non-Indigenous 
women, respectively) and highest for women living in regional areas (54.8% and 20.7%) 
(Table 3.4).  Disparity in smoking rates was greatest for women living in urban areas (RR 
3.22, 95% CI 3.11-3.33) and smallest for women living in regional areas (RR 2.65, 95% CI 
2.60-2.70) (Table 3.5). 
Substance use rates for Indigenous and non-Indigenous women were highest in urban 
areas (3.3% and 0.6%, respectively), followed by regional areas (1.3% and 0.5%) and then 
remote areas (0.7% and 0.2%)(Table 3.4).  Disparity in substance use rates was greatest 
for women living in urban areas (RR 5.32, 95% CI 4.76-5.95) and least for women living in 
regional areas (RR 2.85, 95% CI 2.54-3.19)(Table 3.5). 
Overall Indigenous women were more than twice as likely to be classified in the lowest 
quintile of socioeconomic disadvantage index.  Disparity was least marked for women 
living in regional areas (RR 1.83, 95% CI 1.79-1.86) and most marked for women living in 
remote areas (RR 3.31, 95% CI 3.22-3.42) (Table 3.5).  Both Indigenous and non-
Indigenous women living in urban areas were more likely to be primigravid than their 
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regional and remote dwelling counterparts.  Disparity in rates of primigravidity was greatest 
in remote areas (25.2% vs 31.0%, RR 0.75, 95% CI 0.72-0.78) (Table 3.5). 
Rates of assisted conception technology use were highest in urban areas, followed by 
regional and remote areas (Table 3.4); overall, Indigenous women were less likely to use 
these technologies (RR 0.16, 95% CI 0.14-0.18).  Disparity in rates of assisted conception 
technology use between Indigenous and non-Indigenous women was greatest in remote 
areas (0.3% vs 2.2%, RR 0.13, 95% CI 0.09-0.18) (Table 3.5). 
Inadequate antenatal care (assessed using less than 2 visits) was higher among 
Indigenous than non-Indigenous women (6.5% vs 1.0%, RR 6.73 95% CI 6.46-7.00). 
Disparity in rates of inadequate antenatal care was greatest for women living in regional 
areas, followed by urban and then remote areas (Table 3.5).  
Overall there was a slightly lower rate of pregnancy complications among Indigenous 
women (61.6% vs 63.4%, RR 0.97, 95% CI 0.96-0.98).  Rates of pregnancy complications 
among women living in urban areas were marginally higher for Indigenous women; and 
marginally higher for non-Indigenous women among women living in regional areas (Table 
3.5). 
Overall Indigenous women had higher rates of preterm birth (11.4% vs 6.5%, RR 1.76, 
95%CI 1.72-1.81), the disparity in rates was larger with regional and remote residence 
than urban residence. 
Disparity in rates of low birthweight (assessed using WHO cut points of <1500g and 
<2500g for extremely low and low birthweight, respectively), showed the greatest disparity 
in rates of low and extremely low birthweight in remote areas, followed by regional and 
then urban areas.  However, when small-for-gestational age was assessed (defined as 
birthweight less than 10th Australian population birthweight percentile for sex and 
gestational age), disparity was greatest for women living in regional areas (RR 1.82, 95% 
CI 1.77-1.87), followed by remote (RR 1.76, 95% CI 1.65-1.87) and then urban areas (RR 
1.59 95% CI 1.52-1.67) (Table 3.5). 
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Table 3.4: Distribution of maternal characteristics by Indigenous status and geographic location, Queensland, 1995-2011 
Characteristics 
Indigenous Non-Indigenous 
Urban 
% 
Regional 
% 
Remote 
% 
Total 
% 
p 
value 
Urban 
% 
Regional 
% 
Remote 
% 
Total 
% 
p 
value 
Total births n=1028
1 
 
n=28820 
 
n=1034
7 
 
n=4944
8 
 
 n=50308
5 
 
n=30640
2 
 
n=2225
5 
 
n=8317
42 
 
 
Maternal age 
    
      
     20 years or less 24.0 26.6 26.6 26.1 <0.001 7.0 9.6 8.0 8.0 <0.001 
     35 years or older 8.7 8.0 7.5 8.1 0.003 18.6 14.9 13.4 17.1 <0.001 
Smoker 46.6 54.8 54.3 53.0 <0.001 14.5 20.7 18.2 16.8 <0.001 
Substance Use 3.3 1.3 0.7 1.6 <0.001 0.6 0.5 0.2 0.5 <0.001 
Socioeconomic status           
     Lowest ranked 20% 33.0 32.2 65.8 39.3 <0.001 15.0 17.7 19.8 16.1 <0.001 
     Highest ranked 20% 9.1 0.6 0.1 2.3 <0.001 20.3 2.5 3.0 13.3 <0.001 
Primigravidity 25.2 23.4 22.0 23.5 <0.001 31.0 28.9 29.4 30.2 <0.001 
Assisted conception 1.1 0.4 0.3 0.5 <0.001 3.6 2.3 2.2 3.1 <0.001 
Public patient 94.2 98.2 99.7 97.7 <0.001 66.2 73.7 77.3 69.3 <0.001 
Number of antenatal care visits           
     Less than 2 5.5 6.9 6.0 6.5 <0.001 0.9 1.1 1.0 1.0 <0.001 
     8 or more 50.6 45.7 52.5 48.1 <0.001 74.8 71.9 69.2 73.6 <0.001 
Pregnancy complications 61.2 57.6 59.4 58.7 <0.001 60.6 56.7 56.6 59.0 <0.001 
Male babies 51.9 51.6 51.6 51.7 0.85 51.4 51.6 51.6 51.5 0.45 
Preterm birth 10.0 11.9 11.6 11.4 <0.001 6.6 6.4 5.8 6.5 <0.001 
Birthweight           
     Extremely low (<1500g) 2.1 2.6 2.7 2.5 0.005 1.1 1.2 1.0 1.1 0.01 
     Low (<2500g) 9.2 11.5 10.3 10.8 <0.001 5.0 5.1 4.4 5.0 <0.001 
     Less than 10
th
 population 
centile 
14.2 17.3 14.9 16.2 
<0.001 
8.9 9.5 8.5 9.1 
<0.001 
Stillbirth (per 1000 births) 8.5 10.8 12.5 10.7 0.02 5.8 6.1 5.3 5.9 0.07 
*remoteness status unavailable for 2 women 
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Table 3.5: Comparison of maternal characteristics (Indigenous versus non-Indigenous) by geographic location, Queensland, 
1995-2011 
Characteristics 
Relative Risk (95% Confidence Interval) 
Urban Regional Remote Total 
Maternal age     
     20 years or younger 3.44 (3.32-3.56) 2.78 (2.72-2.84) 3.33 (3.15-3.52) 3.28 (3.22-3.33) 
     35 years or older 0.47 (0.44-0.50) 0.54 (0.52-0.56) 0.56 (0.52-0.60) 0.47 (0.46-0.49) 
Smoker 3.22 (3.11-3.33) 2.65 (2.60-2.70) 2.98 (2.83-3.14) 3.16 (3.11-3.21) 
Substance Use 5.32 (4.76-5.95) 2.85 (2.54-3.19) 3.52 (2.45-5.06) 2.93 (2.71-3.16) 
Socioeconomic status     
     Lowest ranked 20% 2.20 (2.14-2.26) 1.83 (1.79-1.86) 3.31 (3.22-3.42) 2.44 (2.41-2.47) 
     Highest ranked 20% 0.45 (0.42-0.48) 0.22 (0.19-0.26) 0.04 (0.03-0.07) 0.17 (0.16-0.18) 
Primigravidity 0.82 (0.79-0.84) 0.81 (0.79-0.83) 0.75 (0.72-0.78) 0.78 (0.77-0.79) 
Assisted conception 0.29 (0.24-0.35) 0.16 (0.13-0.19) 0.13 (0.09-0.18) 0.16 (0.14-0.18) 
Public patient 1.42 (1.42-1.43) 1.33 (1.33-1.34) 1.29 (1.28-1.30) 1.41 (1.41-1.41) 
Number of antenatal care visits     
     Less than 2 6.15 (5.65-6.70) 6.52 (6.17-6.88) 5.78 (4.98-6.71) 6.73 (6.46-7.00) 
     8 or more 0.68 (0.66-0.69) 0.64 (0.63-0.64) 0.76 (0.74-0.78) 0.65 (0.65-0.66) 
Pregnancy complications 1.02 (1.00-1.04) 0.98 (0.97-0.99) 1.00 (0.98-1.03) 0.97 (0.96-0.98) 
Male babies 1.01 (0.99-1.03) 1.00 (0.99-1.00) 1.00 (0.98-1.02) 1.00 (1.00-1.01) 
Preterm birth 1.52 (1.44-1.62) 1.85 (1.79-1.91) 2.02 (1.87-2.17) 1.76 (1.72-1.81) 
Birthweight     
     Extremely low (<1500g) 1.86 (1.63-2.14) 2.26 (2.09-2.44) 2.77 (2.32-3.31) 2.24 (2.11-2.37) 
     Low (<2500g) 1.83 (1.72-1.95) 2.25 (2.17-2.33) 2.34 (2.16-2.55) 2.14 (2.09-2.20) 
     Less than 10th population centile 1.59 (1.52-1.67) 1.82 (1.77-1.87) 1.76 (1.65-1.87) 1.77 (1.73-1.81) 
Stillbirth 1.47 (1.18-1.81) 1.76 (1.56-1.98) 2.37 (1.84-3.04) 1.81 (1.66-1.98) 
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Stillbirth rate trends by Indigenous status and geographic location 
Figure 3.3 shows trends in stillbirth rates by Indigenous status and geographic location 
over 17 years. Over the period 1995 to 2011, the stillbirth rate for all women birthing in 
Queensland was steady around 6.2/1000 ongoing pregnancies.  Among Indigenous 
women, stillbirth rates decreased 31.9% from 13.3 to 9.1/1000 ongoing pregnancies 
(ptrend=0.014); while stillbirth rates among non-Indigenous women was steady around 
5.9/1000 ongoing pregnancies.  The difference in overall stillbirth rates between 
Indigenous and non-Indigenous women reduced by 57.3% from 7.5 to 3.2/1000 ongoing 
pregnancies over this period (Figure 3.1).  Stillbirth rates among Indigenous women 
decreased by 10.2%, 29.2% and 49.9% for women living in urban, regional and remote 
areas, respectively.  In contrast, stillbirth rates among non-Indigenous women increased 
by 0.9% and 11.4% for women living in urban and regional areas and decreased by 39.2% 
among non-Indigenous women living in remote areas (Figure 3.3).  
 
Figure 3.3: Stillbirth rates by Indigenous status and geographic location, singleton 
births, Queensland, 1995-2011 
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The difference in stillbirth rates between Indigenous and non-Indigenous women 
decreased by 25.7%, 57.0% and 56.1% for urban, regional and remote areas, 
respectively.   
 
Stillbirth rate trends by Indigenous status and gestational age 
Figures 3.4a and 3.4b show stillbirth rates by Indigenous status and gestational age 
groupings using the Feldman (prospective) and Yudkin (‘instantaneous’) methods, 
respectively.  
Using the Feldman method, stillbirth rates among Indigenous women decreased by 31.9%, 
42.9%, 48.0% and 7.1% for births at ≥20, ≥24, ≥28 and ≥37 weeks, respectively (Figure 
3.4a). Similarly, using the Yudkin method, the corresponding stillbirth rates among 
Indigenous women decreased by 9.5%, 29.3%, 69.1% and 7.1% for births at <24 weeks, 
24-27 weeks, 28-36 weeks and ≥37 weeks, respectively (Figure 3.4b). 
Among non-Indigenous women, using the Feldman method, stillbirth rates increased by 
0.9% at ≥20 weeks and decreased by 14.9%, 16.8% and 21.7% at ≥24, ≥28 and ≥37 
weeks, respectively (Figure 3.4a). Using the Yudkin method, there was a 36.3% increase 
in stillbirth rates at <24 weeks and decreases in the remaining groups of 9.0%, 12.4% and 
21.7%, respectively (Figure 3.4b). Results from both methods showed reductions in the 
difference in stillbirth rates between Indigenous and non-Indigenous women at all 
gestational age groupings except ≥37 weeks.  The difference in stillbirth rates at ≥37 
weeks between Indigenous and non-Indigenous women increased by 18.0% (0.9/1000 to 
1.1/1000 ongoing pregnancies) and between 2001 and 2011, the difference was steady 
around 1.2/1000 ongoing pregnancies. 
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Figure 3.4a: Prospective stillbirth rates by Indigenous status and gestational age 
grouping, singleton births, Queensland, 1995-2011 (Feldman method) 
 
 
Figure 3.4b: Stillbirth rates by Indigenous status and gestational age grouping, 
singleton births, Queensland, 1995-2011 (Yudkin method) 
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Overall stillbirth rates by Indigenous status and gestational age  
Tables 3.6a and 3.6b present overall stillbirth rates by gestational age grouping for 
Indigenous and non-Indigenous women.  Stillbirth rates were higher among Indigenous 
women for all gestational age groupings assessed and all methods used.  The gestational 
age specific stillbirth rates were not statistically different from each other.  
 
Table 3.6a: Overall stillbirth rates by Indigenous status and gestational age 
grouping using Feldman method, Queensland, 1995-2011 
 ≥20 weeks ≥24 weeks  ≥28 weeks ≥37 weeks 
Indigenous 10.60 6.44 4.93 2.42 
Non-Indigenous 5.88 3.65 2.84 1.42 
Relative Risk  
(95% CI)a 
1.80  
(1.65-1.97) 
1.77  
(1.57-1.98) 
1.74  
(1.52-1.98) 
1.71 
(1.40-2.09) 
a
 Relative risk = Indigenous relative to non-Indigenous rates 
 
Table 3.6b: Overall stillbirth rates by Indigenous status and gestational age 
grouping using Yudkin method, Queensland, 1995-2011 
Yudkin method <24 weeks 24-27 weeks 28-36 weeks 37-42+ weeks 
Indigenous 4.21 1.55 2.75 2.42 
Non-Indigenous 2.25 0.82 1.51 1.42 
Relative Risk  
(95% CI)a 
1.87 
(1.62-2.16) 
1.89 
(1.49-2.40) 
1.83 
(1.53-2.18) 
1.71 
(1.40-2.09) 
a
 Relative risk = Indigenous relative to non-Indigenous rates 
 
Comparison of cause-specific stillbirth rates 
The overall stillbirth rate among Indigenous women was higher than for non-Indigenous 
women (10.7 vs 5.9/1000 ongoing pregnancies, RR 1.81, 95%CI 1.66-1.98)(Tables 3.4 
and 3.5).  The major PSANZ-PDC categories contributing to the disparity were: maternal 
conditions, perinatal infection, no obstetric antecedent, spontaneous preterm, 
hypertension, fetal growth restriction, unexplained antepartum fetal death and antepartum 
haemorrhage (Table 3.7). 
Overall, Indigenous women had a nearly four-fold increased risk of stillbirth due to 
maternal conditions (RR 3.78, 95%CI 2.59-5.51) and perinatal infection (RR 3.70, 95% CI 
2.54-5.39).  Pre-existing and gestational diabetes constituted a large component (42.2%) 
of maternal conditions; and Indigenous women had over a six-fold increased risk of 
stillbirth due to diabetes (RR 6.42, 95% 3.89-10.6).  Perinatal infections were comprised of 
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bacterial infections (53.0%), viral and other (fungal and protozoal) infections. While 
numbers are small, there was a significantly increased risk of stillbirth due to syphilis 
infection among Indigenous women (Table 3.7).   
More than half (56.3%; 56.0% Indigenous and 56.3% non-Indigenous) of all stillbirths 
assigned to the category of spontaneous preterm had evidence of placental 
chorioamnionitis and a further 7.6% (6.7% Indigenous and 7.8% non-Indigenous) had 
clinical chorioamnionitis.  Indigenous women had a three-fold increased risk of stillbirth 
due to spontaneous preterm birth (RR 3.08, 95% CI 2.51-3.77).  
The majority of stillbirths (65.5%) attributed to hypertension were due to chronic 
hypertension with or without superimposed pre-eclampsia.  The risk of stillbirth due to 
hypertension was significantly higher for Indigenous compared to non-Indigenous women 
(RR 2.22, 95% CI 1.45-3.39). Indigenous women had an increased risk of stillbirth due to 
fetal growth restriction (RR 1.78, 95% CI 1.17-2.71) and antepartum haemorrhage (RR 
1.58, 95% CI 1.13-2.22). Placental abruption accounted for 86.0% of all stillbirths 
attributed to antepartum haemorrhage. 
The risk of unexplained antepartum fetal death was higher for Indigenous women (RR 
1.61, 95% CI 1.37-1.90), further, there were 69 stillbirths classified as having no obstetric 
antecedent identified and births to Indigenous women were over-represented within this 
category (RR 3.19, 95% CI 1.67-6.08). 
No increased risk of stillbirth was evident for the main categories of congenital 
abnormality, hypoxic peripartum death or stillbirth due to specific perinatal conditions 
(including antenatal cord complication and feto-maternal haemorrhage) among Indigenous 
women compared with non-Indigenous women (Table 3.7). However, within subgroups an 
increased risk of stillbirth due to central nervous system (CNS) abnormality (RR 1.84, 95% 
CI 1.27-2.66) and uterine abnormalities (including cervical incompetence) (RR 2.59, 95% 
CI 1.10-6.11) was observed. 
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Table 3.7: Comparison of cause specific prospective stillbirth rates by Indigenous status, 
singleton births, Queensland, 1995-2011 
PSANZ Perinatal Death Classification 
Category 
Indigenous 
Non-
Indigenous 
Total 
n=49,450 n=831,761 n=881,211 
n rate
b
 n rate
b
 n rate
b
 RR (95% CI) 
All cause
a
 527 10.7 4898 5.9 5425 6.2 1.81 (1.66-1.98) 
Congenital Abnormality 75 1.5 1138 1.4 1213 1.4 1.11 (0.88-1.40) 
   Central nervous system 31 0.6 284 0.3 315 0.4 1.84 (1.27-2.66) 
   Cardiovascular system 5 0.1 122 0.1 127 0.1 0.69 (0.28-1.69) 
   Chromosomal 13 0.3 352 0.4 365 0.4 0.62 (0.36-1.08) 
   Multiple 13 0.3 161 0.2 174 0.2 1.36 (0.77-2.39) 
   Other 13 0.3 219 0.3 232 0.3 1.00 (0.57-1.75) 
Perinatal Infection 33 0.7 150 0.2 183 0.2 3.70 (2.54-5.39) 
   GBS 3 0.1 30 0.0 33 0.0 1.68 (0.51-5.51) 
   Syphilis 15 0.3 1 0.0 16 0.0 252 (33-1910) 
   Other bacterial 7 0.1 41 0.0 48 0.1 2.87 (1.29-6.40) 
   Viral 1 0.0 43 0.1 44 0.0 0.39 (0.05-2.84) 
   Fungal/Protozoal/other 7 0.1 35 0.0 42 0.0 3.36 (1.49-7.57) 
Hypertension 24 0.5 182 0.2 206 0.2 2.22 (1.45-3.39) 
   Pre-existing 9 0.2 53 0.1 62 0.1 2.86 (1.41-5.79) 
   Pregnancy induced/Pre-eclampsia 14 0.3 127 0.2 141 0.2 1.85 (1.07-3.22) 
   Unspecified 1 0.0 2 0.0 3 0.0 8.41 (0.76-92.7) 
Antepartum Haemorrhage 37 0.7 393 0.5 430 0.5 1.58 (1.13-2.22) 
   Abruption 31 0.6 339 0.4 370 0.4 1.54 (1.06-2.22) 
   Other 6 0.1 54 0.1 60 0.1 1.87 (0.80-4.34) 
Maternal conditions 33 0.7 147 0.2 180 0.2 3.78 (2.59-5.51) 
   Diabetes 21 0.4 55 0.1 76 0.1 6.42 (3.88-10.6) 
   Autoimmune (lupus) 3 0.1 7 0.0 10 0.0 7.21 (1.86-27.9) 
   Other 9 0.2 85 0.1 94 0.1 1.78 (0.90-3.54) 
Specific perinatal conditions 16 0.3 261 0.3 277 0.3 1.03 (0.62-1.71) 
   Fetomaternal haemorrhage 4 0.1 49 0.1 53 0.1 1.37 (0.50-3.80) 
   Antenatal cord complication 3 0.1 83 0.1 86 0.1 0.61 (0.19-1.92) 
   Uterine abnormalities 6 0.1 39 0.0 45 0.1 2.59 (1.10-6.11) 
   Other 3 0.1 90 0.1 93 0.1 0.56 (0.18-1.77) 
Hypoxic peripartum death 6 0.1 103 0.1 109 0.1 0.98 (0.43-2.23) 
   With intrapartum complications 2 0.0 49 0.1 51 0.1 0.69 (0.17-2.82) 
   No/Unspecified intrapartum complications 4 0.1 54 0.1 58 0.1 1.25 (0.45-3.44) 
Fetal growth restriction 24 0.5 227 0.3 251 0.3 1.78 (1.17-2.71) 
   Reduced vascular perfusion 13 0.3 128 0.2 141 0.2 1.71 (0.97-3.02) 
   Other 11 0.2 99 0.1 110 0.1 1.87 (1.00-3.48) 
Spontaneous preterm 110 2.2 601 0.7 711 0.8 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 157 3.2 1638 2.0 1795 2.0 1.61 (1.37-1.90) 
No obstetric antecedent 11 0.2 58 0.1 69 0.1 3.19 (1.67-6.08) 
a
 Clinical classification data missing for 1 stillbirth (Indigenous).  “Other” category consists of combinations of 
subcategories.   
b
Rate per 1000 ongoing pregnancies ≥20 weeks or ≥ 400g birthweight 
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Temporal trends in cause-specific stillbirth rates by Indigenous status 
Tables 3.8 and 3.9 show the temporal trends in cause-specific stillbirth rates among 
Indigenous (Table 3.8) and non-Indigenous women (Table 3.9).  Among Indigenous 
women, decreasing rates of stillbirth due to perinatal infection (ptrend<0.001) and 
conversely, increasing rates of stillbirth due to fetal growth restriction (ptrend=0.040) were 
shown over the study period. (Table 3.8).  Among non-Indigenous women, significant 
increases in the rates of stillbirth due to congenital abnormality (ptrend<0.001) and 
spontaneous preterm birth (ptrend=0.013) were shown concurrent with decreases in the 
rates of stillbirth due to hypertension (ptrend<0.001), antepartum haemorrhage 
(ptrend<0.001), perinatal infection (ptrend=0.029), maternal conditions (ptrend=0.044) and 
unexplained antepartum fetal death (ptrend=0.011) (Table 3.9).  
 
Table 3.10 shows trends in the cause specific relative risk of stillbirth for Indigenous 
relative to non-Indigenous women.  The magnitude of disparity in all-cause rates did not 
vary significantly over the study period.  In addition, there were significantly higher rates of 
stillbirth due to maternal conditions and spontaneous preterm birth, with no evidence of 
significant variation in disparity of the 17 years assessed (Table 3.10). 
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Table 3.8: Temporal trends in cause-specific stillbirth rates, Indigenous women, singleton births, Queensland, 1995-2011 
PSANZ-PDC category 1995-97 1998-00 2001-03 2004-06 2007-09 2010-11 Total 
% 
difference 
ptrend 
Congenital abnormality 1.9 1.7 0.4 1.4 2.2 1.6 1.5 -15.8 0.170 
    Central nervous system 0.7 0.8 0.1 0.6 0.7 0.8 0.6 14.3 0.319 
    Cardiovascular system 0.1 0.0 0.1 0.0 0.3 0.0 0.1 -100.0 0.550 
    Chromosomal 0.3 0.1 0.1 0.3 0.4 0.3 0.3 0 0.215 
    Multiple/non-chromosomal 0.4 0.4 0.0 0.1 0.3 0.4 0.3 0 0.688 
Perinatal Infection 2.4 0.5 0.6 0.1 0.3 0.3 0.7 -87.5 <0.001 
    Syphilis 1.2 0.2 0.2 0.0 0.0 0.3 0.3 -75.0 0.003 
    Other bacterial 0.4 0.0 0.2 0.0 0.2 0.0 0.1 -100.0 0.310 
Hypertension 0.7 0.8 0.4 0.3 0.3 0.4 0.5 -42.9 0.351 
    Pregnancy Induced/Pre-eclampsia 0.4 0.5 0.4 0.1 0.1 0.3 0.3 -25.0 0.337 
Antepartum haemorrhage 1.1 0.7 1.1 0.8 0.6 0.1 0.7 -90.9 0.184 
    Placental abruption 0.8 0.6 1.0 0.8 0.5 0.0 0.6 -100.0 0.226 
Maternal conditions 0.7 0.6 1.2 0.6 0.5 0.4 0.7 -42.9 0.775 
    Diabetes 0.3 0.4 1.0 0.2 0.4 0.3 0.4 0 0.835 
Specific perinatal conditions 0.3 0.5 0.7 0.1 0.2 0.1 0.3 -66.7 0.392 
    Antepartum cord complications 0.1 0.0 0.1 0.0 0.1 0.0 0.1 -100 0.714 
Hypoxic peripartum death 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0 0.343 
Fetal growth restriction 0.1 0.5 0.4 0.6 0.7 0.6 0.5 500.0 0.040 
    Reduced vascular perfusion +/- 
 placental histopathology 
0.0 0.2 0.1 0.2 0.4 0.6 0.3 - 0.010 
Spontaneous preterm 2.7 1.8 2.7 2.2 2.2 1.8 2.2 -33.3 0.697 
Unexplained antepartum fetal death 3.3 3.5 3.2 3.0 2.7 3.5 3.2 6.1 0.294 
No obstetric antecedent 0.1 0.1 0.0 0.8 0.2 0.0 0.2 -100.0 0.455 
All cause 13.3 10.8 10.8 10.0 10.0 9.1 10.6 -31.6 0.015 
Autopsy rate (per 100 SBs) 36.0 48.3 25.0 42.5 40.8 32.8 37.8 8.9  
% difference = (rate (2010-11) minus rate (1995-97)) x 100 / rate (1995-97) 
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Table 3.9: Temporal trends in cause-specific stillbirth rates, non-Indigenous women, singleton births, Queensland, 1995-2011 
PSANZ-PDC category 1995-97 1998-00 2001-03 2004-06 2007-09 2010-11 Total 
% 
difference 
ptrend 
Congenital abnormality 1.0 1.2 1.2 1.4 1.7 1.6 1.4 60.0 <0.001 
    Central nervous system 0.3 0.2 0.3 0.4 0.4 0.5 0.3 66.7 0.003 
    Cardiovascular system 0.1 0.1 0.1 0.1 0.2 0.2 0.1 100.0 0.001 
    Chromosomal 0.3 0.4 0.4 0.4 0.4 0.5 0.4 66.7 0.047 
    Multiple/non-chromosomal 0.2 0.1 0.2 0.2 0.3 0.1 0.2 -50.0 0.639 
Perinatal Infection 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0 0.029 
    Syphilis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0.746 
    Other bacterial 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0 0.185 
Hypertension 0.5 0.2 0.1 0.2 0.2 0.1 0.2 -80.0 <0.001 
   Pregnancy Induced/Pre-
eclampsia 
0.2 0.1 0.1 0.2 0.2 0.1 0.2 -50.0 0.126 
Antepartum haemorrhage 0.6 0.6 0.4 0.5 0.4 0.4 0.5 -33.3 <0.001 
   Placental abruption 0.6 0.4 0.3 0.4 0.4 0.3 0.4 -50.0 0.003 
Maternal conditions 0.2 0.1 0.2 0.2 0.1 0.1 0.2 -50.0 0.044 
    Diabetes 0.1 0.1 0.1 0.1 0.1 0.0 0.1 -100.0 0.389 
Specific perinatal conditions 0.3 0.3 0.4 0.3 0.4 0.3 0.3 0 0.463 
    Antepartum cord 
complications 
0.0 0.1 0.1 0.1 0.1 0.1 0.1 - 0.021 
Hypoxic peripartum death 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0 0.426 
Fetal growth restriction 0.2 0.2 0.3 0.3 0.3 0.3 0.3 50.0 0.068 
    Reduced vascular perfusion 
+/-  placental histopathology 
0.1 0.1 0.2 0.2 0.2 0.2 0.2 100.0 0.029 
Spontaneous preterm 0.5 0.7 0.7 0.8 0.8 0.7 0.7 40.0 0.013 
Unexplained antepartum fetal 
death 
2.1 2.0 2.1 2.0 1.8 1.9 2.0 -9.5 0.011 
No obstetric antecedent 0.0 0.1 0.0 0.1 0.1 0.2 0.1 - <0.001 
All cause 5.8 5.7 5.7 6.1 6.1 5.9 5.9 1.72 0.263 
Autopsy rate (per 100 SBs) 56.1 70.8 45.7 41.3 53.7 51.4 52.8 -8.4  
% difference = (rate (2010-11) minus rate (1995-97)) x 100 / rate (1995-97)      
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Table 3.10: Trends in cause specific relative risk of stillbirth for Indigenous relative to non-Indigenous women, Queensland, 1995-
2011 
PSANZ-PDC category 1995-1997 1998-2000 2001-2003 2004-2006 2007-2009 2010-2011 Total 
Congenital abnormality 1.81 (1.05-3.14) 1.44 (0.83-2.48) 0.29 (0.09-0.92) 0.96 (0.53-1.71) 1.30 (0.84-2.03) 0.97 (0.53-1.78) 1.11 (0.88-1.40) 
    Central nervous system 2.11 (0.83-5.33) 3.64 (1.61-8.27) 0.44 (0.06-3.19) 1.62 (0.65-4.04) 1.82 (0.84-3.97) 1.78 (0.77-4.13) 1.84 (1.27-2.66) 
    Cardiovascular system 1.27 (0.17-9.62) - 1.11 (0.15-8.39) - 1.36 (0.42-4.39) - 0.69 (0.28-1.69) 
    Chromosomal 0.84 (0.20-3.48) 0.28 (0.04-2.04) 0.30 (0.04-2.18) 0.79 (0.25-2.52) 0.92 (0.34-2.50) 0.55 (0.13-2.26) 0.62 (0.36-1.08) 
    Multiple/non-chromosomal 2.13 (0.64-7.04) 2.42 (0.72-8.14) - 0.49 (0.07-3.57) 1.20 (0.37-3.86) 3.20 (0.93-11.1) 1.36 (0.77-2.39) 
Perinatal Infection 9.96 (5.60-17.7) 2.15 (0.76-6.11) 4.38 (1.63-11.7) 0.69 (0.09-5.06) 1.98 (0.60-6.55) 1.78 (0.41-7.66) 3.70 (2.54-5.39) 
    Syphilis - - 33.3 (3.02-367) - - - 252 (33.3-1910) 
    Other bacterial 3.80 (1.09-13.2) - 4.75 (0.99-22.9) - 4.30 (0.91-20.2) - 2.87 (1.29-6.40) 
Hypertension 1.27 (0.51-3.13) 4.91 (2.11-11.4) 2.93 (0.86-10.0) 1.90 (0.58-6.27) 1.78 (0.54-5.83) 3.00 (0.87-10.3) 2.22 (1.45-3.39) 
   Pre-eclampsia/ Eclampsia 1.90 (0.58-6.24) 3.23 (1.10-9.44) 3.33 (0.96-11.5) 0.71 (0.10-5.28) 0.61 (0.08-4.51) 2.67 (0.60-11.9) 1.85 (1.07-3.22) 
Antepartum haemorrhage 1.69 (0.82-3.48) 1.31 (0.57-3.01) 2.82 (1.39-5.72) 1.69 (0.78-3.67) 1.45 (0.63-3.34) 0.40 (0.06-2.91) 1.58 (1.13-2.22) 
   Placental abruption 1.40 (0.61-3.21) 1.42 (0.57-3.53) 3.09 (1.46-6.58) 2.00 (0.91-4.37) 1.34 (0.54-3.33) - 1.54 (1.07-2.22) 
Maternal conditions 3.05 (1.18-7.89) 4.25 (1.59-11.4) 5.36 (2.63-10.9) 2.68 (1.04-6.87) 3.58 (1.37-9.38) 4.00 (1.13-14.2) 3.78 (2.59-5.51) 
    Diabetes 5.06 (1.05-24.4) 4.84 (1.33-17.6) 13.3 (5.25-33.7) 2.28 (0.52-9.99) 6.25 (1.99-19.6) 16.01 (2.26-
113) 
6.42 (3.89-10.6) 
Specific perinatal conditions 1.01 (0.24-4.21) 1.66 (0.59-4.63) 1.96 (0.84-4.56) 0.44 (0.06-3.20) 0.55 (0.14-2.27) 0.46 (0.06-3.34) 1.03 (0.62-1.71) 
    Antepartum cord 
complications 
5.91 (0.61-56.8) - 0.88 (0.12-6.54) - 1.07 (0.14-8.10) -  
Hypoxic peripartum death 1.11 (0.15-8.35) - 0.92 (0.12-6.92) 1.01 (0.13-7.57) 1.49 (0.35-6.34) 1.60 (0.21-12.5) 0.98 (0.43-2.23) 
Fetal growth restriction 0.74 (0.10-5.46) 2.08 (0.74-5.90) 1.19 (0.37-3.83) 1.82 (0.73-4.58) 2.36 (1.07-5.19) 2.00 (0.71-5.66) 1.78 (1.17-2.71) 
    Reduced vascular perfusion 
+/- placental histopathology 
- 1.79 (0.42-7.73) 0.69 (0.09-5.12) 1.31 (0.31-5.55) 2.37 (0.83-6.74) 3.05 (1.05-8.88) 1.71 (0.97-3.02) 
Spontaneous preterm 5.13 (3.12-8.44) 2.50 (1.45-4.30) 3.93 (2.47-6.26) 2.78 (1.71-4.52) 2.56 (1.62-4.05) 2.48 (1.38-4.44) 3.08 (2.51-3.77) 
Unexplained antepartum 
fetal death 
1.62 (1.08-2.44) 1.79 (1.22-2.63) 1.52 (1.02-2.27) 1.47 (0.98-2.19) 1.47 (0.99-2.20) 1.89 (1.25-2.86) 1.61 (1.37-1.90) 
No obstetric antecedent 5.91 (0.61-56.8) 2.02 (0.25-16.1) - 8.57 (3.46-21.2) 3.44 (0.75-15.7) - 3.19 (1.67-6.08) 
All cause 2.29 (1.87-2.82) 1.89 (1.52-2.36) 1.87 (1.50-2.33) 1.64 (1.32-2.04) 1.66 (1.35-2.04) 1.55 (1.20-2.00) 1.81 (1.65-1.98) 
Autopsy rate (per 100 SBs) 0.64 (0.49-0.84) 0.68 (0.55-0.85) 0.55 (0.38-0.79) 1.03 (0.80-1.33) 0.76 (0.60-0.97) 0.64 (0.45-0.91) 0.72 (0.64-0.80) 
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Cause-specific stillbirth rates by geographic location  
 
In urban areas, Indigenous women had increased risk of stillbirth due to perinatal infection 
and spontaneous preterm birth; while Indigenous women living in remote areas had 
increased risk of stillbirth due to central nervous system abnormality (RR 3.38, 95% CI 
1.31-8.72), maternal conditions, spontaneous preterm birth and unexplained antepartum 
fetal death.  Indigenous women living in regional areas had increased risk of stillbirth due to 
perinatal infection [particularly syphilis and non GBS bacterial infection], hypertension 
including gestational hypertension and pre-eclampsia with or without chronic hypertension 
(RR 2.26, 95% CI 1.14-4.48), maternal conditions including diabetes (RR 6.38, 95% CI 
3.12-13.05), fetal growth restriction, spontaneous preterm birth and unexplained 
antepartum fetal death (Table 3.11). 
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Table 3.11: Relative risk of stillbirth for Indigenous versus non-Indigenous women by geographic location, Queensland, 1995-
2011 
PSANZ Perinatal Death Classification 
Category 
Relative Risk 
Indigenous versus Non Indigenous 
Urban Regional Remote Total 
Congenital abnormality 1.02 (0.60-1.73) 1.06 (0.78-1.45) 1.11 (0.63-1.95) 1.11 (0.88-1.40) 
Perinatal Infection 3.09 (1.35-7.05) 3.67 (2.18-6.19) - 3.70 (2.54-5.39) 
Hypertension 0.81 (0.20-3.27) 3.17 (1.85-5.45) 2.69 (0.72-10.01) 2.22 (1.45-3.39) 
Antepartum haemorrhage 1.75 (0.82-3.71) 1.31 (0.85-2.03) 1.37 (0.53-3.52) 1.58 (1.13-2.22) 
Maternal conditions 2.15 (0.79-5.85) 4.38 (2.63-7.28) 3.44 (1.13-10.52) 3.78 (2.59-5.51) 
     Diabetes 2.80 (0.67-11.6) 6.38 (3.12-13.1) - 6.42 (3.88-10.6) 
Specific perinatal conditions 0.63 (0.16-2.53) 0.87 (0.42-1.78) 1.84 (0.62-5.48) 1.03 (0.62-1.71) 
Hypoxic peripartum death 0.78 (0.11-5.60) 1.22 (0.43-3.42) 0.43 (0.05-3.68) 0.98 (0.43-2.23) 
Fetal growth restriction 1.31 (0.49-3.55) 2.70 (1.61-4.52) 0.61 (0.13-2.96) 1.78 (1.17-2.71) 
Spontaneous preterm 2.45 (1.54-3.88) 2.99 (2.24-3.99) 6.26 (3.16-12.41) 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 1.39 (0.95-2.03) 1.50 (1.20-1.86) 2.64 (1.64-4.23) 1.61 (1.37-1.90) 
No obstetric antecedent 1.69 (0.23-12.39) 2.28 (0.94-5.50) 8.60 (0.96-76.96) 3.19 (1.67-6.08) 
All cause 1.47 (1.18-1.81) 1.76 (1.56-1.98) 2.37 (1.84-3.04) 1.81 (1.66-1.98) 
Autopsy rate  
(Indigenous,  Non-Indigenous) 
Relative Risk (95% CI) 
 
28.7%, 40.0% 
0.72 (0.51-1.00) 
 
27.4%, 36.9% 
0.74 (0.61-0.90) 
 
18.6%, 42.7% 
0.44 (0.29-0.66) 
 
25.5%, 38.9% 
0.65 (0.56-0.76) 
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Cause-specific stillbirth rates by gestational age   
No change was shown in all-cause stillbirth risk for Indigenous women relative to non-
Indigenous women as gestational age increased (Table 3.12a and Table 3.13b).  Similarly, 
there were no statistically significant differences in cause-specific stillbirth risk by 
gestational age group. 
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Table 3.12a: Cause-specific relative risk of stillbirth for Indigenous relative to non-Indigenous women by gestational age 
grouping, Feldman method, singleton births, Queensland, 1995-2011 
PSANZ Perinatal Death Classification 
Category 
Relative Risk (95% Confidence Intervals) 
Indigenous versus Non Indigenous 
≥ 20 weeks ≥ 24 weeks ≥ 28 weeks ≥ 37 weeks 
Congenital abnormality 1.11 (0.88-1.41) 1.27 (0.87-1.87) 1.41 (0.91-2.21) 0.83 (0.26-2.65) 
Perinatal Infection 3.61 (2.47-5.29) 4.52 (2.85-7.16) 4.68 (2.69-8.14) 3.23 (1.35-7.71) 
Hypertension 2.22 (1.45-3.40) 1.97 (1.18-3.31) 1.74 (0.87-3.45) 2.09 (0.48-9.04) 
Antepartum haemorrhage 1.58 (1.13-2.22) 1.30 (0.83-2.02) 1.16 (0.69-1.96) 1.91 (0.88-4.17) 
Maternal conditions 3.66 (2.50-5.37) 3.46 (2.27-5.27) 4.02 (2.55-6.34) 5.78 (3.16-10.6) 
Specific perinatal conditions 1.03 (0.62-1.71) 0.82 (0.42-1.60) 1.02 (0.52-2.00) 0.21 (0.03-1.54) 
Hypoxic peripartum death 0.98 (0.43-2.23) 0.99 (0.44-2.26) 1.04 (0.46-2.37) 1.07 (0.43-2.64) 
Fetal growth restriction 1.78 (1.17-2.71) 2.20 (1.44-3.37) 2.36 (1.48-3.76) 2.85 (1.41-5.77) 
Spontaneous preterm 3.06 (2.49-3.75) 3.35 (2.16-5.19) 3.60 (1.59-8.14) - 
Unexplained antepartum fetal death 1.60 (1.36-1.89) 1.63 (1.37-1.95) 1.61 (1.32-1.95) 1.66 (1.28-2.17) 
No obstetric antecedent 2.90 (1.48-5.67) 2.41 (0.95-6.16) 3.03 (1.17-7.85) 1.04 (0.14-7.85) 
All cause 1.79 (1.64-1.96) 1.77 (1.58-1.99) 1.76 (1.54-2.00) 1.75 (1.44-2.13) 
Autopsy rates  
(Indigenous, Non-Indigenous) 
Relative Risk (95% CI) 
 
25.4%, 38.9% 
0.65 (0.56-0.76) 
 
29.2%, 43.7% 
0.67 (0.56-0.80) 
 
31.3%, 44.0% 
0.71 (0.59-0.86) 
 
31.2%, 45.0% 
0.69 (0.52-0.92) 
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Table 3.12b: Cause-specific relative risk of stillbirth for Indigenous relative to non-Indigenous women by gestational age 
grouping, Yudkin method, singleton births, Queensland, 1995-2011 
PSANZ Perinatal Death Classification 
Category 
Relative Risk (95% CI) 
Indigenous versus Non Indigenous 
< 24 weeks 24 - 27 weeks 28 – 36 weeks ≥ 37 weeks Totala 
Congenital abnormality 1.03 (0.77-1.38) 0.99 (0.46-2.13) 1.63 (1.00-2.64) 0.85 (0.27-2.69) 1.11 (0.88-1.40) 
Perinatal Infection 2.63 (1.35-5.12) 4.22 (1.85-9.67) 6.79 (3.26-14.1) 3.23 (1.35-7.71) 3.70 (2.54-5.40) 
Hypertension 2.99 (1.41-6.35) 2.41 (1.09-5.33) 1.67 (0.77-3.64) 1.05 (0.14-7.85) 2.22 (1.45-3.40) 
Antepartum haemorrhage 2.24 (1.33-3.78) 1.88 (0.81-4.36) 0.88 (0.43-1.79) 1.64 (0.71-3.79) 1.58 (1.13-2.22) 
Maternal conditions 5.89 (2.49-13.9) 1.69 (0.52-5.54) 2.83 (1.40-5.73) 5.79 (3.17-10.6) 3.78 (2.59-5.51) 
Specific perinatal conditions 1.55 (0.71-3.36) - 2.06 (0.99-4.29) 0.21 (0.03-1.54) 1.03 (0.62-1.71) 
Hypoxic peripartum death - - 1.13 (0.15-8.57) 1.08 (0.44-2.67) 0.98 (0.43-2.23) 
Fetal growth restriction - 1.69 (0.60-4.72) 2.12 (1.13-3.97) 2.86 (1.41-5.77) 1.78 (1.17-2.71) 
Spontaneous preterm 3.01 (2.40-3.79) 3.26 (1.94-5.49) 3.40 (1.41-8.16) - 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 1.53 (0.98-2.39) 1.81 (1.19-2.76) 1.63 (1.23-2.16) 1.67 (1.28-2.17) 1.61 (1.37-1.90) 
No obstetric antecedent 4.39 (1.79-10.78) - 6.17 (1.97-19.4) 1.11 (0.15-8.37) 3.19 (1.68-6.08) 
All cause 1.87 (1.62-2.16) 1.87 (1.47-2.37) 1.83 (1.53-2.18) 1.71 (1.40-2.09) 1.81 (1.65-1.98) 
Autopsy rates (Indigenous, Non-Indigenous) 
Relative Risk (95% CI) 
19.7%, 31.1% 
0.63 (0.48-0.84) 
22.7%, 42.7% 
0.53 (0.35-0.81) 
31.3%, 43.1% 
0.73 (0.56-0.94) 
30.2%, 45.1% 
0.67 (0.50-0.90) 
25.5%, 38.9% 
0.66 (0.56-0.76) 
a
 includes all birth ≥ 20 weeks 
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3.4 Discussion 
Main Findings   
The objective of this study was to examine the differences in stillbirth rates between 
Indigenous and non-Indigenous women birthing in Queensland over the period 1995-2011 
with a particular emphasis on variation by geographic location, gestational age and clinical 
classification of cause of stillbirth.  
We found that although Indigenous stillbirth rates were consistently higher than non-
Indigenous stillbirth rates, the gap had narrowed.  These findings mirror national reports of 
declining Indigenous stillbirth rates over the period 1991-2004 [56] and US reports among 
American Indian and Alaskan Native women  (7.5 to 6.2/1000 births between 1990 and 
2005)[188].  However, our study found that these reductions were not uniform across sub-
groups of Indigenous women.  Indigenous women living in regional and remote areas 
experienced greater reductions in stillbirth rates than their urban counterparts, and the 
stillbirth rate among Indigenous women varied significantly with geographic location.  
These findings are in contrast to two population-based studies carried out in Queensland 
[189] and nationally [190] that reported similar risk of stillbirth among Indigenous women 
regardless of urban or rural/remote residence.  The incongruence in findings may be due 
to confounding factors controlled for by Coory et al and Graham et al, as confounders 
were not adjusted for at this stage.   
In some high income countries, reports of increasing stillbirth rates have been attributed to 
inclusion of terminations for congenital abnormality in national counts of stillbirths [191]. In 
this study, we were unable to adequately quantify the contribution of terminations of 
pregnancy for congenital abnormality to the trends in stillbirth rates.  This was because 
such terminations were not systematically identified within the Queensland Perinatal Data 
Collection.  Provision was made in 2009 for identification of such terminations [124] 
however the data from that time period were incomplete. Analysis of the available data 
suggested higher rates of terminations among non-Indigenous women compared with 
Indigenous women (14.4% versus 6.7%), further suggesting that disparity between 
Indigenous and non-Indigenous women may be underestimated.  Our study also found 
that there was little narrowing of the stillbirth rate gap in gestational ages of 37 weeks or 
more. At these gestational ages, there was increased risk of stillbirth for Indigenous 
women due to maternal conditions (mainly diabetes), perinatal infection, fetal growth 
restriction.  Similar findings were reported among Inuit and First Nation women in Canada, 
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where excess stillbirths compared with non-Aboriginal women were attributed to fetal 
growth restriction, placental disorders and congenital anomalies among Inuit women and 
diabetes and hypertension among First Nation women [180].  In New Zealand, Māori 
women had increased risk for all PSANZ-PDC categories compared with New Zealand 
European women except hypoxic peripartum death and specific perinatal conditions, 
although the differences were not statistically significant [192]. Unexplained antepartum 
fetal death was also higher for Indigenous women at term.  These findings highlight the 
opportunity for further reductions in term stillbirths among the Indigenous population.  
Overall, we found an increased risk of stillbirth due to maternal conditions, perinatal 
infection, spontaneous preterm birth, hypertension, fetal growth restriction, antepartum 
haemorrhage and unexplained antepartum fetal death among Indigenous women 
compared with non-Indigenous women.  Most of these categories of stillbirth are 
potentially amenable to interventions in the pre-pregnancy and antenatal periods.  Flenady 
and colleagues highlighted strategies and interventions to address priority areas for 
stillbirth prevention in high income countries [28].  These strategies involve addressing risk 
factors for adverse pregnancy outcomes.  
 
Interpretation of findings 
Antenatal Care 
Inadequate antenatal care has been associated with increased risk of stillbirth [32] and 
Indigenous women in our study population had a six-fold higher rate of inadequate 
antenatal care (defined as less than two antenatal care visits).  Detection of fetal growth 
restriction, though challenging, is a key component of antenatal care. There is limited 
evidence from randomised controlled trials to inform best practice surveillance for 
pregnancies with growth restriction [193]. There is low level evidence for the use of 
Doppler ultrasound in high risk pregnancies to reduce the risk of perinatal death [194], 
however there is no conclusive evidence for the routine use of Doppler ultrasound in low 
risk or unselected populations [195].  Serial fundal height measurements with customised 
charts and clinical practice guidelines have been shown to increase antenatal detection of 
growth restriction [196]. Differentials in the rates of attendance and early initiation of 
antenatal care have been reported between Indigenous and non-Indigenous women [23].  
In addition, significant variation in the quality of antenatal care received by Indigenous 
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women has been reported including low rates of morphology ultrasound and screening for 
gestational diabetes and infection [197].  A number of maternal and child health programs 
and service delivery models aimed at improving outcomes for women within Indigenous 
communities in various states and territories have shown varying levels of success [198, 
199].  Features common to many successful programs are: community-based or controlled 
services, respect for Indigenous people and culture, continuity of care and an integrated 
spectrum of services, and consideration of logistic issues (e.g. transportation and child 
care) [198].  
 
Maternal smoking 
Maternal smoking during pregnancy has been associated with fetal growth restriction, 
placenta praevia, placental abruption, low birthweight, preterm birth and stillbirth [32, 57, 
200, 201]. The smoking rates among Indigenous women in our study were high (53.0%), 
similar to national rates (49.3% in 2010) [23], furthermore, smoking quit rates among 
Indigenous women are lower than for non-Indigenous women [23, 202].  There is evidence 
to show that psychosocial interventions can increase smoking cessation rates in late 
pregnancy and decrease rates of preterm birth and low birthweight [203]; however, there is 
insufficient evidence to show the safety or effectiveness of nicotine replacement therapy 
for smoking cessation in pregnancy [204]. Incentive-based programs look promising in 
increasing quit rates post-pregnancy, however further research is needed to investigate 
the endurance of such programs [205]. This highlights a need for effective policy and 
guidelines for smoking cessation interventions tailored and targeted to Indigenous women.  
 
Diabetes 
There was a six-fold increased risk of stillbirth due to diabetes among Indigenous mothers.  
These findings are consistent with reports that Indigenous women have disproportionally 
higher rates of pre-existing and gestational diabetes in pregnancy than non-Indigenous 
women [89].  At present there is little evidence for or against pre-conception care for 
women with pre-existing diabetes [206], although lower rates of congenital abnormalities 
have been reported among women with Type 1 diabetes receiving preconception care 
compared to those who did not [207].  Likewise, lifestyle modifications in combination with 
insulin were found to improve birth outcomes for women with mild gestational diabetes 
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[208].  However, interventions to prevent or manage diabetes have not had the same 
magnitude of impact within the Indigenous population and not enough clinical focus on 
women at risk or women with diabetes has been given as a possible explanation for 
this[198].  Gestational diabetes is strongly linked with high body mass index 
(BMI>35kg/m2) [9]. High BMI is also independently associated with stillbirth [32].  With 
increasing prevalence of high BMI in women of childbearing age and higher rates of 
obesity among Indigenous women of childbearing age [209], efforts to ensure that women 
enter pregnancy with a normal BMI is critically important to optimise outcomes for both the 
woman and her offspring [32].  
 
Congenital abnormalities 
Our study found an increased risk of stillbirth due to CNS abnormalities among Indigenous 
women, especially those living in remote areas.  These findings are supported by national 
reports of higher rates of neural tube defects (NTDs), the most common CNS 
abnormalities, among Indigenous women and women living in remote areas [210]. The 
association between folate and reduced risk of NTDs has been well established.  Lifestyle 
factors such as fruit and vegetable intake, smoking and high levels of alcohol consumption 
have been associated with folate deficiency [211]. It has been suggested that for some 
remote Aboriginal and Torres Strait Islander communities, micronutrient deficiency may be 
a direct result of limited availability and high costs of healthy food such as fruit and 
vegetables [212, 213].   A number of strategies were employed to reduce the prevalence 
of folate deficiency among women of childbearing age including promotion of peri-
conceptual folic acid supplementation (1992), voluntary fortification of specified food 
products (1996) and mandatory folic acid fortification of wheat flour (2009) [214].  
Reductions in rates of NTD were observed following voluntary fortification but these 
reductions were limited mainly to the non-Indigenous population [214, 215].  At present, 
there is limited information on the impact of mandatory fortification on folate levels among 
women of childbearing age or Indigenous women [216].   
 
Perinatal Infection 
We found a disproportionately high burden of stillbirth due to perinatal infection among 
Indigenous women, particularly syphilis. This finding is supported by several studies that 
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found high rates of sexually transmitted infections (STIs) among Indigenous women of 
reproductive age living in rural communities [217, 218] and pregnant Indigenous women 
living in urban areas [219]. Similarly, a population based study in Western Australia found 
infection to be an important cause of death for Indigenous infants [220].  Early diagnosis 
and treatment of syphilis has been shown to be associated with similar risk of stillbirth as 
general uninfected population [221].  A number of programs which demonstrated 
sustained reductions in rates of STIs in Aboriginal and Torres Strait Islander communities 
have highlighted the need for STI screening to be incorporated into antenatal care 
protocols for Indigenous women [198]. 
 
Preterm birth 
We found higher rates of preterm birth and higher risk of stillbirth due to spontaneous 
preterm birth among Indigenous compared with non-Indigenous women.  While preterm 
birth may be as a result of early induction of labour for medical or non-medical indications, 
most occur spontaneously and have been associated with infection, chronic diseases 
(diabetes and hypertension), socioeconomic disadvantage and genetic influence, however 
many are idiopathic [222].  Evidence for strategies to reduce preterm birth is limited and a 
better understanding of the mechanisms and causes of preterm to enable focused 
intervention studies is required [222]. 
 
Summary of findings 
The key findings in this study were that the gap in stillbirth rates between Indigenous and 
non-Indigenous women is decreasing; however Indigenous women remain at increased 
risk of stillbirth due to a number of potentially preventable conditions.  There has been no 
reduction in the gap for term stillbirths; and Indigenous women have higher rates of 
stillbirth at term due to diabetes, perinatal infection, fetal growth restriction and 
unexplained antepartum fetal death.  In addition, during the study period we found 
decreasing rates of maternal smoking, inadequate antenatal care and fetal growth 
restriction among Indigenous women. It is possible that decreasing rates of maternal 
smoking may play a role in the decreasing rates of fetal growth restriction observed. 
However, without trends data on maternal body mass index, it is difficult to comment on 
the role of maternal obesity on fetal growth restriction rates among Indigenous women.  
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We observed increasing rates of women birthing at 35 years or older, substance use and 
evidence of socioeconomic affluence.  Among non-Indigenous women, there were 
increasing proportions of women birthing at 35 years or older, women utilising assisted 
conception technology and increasing rates of preterm birth.  There was also evidence of 
decreasing rates of maternal smoking, fetal growth restriction and increased affluence.  
There was no change in the rates of substance use or primigravidity. 
Analysis of trends in maternal sociodemographic characteristics suggest that there may be 
an association with stillbirth risk and highlights the need to evaluate the effect of these 
characteristics on gestational age-specific prospective stillbirth risk.  This will be the main 
focus of the fetal death risk analysis study presented in Chapter 4 and 5.  
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3.5 Conclusion 
The gap in stillbirth rates between Indigenous and non-Indigenous women is narrowing, 
but Indigenous women continue to be at increased risk of stillbirth due to a number of 
potentially preventable causes.  There has been no reduction in the gap between 
Indigenous and non-Indigenous women in relation to term stillbirth rates and this presents 
an area of focus for further preventive efforts.  At term, Indigenous women had increased 
risk of stillbirth due to maternal conditions (mainly diabetes), perinatal infection, fetal 
growth restriction and unexplained antepartum fetal death.  High quality antenatal care at 
all levels using culturally appropriate service delivery models which incorporate diabetes 
management, smoking cessation, STI screening and treatment, folic acid and fetal growth 
monitoring hold some promise of helping to improve pregnancy outcomes for Indigenous 
women.  
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Chapter 4 
Gestational age specific risk of stillbirth among Indigenous and non-
Indigenous women 
 
4.1 Introduction 
In Australia, stillbirth rates have failed to improve over the past two decades and reports 
indicate rates may be slowly increasing [3].  Marked variation in stillbirth rates within 
population subgroups indicate that further reductions may be achievable [3, 28].  There 
persists marked disparity in stillbirth rates between Aboriginal and Torres Strait Islander 
(Indigenous) and non-Indigenous women [24, 223]. In 2012, national stillbirth rates among 
Indigenous women were one and a half times higher (10.8 vs 7.1 per 1000) than among 
non-Indigenous women [24].  Moreover, this disparity persists in the rate of term stillbirths 
(RR 1.71, 95% CI 1.40-2.09) with little change in the disparity over time [223]. 
Diabetes, hypertension, antepartum haemorrhage and small-for-gestational age are 
important contributors to the higher stillbirth rates observed among Indigenous women 
[223]. In Queensland, pre-existing and gestational diabetes affected around 0.6% and 
6.7% of pregnancies [24]; while Australian national estimates are 0.6% and 4.7%, 
respectively [89].  There is evidence of increasing prevalence of pre-existing and 
gestational diabetes within Queensland [24, 49]; with consistently higher rates of diabetes 
reported for Indigenous women [86]. Also of concern are reports of larger increases in the 
prevalence of gestational diabetes among non-Indigenous women [87]. Hypertensive 
disorders of pregnancy (including pre-existing and pregnancy induced hypertension) affect 
around 0.6% and 4.4% of pregnancies in Queensland [24]. Antepartum haemorrhage 
(including placenta praevia and abruption) is associated with up to 20% of very preterm 
births [224] and affects 2.4% of pregnancies in Queensland [24]. Indigenous women have 
higher rates of small-for-gestational age births than non-Indigenous women [225]. 
Given the contribution of these conditions to the rates of stillbirth and the disproportionate 
burden among Indigenous women, determining the periods of increased risk of stillbirth 
associated with these conditions is important for clinical management and potential further 
reductions in stillbirth rates.  The specific objectives of this study were to: 1) describe the 
all-cause gestational age specific risk of stillbirth among Indigenous and non-Indigenous 
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women, 2) examine the gestational age-specific risk of stillbirth associated with diabetes, 
hypertension, antepartum haemorrhage and small-for-gestational age among Indigenous 
and non-Indigenous women, and 3) examine the influence of geographic location on these 
gestational age specific risks among Indigenous and non-Indigenous women.  
Presented in this chapter are findings from a large population based study (n=360,987 
births) assessing gestational age specific risk of stillbirth among Indigenous and non-
Indigenous women birthing in Queensland.  Findings from this study were presented at the 
Perinatal Society of Australia and New Zealand conference in April 2015 (Appendix G3) 
and a manuscript was published in BMC Pregnancy and Childbirth in July 2016 (Appendix 
F). 
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4.2 Methods 
Study Population 
This was a population based retrospective database study involving all singleton livebirths 
and stillbirths of at least 20 weeks gestational age or at least 400g birthweight occurring in 
Queensland between July 2005 and December 2011.  There were 379,107 singleton births 
registered in the Queensland Perinatal Data Collection for the period July 2005 to 
December 2011.  Among these 18,119 births were excluded for the following reasons: 
congenital anomalies (99.2%), unknown maternal Indigenous status (0.7%), gestational 
age less than 20 weeks and birthweight less than 400g (0.1%) and terminations of 
pregnancy for maternal psychosocial reasons (0.0%) (Figure 4.1). Births with congenital 
anomalies were excluded from analyses because of the association between diabetes and 
congenital anomalies [226]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Flowchart showing study population, Gestational age specific stillbirth 
risk analysis, mid 2005-2011 
  
Eligible births 
 
379 107 singleton births 
Included births 
 
360 987 singleton births 
(incl 1552 stillbirths) 
Excluded births 
- 1 termination of pregnancy for 
maternal psychosocial reasons 
- 17 970 congenital anomalies 
- 130 unknown maternal Indigenous 
status 
- 18 less than 20 weeks AND less 
than 400g birthweight 
 
 
92 
 
Statistical Analysis 
Data from the Queensland Perinatal Data Collection (QPDC) was utilised for this study 
and data management was undertaken as outlined in Section 2.2.  Maternal demographic 
data included age, marital status, socioeconomic status and geographic location.  
Pregnancy data included primigravidity, hospital accommodation, smoking, substance use, 
pregnancy complications, assisted conception and number of antenatal care visits.  Birth 
outcome data included baby’s sex, gestational age at birth, birthweight, small-for-
gestational age and stillbirth.  All variables measured on a continuous scale were classified 
into categories and Chi square or Fisher’s exact test used to explore differences in 
maternal and pregnancy factors between women with a stillbirth and women with a 
livebirth.  Statistical significance was set at p<0.05. Analysis was carried out for the 
population as a whole and also stratified by Indigenous status as Indigenous women 
differed significantly on a number of maternal and pregnancy factors. 
The main outcome of interest was stillbirth risk by gestational age group and Indigenous 
status.  The conditional probability of stillbirth for each week gestation between 20 and 42 
weeks was calculated using lifetable approach [227].  This method was preferred over the 
Yudkin method (described in Chapter 3) because of overestimation of the denominator 
with the Yudkin method [227].  
Gestational age specific risk of stillbirth associated with diabetes, hypertension, 
antepartum haemorrhage and small-for-gestational age was assessed using time-to-event 
analysis.  This method is particularly appropriate for addressing the study objectives 
because it uses the appropriate population (i.e. number of ongoing pregnancies) as its 
denominator, allows for assessment of cumulative risk, simultaneous adjustment for 
multiple covariates, correction for duration of pregnancy and enables formal testing of the 
assumption that the risk associated with predictors varies over the duration of pregnancy 
[6] which were particularly useful for this study.   
The association between stillbirth and various predictors was explored using univariate 
Cox Proportional Hazard model.  In the model, stillbirth was the event, gestational age was 
the timescale and all livebirths were censored. A p=0.25 cutoff was used to select potential 
candidates for multivariate analysis [228].  To enable comparisons across Indigenous and 
non-Indigenous women, the same predictors were retained in the multivariate model if the 
p value was less than 0.25 for one or both populations.  Multivariate Cox Proportional 
Hazard models were built for each condition of interest.  Models were tested for violation of 
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assumption of proportionality using methods described by Grambsh and Therneau [229].  
This involved testing for a non-zero slope in a linear regression of the scaled Shoenfeld 
residuals for each predictor against time.  This test was run for each predictor within the 
model as well as a global test of the model.  A resulting p value of less than 0.05 was 
taken as an indication that the association between stillbirth and the predictor varied with 
gestational age.  In addition, for each model the Shoenfeld residuals were graphed against 
the scaled time vector and the graph was inspected for deviation from zero-slope.  The 
graphical method was used in addition to hypothesis testing to detect any cases of 
violation of proportionality where there was a nonlinear relationship between time and the 
residuals, which may not have been detected using hypothesis testing alone. 
 
Checking for Interactions between characteristics 
In exploring the associations between maternal/pregnancy characteristics and stillbirth as 
potential candidates for multivariate analysis, interactions between these characteristics 
were also explored.  Exploration of interactions was guided by previous knowledge from 
published literature. Significant interactions were found between maternal age and 
smoking status, and maternal age and marital status among Indigenous women; 
additionally among non-Indigenous women there was a significant interaction between 
smoking status and small-for-gestational age (Appendix B1). Interaction terms were 
included in the multivariate regression models.  Care was taken with derived variables 
such as socioeconomic status and geographic location and other related variables which 
may have shared common factors in their derivation (eg accommodation status and 
maternal age).  Some of these factors produced unstable estimates. 
 
Assessment and management of violation of assumption of proportionality 
Univariate analysis indicated the stillbirth hazard varied with gestational age for all 
conditions except antepartum haemorrhage for non-Indigenous women and pre-existing 
diabetes for Indigenous women (Appendix B2).  As a result, the violation of the 
proportionality assumption was handled by assessing gestational age specific risk using 
logistic regression and assessing risk in five gestational age groupings.  The groups used 
were: 20-23 weeks, 24-27 weeks, 28-32 weeks, 33-36 weeks and 37-42 weeks.  These 
groups were used to allow comparison with literature [230].  Within each gestational age 
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grouping, the denominator was adjusted to reflect the population at risk.  This was 
achieved by dropping all births prior to the gestational age interval of interest and recoding 
all stillbirths occurring after the gestational age interval of interest as livebirths.  The 
logistic regression model for each condition was adjusted for the same predictors as the 
corresponding multivariate Cox model.  Where numbers in each gestational age group 
were small, exact logistic regression was used.   
To assess the proportion of stillbirths that would be eliminated if each of the factors 
associated with stillbirth was eliminated, population attributable risk or fractions (PAR/PAF) 
were calculated using the adjusted effect estimates. In the literature, the terms population 
attributable risk (PAR) and fraction (PAF) are used interchangeably. 
Results are presented from the logistic regression models in Section 4.3.  Results from 
preliminary steps involving univariate and multivariate Cox regression models are shown in 
Appendix B1-B7.  Analyses were also carried out using Poisson regression with no 
material difference in results compared with logistic regression. Statistical analysis was 
performed using Stata/SE for Windows 13.1 (StataCorp LP, College Station, TX, USA) and 
SAS version 9.3 (SAS Institute, Cary, NC, USA.) for exact logistic regression. 
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4.3 Results 
A total of 360,987 births were included in the analyses.  Of these, 20,273 (5.6%) births 
were to Indigenous women and 340,714 (94.4%) were to non-Indigenous women.  The 
stillbirth rates were 7.9 (95% CI 6.8-9.2) and 4.1 (95% CI 3.9-4.3) per 1000 births, 
respectively. There were differences in the prevalence of the conditions of interest 
between Indigenous and non-Indigenous women as follows: pre-existing diabetes (1.3% 
vs 0.5%, Rate Ratio 2.54, 95% CI 2.23-2.89), gestational diabetes (6.6% vs 5.3%, Rate 
Ratio 1.23, 95% CI 1.16-1.29), pre-existing hypertension (1.0% vs 0.7%, Rate Ratio 1.49, 
95% CI 1.29-1.72), pregnancy induced hypertension (2.4% vs 2.9%, Rate Ratio 0.83, 95% 
CI 0.76-0.91), pre-eclampsia/eclampsia (2.9% vs 2.2%, Rate Ratio 1.31, 95% CI 1.20-
1.42), antepartum haemorrhage (2.3% vs 2.7%, Rate Ratio 0.83, 95% CI 0.75-0.91) and 
small-for-gestational age (15.2% vs 8.4%, Rate Ratio 1.81, 95% CI 1.75-1.87). 
 
Although pregnancies with a congenital abnormality were excluded from the main analysis 
because of the association between diabetes and congenital abnormality, secondary 
analysis showed that there was little difference in the proportion of stillbirths due to 
congenital abnormality between Indigenous and non-Indigenous women (0.19% versus 
0.16%).  
 
Characteristics by birth outcome and Indigenous status 
Table 4.1 shows the maternal, medical and obstetric characteristics of the study population 
by birth outcome (stillbirth or livebirth) for Indigenous and non-Indigenous women. For 
Indigenous and non-Indigenous women, there were higher rates of smoking, substance 
use, preterm birth and fewer than 8 antenatal care visits among women with a stillbirth 
compared to women who had a livebirth (Table 4.1).  Among non-Indigenous women, 
there were higher rates of socioeconomic disadvantage, not having a domestic partner 
and public hospital accommodation among women who had a stillbirth compared with 
those who did not.  
 
 
 
 
96 
 
Table 4.1: Maternal and pregnancy characteristics by birth outcome and Indigenous status, singleton births, Queensland, mid 
2005-2011 
 
Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Odds Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Odds Ratio 
(95% CI) 
Maternal age (years)       
     ≤18 years 10 (6.3) 1 444 (7.2) 0.81 (0.41-1.61) 42 (3.0) 4 360 (1.3) 2.62 (1.91-3.60) 
     19-24 years 67 (41.9) 8 698 (43.3) 0.91 (0.62-1.31) 313 (22.5) 67 583 (19.9) 1.26 (1.09-1.46) 
     25-30 years 48 (30.0) 5 645 (28.1) Ref (1.00) 437 (31.4) 118 816 (35.0) Ref (1.00) 
     31-34 years 14 (8.8) 2 413 (12.0) 0.68 (0.38-1.24) 290 (20.8) 81 032 (23.9) 0.97 (0.84-1.13) 
     ≥35 years 21 (13.1) 1 913 (9.5) 1.29 (0.77-2.16) 310 (22.3) 67 531 (19.9) 1.25 (1.08-1.44) 
Geographic Location       
     Major City 26 (16.3) 4 143 (20.6) Ref (1.00) 835 (60.0) 208 943 (61.6) Ref (1.00) 
     Regional area 95 (59.4) 11 825 (58.8) 1.28 (0.83-1.98) 525 (37.7) 122 065 (36.0) 1.08 (0.96-1.20) 
     Remote area 39 (24.4) 4 145 (20.6) 1.50 (0.91-2.47) 31 (2.2) 8 303 (2.5) 0.93 (0.65-1.34) 
     missing 0 (0.0) 0 (0.0)  1 (0.1) 11 (0.0)  
Marital Status       
     Domestic partner 102 (63.8) 12 931 (64.3) Reference 1 148 (82.5) 301 064 (88.7) Reference 
     No domestic 
partner 
58 (36.3) 7 174 (35.7) 1.02 (0.74-1.42) 241 (17.3) 38 211 (11.3) 1.65 (1.44-1.90) 
     missing 0 (0.0) 8 (0.0)  3 (0.2) 47 (0.0)  
Relative socioeconomic disadvantage 
     Highest 20%  4 (2.5) 549 (2.7) Reference 201 (14.4) 55 422 (16.3) Reference 
     Middle 60% 97 (60.6) 12 164 (60.6) 1.09 (0.40-2.99) 997 (71.6) 244 228 (72.0) 1.13 (0.97-1.31) 
     Lowest 20%  59 (36.9) 7 363 (36.6) 1.10 (0.40-3.04) 190 (13.6) 39 313 (11.6) 1.33 (1.09-1.63) 
     missing 0 (0.0) 37 (0.2)  4 (0.3) 359 (0.1)  
Any smoking during pregnancy 
     No 58 (36.3) 9 389 Reference 1016 (73.0) 281 286 (82.9) Reference 
     Yes 95 (59.4) 10 597 (52.7) 1.45 (1.05-2.01) 332 (23.9) 56 388 (16.6) 1.63 (1.44-1.85) 
     missing 7 (4.4) 127 (0.6)  44 (3.2) 1 648 (0.5)  
Substance Use during pregnancy 
     No 149 (93.1) 19 781 (98.4) Reference 1377 (98.9) 337 632 (99.5) Reference 
     Yes 11 (6.9) 332 (1.7) 4.40 (2.36-8.19) 15 (1.1) 1 690 (0.5) 2.18 (1.31-3.63) 
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Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Odds Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Odds Ratio 
(95% CI) 
Hospital accommodation status 
     Private 3 (1.8) 417 (2.1) Reference 305 (21.9) 110 687 (32.6) Reference 
     Public 157 (98.1) 19 696 (97.9) 1.11 (0.35-3.49) 1 084 (77.9) 228 633 (67.4) 1.72 (1.52-1.95) 
     missing 0 (0.0) 0 (0.0)  3 (0.2) 2 (0.0)  
Assisted Conception       
     No 159 (99.4) 20 022 (99.6) Reference 1 321 (94.9) 326 459 (96.2) Reference 
     Yes 1 (0.6) 91 (0.5) 1.38 (0.19-9.99) 66 (4.7) 12 843 (3.8) 1.27 (0.99-1.63) 
     missing 0 (0.0) 0 (0.0)  5 (0.4) 20 (0.0)  
Primigravidity       
     No 123 (76.8) 15 316 (76.2) Reference 973 (69.9) 237 647 (70.0) Reference 
     Yes 37 (23.1) 4 797 (23.9) 0.96 (0.90-1.13) 418 (30.0) 101 673 (30.0) 1.00 (0.90-1.13) 
     missing 0 (0.0) 0 (0.0)  1 (0.1) 2 (0.0)  
Number of antenatal care visits 
     Less than 2 47 (29.4) 1 055 (5.2) 14.2 (8.98-22.4) 147 (10.6) 2 144 (0.6) 43.3 (35.7-52.5) 
     2 – 4 57 (35.6) 3 348 (16.6) 5.43 (3.50-8.42) 459 (33.0) 16 890 (5.0) 17.2 (15.0-19.6) 
     5 – 7 23 (14.4) 5 805 (28.9) 1.26 (0.74-2.17) 367 (26.4) 63 019 (18.6) 3.68 (3.19-4.24) 
     8 or more 31 (19.4) 9 880 (49.1) Reference 407 (29.2) 257 089 (75.8) Reference 
     missing 2 (1.3) 25 (0.1)  12 (0.9) 180 (0.1)  
Gestational age at birth (weeks) 
     < 37 weeks 117 (73.1) 2 073 (10.3) 23.5 (16.5-33.4) 1030 (74.0) 20 426 (6.0) 44.8 (39.7-50.5) 
     ≥37 weeks 43 (26.9) 18 029 (89.6) Reference 359 (25.8) 318 877 (94.0) Reference 
     missing 0 (0.0) 11 (0.1)  3 (0.2) 19 (0.0)  
Baby’s gender       
     Female 66 (41.5) 9 782 (48.6) Reference 675 (48.5) 165 084 (48.7) Reference 
     Male 93 (58.1) 10 331 (51.4) 1.33 (0.97-1.83) 715 (51.4) 174 237 (51.4) 1.00 (0.90-1.12) 
     missing 1 (0.6) 0 (0.0)  2 (0.1) 1 (0.0)  
Percentages may add up to greater than 100% due to rounding.     Missing values omitted from calculation of odds ratios (ORs)  
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Table 4.2 shows the differences in prevalence of diabetes, hypertension, antepartum 
haemorrhage and small-for-gestational age by birth outcome (stillbirth or livebirth) for 
Indigenous and non-Indigenous women. Relative to women who had a livebirth, there 
were higher rates of pre-existing diabetes, pre-existing hypertension, antepartum 
haemorrhage and small-for-gestational age among women who had a stillbirth for both 
Indigenous and non-Indigenous women.  Furthermore, among non-Indigenous women, the 
rate of pre-eclampsia and eclampsia was higher among women who had a stillbirth.  
Conversely, the rate of gestational diabetes was lower among women who had a stillbirth, 
and the rate of pregnancy-induced hypertension was lower among non-Indigenous women 
who had a stillbirth.  
Univariate associations from Cox proportional hazard models are shown in Appendix B3 
and B4.  The magnitude of association was similar between univariate hazard ratios and 
univariate odds ratios. 
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Table 4.2: Maternal and pregnancy conditions by birth outcome and Indigenous status, singleton births, Queensland, mid 2005-
2011  
Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Odds Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Odds Ratio 
(95% CI) 
Pre-existing diabetes*      
     No 148 (92.5) 19 865 (98.8) Reference 1 371 (98.5) 337 620 (99.5) Reference 
     Yes 12 (7.5) 248 (1.2) 6.49 (3.56-11.9) 21 (1.5) 1 702 (0.5) 3.04 (1.97-4.69) 
Gestational diabetes      
     No 156 (97.5) 18 789 (93.4) Reference 1 334 (95.8) 321 187 (94.7) Reference 
     Yes 4 (2.5) 1 324 (6.6) 0.36 (0.13-0.98) 58 (4.2) 18 135 (5.3) 0.77 (0.59-1.00) 
Pre-existing hypertension 
     No 153 (95.6) 19 923 (99.1) Reference 1 361 (97.8) 337 133 (99.4) Reference 
     Yes 7 (4.4) 190 (0.9) 4.80 (2.22-10.4) 31 (2.2) 2 189 (0.7) 3.51 (2.45-5.02) 
Pre-eclampsia/Eclampsia 
     No 155 (96.9) 19 539 (97.2) Reference 1 315 (94.5) 331 963 (97.8) Reference 
     Yes 5 (3.1) 574 (2.9) 1.10 (0.45-2.69) 77 (5.5) 7 359 (2.2) 2.64 (2.10-3.33) 
Pregnancy Induced hypertension 
     No 159 (99.4) 19 625 (97.6) Reference 1 365 (98.1) 329 425 (97.1) Reference 
     Yes 1 (0.6) 488 (2.4) 0.25 (0.04-1.81) 27 (1.9) 9 897 (2.9) 0.66 (0.45-0.96) 
Antepartum haemorrhage 
     No 116 (72.5) 19 701 (98.0) Reference 1 055 (75.8) 330 374 (97.4) Reference 
     Yes 44 (27.5) 412 (2.0) 18.1 (12.6-26.0) 337 (24.2) 8 948 (2.6) 11.8 (10.4-13.4) 
Small for gestational age** 
     No 99 (61.9) 17 079 (84.9) Reference 967 (69.5) 311 059 (91.7) Reference 
     Yes 58 (36.3) 3 021 (15.0) 3.31 (2.39-4.59) 410 (29.5) 28 214 (8.3) 4.67 (4.16-5.25) 
     missing 3 (1.9) 13 (0.1)  15 (1.1) 49 (0.0)  
ICD10-AM codes: Antepartum haemorrhage (O44.1, O45-O46), Essential hypertension (O10.0, O10.2-10.4, O10.9, O11), Pregnancy Induced hypertension (O13), 
Pre-eclampsia/Eclampsia (O14, O15), Pre-existing diabetes (O24.0, O24.1, O24.3, O24.8), Gestational diabetes (O24.4, O24.9).   *Insufficient detail in codes to 
differentiate types of pre-existing diabetes mellitus.   **Small for gestational age = less than 10
th
 Australian population percentile for gestational age, sex and 
plurality. 
 
 
 
100 
 
Description of all-cause gestational age specific risk of stillbirth  
The all-cause gestational age specific risk of stillbirth is characterised in Figure 4.2. For 
Indigenous and non-Indigenous women, the probability of stillbirth is initially low; averaging 
around 0.6/1000 and 0.3/1000 ongoing pregnancies between 20 and 24 weeks, 
respectively.  The probability of stillbirth between 25 and 37 weeks is about 0.2/1000 and 
0.1/1000 for Indigenous and non-Indigenous women.  A sharp increase in the probability of 
stillbirth is observed around term (≥37 weeks); reaching 30/1000 and 6/1000 ongoing 
pregnancies at 42+ weeks among Indigenous and non-Indigenous women, respectively.  
The ratio of probability steadily increases from 38 weeks onwards as shown in Figure 4.3 
 
  
Figure 4.2: Gestational age specific risk of stillbirth by Indigenous status, singleton 
births, Queensland, mid 2005-2011 
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Figure 4.3: Ratio of stillbirth risk, Indigenous relative to non-Indigenous 
 
The gestational age specific risk of stillbirth associated with diabetes, hypertension, 
antepartum haemorrhage and small-for-gestational age is shown in Figure 4.4. The risk 
was generally higher for Indigenous women, particularly at 37-42+ weeks. 
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Figure 4.4: Gestational age specific risk of stillbirth by maternal/pregnancy condition of interest for Indigenous and non-
Indigenous women, singleton births, Queensland, mid 2005 – 2011  
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Adjusted gestational age specific stillbirth risk associated with diabetes, hypertension, 
antepartum haemorrhage and small-for-gestational age 
The gestational age specific risk of stillbirth associated with diabetes, hypertension, 
antepartum haemorrhage and small-for-gestational age for the total population (Indigenous 
and non-Indigenous women) is shown in Table 4.3 and the effect of Indigenous status 
(relative to non-Indigenous status) is shown in Table 4.3a.  For all conditions of interest, an 
increased risk of stillbirth from 37 weeks onwards was observed for Indigenous women 
(Table 4.3a).  Gestational age specific risk for each condition of interest is given for 
Indigenous and non-Indigenous women separately in Table 4.4. 
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Table 4.3: Gestational age-specific odds of stillbirth associated with diabetes, hypertension, antepartum haemorrhage and 
SGA, combined Indigenous and non-Indigenous women, Queensland, mid 2005-2011   
Conditions 
All births (n=360 987) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes^ 1.02 (0.31-3.37) 3.34 (1.17-9.57) 3.00 (0.92-9.78) 7.28 (3.35-15.8) 8.26 (4.70-14.5) 
Gestational diabetes^ 0.41 (0.18-0.91) 0.68 (0.28-1.67) 1.12 (0.55-2.28) 1.80 (1.07-3.02) 1.24 (0.82-1.87) 
Pre-existing hypertension* 6.30 (3.70-10.7) 6.29 (2.97-13.3) 4.39 (1.75-11.0) 2.76 (1.00-7.64) 1.36 (0.50-3.70) 
Pre-Eclampsia/Eclampsia 0.92 (0.49-1.73) 5.50 (3.57-8.46) 4.47 (2.76-7.26) 2.10 (1.03-4.27) 2.63 (1.61-4.30) 
Antepartum haemorrhage^ 9.68 (7.85-12.0) 8.49 (6.14-11.7) 13.8 (10.1-18.6) 16.4 (12.1-22.2) 8.44 (6.32-11.3) 
Small-for-gestational agea 3.26 (2.64-4.02) 5.95 (4.47-7.93) 3.98 (2.93-5.40) 3.51 (2.56-4.81) 3.35 (2.66-4.22) 
     Smoker 1.76 (1.21-2.57) 3.51 (2.07-5.95) 3.08 (1.85-5.12) 2.82 (1.64-4.84) 2.80 (1.89-4.15) 
     Non smoker 4.45 (3.48-5.69) 7.42 (5.32-10.3) 4.65 (3.19-6.77) 3.93 (2.68-5.77) 3.65 (2.75-4.83) 
 
 
 
Table 4.3a: Effect of Indigenous status on gestational age specific odds of stillbirth (Indigenous relative to non-Indigenous) 
Conditions 
All births (n=360 987) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes^ 0.71 (0.51-0.98) 0.51 (0.30-0.86) 0.66 (0.39-1.11) 0.86 (0.51-1.46) 1.45 (1.01-2.09) 
Gestational diabetes^ 0.71 (0.51-0.99) 0.53 (0.31-0.89) 0.67 (0.40-1.12) 0.89 (0.52-1.51) 1.49 (1.04-2.15) 
Pre-existing hypertension* 0.71 (0.51-0.98) 0.51 (0.30-0.86) 0.66 (0.39-1.11) 0.86 (0.51-1.46) 1.45 (1.01-2.09) 
Pre-Eclampsia/Eclampsia 0.72 (0.52-1.00) 0.53 (0.31-0.89) 0.67 (0.40-1.12) 0.90 (0.53-1.53) 1.50 (1.04-2.15) 
Antepartum haemorrhage^ 0.77 (0.55-1.08) 0.56 (0.33-0.96) 0.73 (0.43-1.23) 0.99 (0.58-1.69) 1.53 (1.07-2.21) 
Small-for-gestational agea 0.68 (0.49-0.95) 0.49 (0.29-0.83) 0.58 (0.34-0.99) 0.85 (0.50-1.45) 1.42 (0.98-2.04) 
     Smoker 0.73 (0.46-1.16) 0.36 (0.16-0.80) 0.69 (0.34-1.38) 0.68 (0.32-1.43) 1.60 (0.99-2.58) 
     Non smoker 0.65 (0.39-1.07) 0.68 (0.33-1.38) 0.46 (0.19-1.12) 1.13 (0.54-2.37) 1.06 (0.57-1.97) 
All models adjusted for maternal age, smoking status, gravidity, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception 
use, socioeconomic status, marital status, number of antenatal care visits.  
a
Models include the following interaction term: smoke*FGR10 (analysis stratified by 
smoking).  ^These models additionally adjusted for pre-existing hypertension.  *These models additionally adjusted for pre-existing diabetes.   
Bold estimates indicate statistically significant effect of Indigenous status. 
  
 
 
105 
 
Table 4.4: Gestational age-specific odds of stillbirth associated with medical/pregnancy conditions, by Indigenous status, 
Queensland, mid 2005-2011  
Conditions 
Indigenous (n=20,273 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes^~ 1.21 (0.14-10.3) 2.55 (0.21-31.5) 5.80 (0.86-39.2) 18.8 (5.04-69.7) 16.5 (5.20-52.1) 
Gestational diabetes^~ - - - 0.61 (0.08-4.81) 0.90 (0.21-3.92) 
Pre-existing hypertension*~ 2.18 (0.25-18.7) 4.23 (0.35-50.8) 15.0 (2.17-104) 1.27 (0.12-13.0) 2.66 (0.31-22.9) 
Pre-Eclampsia/Eclampsia~ 0.70 (0.09-5.18) 1.19 (0.15-9.52) - 2.88 (0.37-22.4) 2.67 (0.62-11.5) 
Antepartum haemorrhage^ 18.1 (9.86-33.3) 15.4 (5.44-43.6) 38.1 (14.1-102) 2.34 (0.29-19.2) 18.2 (7.61-43.4) 
Small-for-gestational age 1.30 (0.67-2.54) 3.03 (1.17-7.85) 7.47 (2.86-19.6) 3.10 (1.18-8.17) 1.97 (1.02-3.83) 
Conditions 
Non-Indigenous (n=340,714 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes^ 0.87 (0.18-4.17) 3.29 (0.94-11.6) 1.35 (0.18-10.1) 8.79 (3.83-20.2) 7.66 (3.92-15.0) 
Gestational diabetes^ 0.50 (0.22-1.12) 0.84 (0.34-2.05) 1.30 (0.63-2.66) 1.87 (1.08-3.25) 1.32 (0.86-2.02) 
Pre-existing hypertension* 6.24 (3.54-11.0) 5.28 (2.33-12.0) 2.95 (0.92-9.50) 2.42 (0.76-7.75) 1.26 (0.40-3.97) 
Pre-eclampsia/Eclampsia 0.77 (0.39-1.51) 4.63 (2.96-7.24) 4.36 (2.67-7.12) 1.75 (0.82-3.75) 2.39 (1.42-4.02) 
Antepartum haemorrhage^ 9.63 (7.65-12.1) 8.61 (6.08-12.2) 13.1 (9.41-18.2) 18.1 (13.3-24.8) 7.81 (5.73-10.6) 
Small-for-gestational age      
     Smoker 1.89 (1.23-2.91) 3.79 (2.14-6.71) 2.51 (1.39-4.53) 2.93 (1.62-5.32) 3.49 (2.21-5.52) 
     Non Smoker 4.84 (3.76-6.22) 7.74 (5.49-10.9) 4.57 (3.10-6.73) 3.90 (2.62-5.81) 3.66 (2.74-4.88) 
Models adjusted for maternal age, smoking status, remoteness, substance use, gender, gravidity, hospital accommodation status, assisted conception use, 
socioeconomic status, marital status, number of antenatal care visits.  ^ These models additionally adjusted for pre-existing hypertension.  * These models 
additionally adjusted for pre-existing diabetes.    ~Exact logistic regression model 
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Diabetes 
In the population as a whole, increased odds of stillbirth associated with pre-existing 
diabetes was found at 24-27 weeks (adjusted OR 3.34, 95% CI 1.17-9.57) and from 33 
weeks onwards [adjusted OR 33-36 weeks (7.28 95% CI 3.35-15.8) and adjusted OR 37-
42+ weeks (8.26 95% CI 4.70-14.5)] (Table 4.3). Among Indigenous women, increased 
risk of stillbirth associated with pre-existing diabetes was found from 33 weeks onwards 
[adjusted OR 33-36 weeks (18.8 95% CI 5.04-69.7) and adjusted OR 37-42+ weeks (16.5 
95% CI 5.20-52.1)] (Table 4.4).  However, these risk estimates were not significantly 
different from each other.  While among non-Indigenous women, increased risk of stillbirth 
associated with pre-existing diabetes was found from 33 weeks gestation onwards 
[adjusted OR 33-36 weeks (8.79 95% CI 3.83-20.2) and adjusted OR 37-42+ weeks (7.66 
95% CI 3.92-15.0)] (Table 4.4).  The effect estimates for non-Indigenous women were 
around half those of Indigenous women from around 28 weeks gestation onwards. 
In the whole population, increased odds of stillbirth associated with gestational diabetes 
were observed at 33-36 weeks (adjusted OR 1.80, 95% CI 1.07-3.02) but no association 
was found at other gestational age intervals.  Risk estimates suggest stillbirth was less 
common among Indigenous women with gestational diabetes, however, no significant 
association was found (Table 4.4). Among non-Indigenous women, a nearly two fold 
increased risk of stillbirth associated with gestational diabetes was found for births at 33-
36 weeks gestation (adjusted OR 1.87 95% CI 1.08-3.25).   
 
Hypertension 
In the whole population, increased odds of stillbirth associated with pre-existing 
hypertension was found at gestational ages less than 37 weeks [adjusted OR 20-23 weeks 
(6.30 95% CI 3.70-10.7), adjusted OR 24-27 weeks (6.29 95% CI 2.97-13.3), adjusted OR 
28-32 weeks (4.39 95% CI 1.75-11.0) and adjusted OR 33-36 weeks (2.76 95% CI 1.00-
7.64)] (Table 4.3).  Increased risk of stillbirth associated with pre-existing hypertension was 
found among Indigenous women at 28-32 weeks gestation (adjusted OR 15.0 95% CI 
2.17-104). The estimates suggest increasing risk with gestational age with a peak at 28-32 
weeks followed by decreasing risk from late preterm to term gestational ages, however, 
the numbers are small and the results did not reach statistical significance (Table 4.4).  A 
different pattern was shown among non-Indigenous women, with decreasing risk as 
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gestational age increased, with an initial peak at 20-23 weeks (adjusted OR 6.24 95% CI 
3.54-11.0).  However, the risk estimates for the first three groups are not significantly 
different from each other. 
Increased odds of stillbirth associated with pre-eclampsia and eclampsia was found from 
24 weeks onwards in the whole population (Table 4.3).  Among Indigenous women, no 
significant association was found between stillbirth and pre-eclampsia at any of the 
gestational ages examined.  However, the risk estimates suggest decreasing risk of 
stillbirth with increasing gestational age.  In contrast, among non-Indigenous women, there 
was increased risk of stillbirth at 24-27 weeks (adjusted OR 4.63 95% CI 2.96-7.24), 28-32 
weeks (adjusted OR 4.36 95% CI 2.67-7.12) and at term (adjusted OR 2.39 95% CI 1.42-
4.02). The results suggest the risk of stillbirth may be higher in preterm gestational ages, 
however, the estimates were not significantly different from each other.  
 
Antepartum haemorrhage 
Antepartum haemorrhage was associated with increased odds of stillbirth at all gestational 
ages examined in the whole population [adjusted OR range 8.44-16.4] (Table 4.3). 
Antepartum haemorrhage was associated with increased risk of stillbirth among 
Indigenous women at all gestational ages examined, although estimate for 33-36 weeks 
(adjusted OR 2.34 95% CI 0.29-19.2) did not reach statistical significance. The adjusted 
odds ratios suggest the risk may be highest at 28-32 weeks (adjusted OR 38.1 95% CI 
14.1-102), however, numbers were small and this result was not significantly different from 
the estimates at the other gestational ages (Table 4.4).  In contrast, among non-
Indigenous women the magnitude of the risk estimates were around half those for 
Indigenous women.  Increased risk of stillbirth was associated with the presence of 
antepartum haemorrhage for all gestational age groups assessed; with the risk of stillbirth 
significantly higher at 33-36 weeks (adjusted OR 18.1 95% CI 13.3-24.8). 
 
Small-for-gestational age 
Increased odds of stillbirth associated with small-for-gestational age were found at all 
gestational age intervals examined with a peak at 24-27 weeks (adjusted OR 5.95 95% CI 
4.47-7.93) which was significantly higher than the risk estimate for 20-23 weeks (adjusted 
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OR 3.26 95% CI 2.64-4.02) and term (adjusted OR 3.35 95% CI 2.66-4.22) (Table 4.3). 
Moreover, an interaction between smoking and small for gestational age was found among 
non-Indigenous women (Table 4.3 and 4.4); with effect modification of the risk of stillbirth 
at 20-23 weeks (higher odds of stillbirth for non-smokers compared with smokers) but this 
effect was not observed at older gestational ages.  Among Indigenous women, increased 
risk of stillbirth was observed from 24 weeks onwards. The risk estimates suggest there 
may be an inverted “V” shaped relationship between small-for-gestational age and stillbirth 
among Indigenous women with a peak at 28-32 weeks (adjusted OR 7.47 95% CI 2.86-
19.6), however, the risk estimates were not significantly different from each other from 24 
weeks gestation onwards.   
 
Table 4.5: Population attributable fraction associated with conditions of interest 
Condition 
Indigenous Non Indigenous 
P Adjusted HR PAF 
(%) 
P Adjusted HR PAF 
(%) 
Pre-existing diabetes 1.28 7.28 (3.70-14.3) 7.44 0.51 4.20 (2.70-6.56) 1.61 
Pre-existing hypertension 0.97 2.82 (1.11-7.19) 1.73 0.65 3.67 (2.54-5.31) 0.17 
Pre eclampsia/ Eclampsia - - - 2.18 2.67 (2.11-3.39) 3.51 
Antepartum haemorrhage 2.25 18.7 (12.9-27.3) 28.5 2.73 11.6 (10.2-13.2) 22.4 
Small-for gestational age 15.2 2.34 (1.65-3.30) 16.9 8.40 3.97 (3.51-4.47) 20.0 
P = Prevalence (%)  PAF(%) = Population attributable fraction 
 
Presented in Table 4.5 are the population attributable fractions associated with the 
conditions of interest. Antepartum haemorrhage had the highest values for both 
Indigenous and non-Indigenous women (28.5% and 22.4%, respectively), followed by 
small-for-gestational age with 16.9% and 20.0% for Indigenous and non-Indigenous 
women, respectively. 
 
Maternal characteristics by geographic location and Indigenous status 
Table 4.6 shows the distribution of maternal, medical and obstetric factors by geographic 
location and birth outcome for Indigenous women.  Indigenous women with a stillbirth, 
regardless of where they lived, were more likely to: attend fewer antenatal care visits, have 
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a preterm infant, have a growth restricted infant, have antepartum haemorrhage and pre-
existing diabetes.  A higher proportion of Indigenous women with a stillbirth who lived in 
major city or regional areas were more likely to have substance use issues; while 
Indigenous women with a stillbirth who lived in a remote area were more likely to have a 
male infant. 
 
Table 4.6: Maternal and pregnancy characteristics by birth outcome and geographic 
location, Indigenous women, Queensland, mid 2005-2011 
 
Characteristics 
Indigenous 
(n=20273) 
Major City 
(n=4169) 
Regional 
(n=11920) 
Remote 
(n=4184) 
Stillbirth 
(n=26) 
Livebirth 
(n=4143) 
Stillbirth 
(n=95) 
Livebirth 
(n=11825) 
Stillbirth 
(n=39) 
Livebirth 
(n=4145) 
n(%) n(%) n(%) n(%) n(%) n(%) 
Maternal age (years) 
     ≤18 years 2 (7.7) 233 (5.6) 5 (5.3) 907 (7.7) 3 (7.7) 304 (7.3) 
     19-24 years 11 (42.3) 1684 
(40.7) 
38 (40.0) 5191 
(43.9) 
18 (46.2) 1823 
(44.0) 
     25-30 years 6 (23.1) 1263 
(30.5) 
28 (29.5) 3211 
(27.2) 
14 (35.9) 1171 
(28.3) 
     31-34 years 3 (11.5) 527 
(12.7) 
9 (9.5) 1393 
(11.8) 
2 (5.1) 493 
(11.9) 
     ≥35 years 4 (15.4) 436 
(10.5) 
15 (15.8) 1123 (9.5) 2 (5.1) 354 (8.5) 
     p value 0.779* 0.280* 0.630* 
Marital Status 
     Partner 
14 (53.9) 
2474 
(59.7) 
62 (65.3) 
7668 
(64.9) 
26 (66.7) 
2789 
(67.3) 
     No partner 
12 (46.2) 
1667 
(40.3) 
33 (34.7) 
4153 
(35.1) 
13 (33.3) 
1354 
(32.7) 
     p value 0.541 0.936 0.931 
     missing 0 (0.0) 2 (0.0) 0 (0.0) 4 (0.0) 0 (0.0) 2 (0.0) 
Relative socioeconomic disadvantage  
     Highest 20% (least 
disadvantaged) 
3 (11.5) 
426 
(10.3) 
1 (1.1) 114 (1.0) 0 (0.0) 9 (0.2) 
     Lowest 20% (most 
disadvantaged) 
8 (30.8) 
1123 
(27.1) 
26 (27.4) 
3413 
(28.9) 
25 (64.1) 
2827 
(68.4) 
     p value 0.792*  0.795* 0.636* 
     missing 0 (0.0) 0 (0.0) 0 (0.0) 25 (0.2) 0 (0.0) 12 (0.3) 
Any smoking during pregnancy 
     Yes 
13 (56.5) 
1903 
(45.9) 
59 (62.1) 
6447 
(54.5) 
23 (59.0) 
2247 
(54.2) 
     p value 0.342 0.054 0.575 
     missing 3 (11.5) 60 (1.4) 4 (4.2) 46 (0.4) 0 (0.0) 21 (0.5) 
Substance Use during pregnancy 
     Yes 5 (19.2) 147 (3.6) 5 (5.3) 152 (1.3) 1 (2.6) 33 (0.8) 
     p value 0.002* 0.008* 0.274* 
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Characteristics 
Indigenous 
(n=20273) 
Major City 
(n=4169) 
Regional 
(n=11920) 
Remote 
(n=4184) 
Stillbirth 
(n=26) 
Livebirth 
(n=4143) 
Stillbirth 
(n=95) 
Livebirth 
(n=11825) 
Stillbirth 
(n=39) 
Livebirth 
(n=4145) 
n(%) n(%) n(%) n(%) n(%) n(%) 
Accommodation status 
     Public patient 
25 (96.2) 
3949 
(95.3) 
93 (97.9) 
11613 
(98.2) 
39 
(100.0) 
4134 
(99.7) 
     p value 1.000* 0.689* 1.000* 
Assisted Conception 
     Yes 0 (0.0) 51 (1.2) 1 (1.1) 33 (0.3) 0 (0.0) 7 (0.2) 
     p value 1.000* 0.238* 1.000* 
Primigravidity 
      Yes 
6 (23.1) 
1022 
(24.7) 
24 (25.3) 
2816 
(23.8) 
7 (18.0) 
959 
(23.1) 
     p value 0.851 0.741 0.444 
Number of antenatal care visits 
     Less than 2 8 (30.8) 174 (4.2) 22 (23.2) 650 (5.5) 17 (43.6) 231 (5.6) 
     2 – 4 
10 (38.5) 
700 
(16.9) 
35 (36.8) 
2007 
(17.0) 
12 (30.8) 
641 
(15.5) 
    5 – 7 
3 (11.5) 
1160 
(28.1) 
15 (15.8) 
3427 
(29.0) 
5 (12.8) 
1218 
(29.4) 
    8 or more 
5 (19.2) 
2101 
(50.8) 
21 (22.1) 
5731 
(48.5) 
5 (12.8) 
2048 
(49.5) 
     p value <0.001 <0.001 <0.001 
     missing 0 (0.0) 8 (0.2) 2 (2.1) 10 (0.1) 0 (0.0) 7 (0.2) 
Gestational age at birth 
     <24 weeks 8 (30.8) 5 (0.1) 33 (34.7) 36 (0.3) 15 (38.5) 12 (0.3) 
     24-27 weeks 2 (7.7) 17 (0.4) 11 (11.6) 67 (0.6) 8 (20.5) 26 (0.6) 
     28-32 weeks 5 (19.2) 53 (1.3) 10 (10.5) 220 (1.9) 6 (15.4) 78 (1.9) 
     33-36 weeks 2 (7.7) 298 (7.2) 12 (12.6) 934 (7.9) 5 (12.8) 327 (7.9) 
     ≥37 weeks 
9 (34.6) 
3768 
(91.0) 
29 (30.5) 
10559 
(89.4) 
5 (12.8) 
3702 
(89.3) 
     p value <0.001* <0.000 <0.001* 
     missing 0 (0.0) 2 (0.0) 0 (0.0) 8 (0.1) 0 (0.0) 0 (0.0) 
Baby’s gender 
     Male 
11 (42.3) 
2137 
(51.6) 
56 (59.6) 
6089 
(51.5) 
26 (66.7) 
2105 
(50.8) 
     p value 0.346 0.118 0.048 
     missing 0 (0.0) 0 (0.0) 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Small-for-gestational age 
     Yes 
11 (42.3) 
532 
(12.9) 
36 (37.9) 
1899 
(16.1) 
11 (28.2) 
590 
(14.2) 
     p value <0.001 <0.001 0.013 
     missing 0 (0.0) 2 (0.0) 3 (3.2) 11 (0.1) 0 (0.0) 0 (0.0) 
Antepartum haemorrhage 
     Yes 8 (30.8) 107 (2.6) 24 (25.3) 221 (1.9) 12 (30.8) 84 (2.0) 
     p value <0.001 <0.001 <0.001 
Essential hypertension (with or without superimposed pre-eclampsia) 
     Yes 0 (0.0) 30 (0.7) 6 (6.3) 109 (0.9) 1 (2.6) 51 (1.2) 
     p value 1.000* <0.001 0.387* 
Eclampsia/Pre-eclampsia 
     Yes 0 (0.0) 84 (2.0) 4 (4.2) 321 (2.7) 1 (2.6) 169 (4.1) 
     p value 1.000* 0.332* 1.000* 
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Characteristics 
Indigenous 
(n=20273) 
Major City 
(n=4169) 
Regional 
(n=11920) 
Remote 
(n=4184) 
Stillbirth 
(n=26) 
Livebirth 
(n=4143) 
Stillbirth 
(n=95) 
Livebirth 
(n=11825) 
Stillbirth 
(n=39) 
Livebirth 
(n=4145) 
n(%) n(%) n(%) n(%) n(%) n(%) 
Pregnancy Induced hypertension 
     Yes 0 (0.0) 100 (2.4) 1 (1.1) 271 (2.3) 0 (0.0) 117 (2.8) 
     p value 1.000* 0.727* 0.627* 
Pre-existing diabetes 
     Yes 2 (7.7) 37 (0.9) 7 (7.4) 142 (1.2) 3 (7.7) 69 (1.7) 
     p value 0.024* <0.001 0.029* 
Gestational diabetes 
     Yes 1 (3.9) 201 (4.9) 3 (3.2) 777 (6.6) 0 (0.0) 346 (8.4) 
     p value 1.000* 0.215* 0.072* 
Percentages may add up to greater than 100% due to rounding  ICD10-AM codes: Antepartum haemorrhage 
(O44.1, O45-46), Essential hypertension (O10.0, O10.2-10.4, O10.9, O11), Pregnancy Induced hypertension 
(O13), Pre-eclampsia/Eclampsia (O14, O15), Pre-existing diabetes (O24.0, O24.1, O24.3, O24.8), 
Gestational diabetes (O24.4, O24.9).   
 
In Table 4.7 is presented the distribution of maternal, medical and obstetric factors by birth 
outcome and geographic location for non-Indigenous women.  Maternal age profile for 
non-Indigenous women was significantly different between those with a stillbirth and those 
with a livebirth.  Among women with a stillbirth, there was a higher proportion of younger 
women aged 18 years or younger in urban, regional and remote areas; there was also a 
higher proportion of older women aged 35 years or older in urban and regional areas. 
Regardless of geographic location, non-Indigenous women with a stillbirth were more likely 
to: attend fewer antenatal care visits, not have a domestic partner, have a preterm birth, 
have a growth restricted infant and antepartum haemorrhage.  Among women living in 
urban areas, non-Indigenous women with a stillbirth were more likely to: smoke, have 
substance use issues, utilise health services as a public patient, have essential 
hypertension, pre-eclampsia or eclampsia and pre-existing diabetes.  In contrast, non-
Indigenous women with a stillbirth living in regional areas were more likely to: smoke, 
utilise health services as a public patient, utilise assisted conception technology, have 
essential hypertension, pre-eclampsia or eclampsia and gestational diabetes.  Non-
Indigenous women with a stillbirth in remote areas were more likely to be primigravid. 
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Table 4.7: Maternal and pregnancy characteristics by birth outcome and geographic 
location, non-Indigenous women, Queensland, mid 2005–2011 
Characteristics 
Non-Indigenous 
(n=340,714) 
Major City 
(n=209,778) 
Regional 
(n=122,590) 
Remote 
(n=8,334) 
Stillbirth 
(n=835) 
Livebirth 
(n=208,943) 
Stillbirth 
(n=525) 
Livebirth 
(n=122,065) 
Stillbirth 
(n=31) 
Livebirth 
(n=8303) 
n(%) n(%) n(%) n(%) n(%) n(%) 
Maternal age (years) 
     ≤18 years 19 (2.3) 2290 (1.1) 20 (3.8) 1985 (1.6) 3 (9.7) 85 (1.0) 
     19-24 years 177 
(21.2) 
36689 
(17.6) 
127 (24.2) 28968 
(23.7) 
8 (25.1) 1922 
(23.2) 
     25-30 years 257 
(30.8) 
71128 
(34.0) 
166 (31.6) 44472 
(36.4) 
14 (45.2) 3212 
(38.7) 
     31-34 years 190 
(22.8) 
53482 
(25.6) 
96 (18.3) 25790 
(21.1) 
4 (12.9) 1760 
(21.2) 
     ≥35 years 192 
(23.0) 
45354 
(21.7) 
116 (22.1) 20850 
(17.1) 
2 (6.5) 1324 
(16.0) 
     p value <0.001 <0.001 0.008* 
Marital Status 
     Partner 680 
(81.5) 
183808 
(88.0) 
444 (84.7) 109596 
(89.8) 
24 (77.4) 7655 
(92.2) 
     No partner 154 
(18.5) 
25097 
(12.0) 
80 (15.3) 12461 
(10.2) 
7 (22.6) 647 (7.8) 
     p value <0.001 <0.001 0.002 
     missing 1 (0.1) 38 (0.0) 1 (0.2) 8 (0.0) 0 (0.0) 1 (0.0) 
Relative socioeconomic disadvantage  
     Highest 20% 
(least 
disadvantaged) 
182 
(21.8) 
49513 
(23.7) 
18 (3.5) 5368 (4.4) 1 (3.2) 541 (6.6) 
     Lowest 20% 
(most 
disadvantaged) 
98 (11.7) 21390 
(10.2) 
84 (16.1) 16127 
(13.2) 
8 (25.8) 1796 
(21.8) 
     p value 0.211 0.106 0.776* 
     missing 0 (0.0) 3 (0.0) 3 (0.6) 281 (0.2) 0 (0.0) 64 (0.8) 
Any smoking during pregnancy 
     Yes 172 
(21.3) 
29809 
(14.4) 
154 (30.1) 25069 
(20.6) 
6 (19.4) 1505 
(18.2) 
     p value <0.001 <0.001 0.795 
     missing 28 (3.4) 1245 (0.6) 14 (2.7) 383 (0.3) 1 (3.2) 20 (0.2) 
Substance Use during pregnancy 
     Yes 12 (1.4) 1218 (0.6) 3 (0.6) 450 (0.4) 0 (0.0) 20 (0.2) 
     p value 0.001 0.450* 1.000* 
Accommodation status 
     Public patient 634 
(76.1) 
133001 
(63.7) 
423 (80.6) 89416 
(73.3) 
27 (87.1) 6207 
(74.8) 
     p value <0.001 <0.001 0.146 
     missing 2 (0.2) 0 (0.0) 0 (0.0) 2 (0.0) 0 (0.0) 0 (0.0) 
Assisted Conception 
     Yes 41 (4.9) 9418 (4.5) 23 (4.4) 3216 (2.6) 2 (6.5) 209 (2.5) 
     p value 0.570 0.012 0.176 
     missing 1 (0.1) 3 (0.0) 2 (0.4) 15 (0.0) 1 (3.2) 2 (0.0) 
Primigravidity 
      Yes 263 
(31.5) 
64544 
(30.9) 
137 (26.2) 34683 
(28.4) 
17 (54.8) 2444 
(29.4) 
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Characteristics 
Non-Indigenous 
(n=340,714) 
Major City 
(n=209,778) 
Regional 
(n=122,590) 
Remote 
(n=8,334) 
Stillbirth 
(n=835) 
Livebirth 
(n=208,943) 
Stillbirth 
(n=525) 
Livebirth 
(n=122,065) 
Stillbirth 
(n=31) 
Livebirth 
(n=8303) 
n(%) n(%) n(%) n(%) n(%) n(%) 
     p value 0.705 0.250 0.002 
     missing 0 (0.0) 1 (0.0) 1 (0.2) 1 (0.0) 0 (0.0) 0 (0.0) 
Number of antenatal care visits 
     Less than 2 94 (11.3) 1290 (0.6) 48 (9.2) 812 (0.7) 5 (16.1) 40 (0.5) 
     2 – 4 264 
(31.6) 
10392 (5.0) 187 (35.8) 6027 (4.9) 8 (25.8) 469 (5.7) 
    5 – 7 221 
(26.5) 
38642 
(18.5) 
136 (26.0) 
22540 
(18.5) 
10 (32.3) 
1835 
(22.1) 
    8 or more 247 
(29.6) 
158528 
(75.9) 
152 (29.1) 
92602 
(75.9) 
8 (25.8) 
5954 
(71.8) 
     p value <0.001 <0.001 <0.001* 
     missing 9 (1.1) 91 (0.0) 2 (0.4) 84 (0.1) 0 (0.0) 5 (0.1) 
Gestational age at birth 
     <24 weeks 272 
(32.7) 
163 (0.1) 170 (32.4) 75 (0.1) 9 (29.0) 5 (0.1) 
     24-27 weeks 113 
(13.6) 
362 (0.2) 81 (15.4) 275 (0.2) 5 (16.1) 21 (0.3) 
     28-32 weeks 113 
(13.6) 
1645 (0.8) 68 (13.0) 1014 (0.8) 4 (12.9) 55 (0.7) 
     33-36 weeks 120 
(14.4) 
10386 (5.0) 72 (13.7) 6052 (5.0) 3 (9.7) 370 (4.5) 
     ≥37 weeks 215 
(25.8) 
196373 
(94.0) 
134 (25.5) 
114644 
(93.9) 
9 (29.0) 
7852 
(94.6) 
     p value <0.001 <0.001 <0.001 
     missing 2 (0.2) 14 (0.0) 0 (0.0) 5 (0.0) 1 (3.2) 0 (0.0) 
Baby’s gender 
     Male 439 
(52.6) 
107095 
(51.3) 
263 (50.1) 
62865 
(51.5) 
12 (38.7) 
4272 
(51.5) 
     p value 0.426 0.520 0.210 
     missing 1 (0.1) 1 (0.0) 0 (0.0) 0 (0.0) 1 (3.2) 0 (0.0) 
Small-for-gestational age 
     Yes 244 
(29.2) 
17174 (8.2) 160 (30.5) 10393 (8.5) 6 (19.4) 645 (7.8) 
     p value <0.001 <0.001 0.007 
     missing 9 (1.1) 27 (0.0) 3 (0.6) 20 (0.0) 3 (9.7) 2 (0.0) 
Antepartum haemorrhage 
     Yes 194 
(23.2) 
6025 (2.9) 136 (25.9) 2741 (2.3) 7 (22.6) 181 (2.2) 
     p value <0.001 <0.001 <0.001 
Pre-existing hypertension (with or without superimposed pre-eclampsia) 
     Yes 18 (2.2) 1293 (0.6) 12 (2.3) 831 (0.7) 1 (3.2) 65 (0.8) 
     p value <0.001 <0.001 0.219* 
Eclampsia/Pre-eclampsia 
     Yes 45 (5.4) 4085 (2.0) 32 (6.1) 2991 (2.5) 0 (0.0) 282 (3.4) 
     p value <0.001 <0.001 0.626 
Pregnancy Induced hypertension 
     Yes 17 (2.0) 5778 (2.8) 10 (1.9) 3776 (3.1) 0 (0.0) 343 (4.1) 
     p value 0.199 0.116 0.638* 
Pre-existing diabetes 
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Characteristics 
Non-Indigenous 
(n=340,714) 
Major City 
(n=209,778) 
Regional 
(n=122,590) 
Remote 
(n=8,334) 
Stillbirth 
(n=835) 
Livebirth 
(n=208,943) 
Stillbirth 
(n=525) 
Livebirth 
(n=122,065) 
Stillbirth 
(n=31) 
Livebirth 
(n=8303) 
n(%) n(%) n(%) n(%) n(%) n(%) 
     Yes 15 (1.8) 1003 (0.5) 6 (1.1) 663 (0.5) 0 (0.0) 36 (0.4) 
     p value <0.001 0.063 1.000* 
Gestational diabetes 
     Yes 42 (5.0) 11234 (5.4) 16 (3.1) 6438 (5.3) 0 (0.0) 463 (5.6) 
     p value 0.658 0.023 0.416 
Data missing on geographic location for 12 births (1 stillbirth and 11 livebirths).    Percentages may add up to 
greater than 100% due to rounding    ^ ICD10-AM codes: .     ICD10-AM codes: Antepartum haemorrhage 
(O44.1, O45-46), Essential hypertension (O10.0, O10.2-10.4, O10.9, O11), Pregnancy Induced hypertension 
(O13), Pre-eclampsia/Eclampsia (O14, O15), Pre-existing diabetes (O24.0, O24.1, O24.3, O24.8), 
Gestational diabetes (O24.4, O24.9).  
 
 
Table 4.8 and 4.9 show adjusted odds ratios for stillbirth associated with antepartum 
haemorrhage, hypertension, diabetes and small-for-gestational age by gestational age 
group and Indigenous status for regional (Table 4.8) and remote residence (Table 4.9).  
No significant association was found between regional residence and stillbirth for all of the 
conditions examined.  However, the results suggest differences in the gestational age 
specific risk profiles for Indigenous and non-Indigenous women.  These differences were 
particularly evident at 28-32 weeks and 33-36 weeks.  At 28-32 weeks, regional residence 
was associated with 28-43% reduction in risk of stillbirth among Indigenous women and a 
1-5% increase in risk among non-Indigenous women.  Likewise at 33-36 weeks, regional 
residence was associated with 261-280% increased risk of stillbirth among Indigenous 
women compared with a 5-10% increase in risk for non-Indigenous women.  However, 
none of these risk estimates reached statistical significance.  Similarly, remote residence 
was not significantly associated with stillbirth after adjusting for other maternal factors for 
all the conditions examined.  There were also marked differences in the gestational age 
specific risk profile between Indigenous and non-Indigenous women.  For example, at 33-
36 weeks, remote residence was associated with 295-330% increase in risk of stillbirth for 
Indigenous women, while among non-Indigenous women, remote residence was 
associated with 35-38% decreased risk of stillbirth.  However, none of these risk estimates 
reached statistical significance. 
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Table 4.8: Gestational age-specific stillbirth risk by Indigenous status, regional areas, Queensland, mid 2005–2011 
Conditions 
Indigenous (n=20,273 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Antepartum 
haemorrhage^ 
1.62 (0.66-4.01) 1.26 (0.27-5.92) 0.72 (0.21-2.48) 3.80 (0.73-19.79) 1.38 (0.61-3.15) 
Essential hypertension*~ 1.58 (0.65-3.85) 1.25 (0.27-5.84) 0.62 (0.19-2.04) 3.71 (0.72-19.19) 1.28 (0.57-2.91) 
Pre-
Eclampsia/Eclampsia~ 
1.60 (0.66-3.90) 1.29 (0.28-6.00) 0.71 (0.22-2.32) 3.61 (0.71-18.48) 1.31 (0.58-2.97) 
Pre-existing diabetes^~ 1.58 (0.65-3.85) 1.25 (0.27-5.84) 0.62 (0.19-2.04) 3.71 (0.72-19.19) 1.28 (0.57-2.91) 
Gestational diabetes^~ 1.62 (0.66-3.95) 1.28 (0.27-5.97) 0.66 (0.20-2.18) 3.71 (0.72-19.04) 1.31 (0.58-2.97) 
Small-for-gestational age 1.58 (0.65-3.85) 1.26 (0.27-5.89) 0.57 (0.17-1.92) 3.79 (0.73-19.84) 1.28 (0.57-2.89) 
Conditions 
Non-Indigenous (n=340,714 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Antepartum 
haemorrhage^ 
1.12 (0.91-1.38) 1.30 (0.96-1.76) 1.05 (0.76-1.44) 1.10 (0.81-1.50) 1.09 (0.87-1.37) 
Essential hypertension* 1.13 (0.92-1.39) 1.30 (0.96-1.75) 1.03 (0.75-1.41) 1.05 (0.77-1.42) 1.05 (0.84-1.32) 
Pre-eclampsia/Eclampsia 1.12 (0.91-1.38) 1.29 (0.96-1.75) 1.02 (0.74-1.40) 1.05 (0.77-1.42) 1.05 (0.83-1.31) 
Pre-existing diabetes^ 1.13 (0.92-1.39) 1.30 (0.96-1.75) 1.03 (0.75-1.41) 1.05 (0.77-1.42) 1.05 (0.84-1.32) 
Gestational diabetes^ 1.13 (0.91-1.38) 1.30 (0.96-1.75) 1.02 (0.75-1.41) 1.05 (0.77-1.43) 1.05 (0.84-1.32) 
Small-for-gestational age 1.10 (0.89-1.36) 1.28 (0.95-1.74) 1.01 (0.74-1.39) 1.06 (0.78-1.44) 1.05 (0.84-1.32) 
All models adjusted for maternal age, smoking status, gravidity, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception 
use, socioeconomic status, marital status, number of antenatal care visits.  
a
Indigenous models include the following interaction terms: smoking*maternal age and 
marital status*maternal age.  
b
 Non-Indigenous models include the following interaction term: smoke*FGR10.  ^These models additionally adjusted for pre-existing 
hypertension.  *These models additionally adjusted for pre-existing diabetes.  ~Exact logistic regression model 
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Table 4.9: Gestational age-specific stillbirth risk by Indigenous status, remote areas, Queensland, mid 2005–2011  
Conditions 
Indigenous (n=20,273 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Antepartum 
haemorrhage^ 
1.83 (0.68-4.95) 2.53 (0.51-12.46) 1.24 (0.30-5.14) 4.01 (0.65-24.83) 0.77 (0.24-2.53) 
Essential hypertension*~ 2.11 (0.80-5.58) 2.97 (0.61-14.34) 1.34 (0.35-5.03) 3.95 (0.64-24.54) 0.72 (0.22-2.34) 
Pre-
Eclampsia/Eclampsia~ 
2.16 (0.52-5.71) 3.07 (0.64-14.84) 1.65 (0.44-6.17) 4.00 (0.66-24.41) 0.75 (0.23-2.43) 
Pre-existing diabetes^~ 2.11 (0.80-5.58) 2.97 (0.61-14.34) 1.34 (0.35-5.03) 3.95 (0.64-24.54) 0.72 (0.22-2.34) 
Gestational diabetes^~ 2.19 (0.83-5.79) 3.05 (0.63-14.77) 1.39 (0.37-5.24) 4.04 (0.66-24.75) 0.77 (0.24-2.49) 
Small-for-gestational age 2.12 (0.80-5.60) 3.01 (0.63-14.52) 1.37 (0.36-5.14) 4.30 (0.69-26.78) 0.77 (0.24-2.48) 
Conditions 
Non-Indigenous (n=340,714 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Antepartum 
haemorrhage^ 
0.65 (0.31-1.34) 1.00 (0.40-2.50) 0.87 (0.32-2.37) 0.65 (0.21-2.06) 1.10 (0.56-2.15) 
Essential hypertension* 0.67 (0.33-1.37) 1.04 (0.42-2.56) 0.84 (0.31-2.30) 0.63 (0.20-1.99) 1.07 (0.55-2.08) 
Pre-eclampsia/Eclampsia 0.71 (0.35-1.45) 0.98 (0.40-2.42) 0.80 (0.29-2.18) 0.62 (0.20-1.97) 1.04 (0.53-2.03) 
Pre-existing diabetes^ 0.67 (0.33-1.37) 1.04 (0.42-2.56) 0.84 (0.31-2.30) 0.63 (0.20-1.99) 1.07 (0.55-2.08) 
Gestational diabetes^ 0.68 (0.33-1.39) 1.03 (0.42-2.55) 0.84 (0.31-2.29) 0.63 (0.20-1.98) 1.06 (0.54-2.08) 
Small-for-gestational age 0.73 (0.36-1.50) 0.90 (0.33-2.46) 0.86 (0.32-2.35) 0.65 (0.21-2.06) 1.08 (0.55-2.12) 
All models adjusted for maternal age, smoking status, gravidity, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception 
use, socioeconomic status, marital status, number of antenatal care visits.  
a
Indigenous models include the following interaction terms: smoking*maternal age and 
marital status*maternal age.  
b
 Non-Indigenous models include the following interaction term: smoke*FGR10.  ^These models additionally adjusted for pre-existing 
hypertension.  *These models additionally adjusted for pre-existing diabetes.  ~Exact logistic regression model 
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4.4 Discussion 
Main findings 
The first objective of this study was to describe the absolute risk of stillbirth by gestational 
age among Indigenous women and non-Indigenous women.  The profile was 
characterised by low risk during much of the gestational ages; with a dramatic increase in 
risk around term.  This profile of all-cause stillbirth risk was similar to profiles reported in 
USA and UK populations using a fetus-at-risk methodology [187, 227].  However, the 
overall magnitude of risk for Indigenous women was about twice that of non-Indigenous 
women.  
The second objective of our study was to examine the gestational age specific risk of 
stillbirth associated with diabetes, hypertension, small-for-gestational age and antepartum 
haemorrhage.  The prevalence of these conditions in our study was comparable to 
national estimates [24] and international estimates from other high income countries [32]. 
There were differences in the profile and magnitude of risk between Indigenous and non-
Indigenous women. This study found increased odds of stillbirth associated with pre-
existing diabetes, pre-existing hypertension, antepartum haemorrhage and small for 
gestational age across most gestational age groups for both Indigenous and non-
Indigenous women. However, there were mixed results for pre-eclampsia/eclampsia and 
gestational diabetes.  The odds of stillbirth for pre-existing diabetes and small for 
gestational age were twice as high for Indigenous women as non-Indigenous women. 
The third objective of this study was to examine the effect of geographic location on 
gestational age specific risk of stillbirth associated with the aforementioned conditions of 
interest.  The findings suggest an elevated risk of stillbirth for Indigenous women living in 
regional and remote areas particularly around 33-36 weeks.  There was also a suggestion 
of increased risk of stillbirth for non-Indigenous women living in regional areas.  These 
findings mirror reports of higher rates of stillbirth among Indigenous women living in 
regional and remote areas [190, 223].  There is evidence for the need to improve the 
quality of antenatal care for Indigenous women living in remote areas [231]. 
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Interpretation of findings 
Diabetes 
Increased risk of stillbirth associated with pre-existing diabetes was found from 33 weeks 
onwards for both Indigenous and non-Indigenous women.  Similar findings of increased 
risk of stillbirth due to pre-existing diabetes from 32 weeks onwards have been reported 
elsewhere [35, 232]. A two-fold disparity in the magnitude of stillbirth risk associated with 
pre-existing diabetes between Indigenous and non-Indigenous women also mirror higher 
rates of pre-existing diabetes among Indigenous women in this study (1.3% vs 0.5%).  
Higher rates of pre-existing diabetes among pregnant Indigenous women have also been 
reported nationally [89]. Furthermore, there was disparity in the population attributable 
fractions associated with pre-existing diabetes among Indigenous and non-Indigenous 
women (7.4% vs 1.6%); however, these were similar to those reported for other high 
income countries (3-5%) [32]. Similarly, this study found increased risk of stillbirth due to 
gestational diabetes from 28 weeks onwards, in concordance with Hutcheon and 
colleagues [233]. It has been argued that the ‘protective’ effect observed in relation to 
gestational diabetes at earlier gestational ages may be due to routine screening for GDM 
around 24-28 weeks [233]. There is evidence of higher rates of increase in gestational 
diabetes among non-Indigenous women, despite currently lower absolute rates of GDM 
compared with Indigenous women [87]. 
Current management for pre-existing diabetes includes strict glycaemic control, pre-
conceptual folate supplementation, cessation of oral hypoglycaemic agents, diabetes 
complication review, periodic ultrasound scans for fetal morphology (18-20 weeks), cardiac 
views (24 weeks), fetal growth (28-30 and 34-36 weeks)[13].  The International 
Association of Diabetes and Pregnancy Study Groups (IADPSG) recommend screening all 
women at their first antenatal visit for gestational diabetes or previously undiagnosed pre-
existing diabetes [234]; however, Australian and New Zealand guidelines recommend a 
tiered approach with early screening of women at high risk or with multiple risk factors [9, 
235].  Perinatal mortality audits in high income countries have identified poor glycaemic 
control [236, 237] and inadequate screening among women at risk [238] as suboptimal 
care factors associated with stillbirth.  Conversely, pre-pregnancy counselling has been 
found to significantly lower the risk of major congenital anomalies associated with diabetes 
during pregnancy (RR 0.36, 95% CI 0.22-0.59; absolute risk 2.1% versus 6.5%) [9].  Pre-
conception care was found to reduce perinatal mortality while optimal vs suboptimal serum 
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blood glucose control was associated with reduced perinatal mortality (RR 0.40, 95% CI 
0.25-0.63) but not stillbirth (RR 0.51 95% CI 0.14-1.88) [239].  Our findings highlight the 
need for early initiation of monitoring of women with pre-existing diabetes, especially for 
Indigenous women; and early identification and management of gestational diabetes. 
 
Hypertension 
An increased risk of stillbirth associated with pre-existing hypertension was suggested at 
all gestational ages assessed; and pre-eclampsia/eclampsia was likely to be associated 
with increased risk of stillbirth (although the numbers were small and did not reach 
statistical significance). However, increased risk of stillbirth associated with pre-existing 
hypertension and pregnancy induced hypertension has been reported by others [35]. Our 
findings in relation to population attributable risk associated with pre-existing hypertension 
[(1.7% for Indigenous women and 0.2% for non-Indigenous women] was much lower than 
national estimates (6.9%) and estimates from other high income countries (7-14%) [32]. 
However, our estimate of 3.5% among non-Indigenous women was similar to findings from 
other high income countries (about 3%) [32]. 
The main objectives of antenatal care for women with hypertensive disorders during 
pregnancy are: blood pressure control, early diagnosis of pre-eclampsia, eclampsia 
prevention and optimising pregnancy outcomes [94]. 
 
Antepartum Haemorrhage 
This study found increased risk of stillbirth due to antepartum haemorrhage at all 
gestational age groups assessed; and the magnitude of risk for Indigenous women was 
nearly two fold higher than for non-Indigenous women.  Despite differences in 
methodology, similar magnitude of risk has been reported in population based studies from 
Canada and USA with adjusted odds ratios ranging from 11.40-18.90 for stillbirth 
associated with placental abruption in births of at least 20 weeks [240, 241]. Our study 
found population attributable fractions associated with antepartum haemorrhage of 28.5% 
and 22.4% for Indigenous and non-Indigenous women, respectively. This is comparable to 
estimates of 15.2% for abruption only in other high income countries [32].  The disparity in 
risk seen between Indigenous and non-Indigenous women may be a reflection of higher 
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prevalence of risk factors for placenta praevia and abruption such as maternal smoking 
(52.7% vs 16.6%), substance use (1.7% vs 0.5%) and small for gestational age (15.2% vs 
8.4%).  At present, there is limited evidence for the prediction or prevention of abruption; 
and antepartum haemorrhage usually constitutes a sudden obstetric emergency.  The 
mainstay of management includes: assessment of maternal and fetal condition, prompt 
resuscitation if required and early delivery if there is fetal distress or the baby is suitably 
mature [242, 243]. It is estimated that up to 70% of APH cases occur in apparently low risk 
pregnancies [244]. 
 
Small-for-gestational age 
Increased risk of stillbirth associated with SGA was found from 24 weeks onwards for both 
Indigenous and non-Indigenous women; and similar findings have been reported 
elsewhere [35].  Although not reflected in the stillbirth risk, Indigenous women in this study 
had higher prevalence of SGA (15.2% vs 8.4%), similar to reports from the Northern 
Territory (Indigenous 11.9% vs non-Indigenous 5.0%) [245]. The higher prevalence of 
SGA was also not reflected in the population attributable risk (16.9% for Indigenous 
women versus 20.0% for non-Indigenous women), which was similar to estimates from 
other high income countries (23%) [32].  Indigenous women in this study also had higher 
prevalence of risk factors for SGA as follows: maternal smoking (52.7% vs 16.6%), 
substance use (1.7% vs 0.5%), pre-existing hypertension (1.0% vs 0.7%), diabetes (7.9% 
vs 5.8%) and pre-eclampsia/eclampsia (2.9% vs 2.2%).  This study found the risk of 
stillbirth associated with SGA was modified by maternal smoking status, as has been 
reported by others [246, 247].  The association between SGA and placental dysfunction 
has been established [248]; however, the interaction with smoking suggests there may be 
other factors at play in the aetiology of stillbirth among maternal non-smokers. 
SGA has been used as a proxy for fetal growth restriction and undetected fetal growth 
restriction has been identified as a significant potentially modifiable risk factor for stillbirth 
[247].  There are currently no antenatal interventions to treat fetal growth restriction and 
the mainstay of management is fetal monitoring to determine the optimal timing for delivery 
(balancing risks and benefits of adverse fetal outcomes against morbidity and mortality 
associated with early delivery at a given gestational age) [248].  Management for SGA 
involves accurate determination of gestational age and serial monitoring of fetal growth 
(using symphysis-fundal height measurement or ultrasound biometry).  However, 
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controversy exists over the accuracy of symphysis-fundal height measurement especially 
in obese women [249] and the use of customised growth charts due to lack of high level 
evidence [250].  A number of interventions have been found to be effective in the 
prevention of SGA among women at increased risk, including: antiplatelet agents, smoking 
cessation, progesterone therapy, anti-thrombotic therapy and interventionist care in severe 
pre-eclampsia [251].  Further studies are needed into preventive strategies for SGA that 
also include pre-eclampsia and preterm birth [251], as well as investigating the serious 
adverse effects of antenatal antithrombotic therapies [252]. 
 
Equity in access to antenatal care 
Overall, this study highlights the importance of optimal maternal health prior to pregnancy 
as well as early initiation of high quality antenatal care in the context of continued disparity 
in risk of stillbirth among Indigenous and non-Indigenous women.  Equity in access and 
utilisation antenatal care services is important to addressing disparities in health outcomes 
for Indigenous women [197].  Indigenous women in our study were more likely to have 
fewer antenatal care visits, a finding supported by others [24, 200]. Limited availability of 
culturally appropriate services may affect attendance for antenatal care; for example there 
were on average 5.5 antenatal care visits within mainstream services versus 10.5 visits 
within community controlled services setting for Indigenous women [253].  Active efforts to 
ensure appropriate and responsive care in the clinical environment both at the level of the 
individual health practitioner and within mainstream health care services are essential to 
reduce or eliminate social barriers to accessing health care. Embedding cultural 
competence in continuing organisational quality improvement processes has been shown 
to enhance health outcomes for Indigenous people [254]. This is especially important for 
Indigenous women who seek care within mainstream health services.  Factors affecting 
provision of high quality antenatal care to Indigenous women are likely to be different in 
rural and remote areas because of the challenges of delivering services to small discrete 
communities in sparsely populated areas; a limited workforce has been identified as such 
[253].  
The Australian government has recognised the importance of maternal and child health to 
the “Closing the Gap” initiative and has prioritised maternal and child health [255]. It has 
been shown that an investment in stillbirth prevention provides a three-fold return in terms 
of maternal, neonatal and child health [256].  While there has been continued support for 
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community controlled health centres and their Mums and Bubs centres, many health and 
lifestyle modification programs have been defunded.  Declines seen in smoking and under-
5 child mortality rates are further evidence for the need to maintain funding for successful 
lifestyle modification programs and antenatal care services operated by the community 
controlled health services [255].  More broadly, access to primary care services is critical 
to reducing health inequity and policies that undermine universal health care pose a 
significant threat to this goal by presenting further financial barriers that are likely to 
disproportionately affect the most vulnerable [257].  
 
 
4.5 Conclusion 
In summary, this study highlights the stillbirth risk associated with diabetes, hypertension, 
antepartum haemorrhage and small for gestational age.  It also highlights the disparity in 
stillbirth risk between Indigenous and non-Indigenous women and the need to prioritise 
early detection and management of these conditions and to work with women before, 
during and between pregnancies. Improving access to and utilisation of appropriate and 
responsive healthcare may help to address disparities in stillbirth risk for Indigenous 
women. 
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Chapter 5 
Prediction of term antepartum stillbirth risk 
 
5.1 Introduction 
In Chapter 3 and 4 it was shown that stillbirth rates at term have not decreased for 
Indigenous women and stillbirth risk varies with gestational age and increases sharply 
around term.  At present, fetal deaths occurring prior to delivery (antepartum stillbirths) 
constitute nearly 80% of stillbirths within the Queensland and Australian context [258].  
Risk factors for antepartum stillbirth include advanced maternal age, smoking, primiparity, 
pre-existing hypertension and pre-existing diabetes [259]. There is significantly increased 
risk of antepartum stillbirth beyond 40 weeks gestation for older (aged 40 years or older) 
and primiparous women [259].  These deaths may potentially be preventable by elective 
delivery; however, this is dependent on gestational age [260].  While elective delivery at 
extremely premature gestation may lead to neonatal death or survival with long-term 
morbidity or disability [261]; there is also increased risk of morbidity [262] and long term 
mortality associated with delivery at early term (37-38 weeks) gestation [263].  Therefore, 
the timing of elective delivery during early term gestation requires careful consideration of 
the risk of stillbirth with continuation of the pregnancy versus the risk of morbidity and 
mortality associated with delivery.  Therefore, the ability to predict pregnancies at 
increased risk of stillbirth around term is important to preventing term antepartum 
stillbirths.   
A number of studies have examined the ability to predict stillbirth risk at term using 
maternal factors alone [230, 264], and could not recommend screening pregnancies based 
on individual maternal factors alone [264].  Furthermore, a recent systematic review 
assessing the ability of ultrasound biometry and biomarker testing during the first and 
second trimester to predict stillbirth found that such testing either singly or in combination 
was not useful in predicting stillbirth, however, uterine artery pulsativity index and 
pregnancy associated plasma protein A during the first trimester were useful to predicting 
stillbirths related to placental dysfunction [265].  At present, only a few studies have been 
undertaken to predict antepartum stillbirth risk around term within the Australian context.  
From Chapter 3, we found geographic location was an important risk factor for stillbirth in 
the Australian context, especially for Indigenous women.  We found that Indigenous 
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women living in regional and remote areas had significantly higher rates of stillbirth than 
their counterparts living in major cities.   
In this study, the aim was to determine whether geographic location of maternal usual 
residence could improve the ability of a statistical model based on maternal clinical factors 
to detect women at increased risk of antepartum stillbirth at term.  The specific objectives 
of this study were to: 1) derive and validate a statistical model to predict antepartum 
stillbirth for pregnancies that reach 37 weeks gestation, based on maternal clinical factors 
available in a routinely-maintained population-based perinatal database, 2) assess the 
effect of addition of geographic location to the described model, and 3) determine the 
screening properties of the models. 
Presented in this chapter are findings from this population based study (n=352,515 
singleton term births).   
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5.2 Methods 
Study Population 
This population based retrospective database study involved all singleton livebirths and 
stillbirths of at least 37 weeks gestational age born in Queensland between July 2005 and 
December 2011.  This time period was chosen to maximise the available data on maternal 
characteristics such as smoking status and whether or not a woman had diabetes (pre-
existing or gestational) which have been found to be associated with stillbirth [32]. There 
were 379 102 singleton births registered in Queensland during this period.  Of these, 108 
births with unknown maternal Indigenous status were excluded as were a further 100 
births resulting in intrapartum stillbirth or stillbirths where it was unknown if the timing of 
death was antepartum or intrapartum (Figure 5.1). 
 
 
 
 
 
 
 
 
Figure 5.1: Flowchart showing study population and exclusions, Stillbirth Risk 
Prediction Study, mid 2005-2011 
 
Statistical Analysis 
The K fold approach was utilised to derive and validate the stillbirth risk prediction models. 
The study population was randomly divided into 8 roughly equal groups.  Differences in the 
characteristics of the subgroups were assessed using Chi square or Fisher’s exact test, 
All births 
379 102 singleton births 
Included births 
352 515 births 
(incl 383 antepartum stillbirths) 
Excluded births 
- 26 384 less than 37 weeks 
gestation 
- 108 unknown maternal 
Indigenous status 
- 53 stillbirths of unknown timing 
- 47 intrapartum stillbirths 
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where appropriate.  Within each ‘fold’, one subgroup was designated the validation cohort 
and the other seven subgroups combined were designated the derivation cohort.  As 
shown in Figure 5.2, each subgroup was subsequently designated as the validation cohort. 
 
K-Fold Subgroups 
1 1 2 3 4 5 6 7 8 
2 1 2 3 4 5 6 7 8 
3 1 2 3 4 5 6 7 8 
4 1 2 3 4 5 6 7 8 
5 1 2 3 4 5 6 7 8 
6 1 2 3 4 5 6 7 8 
7 1 2 3 4 5 6 7 8 
8 1 2 3 4 5 6 7 8 
 
 Validation cohort 
 Derivation cohort 
Figure 5.2: Diagram showing derivation and validation cohorts within 8 folds 
 
Selection of variables and fitting the model 
Using the derivation cohort, univariate logistic regression was used to assess the 
relationship between maternal sociodemographic, pregnancy and medical factors and the 
outcome of antepartum stillbirth.  All factors associated with antepartum stillbirth (p<0.05) 
were retained in the multivariate logistic regression model except gestational age. The 
effect of gestational age on the multivariate model as a categorical and continuous 
variable was assessed and found to be minimal. Other population based studies did not 
adjust for gestational age within the strata of ≥37 week births [230, 264]. Furthermore, the 
variable fetal growth included in the model was derived from birthweight and gestational 
age.  For these reasons, gestational age was not included in the final multivariate model.  
Factors such as primiparity and socioeconomic status were considered for inclusion in the 
model because of a-priori knowledge of their association with stillbirth [32], however they 
were not significantly associated with antepartum stillbirth within this population and were 
ultimately not included in the multivariate model.  An exploration of two way interactions 
between factors was undertaken informed by the literature [32].  Two significant 
interactions were found for maternal age*smoking status and pre-
eclampsia/eclampsia*antepartum haemorrhage.  The effects of these interaction terms 
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collectively and individually on the predictive ability of the multivariate model were 
assessed and they were ultimately not included in the model as the effect on the model 
was minimal. The final parsimonious model was then assessed with and without inclusion 
of geographic location.   
To assess the proportion of stillbirths that would be eliminated if each of the factors 
associated with antepartum stillbirth was eliminated, population attributable risk or 
fractions (PAR/PAF) were calculated using the adjusted effect estimates. In the literature, 
the terms population attributable risk (PAR) and fraction (PAF) are used interchangeably.  
 
Assessing performance of the predictive models 
Calibration of the model with the validation cohort, that is agreement between predicted 
and observed probabilities of antepartum stillbirth or livebirth was assessed using the 
Hosmer-Lemeshow goodness of fit test [266]. The discriminative ability (or the ability of the 
model to differentiate low from high risk women) was assessed using the area under the 
receiver operating characteristics (ROC) curve [267].  The sensitivity, specificity, negative 
predictive and positive predictive values for the models using each of the eight validation 
cohorts were calculated.  In order to obtain meaningful values for these screening 
characteristics, the cut-offs for the predicted probabilities were set at 0.01 and 0.005.  This 
procedure was repeated for the remaining seven ‘folds’, so that each subgroup was used 
once as a validation cohort.  The entire process was repeated for the parsimonious model 
including geographic location.  
 
Validation of the model 
This population based study utilised the k fold cross validation methodology to derive and 
validate the prediction model.  Cross validation was used to address the issue of model 
overfitting which arises when a model performs well during derivation but poorly during 
later validation [268]. A number of cross validation methods were available, namely the 
hold-out, k-fold and leave-one-out (LOO) methods.  The hold out method involves a single 
derivation and validation cohort and produces estimates with large variance depending on 
which data points are included in the respective cohorts [269].  In contrast, the k-fold 
method involves k trials in which the data is divided into k groups with each group used 
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once as the validation cohort and k-1 times as the derivation cohort [269]. Variance in the 
estimate is reduced as k increases. In contrast, the leave-one-out method is an extension 
of the k-fold method in which k=N, the number of data points in the dataset.  One point is 
left out and derivation and validation is carried out on the remaining points and this is 
repeated N times.  It has been reported that there is greater variance in the estimates of 
prediction error for the LOO cross validation than for K-fold validation [270].  For this 
reason, the k-fold methodology was utilised. 
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5.3 Results 
Characteristics of the study population 
A total of 352,515 singleton births were included in these analyses; among these were 383 
antepartum stillbirths.  The antepartum stillbirth rate was 1.1 per 1000 total births (95% CI 
1.0-1.2 per 1000 total births). The characteristics of the study population are summarised 
in Table 5.1.  Of 352 515 women, 5595 (1.6%) were aged 18 years or younger while 6658 
(1.9%) were 41 years or older.  About 5.3% of women self-identified as Aboriginal or 
Torres Strait Islander.  A majority of women (60.1%) lived in major cities while 12.9% of 
women lived in the most socioeconomically disadvantaged neighbourhoods.  About 18.3% 
of women reported smoking during pregnancy and nearly a third (29.7%) were 
primiparous.  The prevalence of pre-existing diabetes and pre-existing hypertension were 
0.4% and 0.6% among the study population, respectively.  As shown in Table 1, the 
distribution of maternal sociodemographic, pregnancy and medical characteristics was 
similar across the eight subgroups, including marital status although it was associated with 
a Chi square test result of p=0.021. 
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Table 5.1: Characteristics of the study population, by subgroups and total, mid 2005-2011 
Characteristics 
Group 1 
(n=44,070) 
Group 2 
(n=44,065) 
Group 3 
(n=44,064) 
Group 4 
(n=44,065) 
Group 5 
(n=44,064) 
Group 6 
(n=44,066) 
Group 7 
(n=44,061) 
Group 8 
(n=44,060) 
Total 
(n=352,515) 
p 
value 
Maternal age (years) 
     18 or less 686 (1.6) 648 (1.5) 708 (1.6) 701 (1.6) 746 (1.7) 716 (1.6) 698 (1.6) 692 (1.6) 5,595 (1.6) 
0.931 
     19-24 
9,467 
(21.5) 
9,271 
(21.0) 
9,228 
(20.9) 
9,361 
(21.2) 
9,310 
(21.1) 
9,367 
(21.3) 
9,320 
(21.2) 
9,384 
(21.3) 
74,708 
(21.2) 
     25-30 
15,341 
(34.8) 
15,333 
(34.8) 
15,366 
(34.9) 
15,283 
(34.7) 
15,266 
(34.7) 
15,239 
(34.6) 
15,301 
(34.7) 
15,271 
(34.7) 
122,400 
(34.7) 
     31-34 
10,231 
(23.2) 
10,316 
(23.4) 
10,227 
(23.2) 
10,244 
(23.3) 
10,295 
(23.4) 
10,246 
(23.3) 
10,174 
(23.1) 
10,297 
(23.4) 
82,030 
(23.3) 
     35-40 
7,509 
(17.0) 
7 684 
(17.4) 
7 625 
(17.3) 
7 668 
(17.4) 
7 626 
(17.3) 
7 651 
(17.4) 
7 740 
(17.6) 
7 621 
(17.3) 
61,124 
(17.3) 
     40+ 836 (1.9) 813 (1.9) 910 (2.1) 808 (1.8) 821 (1.9) 847 (1.9) 828 (1.9) 795 (1.8) 6,658 (1.9) 
Indigenous status 
     Indigenous 2,331 (5.3) 2,251 (5.1) 2,365 (5.4) 2,348 (5.3) 2,351 (5.3) 2,341 (5.3) 2,343 (5.3) 2,446 (5.6) 18,776 (5.3) 
0.261 
     Non-Indigenous 
41,739 
(94.7) 
41,814 
(94.9) 
41,699 
(94.6) 
41,717 
(94.7) 
41,713 
(94.7) 
41,725 
(94.7) 
41,718 
(94.7) 
41,614 
(94.5) 
333,739 
(94.7) 
Marital status 
     Domestic partner 
38 416 
(87.2) 
38 725 
(87.9) 
38 500 
(87.4) 
38 699 
(87.8) 
38 513 
(87.4) 
38 531 
(87.5) 
38 510 
(87.4) 
38 607 
(87.6) 
308 501 
(87.5) 
0.021 
     No Domestic 
partner 
5 646 
(12.8) 
5 333 
(12.1) 
5 552 
(12.6) 
5 359 
(12.2) 
5548  
(12.6) 
5527  
(12.5) 
5546 
(12.6) 
5450  
(12.4) 
43,961 
(12.5) 
Relative socioeconomic disadvantage 
     Highest 20% 
6,956 
(15.8) 
7,010 
(15.9) 
6,915 
(15.7) 
6,967 
(15.8) 
6,905 
(15.7) 
6,896 
(15.7) 
6,986 
(15.9) 
6,919 
(15.7) 
55,554 
(15.8) 
0.977      Middle 60% 
31,374 
(71.3) 
31,303 
(71.1) 
31,408 
(71.4) 
31,444 
(71.4) 
31,361 
(71.3) 
31,454 
(71.5) 
31,432 
(71.4) 
31,416 
(71.4) 
251,192 
(71.3) 
     Lowest 20% 
5,698 
(12.9) 
5,710 
(13.0) 
5,690 
(12.9) 
5,621 
(12.8) 
5,752 
(13.1) 
5,668 
(12.9) 
5,588 
(12.7) 
5,672 
(12.9) 
45,399 
(12.9) 
Geographic location 
     Major city 
26 490 
(60.1) 
26 438 
(60.0) 
26 402 
(59.9) 
26 473 
(60.1) 
26 375 
(59.9) 
26 564 
(60.3) 
26 486 
(60.1) 
26 501 
(60.2) 
211 729 
(60.1) 
0.905 
     Regional area 
16 075 
(36.5) 
16 166 
(36.7) 
16 118 
(36.6) 
16 142 
(36.6) 
16 163 
(36.7) 
16 026 
(36.4) 
16 118 
(36.6) 
16 083 
(36.5) 
128 891 
(36.6) 
     Remote area 1 503 (3.4) 1 458 (3.3) 1 544 (3.5) 1 449 (3.3) 1 526 (3.5) 1 475 (3.4) 1 456 (3.3) 1 476 (3.4) 11 887 (3.4) 
Maternal region of birth 
     Africa 746 (1.7) 707 (1.6) 720 (1.6) 720 (1.6) 743 (1.7) 719 (1.6) 772 (1.8) 707 (1.6) 5 834 (1.7) 
0.726* 
     Americas and 483 (1.1) 473 (1.1) 491 (1.1) 494 (1.1) 490 (1.1) 479 (1.1) 467 (1.1) 477 (1.1) 3 854 (1.1) 
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Characteristics 
Group 1 
(n=44,070) 
Group 2 
(n=44,065) 
Group 3 
(n=44,064) 
Group 4 
(n=44,065) 
Group 5 
(n=44,064) 
Group 6 
(n=44,066) 
Group 7 
(n=44,061) 
Group 8 
(n=44,060) 
Total 
(n=352,515) 
p 
value 
Caribbean 
     East Asia 841 (1.9) 883 (2.0) 863 (2.0) 866 (2.0) 780 (1.8) 788 (1.8) 854 (1.9) 841 (1.9) 6 716 (1.9) 
     Central, South & 
West Asia 
783 (1.8) 787 (1.8) 782 (1.8) 795 (1.8) 775 (1.8) 813 (1.9) 850 (1.9) 794 (1.8) 6 379 (1.8) 
     South East Asia 1 173 (2.7) 1 141 (2.6) 1 143 (2.6) 1 233 (2.8) 1 148 (2.6) 1 181 (2.7) 1 176 (2.7) 1 144 (2.6) 9 339 (2.7) 
     Europe 1,849 (4.2) 1,947 (4.4) 1,921 (4.4) 1,968 (4.5) 1,901 (4.3) 1,854 (4.2) 1,950 (4.4) 1,840 (4.2) 15,230 (4.3) 
     Australia & New 
Zealand 
37,490 
(85.1) 
37,438 
(85.0) 
37,441 
(85.0) 
37,271 
(84.6) 
37,520 
(85.2) 
37,523 
(85.2) 
37,315 
(84.7) 
37,594 
(85.4) 
299,592 
(85.0) 
     Oceania (excl ANZ) 686 (1.6) 668 (1.5) 682 (1.6) 696 (1.6) 680 (1.5) 692 (1.6) 657 (1.5) 638 (1.5) 5,399 (1.5) 
Smoking during 
pregnancy 
7,971 
(18.2) 
7,972 
(18.2) 
8,022 
(18.3) 
8,086 
(18.4) 
8,071 
(18.4) 
7,999 
(18.2) 
8,026 
(18.3) 
7,903 
(18.0) 
64,050 
(18.3) 
0.804 
Substance Use 
during pregnancy 
201 (0.5) 240 (0.5) 241 (0.6) 209 (0.5) 224 (0.5) 219 (0.5) 219 (0.5) 245 (0.6) 1,798 (0.5) 0.333 
Assisted conception 
use 
1,497 (3.4) 1,500 (3.4) 1,490 (3.4) 1,499 (3.4) 1,643 (3.7) 1,539 (3.5) 1,546 (3.5) 1,537 (3.5) 12,251 (3.5) 0.101 
Primiparity 
13,203 
(30.0) 
13,003 
(29.5) 
13,029 
(29.6) 
13,089 
(29.7) 
13,235 
(30.0) 
13,005 
(29.5) 
13,029 
(29.6) 
13,051 
(29.6) 
104,644 
(29.7) 
0.525 
Hospital accommodation status 
     Private 
13,420 
(30.5) 
13,575 
(30.8) 
13,527 
(30.7) 
13,453 
(30.5) 
13,516 
(30.7) 
13,532 
(30.7) 
13,497 
(30.6) 
13,261 
(30.1) 
107,781 
(30.6) 
0.412 
     Public 
30,650 
(69.6) 
30,490 
(39.2) 
30,537 
(69.3) 
30,610 
(69.5) 
30,547 
(69.3) 
30,534 
(69.3) 
30,564 
(69.4) 
30,799 
(69.9) 
244,731 
(69.4) 
Hospital level           
     Level 1 3,802 (8.6) 3,858 (8.8) 3,838 (8.7) 3,724 (8.5) 3,899 (8.9) 3,858 (8.8) 3,852 (8.7) 3,814 (8.7) 30,645 (8.7) 
0.503 
     Level 2 
29,347 
(66.6) 
29,350 
(66.6) 
29,329 
(66.6) 
29,351 
(66.6) 
29,294 
(66.5) 
29,499 
(66.9) 
29,337 
(66.6) 
29,133 
(66.1) 
234,640 
(66.6) 
     Level 3 
10,551 
(23.9) 
10,515 
(23.9) 
10,553 
(24.0) 
10,633 
(24.1) 
10,498 
(23.8) 
10,378 
(23.6) 
10,499 
(23.8) 
10,745 
(24.4) 
84,372 
(23.9) 
Number of antenatal visits 
     Less than 2 352 (0.8) 319 (0.7) 324 (0.7) 303 (0.7) 311 (0.7) 308 (0.7) 309 (0.7) 321 (0.7) 2,547 (0.7) 
0.514 
     2-4 2,169 (4.9) 2,236 (5.1) 2,227 (5.1) 2,221 (5.0) 2,174 (4.9) 2,275 (5.2) 2,240 (5.1) 2,261 (5.1) 17,803 (5.1) 
     5-7 
8,167 
(18.5) 
8,054 
(18.3) 
8,244 
(18.7) 
8,057 
(18.3) 
8,121 
(18.4) 
8,242 
(18.7) 
8,083 
(18.4) 
8,299 
(18.8) 
65,267 
(18.5) 
     8 or more 
33,364 
(75.7) 
33,434 
(75.9) 
33,237 
(75.5) 
33,463 
(76.0) 
33,433 
(75.9) 
33,219 
(75.4) 
33,404 
(75.9) 
33,162 
(75.3) 
266,716 
(75.7) 
Gestational age at birth 
     mean(sd) 39.3 (1.1) 39.3 (1.2) 39.3 (1.2) 39.3 (1.1) 39.3 (1.1) 39.3 (1.1) 39.3 (1.2) 39.3 (1.1) 39.3 (1.1) 0.971^ 
      37 weeks 2,726 (6.2) 2,824 (6.4) 2,835 (6.4) 2,767 (6.3) 2,721 (6.2) 2,803 (6.4) 2,831 (6.4) 2,813 (6.4) 22,320 (6.3) 0.959* 
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Characteristics 
Group 1 
(n=44,070) 
Group 2 
(n=44,065) 
Group 3 
(n=44,064) 
Group 4 
(n=44,065) 
Group 5 
(n=44,064) 
Group 6 
(n=44,066) 
Group 7 
(n=44,061) 
Group 8 
(n=44,060) 
Total 
(n=352,515) 
p 
value 
      38 weeks 
9,183 
(20.8) 
9,077 
(20.6) 
9,058 
(20.6) 
9,090 
(20.6) 
9,087 
(20.6) 
8,976 
(20.4) 
9,063 
(20.6) 
9,022 
(20.5) 
72,556 
(20.6) 
     39 weeks 
12,259 
(27.8) 
12,181 
(27.7) 
12,227 
(27.8) 
12,351 
(28.0) 
12,213 
(27.7) 
12,283 
(27.9) 
12,093 
(27.5) 
12,231 
(27.8) 
97,838 
(27.8) 
     40 weeks 
13,373 
(30.4) 
13,414 
(30.4) 
13,335 
(30.3) 
13,334 
(30.3) 
13,427 
(30.5) 
13,384 
(30.4) 
13,491 
(30.6) 
13,388 
(30.4) 
107,146 
(30.4) 
     41 weeks 
6,202 
(14.1) 
6,252 
(14.2) 
6,271 
(14.2) 
6,205 
(14.1) 
6,289 
(14.3) 
6,326 
(14.4) 
6,285 
(14.3) 
6,311 
(14.3) 
50,141 
(14.2) 
     42 weeks 319 (0.7) 306 (0.7) 327 (0.7) 308 (0.7) 319 (0.7) 286 (0.7) 291 (0.7) 288 (0.7) 2,444 (0.7) 
     43 weeks 4 (0.0) 7 (0.0) 3 (0.0) 4 (0.0) 2 (0.0) 3 (0.0) 2 (0.0) 5 (0.0) 30 (0.0) 
Male sex 
22,505 
(51.1) 
22,541 
(51.2) 
22,812 
(51.8) 
22,568 
(51.2) 
22,687 
(51.5) 
22,644 
(51.3) 
22,614 
(51.3) 
22,644 
(51.4) 
181,015 
(51.4) 
0.553 
Small for gestational 
age 
3,885 (8.8) 3,952 (9.0) 3,872 (8.8) 3,919 (8.9) 3,918 (8.9) 3,909 (8.9) 3,962 (9.0) 3,932 (8.9) 31,349 (8.9) 
0.811 
Appropriate for 
gestational age 
35,070 
(79.6) 
35,036 
(79.5) 
35,053 
(79.6) 
34,999 
(79.4) 
35,005 
(79.5) 
34,884 
(79.2) 
35,071 
(79.6) 
34,971 
(79.4) 
380,089 
(79.5) 
Large for gestational 
age 
5,113 
(11.6) 
5,069 
(11.5) 
5,132 
(11.7) 
5,141 
(11.7) 
5,135 
(11.7) 
5,267 
(12.0) 
5,022 
(11.4) 
5,153 
(11.7) 
41,032 
(11.6) 
Gestational diabetes 2,379 (5.4) 2,374 (5.4) 2,329 (5.3) 2,295 (5.2) 2,343 (5.3) 2,342 (5.3) 2,327 (5.3) 2,382 (5.4) 18,771 (5.3) 0.894 
Pre-existing diabetes 186 (0.4) 187 (0.4) 210 (0.5) 177 (0.4) 198 (0.5) 208 (0.5) 179 (0.4) 180 (0.4) 1,525(0.4) 0.503 
Pregnancy induced 
hypertension 
1,267 (2.9) 1,324 (3.0) 1,277 (2.9) 1,282 (2.9) 1,321 (3.0) 1,237 (2.8) 1,242 (2.8) 1,243 (2.8) 10,193 (2.9) 0.471 
Pre-
eclampsia/Eclampsia 
682 (1.6) 753 (1.7) 721 (1.6) 719 (1.6) 727 (1.7) 785 (1.8) 777 (1.8) 773 (1.8) 5,937 (1.7) 0.091 
Pre-existing 
hypertension 
257 (0.6) 256 (0.6) 271 (0.6) 257 (0.6) 257 (0.6) 249 (0.6) 245 (0.6) 290 (0.7) 2,082 (0.6) 0.605 
Antepartum 
haemorrhage 
878 (2.0) 848 (1.9) 903 (2.1) 937 (2.1) 873 (2.0) 880 (2.0) 886 (2.0) 876 (2.0) 7,081 (2.0) 0.609 
Antepartum stillbirth 46 (0.1) 42 (0.1) 51 (0.1) 50 (0.1) 51 (0.1) 48 (0.1) 50 (0.1) 45 (0.1) 383 (0.1) 0.980 
*Fisher’s exact test      ^ANOVA p value 
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Derivation of the prediction model 
Table 5.2 shows the magnitude of univariate associations between maternal 
sociodemographic, pregnancy and medical factors and stillbirth as an indication of the 
univariate associations within the various derivation cohorts.  For derivation cohort 1 (that 
is subgroups 2-8), factors associated with increased risk of stillbirth included: Indigenous 
race (OR 2.26, 95% CI 1.61-3.17), maternal age [19-24 years (OR 1.50, 95% CI 1.12-
2.01) and ≥41 years (OR 2.57, 95% CI 1.44-4.60)], smoking during pregnancy (OR 1.96, 
95% CI 1.55-2.47), substance use during pregnancy (OR 2.90, 95% CI 1.20-7.02) and 
accessing health care as a public patient (OR 1.64, 95% CI 1.26-2.13).  Women who had 
a stillbirth were more likely to have pre-existing diabetes (OR 11.6, 95% CI 6.98-19.2) and 
pre-existing hypertension (OR 3.05, 95% CI 1.36-6.85)(Table 5.2). Geographic location 
was not associated with antepartum stillbirth. 
 
Table 5.2: Univariate association between stillbirth and maternal factors for 
derivation cohort 1 (subgroups 2-8) 
Characteristics Stillbirth 
(n=337) 
Livebirth 
(n=308 108) 
Odds ratio (95% CI) 
Maternal age (years)    
     18 or less 7 (2.1) 4 902 (1.6) 1.64 (0.76-3.54) 
     19-24 85 (25.2) 65 156 (21.2) 1.50 (1.12-2.01) 
     25-30 93 (27.6) 106 966 (34.7) 1.00 (Ref) 
     31-34 78 (23.2) 71 721 (23.3) 1.25 (0.93-1.69) 
     35-40 61 (18.1) 53 554 (17.4) 1.31 (0.95-1.81) 
     41+ 13 (3.9) 5 809 (1.9) 2.57 (1.44-4.60) 
Indigenous status    
     Indigenous 38 (11.3) 16 407 (5.3) 2.26 (1.61-3.17) 
     Non-Indigenous 299 (88.7) 291 701 (94.7) 1.00 (Ref) 
Marital status    
    No Partner 56 (16.7) 38 259 (12.4) 1.42 (1.06-1.89) 
     Partner 279 (83.3) 269 806 (87.6) 1.00 (Ref) 
Socioeconomic disadvantage    
     Highest 20% 41 (12.2) 48 557 (15.8) 1.00 (Ref) 
     Middle 60% 249 (73.9) 219 569 (71.3) 1.34 (0.97-1.87) 
     Lowest 20% 47 (14.0) 39 654 (12.9) 1.40 (0.92-2.13) 
Geographic location    
     Major city 207 (61.4) 185 032 (60.1) 1.00 (Ref) 
     Regional area 122 (36.2) 112 694 (36.6) 0.97 (0.77-1.21) 
     Remote area 8 (2.4) 10 376 (3.4) 0.69 (0.34-1.40) 
Maternal Region of birth    
     Africa 7 (2.1) 5 081 (1.7) 1.27 (0.60-2.69) 
     Americas and Caribbean 5 (1.5) 3 366 (1.1) 1.37 (0.57-3.32) 
     East Asia 4 (1.2) 5 871 (1.9) 0.63 (0.23-1.69) 
     Central, South & West Asia 8 (2.4) 5 589 (1.8) 1.32 (0.65-2.67) 
     South East Asia 8 (2.4) 8 158 (2.7) 0.90 (0.45-1.83) 
     Europe 10 (3.0) 13 371 (4.3) 0.69 (0.37-1.30) 
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Characteristics Stillbirth 
(n=337) 
Livebirth 
(n=308 108) 
Odds ratio (95% CI) 
     Australia & New Zealand 284 (84.8) 261 818 (85.0) 1.00 (Ref) 
     Oceania (excl ANZ) 9 (2.7) 4 704 (1.5) 1.76 (0.91-3.43) 
Smoking during pregnancy    
     No 229 (69.6) 250 726 (81.8) 1.00 (Ref) 
     Yes 100 (30.4) 55 979 (18.3) 1.96 (1.55-2.47) 
Substance Use during pregnancy    
     No 332 (98.5) 306 516 (99.5) 1.00 (Ref) 
     Yes 5 (1.5) 1 592 (0.5) 2.90 (1.20-7.02) 
Assisted Conception Use    
     No 324 (96.7) 297 350 (96.5) 1.00 (Ref) 
     Yes 11 (3.3) 10 743 (3.5) 0.94 (0.52-1.71) 
Primigravidity    
     No 235 (69.9) 216 765 (70.4) 1.00 (Ref) 
     Yes 101 (30.1) 91 340 (29.7) 1.02 (0.81-1.29) 
Hospital accommodation status    
     Private 71 (21.2) 94 290 (30.6) 1.00 (Ref) 
     Public 264 (78.8) 213 817 (69.4) 1.64 (1.26-2.13) 
Hospital level    
     Level 1 24 (7.1) 26 819 (8.7) 0.77 (0.49-1.21) 
     Level 2 225 (66.8) 205 068 (66.6) 0.94 (0.73-1.21) 
     Level 3 86 (25.5) 73 735 (23.9) 1.00 (Ref) 
Number of antenatal care visits    
     Less than 2 14 (4.2) 2 181 (0.7) 7.30 (4.24-12.6) 
     2-4 36 (10.8) 15 598 (5.1) 2.62 (1.84-3.74) 
     5-7 79 (23.7) 57 021 (18.5) 1.58 (1.22-2.04) 
     8 or more 205 (61.4) 233 147 (75.7) 1.00 (Ref) 
Gestational age at birth    
     mean (sd) 38.9 (1.4) 39.3 (1.1) p<0.001* 
     37 weeks 66 (19.6) 19 528 (6.3) 1.00 (Ref) 
     38 weeks 84 (25.0) 63 289 (20.5) 0.39 (0.28-0.54) 
     39 weeks 67 (19.9) 85 512 (27.8) 0.23 (0.16-0.33) 
     40 weeks 76 (22.6) 93 697 (30.4) 0.24 (0.17-0.33) 
     41 weeks 36 (10.7) 43 903 (14.3) 0.24 (0.16-0.36) 
     42 weeks 6 (1.8) 2 119 (0.7) 0.84 (0.36-1.93) 
     43 weeks 1 (0.3) 25 (0.0) 11.8 (1.58-88.6) 
Baby’s sex    
     Male 167 (49.6) 158 343 (51.4) 0.93 (0.75-1.15) 
Gestational diabetes 24 (7.1) 16 368 (5.3) 1.37 (0.90-2.07) 
Pre-existing diabetes 16 (4.8) 1 323 (0.4) 11.6 (6.98-19.2) 
Pregnancy Induced hypertension 9 (2.7) 8 917 (2.9) 0.92 (0.47-1.79) 
Pre-eclampsia/Eclampsia 9 (2.7) 5 246 (1.7) 1.58 (0.82-3.07) 
Pre-existing hypertension 6 (1.8) 1 819 (0.6) 3.05 (1.36-6.85) 
*t test 
 
Table 5.3 shows the final parsimonious model predicting antepartum stillbirth risk at term 
from derivation cohort 1.  After adjusting for maternal, pregnancy and medical risk factors, 
increased risk of stillbirth persisted for: maternal age 41+ years (adjusted OR 2.40, 95% CI 
1.31-4.40), less than 8 antenatal care visits [(adjusted OR less than 2 visits 5.20, 95% CI 
2.89-9.37), (adjusted OR 2-4 visits 2.25, 95% CI 1.55-3.26) and (adjusted OR 5-7 visits 
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1.48, 95% CI 1.14-1.94)]. Pre-existing diabetes (adjusted OR 10.9, 95% CI 6.45-18.3) and 
maternal smoking (adjusted OR 1.49, 95% CI 1.15-1.94).  
 
Table 5.3: Predictors of antepartum stillbirth risk at term for derivation cohort 1 
(subgroups 2-8) 
Characteristic 
Adjusted 
Odds Ratio 
95% CI 
Maternal age (Ref: 25-30 years)   
     18 or less 1.02 0.44-2.38 
     19-24 1.23 0.91-1.67 
     31-34 1.31 0.96-1.78 
     35-40 1.38 0.99-1.92 
     41+ 2.40 1.31-4.40 
Indigenous status (Ref: Non-Indigenous)   
     Indigenous 1.37 0.95-1.99 
Marital Status (Ref: Domestic partner)   
     No Partner 0.99 0.72-1.35 
Any smoking during pregnancy (Ref: No)   
     Yes 1.49 1.15-1.94 
Substance Use during pregnancy (Ref: No)   
     Yes 1.48 0.60-3.67 
Hospital Accommodation status (Ref: Private)   
     Public 1.23 0.92-1.65 
Number of antenatal care visits (Ref: 8 or more)   
     Less than 2 5.20 2.89-9.37 
     2-4 2.25 1.55-3.26 
     5-7 1.48 1.14-1.94 
Pre-existing diabetes (Ref: No)   
     Yes 10.9 6.45-18.3 
Pre-existing hypertension (Ref: No)   
     Yes 2.17 0.94-5.00 
 
 
 
Predicted probability of stillbirth = 𝒆𝒙 (𝟏 + 𝒆𝒙)⁄  
where X = -7.82 + (0.02 x maternal age ≤18 years, 0.21 x maternal age 19-24 years, 
0.27 x maternal age 31-34years, 0.32 x maternal age 35-40 years, 0.87 x maternal 
age >41 years) + (0.32 x Indigenous ethnicity) + (-0.01 x no partner) + (0.40 x 
smoker) + (0.39 x substance use) + (0.21 x public patient) + (1.65 x less than 2 
antenatal care visits, 0.81 x 2 to 4 antenatal care visits; 0.39 x 5 to 7 antenatal care 
visits) + (2.39 x pre-existing diabetes) + (0.78 x pre-existing hypertension) 
Figure 5.3: Prediction model for risk of antepartum stillbirth at term 
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The prediction model for antepartum stillbirth risk at term is given in Figure 5.3. The 
adjusted population attributable fraction for factors with a significant association with term 
antepartum stillbirth is shown in Table 5.4.  The population attributable fractions 
associated with less than 8 antenatal care visits, maternal smoking and pre-existing 
diabetes were 15.4%, 8.2% and 3.8%, respectively. 
Table 5.4: Population attributable fractions 
Characteristic 
Adjusted 
Odds Ratio 
P 
(%) 
PAF% 
Maternal age 
     41 years and older 
 
2.40 (1.31-4.40) 
 
1.9 
 
2.6 
Number of antenatal care visits 
     Less than 2 
     2 to 4 
     5 to 7 
     Less than 8 
 
5.20 (2.89-9.37) 
2.25 (1.55-3.26) 
1.48 (1.14-1.94) 
1.75 (1.38-2.21) 
 
0.7 
5.1 
18.5 
24.3 
 
2.9 
6.0 
8.2 
15.4 
Pre-existing diabetes 10.9 (6.45-18.3) 0.4 3.8 
Maternal smoking 1.49 (1.15-1.94) 18.3 8.2 
 
Model validation and screening properties 
Presented in Table 5.5 and 5.6 are results of the Hosmer-Lemeshow goodness of fit tests 
using the derivation and validation cohorts for both models (final model and final model 
including geographic location).  The test p values indicate that the fit of the models to the 
derivation and validation cohorts was reasonable.  There was no material difference in the 
value of pseudo R2 averaged over the eight folds between the model with and without 
geographic location (0.03 versus 0.03). 
 
Table 5.5: Calibration of the final model without geographic location using the 
derivation and validation cohorts 
Fold 
Derivation Cohort Validation Cohort 
p value Pseudo R2 p value 
1 0.39 0.03 0.57 
2 0.77 0.02 0.95 
3 0.60 0.03 0.65 
4 0.83 0.02 0.57 
5 0.59 0.03 0.85 
6 0.83 0.02 0.41 
7 0.47 0.03 0.93 
8 0.52 0.03 0.79 
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Table 5.6: Calibration of the final model with geographic location using the 
derivation and validation cohorts 
Fold 
Derivation Cohort Validation Cohort 
p value Pseudo R2 p value 
1 0.38 0.03 0.24 
2 0.66 0.03 0.93 
3 0.86 0.03 0.32 
4 0.43 0.03 0.09 
5 0.67 0.03 0.32 
6 0.82 0.03 0.47 
7 0.58 0.03 0.96 
8 0.39 0.03 0.67 
 
Presented in Table 5.7 are the areas under the receiver operating curve (AUROC) for the 
model with and without geographic location. Similar to the pseudo R2, there was little 
difference in the discriminative ability of the models in the validation cohort evidenced by 
the average values of AUROC (0.63 vs 0.62). The average AUROC for the model without 
geographic location (0.62) means that there was a 62% probability that a woman with an 
antepartum stillbirth had a higher predicted probability that a woman with a livebirth for a 
random pair of women with and without antepartum stillbirth. 
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Table 5.7: Area under the curve (AUC) values for the stillbirth risk prediction model 
using derivation and validation cohorts 
Fold 
Derivation Cohort Validation Cohort 
AUC 95% CI SE AUC 95% CI SE 
Final model (without geographic location) 
1 0.63 0.60-0.66 0.02 0.56 0.47-0.65 0.05 
2 0.63 0.60-0.66 0.02 0.60 0.50-0.70 0.05 
3 0.62 0.59-0.65 0.02 0.67 0.59-0.75 0.04 
4 0.62 0.59-0.65 0.02 0.60 0.51-0.68 0.04 
5 0.62 0.59-0.66 0.02 0.61 0.52-0.69 0.05 
6 0.62 0.59-0.65 0.02 0.64 0.55-0.72 0.04 
7 0.62 0.59-0.66 0.02 0.61 0.52-0.70 0.05 
8 0.63 0.60-0.66 0.02 0.59 0.51-0.67 0.04 
Final model (with geographic location) 
1 0.64 0.61-0.67 0.02 0.56 0.46-0.65 0.05 
2 0.63 0.60-0.67 0.02 0.61 0.50-0.71 0.05 
3 0.63 0.59-0.66 0.02 0.68 0.60-0.76 0.04 
4 0.63 0.59-0.66 0.02 0.61 0.53-0.70 0.04 
5 0.63 0.60-0.66 0.02 0.60 0.51-0.69 0.05 
6 0.62 0.59-0.66 0.02 0.64 0.56-0.72 0.04 
7 0.63 0.60-0.67 0.02 0.60 0.51-0.69 0.05 
8 0.64 0.60-0.67 0.02 0.59 0.51-0.67 0.04 
AUC = Area under the curve 
SE = Standard Error 
95% CI = 95% Confidence interval 
 
Presented in Figure 5.4 are the ROC curves using the validation cohorts for the model 
without geographic location. 
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Figure 5.4: Receiver Operating Characteristic (ROC) curves for antepartum stillbirth prediction model without geographic 
location using validation cohorts 
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Tables 5.8 and 5.9 show the screening characteristics of the prediction model without and 
with geographic location, respectively.  The positive likelihood ratios fell over a wide range 
of values while most of the negative likelihood ratios failed to reach statistical significance.  
As with the AUROC values, there was little difference in the values for the screening 
characteristics between the model with or without geographic location. 
 
Table 5.8: Screening characteristics for the model without geographic location 
using the validation cohorts at two predicted probability cut-offs.  
Fold Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
Positive LR 
(95% CI) 
Negative LR 
(95% CI) 
Predicted probability cutoff = 0.01 
1 4.4 99.8 2.4 99.9 23.8 (6.03-93.9) 0.96 (0.90-1.02) 
2 2.4 99.8 1.2 99.9 12.4 (1.77-87.1) 0.98 (0.93-1.03) 
3 4.1 99.7 1.6 99.9 14.2 (3.61-55.7) 0.96 (0.91-1.02) 
4 4.2 99.9 2.9 99.9 27.2 (6.87-108) 0.96 (0.91-1.02) 
5 2.0 99.9 1.5 99.9 13.2 (1.87-93.3) 0.98 (0.94-1.02) 
6 6.5 99.8 3.4 99.9 33.6 (11.0-102) 0.94 (0.87-1.01) 
7 2.0 99.8 1.1 99.9 9.71 (1.38-68.3) 0.98 (0.94-1.02) 
8 0.0 99.7 0.0 99.9 - 1.00 (1.00-1.00) 
Predicted probability cutoff = 0.005 
1 10.9 99.1 1.2 99.9 11.5 (4.99-26.4) 0.90 (0.81-1.00) 
2 11.9 99.1 1.3 99.9 13.5 (5.90-31.0) 0.89 (0.80-0.99) 
3 4.1 98.9 0.4 99.9 3.64 (0.93-14.2) 0.97 (0.92-1.03) 
4 8.3 99.1 1.0 99.9 9.27 (3.61-23.8) 0.93 (0.85-1.01) 
5 15.7 99.1 2.0 99.9 17.9 (9.39-34.0) 0.85 (0.76-0.96) 
6 10.9 99.1 1.2 99.9 11.4 (4.98-26.3) 0.90 (0.81-1.00) 
7 10.2 99.1 1.2 99.9 10.8 (4.69-25.0) 0.91 (0.83-1.00) 
8 0.0 98.9 0.0 99.9 - 1.01 (1.01-1.01) 
PPV = positive predictive value 
NPV = negative predictive value 
LR = likelihood ratio 
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Table 5.9: Screening characteristics for the model with geographic location using 
the validation cohorts at two predicted probability cut-offs.  
Fold Sensitivity 
(%) 
Specificity 
(%) 
PPV 
(%) 
NPV 
(%) 
Positive LR 
(95% CI) 
Negative LR 
(95% CI) 
Predicted probability cutoff = 0.01 
1 4.4 99.8 2.1 99.9 20.7 (5.25-81.5) 0.96 (0.90-1.02) 
2 2.4 99.8 0.9 99.9 9.66 (1.38-67.6) 0.98 (0.93-1.03) 
3 4.1 99.7 1.3 99.9 11.7 (2.98-45.8) 0.96 (0.91-1.02) 
4 4.2 99.8 2.7 99.9 25.0 (6.32-99.0) 0.96 (0.91-1.02) 
5 2.0 99.8 1.4 99.9 11.9 (1.69-84.1) 0.98 (0.95-1.02) 
6 6.5 99.8 2.9 99.9 28.0 (9.22-85.1) 0.94 (0.87-1.01) 
7 2.0 99.7 0.8 99.9 7.57 (1.08-53.1) 0.98 (0.94-1.02) 
8 0.0 99.6 0.0 99.9 - 1.00 (1.00-1.00) 
Predicted probability cutoff = 0.005 
1 10.9 99.1 1.3 99.9 12.4 (5.40-28.6) 0.90 (0.81-1.00) 
2 11.9 99.1 1.3 99.9 13.8 (6.01-31.5) 0.89 (0.80-0.99) 
3 4.1 98.9 0.4 99.9 3.78 (0.97-14.7) 0.97 (0.92-1.03) 
4 8.3 99.1 1.1 99.9 9.68 (3.77-24.9) 0.93 (0.85-1.01) 
5 15.7 99.2 2.1 99.9 18.5 (9.69-35.2) 0.85 (0.76-0.96) 
6 10.9 99.1 1.3 99.9 12.0 (5.22-27.7) 0.90 (0.81-1.00) 
7 8.2 99.1 1.0 99.9 9.16 (3.56-23.6) 0.93 (0.85-1.01) 
8 0.0 98.9 0.0 99.9 - 1.01 (1.01-1.01) 
PPV = positive predictive value 
NPV = negative predictive value 
LR = likelihood ratio 
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5.4 Discussion  
Main findings 
This large population based study aimed to derive and validate a prediction model for 
antepartum stillbirth at term (≥ 37 weeks) based on maternal, pregnancy and medical 
factors.  A number of factors were found to be independently associated with term 
antepartum stillbirth including advanced maternal age (41 years and older), fewer than 
eight antenatal care visits,  pre-existing diabetes and maternal smoking..  Despite the 
strong association between these characteristics and term antepartum stillbirth risk, very 
little of the stillbirth risk was explained by the variables in the prediction model.  
 
Interpretation of findings 
Term antepartum stillbirth is an endpoint of various etiological pathways, and our results 
suggest that many factors not included in this model influence the risk of stillbirth. These 
findings are in accordance with studies in USA and UK that report poor ability to predict 
antepartum stillbirth at term based on maternal risk factors alone [230, 264]. Antepartum 
stillbirth is a rare outcome and as such a useful diagnostic test should yield high positive 
likelihood ratios (>10) and low negative likelihood ratios (<0.10) [271]. However, the 
negative likelihood ratios from our model were greater than 0.10 and many did not reach 
statistical significance.  Nevertheless, our model had a slightly reduced ability to 
discriminate low from high risk women (average area under the ROC curve 0.61) 
compared to a UK study which reported area under ROC curve of 0.64 (95% CI 0.60-0.68) 
for a model with maternal risk factors predicting antepartum stillbirth risk between 37-43 
weeks [230]. This may be due to our model adjusting for maternal and pregnancy factors 
only. 
Our study identified a number of maternal medical and pregnancy factors that were 
independently associated with antepartum stillbirth at term. There was limited published 
data on population attributable fraction or risk associated with these factors for stillbirths 
occurring at term; therefore, direct comparisons could not be made.  
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Antenatal Care 
Antenatal care is associated with improved perinatal and maternal outcomes [9]; however 
it is unclear which specific components are associated with decreased risk of stillbirth 
[100].  Both WHO and Australian national antenatal care guidelines recommend antenatal 
care as an opportunity to identify and manage any underlying conditions or obstetric 
complications so that the woman is as healthy as possible during pregnancy [272]. WHO 
recommends a minimum of 4 antenatal care visits [272]; while the Australian national 
antenatal care guidelines recommend a schedule of 10 visits for an initial uncomplicated 
pregnancy and seven visits for a subsequent uncomplicated pregnancy [273].  Our study 
found increased odds of stillbirth associated with attending fewer than 8 antenatal care 
visits; with a corresponding PAF of 15.1%. It was difficult to quantify a measure of 
inadequate antenatal care as data was unavailable for the gestational age at initiation of 
antenatal care. However, it can be proposed that delayed initiation of antenatal care 
represents limited opportunity to access information and interventions to optimise maternal 
and fetal health during pregnancy.  This study suggested higher risk with fewer antenatal 
care visits, a finding reported by others [274].  PARs of up to 8% have been reported for 
receiving no antenatal care [32]. Reports on institution-based audits of perinatal mortality 
have found the presence of preventable factors leading to mortality in 25-44% of cases 
[275-277].  Inadequate management of suspected fetal growth restriction, hypertension 
and decreased fetal movements have been identified as suboptimal care factors 
associated with term antepartum stillbirth [278]. 
 
Maternal Smoking 
Maternal smoking has been identified as an important modifiable risk factor for stillbirth as 
well as other adverse pregnancy outcomes.  Smoking is associated with stillbirth in a 
dose-dependent fashion [59]. It has been suggested that smoking increases the risk of 
stillbirth through the mechanism of tobacco-induced placental pathology and fetal growth 
restriction [279, 280]. Our study found a population attributable fraction of 8.2%; similar to 
reports for Australia (6.2%) and other high income countries (3.9-7.1%) [32]. It has been 
estimated that for Indigenous Australian women, the population attributable fraction may 
be as high as 20%, reflecting the higher maternal smoking rates [32].  There is evidence to 
support stillbirth risk reduction with smoking cessation during pregnancy [62, 63], as well 
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as high level evidence for the effectiveness of smoking cessation interventions for 
pregnant women.  However, smoking cessation rates have been consistently lower for 
Indigenous compared with non-Indigenous women [24].  Recent smoke-free legislation 
has been shown to reduce the risk of preterm birth [67], while incentives-based 
interventions show promise in increasing smoking cessation rates during and post 
pregnancy [205]. 
 
Pre-existing diabetes 
The association between pre-existing diabetes and stillbirth has been established.  Our 
study found associated population attributable fraction of 4.3% for term antepartum 
stillbirths, which is somewhat similar to estimates of 3-5% from a number of high income 
countries for stillbirths of >22 weeks or >500g birthweight [32]. It is proposed that fetal 
demise in diabetes-related stillbirths is as a result of hyperglycaemia leading to fetal 
anaerobic metabolism with hypoxia and acidosis [88].  There is controversy around the 
screening and management of women with diabetes during pregnancy. The International 
Association of Diabetes and Pregnancy Study Group recommend screening all women at 
their first antenatal visit for gestational diabetes or previously undiagnosed pre-existing 
diabetes [234], a similar approach is recommended in New Zealand [281] while a tiered 
approach with early screening of women at high risk or with multiple risk factors is 
recommended in Australia [9].  Antenatal care for women with pre-existing diabetes 
focuses on glycaemic control and also includes folate supplementation, ceasing oral 
hypoglycaemic agents in favour of insulin and screening for diabetic complications [234]. 
Currently, there is limited evidence on the long term maternal and infant outcomes of oral 
hypoglycaemic agent use during pregnancy [206, 234].  Areas for future research include 
large scale randomised trials to assess: the effect of diet in combination with lifestyle 
advice compared with pharmacotherapy on the development of gestational diabetes and 
maternal and fetal outcomes, the effect of early diagnosis and treatment on maternal and 
fetal outcomes, as well as the effect of diet and lifestyle advice compared with 
pharmacotherapy for the prevention of type II diabetes among women with a history of 
gestational diabetes [281] 
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Maternal age 
A significant association was found between advanced maternal age (41 years and older) 
and term antepartum stillbirth, with a corresponding population attributable fraction of 
2.3%. In comparison, PAR% of 6-8% was reported across five high income countries 
including Australia for maternal age of ≥35 years [32]. Our lower value may be explained 
by the smaller proportion of women aged ≥ 41 years compared with those aged ≥35 years 
for a similar effect size.  These findings of increased risk of term antepartum stillbirth with 
advanced maternal age after adjusting for maternal medical conditions are corroborated by 
others [35, 264, 282, 283].  Although not examined in our results, increased risk of stillbirth 
with advanced maternal age was found to be higher among primiparous compared with 
multiparous women [284].  It has been proposed that maternal age may affect the ability of 
the vascular system to respond to the increased requirements of pregnancy [35], however 
the exact aetiology of stillbirth in relation to advanced maternal age is unknown [264].  
However, it is important to advice women on the associations between advanced maternal 
age and the risk of stillbirth, especially with the increasing rates of delayed childbearing 
[32]. 
 
Identifying women at increased risk 
A number of studies have explored prediction models for identifying pregnancies at 
increased risk of antepartum stillbirth.  Maternal serum plasma protein A (PAPP-A) and 
uterine artery pulsativity index have been shown to be useful in the first and second 
trimester, respectively, in predicting abruption, pre-eclampsia and SGA related stillbirth 
[265]. However, biophysical and biochemical tests, either singly or in combination had low 
ability to predict stillbirth as a whole [265].  
Antepartum stillbirth is commonly preceded by decreased fetal movements (DFM) [285]. It 
has been established that DFM is an indicator of adaptation to chronic placental 
insufficiency [286]. Maternal perception of decreased fetal movements is used as a means 
of monitoring fetal wellbeing [287]. However, many women delay reporting DFM and there 
is wide variation in management of DFM by health care providers.  Currently, two large 
step wedge cluster randomised trials are underway in the UK and Australia.  The UK study 
(AFFIRM) is evaluating a package of care including increasing awareness and reporting of 
DFM, identification of placental insufficiency and timely delivery [288]. The Australian study 
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(My Baby’s Movements) is using mobile phone technology to increase maternal 
awareness of DFM along with a clinician education program to increase compliance with 
the DFM clinical practice guidelines [289]. Both studies will assess the effect on stillbirth 
rates. 
Unexplained antepartum stillbirth at term is a rare but devastating pregnancy outcome. 
This highlights the need for further research into the underlying aetiological mechanisms. 
Supine sleep position resulting in inferior vena cava compression has been proposed as 
an additional stressor in an already vulnerable fetus [290].  Similarly, genetic 
predisposition and acute placental dysfunction may be possible aetiologic factors.  
However, research is made difficult by relatively small numbers and may be aided by the 
use of composite outcomes. 
 
 
5.5 Conclusion  
The predictive ability of the statistical model based on maternal risk factors was poor.  The 
addition of geographic location made no material difference to the results. This study 
highlights the need for further research into the aetiology of antepartum stillbirth at term. 
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Chapter 6 
Stillbirth Classification Agreement Study 
 
6.1 Introduction 
Accurate cause of death information is essential to guide stillbirth prevention interventions 
as well as counselling women and families for management of future pregnancies.  The 
Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ 
PDC) system was developed for use alongside the Clinical Practice Guidelines for 
Perinatal Mortality to ensure systematic and high quality approach to stillbirth investigation 
and classification [124].  However, uptake of the guidelines by healthcare providers has 
been poor [158].  Furthermore, it has been suggested that there may be differences in the 
application of the perinatal death classification system across states and territories [23].   
Across Australia, each state and territory has processes for multidisciplinary review of 
perinatal deaths and these vary with population size, available resources and legislative 
arrangements [160].  Reviews may be carried out within hospitals (usually large tertiary 
centres) or centrally; each with their relative merits. In NSW, an electronic system is being 
trialled, allowing clinical staff with access to the full medical record to more accurately 
assign cause of death through a series of cascading questions in a decision tree [160]. To 
address the issue of access to comprehensive data for perinatal mortality audit and 
reporting, the PSANZ Perinatal Mortality Group and the Australia and New Zealand 
Stillbirth Alliance (ANZSA) developed the National Perinatal Death Clinical Audit Tool 
(NPDCAT) which is currently being pilot tested [291].  Accurate and consistent 
classification of stillbirth across Australian states and territories is important for: assessing 
trends in stillbirth causes, evaluating effectiveness of interventions to prevent stillbirth and 
for comparisons across states and territories. 
A population based study in New South Wales assessing agreement between hospital 
committee and expert panel review of stillbirths classification found low level of agreement 
and attributed this to lack of familiarity with the perinatal mortality guidelines [131].  Since 
that study was conducted, an education program was developed and rolled out to 
hospitals across Australia to train healthcare providers in the use of the guidelines and 
classification system [159].  
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This study aims to assess consistency in application of the PSANZ-PDC in a cohort of 
stillbirths investigated according to the perinatal mortality audit guidelines in an 
environment where healthcare providers have been trained in the use of the guidelines.  It 
is anticipated that this study will identify areas for quality improvement and possibly inform 
future updates to the perinatal mortality audit guidelines.  
Presented in this chapter are findings from an agreement study involving 217 stillbirth 
cases from 12 hospitals across Australia.  
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6.2 Methods  
Study Design and Population 
This prospective cohort study was nested in a larger multi-centre prospective cohort study. 
The larger study titled “Investigating the cause of stillbirth: a prospective cohort study 
examining use and effectiveness of a comprehensive investigation protocol (short title: 
Stillbirth Investigation study)” aimed to: 1) identify causes of stillbirth in a cohort of 
stillbirths investigated according to the PSANZ guidelines, 2) utilise expert panel review to 
determine yield from stillbirth investigations, and 3) undertake cost effectiveness analysis 
comparing a comprehensive versus selective approach to stillbirth investigation.  
The nested study involved comparison of hospital and expert panel review of a cohort of 
stillbirths investigated according to the Perinatal Mortality Guidelines and classified 
according to PSANZ Perinatal Death Classification system. This methodology was 
employed to assess application of the PSANZ PDC guidelines in an environment where 
clinicians undertaking classification were familiar with and regularly utilised the 
classification system. 
The study population included all stillbirths of at least 20 weeks gestation or 400g 
birthweight occurring at the participating hospitals.  The details of ethics approvals for this 
study are outlined in Appendix A.  Participating hospitals included all level 2 and level 3 
hospitals across Australia where the PSANZ guidelines on audit of perinatal mortality had 
been implemented and lead clinicians in stillbirth investigation and audit received training 
on the use of the guidelines. All eligible study participants were identified at the 
participating hospitals as part of routine procedures. Data was collected for 226 eligible 
stillbirth cases. Of these, stillbirth classification data was missing for 2 and 7 cases from 
the expert panel and hospital reviews, respectively. 
 
Sample Size 
The sample size calculation for this study was based on determining the level of 
agreement between the hospital review and the independent expert panel review with 
regards to stillbirth classification using the PSANZ perinatal death classification system.  A 
sample size of 385 stillbirths would give precision of around ± 0.1 around the estimated 
kappa statistic.  This was based on an expected kappa of 0.60 and a ‘proportion positive’ 
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by each reviewing group ranging from 0.5 to 0.8, with an alpha of 0.05.  A conservative 
estimate of kappa was used, based on data from international studies (kappa of 0.55 to 
0.67) [157] and an Australian study (0.64) using the PSANZ-PDC [131].  However, due to 
delays with obtaining ethics and governance approvals and relatively slow rates of case 
submission, a total of 217 stillbirth cases were available for classification by both groups. A 
sample size of 217 would give precision of around ± 0.10 to 0.12 around the estimated 
kappa of 0.60, with an alpha of 0.05 and a proportion positive by each group ranging from 
0.5 to 0.8. 
 
Study Procedures 
Hospital committee review 
Hospital review and classification of cause of stillbirth was carried out according to the 
PSANZ perinatal mortality investigation protocol as part of routine procedures at the 
participating hospitals.  This included taking a full history, undertaking specific diagnostic 
tests, and review and classification of death through a multidisciplinary perinatal mortality 
audit committee.  Data on hospital review of stillbirth cases was collected in the online 
study database as part of the Stillbirth Investigations Study.  The data collected in the 
study database was based on the National Perinatal Death Clinical Audit Tool (NPDCAT) 
and the PSANZ stillbirth investigation checklist [124].  All stillbirths fulfilling the inclusion 
criteria over the study period at the participating hospitals were identified as part of routine 
procedures within each hospital and included in the study.  Prior to the commencement of 
the study, training in the use of the PSANZ perinatal mortality guidelines was 
implemented.  Following the completion of investigations, the NPDCAT and PSANZ 
stillbirth investigation checklist were completed by the clinician for review by the hospital 
committee.  This information was entered into the online study database.  Following review 
and assignment of clinical classification of stillbirth by the hospital committee, the entry for 
each participant was completed and submitted to the study team through the online study 
database. 
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Expert panel review 
A multidisciplinary expert panel consisting of obstetrics, maternal fetal medicine, 
neonatology, perinatal pathology and perinatal epidemiology disciplines was convened to 
review the stillbirth cases. A number of the panel members were involved in the 
development of the PSANZ perinatal classification system and all were actively involved in 
perinatal mortality reviews at hospital and state levels.  Cases were assigned to panel 
members according to discipline based on case summary information and panel members 
were excluded from reviewing cases from their organisations.  Each case was assigned a 
lead reviewer.  The lead reviewer was responsible for reviewing and classifying the case 
prior to the panel meetings.  At the panel meetings, the lead reviewer presented the facts 
of the case for discussion and any differences in opinion regarding classification were 
discussed and resolved.  The panel was blinded to the hospital classification of cause of 
stillbirth.  Cases were reviewed using both electronic and hardcopy reports from the online 
study database.  
 
Data Management 
Following submission of a stillbirth case by the participating hospital using the online study 
database, an extract was taken. Part of the expert panel review included verifying that data 
was not missing or inappropriately entered for key fields.  In addition, the lead reviewer for 
a case checked that reports were included for investigations reported as performed.  For 
cases with missing or interim reports, the submitting hospital was contacted for additional 
details or reports and the case was held over for review by the expert panel until the 
missing information was uploaded to the study database. For a small number of cases, 
interim classification was undertaken by both hospital and expert panel where there were 
lengthy waits for final pathology reports but the findings were unlikely to change the 
probable cause of death. A paper-based data collection form was used to capture data 
from the expert panel review. The data collection form was completed by the lead reviewer 
prior to and during the panel review meetings. Classification data from the expert panel 
review was input into a standalone database along with the corresponding participant 
study number. The complete dataset for analysis was obtained by taking an extract from 
the online study database and linking it to expert panel review data in the stand-alone 
database using the unique participant study number.   
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Statistical Analysis 
Data on demographic, pregnancy, birth outcomes and stillbirth investigation were obtained 
from the online study database.  Maternal demographic data included: age, body mass 
index, marital status, occupation, ethnicity and level of English comprehension. Pregnancy 
data included pre-existing medical conditions, fertility treatment, any smoking during 
pregnancy, any alcohol or drug use during pregnancy and suspected fetal growth 
restriction.  Pregnancy outcomes included: baby’s birthweight, sex, gestational age at 
birth, type of stillbirth and termination of pregnancy.  Data on stillbirth investigations 
included: whether or not parents were offered autopsy, parental consent for autopsy and 
placental histopathology.  
Characteristics of the study population and investigations performed were summarised 
using frequency and percentages for categorical variables and mean (standard deviation) 
or median (interquartile range) as appropriate for continuous variables.  The main outcome 
measure was primary classification of cause of stillbirth using the PSANZ-PDC system.  
Inter-observer agreement between hospital and expert panel classification was assessed 
by calculating overall Cohen’s kappa with 95% confidence intervals across the eleven (11) 
PSANZ PDC categories.  Agreement within each PSANZ PDC category and within 
gestational age groups (20-27, 28-36, and ≥37 weeks) were also calculated.  Values for 
kappa were interpreted using guidelines proposed by Landis and Koch [292] as follows:  
Poor below 0.0 
Slight 0.00-0.20 
Fair 0.21-0.40 
Moderate 0.41-0.60 
Substantial 0.61-0.80 
Almost perfect 0.81-1.00 
Perfect 1.00 
 
All statistical analysis was performed using Stata 13.1 (StataCorp LP 2013, Texas, USA). 
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6.3 Results  
Study population characteristics 
During the period 2013-2015, hospital and expert panel classification of stillbirth was 
collated for 217 stillbirths across 12 (two level II and ten level III) hospitals across six 
Australian states and territories. The characteristics of the study cohort are shown in Table 
1. The mean maternal age was 30.7 years; and 181 women (83.4 %) lived with a domestic 
partner.  A large proportion of women in this cohort (69.6 %) identified as Māori or Pacific 
Islander and 83.4% of women understood English very well.  Ninety six women (44.2%) 
had a pre-existing medical condition and forty two women (19.4%) reported smoking 
during pregnancy (Table 6.1).   
The mean birthweight was 1360 grams and the median gestational age was 25 weeks. 
More than two thirds of stillbirths occurred during the antepartum period and 24.9% of 
stillbirths were terminations of pregnancy (Table 6.2).   
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Table 6.1: Maternal characteristics of the study cohort 
Characteristics n(%) 
Maternal age* 
30.7 (6.4) 
95% CI 29.8-31.6 
Maternal body mass index (kg/m2)* 
25.8 (5.5) 
95% CI 25.0-26.7 
Marital status 
     Partner 
     No Partner 
     Unknown 
 
181 (83.4) 
26 (12.0) 
10 (4.6) 
Maternal occupation 
     Unemployed/pension 
     Student 
     Home maker 
     Manual/farm/trade 
     Service/Retail 
     Clerical/Management 
     Professional 
     Unknown 
 
28 (12.9) 
11 (5.1) 
42 (19.4) 
2 (0.9) 
42 (19.4) 
21 (9.7) 
29 (13.4) 
42 (19.4) 
Ethnicity 
     Australian Aboriginal and/or Torres Strait Islander 
     Māori/Pacific Islander 
     Caucasian 
     Mediterranean 
     Indian/Pakistani/Bangladeshi/Sri Lankan 
     Cambodian/Lao/ Viet/ Thai 
     Chinese/Korean/ Hong Kong 
     Japanese 
     Middle East/North African 
     African 
     Unknown 
 
22 (10.1) 
151 (69.6) 
14 (6.5) 
4 (1.8) 
5 (2.3) 
5 (2.3) 
4 (1.8) 
6 (2.8) 
2 (0.9) 
1 (0.5) 
3 (1.4) 
Maternal English level 
     Very well 
     Well 
     Not well 
     Not at all 
     Unknown 
 
181 (83.4) 
17 (7.8) 
11 (5.1) 
6 (2.8) 
2 (0.9) 
Pre-existing medical conditions 
     Yes 
     No 
     unknown 
 
96 (44.2) 
116 (53.5) 
5 (2.3) 
Fertility treatment 
     Yes 
     No 
     unknown 
 
33 (15.2) 
181 (83.4) 
3 (1.4) 
Maternal smoking 
     Yes 
     No 
    unknown 
 
42 (19.4) 
161 (72.2) 
14 (6.5) 
Alcohol use 
     Yes 
 
8 (3.7) 
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Characteristics n(%) 
     No 
     Unknown 
175 (80.6) 
34 (15.7) 
Suspected fetal growth restriction 
     No 
     Yes, confirmed by scan 
     Yes, but normal growth on scans 
     Yes, no scan performed 
     Unknown 
 
160 (73.7) 
30 (13.8) 
3 (1.4) 
4 (1.8) 
20 (9.2) 
*mean (standard deviation), 95% CI 
 
 
Table 6.2: Birth outcomes for the study cohort  
Characteristics n(%) 
Baby’s birthweight (grams)* 1360 (1450), 
95% CI 1166-1554 
Gestational age at birth (weeks)^ 25 (22-35) 
Type of stillbirth 
     Antepartum 
     Intrapartum 
     Unknown 
 
152 (70.1) 
51 (23.5) 
14 (6.4) 
Termination of pregnancy 
     Yes 
     No 
 
54 (24.9) 
163 (75.1) 
Baby’s sex 
     Male 
     Female 
     Undeterminate 
 
129 (59.5) 
85 (39.2) 
3 (1.4) 
*mean(standard deviation); 95% CI     ^median(interquartile range) 
 
Table 6.3 presents selected post mortem investigations conducted.  Of the 200 parents 
offered the option of an autopsy, 40.0% consented to a full autopsy and 10.0% consented 
to a limited autopsy. Placental histopathology tests were performed in 91.2% of stillbirth 
cases. Among the 217 stillbirth cases, 56 (25.8%) were classified as ‘unexplained’ by 
either hospital or expert review.  Autopsy rates were 57.1% and 42.2% among 
unexplained and explained cases, respectively among parents offered the option of 
autopsy.  Placental histopathology was performed among 94.6% and 90.1% of 
unexplained and explained stillbirth cases, respectively. 
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Table 6.3: Post mortem investigations by explained or unexplained status  
Investigations 
Total “Unexplained” “Explained” 
n=217 n=56 n=161 
Parents offered option of 
autopsy 
     Yes 
     No 
     Unknown 
     missing 
 
 
200 (92.2) 
5 (2.3) 
7 (3.2) 
5 (2.3) 
 
 
56 (100.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
 
 
144 (89.4) 
5 (3.1) 
7 (4.3) 
5 (3.1) 
Parents consented to 
autopsy (n=200) 
     No 
     Yes, full autopsy 
     Yes, limited autopsy 
     Unknown 
 
 
99 (49.5) 
80 (40.0) 
20 (10.0) 
1 (0.5) 
 
 
24 (42.9) 
27 (48.2) 
5 (8.9) 
0 (0.0) 
 
 
75 (52.1) 
53 (36.8) 
15 (10.4) 
1 (0.7) 
Magnetic Resonance 
Imaging 
     Yes 
     No 
     Unknown 
     missing 
 
 
15 (6.9) 
198 (91.2) 
1 (0.5) 
3 (1.4) 
 
 
2 (3.6) 
53 (94.6) 
1 (1.8) 
0 (0.0) 
 
 
13 (8.1) 
145 (90.1) 
0 (0.0) 
3 (1.9) 
Placental histopathology 
     Yes 
     No 
     Unknown 
     missing 
 
198 (91.2) 
10 (4.6) 
3 (1.4) 
6 (2.8) 
 
53 (94.6) 
3 (5.4) 
0 (0.0) 
0 (0.0) 
 
145 (90.1) 
7 (4.3) 
3 (1.9) 
6 (3.7) 
Chromosomal analysis 
     Yes 
     No 
     Unknown 
     missing 
 
90 (41.5) 
80 (36.9) 
20 (9.2) 
27 (12.4) 
 
26 (46.4) 
21 (37.5) 
6 (10.7) 
3 (5.4) 
 
64 (39.8) 
67 (41.6) 
14 (8.7) 
16 (7.4) 
 
Table 6.4 shows classification of the 217 stillbirth cases according to PSANZ PDC by 
hospital review (rows) and expert panel review (columns). Among hospital classifications, 
the leading categories of stillbirth were: congenital abnormality (26.7%), unexplained 
antepartum fetal death (19.4%) and spontaneous preterm births (12.0%).  Among reviews 
by the expert panel, the leading categories were: congenital abnormality (26.7%), 
unexplained antepartum fetal death (20.7%) and spontaneous preterm birth (14.7%) 
(Table 6.4).  There were no stillbirths in this cohort coded under PSANZ PDC category 11 
“No obstetric antecedent”. 
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Table 6.4: Cross-tabulation of classification by PSANZ-PDC by hospital and expert 
panel  
H
o
s
p
it
a
l 
Expert 
 
1 2 3 4 5 6 7 8 9 10 Total 
1 56 1 0 0 0 0 0 0 0 1 58 
2 1 6 0 0 0 0 0 0 2 2 11 
3 0 0 11 0 0 1 0 0 0 1 13 
4 0 0 1 5 0 1 0 1 3 2 13 
5 0 1 1 1 5 0 0 0 0 1 9 
6 0 0 0 1 0 18 0 1 2 2 24 
7 0 0 0 0 0 0 1 0 0 0 1 
8 0 1 2 0 0 0 1 11 0 5 20 
9 0 0 0 1 0 0 0 0 25 0 26 
10 1 1 0 0 3 2 0 4 0 31 42 
Total 58 10 15 8 8 22 2 17 32 45 217 
κ = 0.737 (0.638-0.759), agreement = 77.9%, expected agreement = 15.8% 
PSANZ PDC categories: 1) Congenital abnormality, 2) Perinatal Infection, 3) Hypertension, 4) Antepartum 
haemorrhage, 5) Maternal conditions, 6) Specific perinatal conditions, 7) Hypoxic peripartum deaths, 8) Fetal 
growth restriction, 9) Spontaneous preterm birth, and 10) Unexplained antepartum death. 
 
 
There was substantial agreement overall between hospital and expert panel classifications 
(κ = 0.737, 95% CI 0.638-0.759).  However, agreement by PSANZ-PDC categories varied 
as shown in Table 6.5.  The categories with the highest levels of agreement were: 
congenital abnormality (κ = 0.953), spontaneous preterm birth (κ =0.841), hypertension (κ 
= 0.771) and specific perinatal conditions (κ = 0.757). The categories with the lowest levels 
of agreement were: antepartum haemorrhage (κ = 0.451), perinatal infection (κ = 0.550), 
fetal growth restriction (κ = 0.557) and maternal conditions (κ = 0.572). 
 
Table 6.5: Kappa values for PSANZ PDC categories 
PSANZ PDC Category Kappa 
95% Confidence 
Interval 
Interpretation 
1 Congenital abnormality 0.953 0.907-0.999 Almost perfect 
2 Perinatal Infection 0.550 0.288-0.812 Moderate 
3 Hypertension 0.771 0.594-0.948 Substantial 
4 Antepartum haemorrhage 0.451 0.181-0.722 Moderate 
5 Maternal Conditions 0.572 0.286-0.857 Moderate 
6 Specific perinatal conditions 0.757 0.613-0.901 Substantial 
7 Hypoxic peripartum deaths 0.665 0.047-1.000 Substantial 
8 Fetal Growth Restriction 0.557 0.357-0.757 Moderate 
9 Spontaneous preterm birth 0.841 0.734-0.948 Almost perfect 
10 Unexplained antepartum death 0.641 0.512-0.770 Substantial 
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Presented in Tables 6.6 and 6.7 are the investigations performed for the concordantly and 
discordantly classified stillbirths.   
 
Table 6.6:  Investigations performed among concordantly classified stillbirths 
PSANZ PDC Category Autopsy MRI 
Placental 
histopathology 
Chromosomal 
analysis 
Congenital abnormality 
(n=56) 
21 (37.5) 8 (14.3) 48 (85.7) 25 (44.6) 
Perinatal Infection (n=6) 4 (66.7) 0 (0.0) 6 (100.0) 3 (50.0) 
Hypertension (n=11) 4 (36.4) 0 (0.0) 9 (81.8) 5 (45.5) 
Antepartum 
haemorrhage (n=5) 
2 (40.0) 0 (0.0) 5 (100.0) 2 (40.0) 
Maternal Conditions 
(n=5) 
3 (60.0) 0 (0.0) 5 (100.0) 4 (80.0) 
Specific perinatal 
conditions (n=18) 
5 (27.8) 3 (16.7) 17 (94.4) 8 (44.4) 
Hypoxic peripartum 
deaths (n=1) 
0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 
Fetal Growth Restriction 
(n=11) 
9 (81.8) 0 (0.0) 11 (100.0) 6 (54.5) 
Spontaneous preterm 
birth (n=25) 
8 (32.0) 0 (0.0) 23 (92.0) 5 (20.0) 
Unexplained antepartum 
death (n=31) 
18 (58.1) 2 (6.5) 28 (90.3) 17 (54.8) 
 
 
Table 6.7: Investigations performed among discordantly classified stillbirths 
PSANZ PDC Category Autopsy MRI 
Placental 
histopathology 
Chromosomal 
analysis 
Congenital abnormality 
(n=4) 
3 (75.0) 1 (25.0) 3 (75.0) 2 (50.0) 
Perinatal Infection (n=9) 6 (66.7) 1 (11.1) 8 (88.9) 5 (55.6) 
Hypertension (n=6) 3 (50.0) 0 (0.0) 5 (83.3) 1 (16.7) 
Antepartum haemorrhage 
(n=11) 
7 (63.6) 1 (9.1) 11 (100.0) 3 (27.3) 
Maternal Conditions (n=7) 4 (57.1) 0 (0.0) 7 (100.0) 2 (28.6) 
Specific perinatal 
conditions (n=10) 
6 (60.0) 0 (0.0) 8 (80.0) 2 (20.0) 
Hypoxic peripartum 
deaths (n=1) 
0 (0.0) 0 (0.0) 1 (100.0) 0 (0.0) 
Fetal Growth Restriction 
(n=15) 
5 (33.3) 0 (0.0) 15 (100.0) 4 (26.7) 
Spontaneous preterm 
birth (n=8) 
3 (37.5) 1 (12.5) 7 (87.5) 2 (25.0) 
Unexplained antepartum 
death (n=25) 
14 (56.0) 0 (0.0) 25 (100.0) 9 (36.0) 
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Agreement between hospital and expert panel classification by gestational age 
20-27 weeks 
Table 6.8 shows classification by hospital and expert panel for stillbirth occurring between 
20 and 27 weeks.  There was substantial agreement for classifications in this gestational 
age group (κ = 0.784).   
 
Table 6.8: Cross-tabulation of classification by PSANZ-PDC by hospital and expert 
panel, stillbirths 20-27 weeks  
H
o
s
p
it
a
l 
Expert 
 
1 2 3 4 5 6 8 9 10 Total 
1 36 1 0 0 0 0 0 0 1 38 
2 1 3 0 0 0 0 0 1 0 5 
3 0 0 8 0 0 1 0 0 0 9 
4 0 0 0 5 0 0 1 3 1 10 
5 0 1 1 1 2 0 0 0 1 6 
6 0 0 0 0 0 10 0 2 0 12 
8 0 0 1 0 0 0 7 0 3 11 
9 0 0 0 1 0 0 0 25 0 26 
10 0 0 0 0 0 1 0 0 6 7 
Total 37 5 10 7 2 12 8 31 12 124 
κ = 0.784 (0.721-0.820), agreement = 82.3%, expected agreement = 17.8% 
PSANZ PDC categories: 1) Congenital abnormality, 2) Perinatal Infection, 3) Hypertension, 4) Antepartum 
haemorrhage, 5) Maternal conditions, 6) Specific perinatal conditions, 8) Fetal growth restriction, 9) 
Spontaneous preterm birth, and 10) Unexplained antepartum death. 
 
 
The PSANZ category specific agreement is shown in Table 6.9.  Agreement was highest 
for congenital abnormality (κ = 0.943) and lower values were found for maternal conditions 
(κ = 0.488) and antepartum haemorrhage (κ = 0.559). 
 
Table 6.9: Kappa values for PSANZ PDC categories (20-27 weeks) 
PSANZ PDC Category Kappa 
95% Confidence 
Interval 
Interpretation 
1 Congenital abnormality 0.943 0.879-1.000 Almost perfect 
2 Perinatal Infection 0.583 0.213-0.953 Moderate 
3 Hypertension 0.829 0.640-1.000 Almost perfect 
4 Antepartum haemorrhage 0.559 0.268-0.850 Moderate 
5 Maternal Conditions 0.488 0.063-0.912 Moderate 
6 Specific perinatal conditions 0.815 0.640-0.991 Almost perfect 
8 Fetal Growth Restriction 0.716 0.480-0.951 Substantial 
9 Spontaneous preterm birth 0.841 0.727-0.954 Almost perfect 
10 Unexplained antepartum death 0.603 0.338-0.868 Moderate 
 
 
160 
 
28-36 weeks 
Overall agreement for classification of stillbirth occurring between 28 and 36 weeks is 
shown in Table 6.10.  There was substantial agreement (κ = 0.624) for review of stillbirths 
within this gestational age group.  
 
Table 6.10: Cross-tabulation of classification by PSANZ PDC by hospital and expert 
panel, stillbirths 28-36 weeks  
H
o
s
p
it
a
l 
Expert 
 
1 2 3 4 5 6 8 9 10 Total 
1 15 0 0 0 0 0 0 0 0 15 
2 0 1 0 0 0 0 0 1 1 3 
3 0 0 2 0 0 0 0 0 1 3 
4 0 0 1 0 0 1 0 0 0 2 
5 0 0 0 0 2 0 0 0 0 2 
6 0 0 0 1 0 3 1 0 1 6 
8 0 0 1 0 0 0 3 0 0 4 
10 1 0 0 0 0 1 4 0 9 15 
Total 16 1 4 1 2 5 8 1 12 50 
κ = 0.624 (0.560-0.776), agreement = 70.0%, expected agreement = 20.1% 
PSANZ PDC categories: 1) Congenital abnormality, 2) Perinatal Infection, 3) Hypertension, 4) Antepartum 
haemorrhage, 5) Maternal conditions, 6) Specific perinatal conditions, 8) Fetal growth restriction, 9) 
Spontaneous preterm birth, and 10) Unexplained antepartum death. 
 
 
Almost perfect agreement was found for congenital abnormalities (κ = 0.953) and perfect 
agreement was found for maternal conditions (based on 2 cases). Conversely, lower levels 
of agreement were found for antepartum haemorrhage (κ = -0.027 based on zero 
agreement between hospital and expert panel reviews), fetal growth restriction (κ = 0.440), 
perinatal infection (κ = 0.485, based on 1 case) (Table 6.11). 
 
Table 6.11: Kappa values for PSANZ PDC categories (28-36 weeks) 
PSANZ PDC Category Kappa 
95% Confidence 
Interval 
Interpretation 
1 Congenital abnormality 0.953 0.863-1.000 Almost perfect 
2 Perinatal Infection 0.485 -0.115-1.000 Moderate 
3 Hypertension 0.540 0.080-0.999 Moderate 
4 Antepartum haemorrhage -0.027 -0.084-0.030 Poor 
5 Maternal Conditions 1.000 1.000-1.000 Perfect 
6 Specific perinatal conditions 0.490 0.105-0.874 Moderate 
8 Fetal Growth Restriction 0.440 0.077-0.804 Moderate 
9 Spontaneous preterm birth - - - 
10 Unexplained antepartum death 0.545 0.286-0.805 Moderate 
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37+ weeks 
For term stillbirths, there was substantial agreement between hospital and expert panel 
reviews (Table 6.12).  There was perfect agreement for the category of congenital 
abnormality and hypertension (based on 1 case). While lower levels of agreement were 
found for fetal growth restriction (κ = 0.306) and maternal conditions (κ = 0.376). However, 
caution should be exercised when interpreting these results as the cell sizes were small 
and the corresponding confidence intervals around the estimates of κ are wide (Table 
6.13). 
 
Table 6.12: Crosstabulation of classification by PSANZ-PDC by hospital and expert 
panel, stillbirths of 37 or more weeks  
H
o
s
p
it
a
l 
Expert 
 
1 2 3 5 6 7 8 10 Total 
1 5 0 0 0 0 0 0 0 5 
2 0 2 0 0 0 0 0 1 3 
3 0 0 1 0 0 0 0 0 1 
4 0 0 0 0 0 0 0 1 1 
5 0 0 0 1 0 0 0 0 1 
6 0 0 0 0 5 0 0 1 6 
7 0 0 0 0 0 1 0 0 1 
8 0 1 0 0 0 1 1 2 5 
10 0 1 0 3 0 0 0 15 19 
Total 5 4 1 4 5 2 1 20 42 
κ = 0.646 (0.537-0.821), agreement = 73.8%, expected agreement = 26.0% 
PSANZ PDC categories: 1) Congenital abnormality, 2) Perinatal Infection, 3) Hypertension, 4) Antepartum 
haemorrhage, 5) Maternal conditions, 6) Specific perinatal conditions, 7) Hypoxic peripartum deaths, 8) Fetal 
growth restriction  and 10) Unexplained antepartum death. 
 
 
Table 6.13: Kappa values for PSANZ PDC categories (≥37 weeks) 
PSANZ PDC Category Kappa 
95% Confidence 
Interval 
Interpretation 
1 Congenital abnormality 1.000 1.000-1.000 Perfect 
2 Perinatal Infection 0.533 0.069-0.997 Moderate 
3 Hypertension 1.000 1.000-1.000 Perfect 
4 Antepartum haemorrhage - - - 
5 Maternal Conditions 0.376 -0.155-0.908 Fair 
6 Specific perinatal conditions 0.896 0.694-1.000 Almost perfect 
7 Hypoxic peripartum death 0.656 0.030-1.000 Substantial 
8 Fetal Growth Restriction 0.306 -0.160-0.772 Fair 
10 Unexplained antepartum death 0.569 0.321-0.818 Moderate 
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Agreement between hospital and expert panel classification 
Excluding congenital abnormalities 
There were 157 stillbirth cases not classified as due to congenital abnormality by either the 
hospital or expert panel reviews.  Of these, 15 (9.6%) were terminations of pregnancy. 
There were similar leading categories of PSANZ PDC as classified by the hospital 
committees [unexplained antepartum fetal death (26.1%), spontaneous preterm birth 
(16.6%) and specific perinatal conditions (15.3%)] and the expert panel [unexplained 
antepartum fetal death (28.0%), spontaneous preterm birth (20.4%) and specific perinatal 
conditions (14.0%)] (Table 6.14).  There was substantial agreement overall within this 
subgroup (κ = 0.666, 95% CI 0.538-0.740.  Among stillbirths less than 37 weeks, there 
was substantial agreement (κ = 0.672, 95% CI 0.608-0.808) and moderate agreement 
among stillbirths of 37 weeks or older (κ = 0.565, 95% CI 0.406-0.649). 
Table 6.14: Cross-tabulation of classification by PSANZ PDC by hospital and expert 
panel, excluding congenital abnormalities 
H
o
s
p
it
a
l 
Expert 
 
2 3 4 5 6 7 8 9 10 Total 
2 6 0 0 0 0 0 0 2 2 10 
3 0 11 0 0 1 0 0 0 1 13 
4 0 1 5 0 1 0 1 3 2 13 
5 1 1 1 5 0 0 0 0 1 9 
6 0 0 1 0 18 0 1 2 2 24 
7 0 0 0 0 0 1 0 0 0 1 
8 1 2 0 0 0 1 11 0 5 20 
9 0 0 1 0 0 0 0 25 0 26 
10 1 0 0 3 2 0 4 0 31 41 
Total 9 15 8 8 22 2 17 32 44 157 
κ = 0.666 (0.538-0.740), agreement = 72.0%, expected agreement = 15.5% 
PSANZ PDC categories: 2) Perinatal Infection, 3) Hypertension, 4) Antepartum haemorrhage, 5) Maternal 
conditions, 6) Specific perinatal conditions, 7) Hypoxic peripartum deaths, 8) Fetal growth restriction, 9) 
Spontaneous preterm birth, and 10) Unexplained antepartum death. 
 
The values of kappa within categories of PSANZ PDC varied as shown in Table 6.15.  The 
highest levels of kappa were found for: spontaneous preterm birth (κ = 0.831), 
hypertension (κ = 0.765) and specific perinatal conditions (κ = 0.745). The lowest levels of 
kappa were found for: antepartum haemorrhage (κ = 0.441), fetal growth restriction (κ = 
0.541) and maternal conditions (κ = 0.565).  
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Table 6.15: Kappa values for PSANZ PDC categories (excluding congenital 
abnormalities) 
PSANZ PDC Category 
Kappa 95% Confidence 
Interval 
Interpretation 
2 Perinatal Infection 0.608 0.342-0.874 Moderate 
3 Hypertension 0.765 0.584-0.946 Substantial 
4 Antepartum haemorrhage 0.441 0.168-0.714 Moderate 
5 Maternal Conditions 0.565 0.276-0.854 Moderate 
6 Specific perinatal conditions 0.745 0.595-0.895 Substantial 
7 Hypoxic peripartum death 0.664 0.045-1.000 Substantial 
8 Fetal Growth Restriction 0.541 0.336-0.746 Moderate 
9 Spontaneous preterm birth 0.831 0.719-0.944 Almost perfect 
10 Unexplained antepartum death 0.629 0.492-0.767 Substantial 
 
Excluding terminations of pregnancy 
Of the 217 stillbirth cases, 54 were terminations of pregnancy.  The majority of these 
terminations (72.2%) were classified as congenital abnormality by either expert or hospital 
review.  There were 163 stillbirths after excluding all terminations of pregnancy.  The 
leading categories according to PSANZ PDC as assigned by the hospital reviews were: 
unexplained antepartum stillbirth (25.8%), spontaneous preterm birth (14.1%) and specific 
perinatal conditions (12.9%).  Similarly for reviews by the expert panel, the leading 
categories were: unexplained antepartum stillbirth (27.6%), spontaneous preterm birth 
(16.0%), and 12.3% each for congenital abnormality and specific perinatal conditions 
(Table 6.16). There was substantial agreement between hospital and expert panel reviews 
for this subgroup (κ = 0.691, 95% CI 0.641-0.725). There was substantial agreement for 
stillbirths less than 37 weeks (κ = 0.694, 95% CI 0.613-0.738) and those of 37 weeks or 
older (κ = 0.634, 95% CI 0.349-0.706). 
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Table 6.16: Cross-tabulation of classification by PSANZ PDC by hospital and expert 
panel, excluding terminations of pregnancy 
H
o
s
p
it
a
l 
Expert 
 
1 2 3 4 5 6 7 8 9 10 Total 
1 18 0 0 0 0 0 0 0 0 1 19 
2 1 6 0 0 0 0 0 0 2 2 11 
3 0 0 8 0 0 1 0 0 0 1 10 
4 0 0 1 4 0 1 0 1 1 2 10 
5 0 0 1 1 5 0 0 0 0 1 8 
6 0 0 0 1 0 16 0 1 1 2 21 
7 0 0 0 0 0 0 1 0 0 0 1 
8 0 1 2 0 0 0 1 9 0 5 18 
9 0 0 0 1 0 0 0 0 22 0 23 
10 1 1 0 0 3 2 0 4 0 31 42 
Total 20 8 12 7 8 20 2 15 26 45 163 
κ = 0.691 (0.641-0.725), agreement = 73.6%, expected agreement = 14.7% 
PSANZ PDC categories: 1) Congenital abnormality, 2) Perinatal infection, 3) Hypertension, 4) Antepartum 
haemorrhage, 5) Maternal conditions, 6) Specific perinatal conditions, 7) Hypoxic peripartum deaths, 8) Fetal 
growth restriction, 9) Spontaneous preterm birth, and 10) Unexplained antepartum death. 
 
Table 6.17: Kappa values for PSANZ PDC categories, excluding terminations of 
pregnancy 
PSANZ PDC Category 
Kappa 95% Confidence 
Interval 
Interpretation 
1 Congenital abnormality 0.913 0.815-1.000 Almost perfect 
2 Perinatal Infection 0.609 0.345-0.873 Moderate 
3 Hypertension 0.708 0.486-0.929 Substantial 
4 Antepartum haemorrhage 0.442 0.140-0.745 Moderate 
5 Maternal Conditions 0.606 0.317-0.894 Moderate 
6 Specific perinatal conditions 0.749 0.593-0.905 Substantial 
7 Hypoxic peripartum death 0.664 0.045-1.000 Substantial 
8 Fetal Growth Restriction 0.495 0.274-0.715 Moderate 
9 Spontaneous preterm birth 0.880 0.777-0.983 Almost perfect 
10 Unexplained antepartum death 0.608 0.470-0.747 Moderate 
 
Variation in agreement across the categories of PSANZ PDC are shown in Table 6.17. 
Almost perfect agreement was found for the categories of congenital abnormality (κ = 
0.913) and spontaneous preterm birth (κ = 0.880); while lower levels of agreement were 
found for antepartum haemorrhage (κ = 0.442) and fetal growth restriction (κ = 0.495). 
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6.4 Discussion 
Main findings 
The aim of this study was to assess consistency in the application of the Perinatal Society 
of Australia and New Zealand perinatal death classification (PSANZ PDC) between 
hospital and expert panel review of a cohort of stillbirths investigated according to the 
Clinical Practice Guidelines for Perinatal Mortality Audit.  A substantial level of agreement 
was found overall (κ = 0.737), however, there were variations in agreement within 
categories of the PSANZ PDC. Compared with the other PSANZ PDC categories, 
congenital abnormalities had the highest level of agreement, followed by spontaneous 
preterm birth and hypertension (even after excluding congenital abnormalities and 
terminations of pregnancy).  Conversely, the lowest levels of agreement were found 
consistently for antepartum haemorrhage and fetal growth restriction. 
Our findings of substantial agreement (κ = 0.737) were slightly higher than those reported 
for a large population based study in New South Wales published in 2008 (κ = 0.638) 
[131]. The higher level of overall agreement found in our study may be due to refinement 
of the PSANZ PDC descriptions within the perinatal mortality audit guidelines in the 2009 
edition as well as increased familiarity with the classification system with the national roll 
out of the IMPROVE and other similar education programs [159].   In contrast the level of 
agreement in our study was lower than the agreement reported previously in validation 
studies for the PSANZ PDC [83% agreement for stillbirths using PSANZ PDC with three 
classifiers (κ ranging from 0.83 to 0.95)] [64].  
Despite differences in the method of calculation of PSANZ PDC category-specific 
agreement, our study and that of Gordon and colleagues found relatively high levels of 
agreement for congenital abnormalities [κ = 0.953 versus 95.0% agreement], spontaneous 
preterm birth (κ = 0.841 versus 76.1% agreement) and specific perinatal conditions (κ = 
0.757 versus 77.6% agreement). Similarly, lower levels of agreement were found for 
perinatal infection (κ = 0.550 versus 56.5% agreement) and maternal conditions (κ = 0.572 
versus 44.7% agreement). However, there were marked differences in findings relating to 
antepartum haemorrhage (κ = 0.451 versus 90.1% agreement) and hypertension (κ = 
0.771 versus 49.0% agreement) [131]. The reasons for these differences in relation to 
antepartum haemorrhage and hypertension are not immediately obvious and do not relate 
to changes to the PSANZ PDC made since the first edition. However, it should be noted 
 
 
166 
 
that our sample size was significantly smaller and may be subject to wider variation in 
estimates of agreement.  
 
Interpretation of findings 
Determining the cause of stillbirth is important for identifying focal areas for improvement 
in care provision and further reducing stillbirth rates. However, identifying the cause of 
death is often difficult because of complex pathophysiological processes and their 
interactions within the mother, baby and placenta [293].  The Perinatal Society of Australia 
and New Zealand Perinatal Death Classification (PSANZ PDC) system uses largely 
clinical categories with few categories for placental pathology and aims to identify the 
antecedent cause of death.  The variation in agreement observed may derive largely from 
the complexity of the stillbirth case, whereby identifying a possible cause of death in the 
presence of many associated possible conditions. 
 
Congenital abnormality 
We found almost perfect agreement in the classification of stillbirths attributed to 
congenital abnormality.  This may be explained by the hierarchical nature of the PSANZ 
PDC system [124] whereby the presence of a congenital abnormality supersedes any 
other associated causes as the main cause of death. Hierarchical classification systems 
tend to preferentially prioritise categories nearer to the top of the list. This has been 
demonstrated in a study by Ego and colleagues where modification of the hierarchy of the 
ReCoDe system resulted in a reduction in the proportion of stillbirths attributed to fetal 
growth restriction the reduction from 38% to 14% [294]. It can be argued that the relatively 
high proportion of stillbirths classified as due to congenital abnormality using the PSANZ 
PDC system may be as a result of congenital abnormality being at the top of the list.  It 
was interesting to note that disagreement in classification for this category included 
perinatal infection and unexplained antepartum fetal death.  It was also interesting to note 
that the autopsy rates among concordantly classified stillbirth was lower than among 
discordantly classified stillbirths (37.5% versus 75.0%), however there were only 4 
discordantly classified stillbirths.  There were similar rates of placental histopathology, 
chromosomal analysis and MRI between the groups of stillbirths.  The category of 
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unexplained antepartum fetal death mainly contained deaths that could not be definitively 
classified elsewhere. 
 
Perinatal Infection 
In comparison to the other PSANZ PDC categories, agreement levels for perinatal 
infection were low.  This may be a reflection of the difficulty in determining whether 
infection was the cause of stillbirth, particularly where autopsy and histologic examinations 
suggest infection as well as other aetiologic factors [295]. Determination of infection 
depends on histological evidence of infection in the fetus or cord or clinical evidence of 
infection in the mother and evidence of infection in the mother or placenta [124]. However, 
evidence of infection does not necessarily prove causation [295, 296] and conversely, 
stillbirth due to infection may not initially appear to be related to the infection [296].  
Infection may be due to a wide range of bacterial, viral or protozoal agents and routine 
histologic examination of the placenta and fetal autopsy may miss some infectious 
organisms [295].  In our study we found disagreement in classification of perinatal infection 
mainly included congenital abnormality, unexplained antepartum fetal death and 
spontaneous preterm birth.  The finding regarding spontaneous preterm birth is 
understandable given the association between perinatal infection and preterm birth [297]. 
 
Spontaneous preterm birth 
We found high levels of agreement for this category.  These findings may be explained by 
clear definitions within the classification system based on gestational age, duration of 
labour or rupture of membranes and findings from microscopic and macroscopic 
examination of the placenta [124]. However, there was some disagreement in 
classification with the categories of antepartum haemorrhage (abruption and other 
antepartum haemorrhage), specific perinatal conditions and perinatal infection.  It is 
particularly challenging to determine the sequence of events involving bleeding with 
preterm birth or antepartum haemorrhage and further instructions within the perinatal 
mortality audit guidelines may assist in reducing ambiguity when assigning classification 
categories.  
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Antepartum haemorrhage 
In ranking levels of agreement across the PSANZ PDC categories, antepartum 
haemorrhage consistently ranked lowest compared with the other categories. These 
findings may be explained by clinical scenarios wherein there are other associated 
probable causes or classification categories such as hypertension or spontaneous preterm 
birth; which make it difficult to unravel which condition initiated the chain of events 
resulting in the stillbirth.  Where there was discordant classification within this category, the 
alternate classifications were: spontaneous preterm birth, specific perinatal conditions 
(twin-twin transfusion and fetomaternal haemorrhage), hypertension (pre-eclampsia) and 
maternal conditions (accidental maternal injury), unexplained antepartum fetal death and 
fetal growth restriction.  The hierarchical nature of the classification system may have 
played a role in some of the discordant classifications.  It was interesting to note that 
autopsy rates were higher among the discordantly classified stillbirths in this category 
(63.6% vs 40.0%). 
 
Fetal growth restriction 
Agreement was relatively low for fetal growth restriction compared with other PSANZ PDC 
categories.  This may relate to difficulty in classifying cases with borderline biometric 
measurements, especially where there is maceration or where there is insufficient 
supporting evidence despite suspicion of growth restriction.  Classification is based on 
antenatal ultrasound evidence of growth restriction, or brain:liver ratio from autopsy 
examination and histopathological examination of the placenta [124]. Where there is 
maceration and an absence of prior ultrasound evidence of growth restriction and an 
autopsy was not performed or the brain:liver ratio is less than 4:1, the PSANZ Perinatal 
Mortality Audit guidelines recommend classification as unexplained antepartum fetal death 
[124].  This hypothesis was supported by the large number of cases involved in 
disagreement between classification as fetal growth restriction and unexplained 
antepartum fetal death found in this cohort. Interestingly, the autopsy rate among 
concordantly classified stillbirths was significantly higher than among the discordantly 
classified stillbirths (81.8% vs 33.3%), this may reflect the importance of information from 
autopsy to assist in classification of stillbirth to the category of fetal growth restriction. 
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Hypertension 
There was relatively high level of agreement for hypertension compared with other 
categories within this cohort.  This may be explained by the well-defined diagnostic criteria 
for hypertensive disorders and information can be easily ascertained from maternal 
history.  Furthermore, the well-established association between maternal hypertensive 
disorders and placental dysfunction can be observed in disagreement in the classification 
of stillbirth cases as due to hypertension (abruption) or fetal growth restriction or maternal 
conditions.  The study findings imply that some of the ambiguity in determining cause of 
death may be due to incomplete information from investigations not performed, as 
suggested by findings for fetal growth restriction. This information may assist by ruling in or 
ruling out possible causes of death.  The study also highlights difficulty with unravelling the 
sequence of events that lead to a stillbirth, particularly for strongly inter-related aetiologies. 
 
Stillbirth Investigations 
The PSANZ Clinical Practice Guideline for Perinatal Mortality recommends a 
comprehensive suite of investigations for stillbirth while acknowledging the limited 
evidence for many of the tests. However, placental histopathology, perinatal autopsy and 
cytogenetic analysis have been identified as important investigations for determining 
cause of stillbirth [298, 299]; as well as changing cause of death classification [126].  
Although the overall autopsy rate in this study cohort was about 46%, well below the 
recommended 75% [129], the rate of placental histopathology was 91%. Placental 
histopathology has been shown to be particularly useful in determining cause of death, 
perhaps more so than perinatal autopsy. Chromosomal analysis was undertaken in 42% of 
cases.  
The rate of magnetic resonance imaging (MRI) in this cohort of stillbirths was 6.9%. Post 
mortem MRI has been proposed as a non-invasive alternative to autopsy, especially where 
parents decline conventional autopsy examination [300].  The main advantages of MRI 
include its non-invasive nature and its accuracy in detecting cerebral, cardiac and renal 
abnormalities [301].  While there is a lack of tissue sampling [300]; MRI can be used to 
estimate organ weight and volume [302, 303].  There is some evidence that post-mortem 
MRI combined with blood tests and other non-invasive ancillary testing may provide similar 
information to conventional autopsy examination in a proportion of perinatal deaths [301].  
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The proportion of unexplained stillbirths was 20.7% and 22.8% among hospital and expert 
panel reviews, respectively.  These values were lower than those reported for the state of 
Queensland for 2004 to 2008 (29.9%) [4]; and significantly lower than the proportion of 
unexplained antepartum fetal death classified by the expert panel in NSW during 2002-
2004 (41.5%).   This may reflect the slightly higher autopsy rates among our study cohort 
(47.8% vs 30.7% for Queensland during 2004-2008 vs 37.5% for NSW during 2002-2004) 
[4, 131] as well as the higher rates of placental histopathology in our cohort compared with 
the NSW cohort (92.4% vs 84.7%) [131].  In addition, the lower limit of gestational age for 
the reviews in NSW was 22 weeks compared with 20 weeks for our cohort, this may have 
impacted on the proportion of unexplained antepartum fetal deaths, as it has been 
reported that this proportion increases with gestational age (Chapter 3). 
In our study cohort, it was interesting that there were higher rates of placental 
histopathology, autopsy and chromosomal analysis among unexplained stillbirths 
compared with ‘explained’ stillbirths.  These findings suggest that for these cases, perhaps 
these investigations provided information to rule out a possible cause of death but not 
definitively point to a cause of death.  
 
Strengths and Limitations 
A substantial number of participating hospitals did not provide data for the study.  It is 
possible that this may have introduced bias whereby hospitals more likely to participate 
were also more likely to comply with the perinatal mortality audit guidelines. A possible 
outcome of this might be more optimistic estimates of agreement between hospital and 
expert panel review. 
Another related issue was regarding representativeness of the stillbirth cohort.  There was 
limited national data available on maternal and pregnancy characteristics of stillbirth.  
Comparison with population data from Queensland showed this study cohort to be similar 
across a number of characteristics including gestational age at birth, maternal smoking, 
type of stillbirth, maternal age and sex distribution; although it should be noted that the 
Queensland data was for singleton stillbirths. Furthermore, there was a significant 
proportion of women of Maori or Pacific Islander background within this cohort. Further 
research is needed to determine if this finding was as a result of bias or if this group of 
women were truly over-represented among women with a stillbirth.   
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All attempts were made to ensure the expert panel had access to the same information as 
the hospital committees; however, it is possible that hospital committees had more 
detailed information from maternal history to inform their classifications.  
 
 
6.5 Conclusion 
This study found substantial agreement between hospital and expert panel classifications 
of stillbirth, however, there is need for additional training and guidance in assigning 
classification for the categories of antepartum haemorrhage and fetal growth restriction, in 
particular.  These findings can inform the education program for the PSANZ perinatal 
mortality audit guidelines and the perinatal death classification system. 
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Chapter 7 
Parental Consent to Stillbirth Autopsy Study 
 
7.1 Introduction 
Stillbirth is a devastating pregnancy outcome for women and families. In 2012, one in 139 
pregnancies reaching 20 weeks ended in stillbirth in Queensland [24].  In recent times, 
there has been little reduction in stillbirth rates in many high income countries [13] and 
Australian reports suggest national rates may be increasing [23, 174]. Accurate 
determination of cause of death is critical to effective prevention; and current lack of 
knowledge about the underlying causes of stillbirth is a barrier to progress with further 
reducing national rates. A large proportion of stillbirths are unexplained and in Queensland 
nearly 60% of stillbirths occurring around term (37 weeks or older) are unexplained 
(Chapter 3).  The disparity in stillbirth rates and risk observed between Indigenous and 
non-Indigenous women also extends to unexplained stillbirths which are higher among 
Indigenous women (3.2 vs 2.0/1000, RR 1.61, 95% CI 1.37-1.90 [223].  
Autopsy is the gold standard for determining cause of death following a stillbirth [125].  
International guides recommend that all parents should be offered the option of an autopsy 
following a stillbirth [28] but perinatal autopsy rates are declining [127, 304]. The stillbirth 
autopsy rate in Queensland is around 37% [223]. Since thorough post mortem 
investigation reveals a cause of death in a substantial number of stillbirths of unknown 
clinical cause it has been argued that many stillbirths are unexplored rather than 
unexplained [305]. The reasons for this decline in autopsy rates are varied; however, 
parental consent is a major factor [132].  The process of counselling and consent is difficult 
for both clinicians and parents.  It is an intrusive process for parents and requires 
understanding of detailed consent procedures in a state of acute grief. Studies show that 
clinicians often feel ill-equipped to initiate such discussions with parents [126]. At present, 
approaches to communication and consent procedures are not evidence-based and 
therefore must rely on the ad hoc knowledge and experience of staff [306]. It is unclear 
how healthcare professionals can support parents in this difficult decision.  Gaining an 
understanding of the factors associated with autopsy consent is important to improving the 
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quality of data on causes of stillbirth and to the wellbeing of bereaved parents including the 
management of subsequent pregnancies.  
Presented in this chapter are findings from a mixed methods investigation aiming to gain 
an understanding of parents’ views and experiences of the autopsy consent process to 
inform clinical practice.  The analysis presented uses three data sources (two quantitative, 
one qualitative) from two separate studies. These are: 
 Population based analysis of predictors of autopsy using perinatal data from the 
Queensland Perinatal Data Collection (quantitative) 
 Information and communication about autopsy following stillbirth: meeting the needs 
of parents (Stillbirth Autopsy Consent Study – mixed methods) 
 Investigating the cause of stillbirth: a prospective cohort study examining use and 
effectiveness of a comprehensive investigation protocol (Stillbirth Investigations 
Study - quantitative) 
 
The qualitative component of the study is informed by quantitative analyses to identify 
sociodemographic, pregnancy and medical factors which are associated with whether or 
not autopsy is performed following a stillbirth. To our knowledge, no recent studies have 
assessed predictors of stillbirth autopsy.  The qualitative component aims to explore and 
understand parents’ experiences of the autopsy consent process within the dimensions of 
factors identified as predictors of parental consent for autopsy. 
 
Findings from the qualitative and quantitative components of this study were presented at 
the Perinatal Society of Australia and New Zealand (PSANZ) conference in April 2015 
(Appendix G2 and G1) and a manuscript based on the quantitative component of the study 
has been submitted for publication. 
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7.2 Methods 
Theoretic Framework and Research Design 
This study focuses primarily on the qualitative component of a study nested in the Stillbirth 
Autopsy Consent Study (SACS). The overall aim of SACS was to improve communication 
regarding perinatal autopsy to increase autopsy rates and enhance bereaved parents’ long 
term mental and reproductive health.  The primary objectives were:  
 determine factors that predict consent, regret and decisional conflict with regards to 
perinatal autopsy,  
 determine parental views and experiences with communication about post mortem 
investigations and autopsy consenting process, and  
 determine effect of parents’ decisions regarding autopsy on longer term 
psychosocial outcomes such as grief.   
The above described SACS was in turn linked to the Stillbirth Investigations Study 
discussed in Chapter 6.  The online database used in the Chapter 6 study was used to 
collect sociodemographic, medical and pregnancy data for women involved in both 
studies. 
The nested mixed methods study involved a quantitative population-based analysis of 
predictors of autopsy to inform recruitment of participants for in-depth qualitative interviews 
exploring the views and experiences of parent going through the autopsy consent process. 
A pragmatic approach was taken in relation to the study design and methodology; this 
meant that the research question was central and any data collection and analysis 
methods that provided insight were utilised [307]. The mixed methods study design was 
particularly appropriate because of the complex nature of the study topic, and the ability to 
explore and integrate lines of enquiry that require qualitative and quantitative methods.  A 
number of issues relating to the mixed methods study design were considered, namely: 
which aspects would be emphasised (priority), how the study would be implemented 
(implementation) and how the qualitative and quantitative components would be 
connected (integration) [307]. Priority was given to the qualitative components of the 
study as these were involved in addressing the main study objective. The qualitative line of 
enquiry was also a natural progression to exploration of the quantitative findings. 
Implementation of the study was carried out sequentially:   
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 Phase 1 was a population based retrospective analysis aiming to determine which 
maternal demographic, pregnancy and medical factors were associated with 
consent to an autopsy following stillbirth; and  
 Phase 2 consisted of in-depth telephone interviews with parents to gain an 
understanding of parents’ experience of autopsy consent processes following a 
stillbirth.   
It was intended that integration of the qualitative and quantitative components occurred at 
the beginning of the qualitative phase with purposive sampling of participants based on 
findings from the quantitative analysis and integration of the components during the 
interpretation and discussion of findings.  However, in practice purposive sampling was not 
possible as a result of prolonged ethics and governance processes and significant barriers 
to recruitment at the hospital level.  Figure 7.1 shows the intended sequence of study 
implementation. 
 
 
Figure 7.1: Relationship between the study phases, Parental Consent to Stillbirth 
Autopsy Study 
 
Phase 1 Quantitative Methods: Study Population and Data source 
This study involved all women with a singleton stillbirth of at least 20 weeks gestation or 
400grams birthweight in Queensland between July 2000 and December 2011. Excluded 
from analyses were stillbirths as a result of termination of pregnancy for maternal 
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recommendations 
Interpretation 
 
 
176 
 
psychosocial reasons and stillbirths with unknown maternal Indigenous status (Figure 7.2).  
Terminations for maternal psychosocial reasons were excluded because it was 
hypothesised that factors affecting decisions for autopsy may apply differently within this 
group.  Indigenous women have higher rates of stillbirth and are a subgroup of interest 
within this thesis, and for these reasons women with missing data on Indigenous status 
were excluded from analysis. The timeframe for births was chosen because mid 2000 was 
the earliest period with complete data on whether or not an autopsy was performed. 
Data for this study was obtained from the Queensland Perinatal Data Collection (QPDC). 
Maternal demographic data included age, Indigenous status, region of birth, marital status, 
socioeconomic status and geographic location.  Pregnancy and medical data included 
parity, hospital accommodation, smoking, substance use, assisted conception use, 
diabetes (pre-existing and gestational), hypertensive disorders (pre-existing, pregnancy 
induced and pre-eclampsia/eclampsia) and antepartum haemorrhage. Birth outcome data 
included congenital abnormality, small for gestational age (defined as birthweight less than 
10th Australian population percentile by gender and plurality), gestational age at birth, 
diagnosis of unexplained stillbirth on the death certificate, and type of stillbirth 
(antepartum, intrapartum and unknown if antepartum or intrapartum). Data management 
was undertaken as outlined in section 2.2.  
 
 
 
 
 
 
 
 
 
Figure 7.2: Flowchart showing study population and exclusions, Parental Consent 
to Stillbirth Autopsy Study  
Eligible births 
 
3902 singleton stillbirths 
Included stillbirths 
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Excluded stillbirths 
- 56 termination of pregnancy 
for maternal psychosocial 
reasons 
- 4 unknown maternal 
Indigenous status 
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Statistical analysis 
The primary outcome measure was autopsy following stillbirth (either full or partial). This 
measure was used as a proxy to indicate parental consent for autopsy.  Triennial perinatal 
autopsy rate per 100 singleton stillbirths were calculated overall and by subgroups.  
Differences in characteristics between women who consented to an autopsy for their baby 
and those who did not were assessed using Chi square test.  Univariate association 
between maternal characteristics and autopsy was explored using logistic regression.  In 
addition, interactions were explored between closely related predictor variables.  
Statistically significant interactions were found between gestational age group and whether 
or not a stillbirth was unexplained on the death certificate, as well as between gestational 
age group and whether or not there was a congenital abnormality.  The odds ratios for the 
interaction terms were as follows:  
Gestational age group AND Unexplained fetal death 
     20-23 weeks AND unexplained fetal death 
     24-27 weeks AND unexplained fetal death 
     28-36 weeks AND unexplained fetal death 
Relative to: ≥ 37 weeks AND explained fetal death 
 
1.92 (1.31-2.81) 
1.88 (1.18-3.01) 
1.58 (1.08-2.33) 
Gestational age group AND congenital abnormality 
     20-23 weeks AND congenital abnormality 
     24-27 weeks AND congenital abnormality 
     28-36 weeks AND congenital abnormality 
Relative to: ≥ 37 weeks AND no congenital abnormality 
 
0.44 (0.28-0.70) 
0.37 (0.21-0.66) 
0.35 (0.21-0.58) 
 
Multivariate analysis was undertaken including all predictors that were significantly 
associated with autopsy in univariate analyses and analysis was stratified by gestational 
age (<24, 24-27, 28-36 and ≥37 weeks). These groups were chosen to reflect 
commencement of active management (24 weeks), for international comparison (28 
weeks) and to differentiate preterm and term stillbirths (37 weeks). Statistical analysis was 
performed using Stata/SE for Windows 13.1 (StataCorp LP 2013, College Station, TX, 
USA). 
 
Phase 2 Qualitative Methods: Study Population/Participants 
This qualitative study was nested in a larger prospective mixed methods study (SACS) 
involving 5 Queensland hospitals.  All women (and their partners) who experienced 
stillbirth (a baby born without signs of life of at least 20 weeks gestation or 400g 
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birthweight) at a participating hospital during a defined 6-month recruitment period were 
eligible to participate in SACS. As the purpose of the study was to gain understanding of 
the range of needs and experiences of parents faced with decisions about autopsy 
following stillbirth, a wide cross section of participants were included.  SACS was expected 
to recruit approximately 60 women (and 30 partners) during a 6 month period.   
For the qualitative study involving in-depth interviews, a subset of 10 participants from 
SACS were to be selected based on key relevant dimensions (ie demographic and 
pregnancy factors) found to be associated with consent for autopsy.  The only group 
specifically excluded from this study design were people with a cognitive impairment, an 
intellectual disability or a mental illness, due to the excessive burden likely to be imposed 
by participation. Women deemed by their attending clinician to be unsuitable to approach 
for any reason relating to their personal or social circumstances were also excluded from 
the study. Parents whose first language was not English were excluded as accessing 
interpreter services for the telephone interview was outside the scope of the study.  
As noted previously, significant delays in obtaining ethics and governance authorisations 
delayed commencement of the study (see Appendix A for details of ethics approvals); as 
well as staffing resource issues at the participating hospitals resulted in slower recruitment 
rates than anticipated.  Despite extending the recruitment period, a total of six parents 
instead of ten were recruited to the study.  
 
Recruitment and Consent for study 
Potentially eligible women and their partners were identified and with the approval of the 
treating doctor were advised of the study.  Full oral and written information about the study 
(Appendix C) was given to women and their partners prior to hospital discharge, where 
possible and appropriate, and informed written consent was obtained from those parents 
who wished to participate. Where it was not possible or appropriate to discuss the study 
with parents at or prior to discharge, the information sheet and consent form was included 
in their take-home pack. Parents wishing to take part in the study could return the 
completed consent form by mail or at their 6-8 week hospital follow up visit. Only parents 
who gave consent to the SACS study were eligible to participate in the in-depth interviews. 
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Procedures 
Six parents were interviewed via telephone at a time period 4-6 months after stillbirth as 
stipulated by the study protocol. Partners were given the option of being interviewed 
together with the mother or separately.  Parents were contacted by the study interviewer to 
arrange a suitable time and verify telephone contact details. Semi structured interviews 
with broad, open ended questions were used to elicit responses from parents regarding 
their experiences of the autopsy consenting process.  The broad nature of the questions 
allowed further exploration of topics raised by parents.  The interview schedule is 
presented in Appendix D.  The interviews ranged from 20 to 40 minutes. 
 
Data Management 
All women in the study were assigned a unique study ID which was included on all 
components of the data collection to enable data linkage. The in-depth qualitative 
interviews were digitally recorded (with the consent of the participants) and transcribed in 
full into a text file that was stored on a password-protected computer. A professional 
transcription service was used to guarantee accuracy and confidentiality.  All hard copies 
of the interview transcripts were rendered non-identifiable and stored securely in a locked 
filing cabinet accessible only to authorised members of the research team.  
 
Data Analysis  
Analysis involved a detailed reading of the transcript by two study team members to 
generate initial categories and codes and identify patterns contained in the data.  The use 
of at least two team members during this process provided analytic triangulation which 
helped to reduce researcher bias and address issues of internal reliability. The data from 
the transcripts was then grouped and classified according to initial codes.  The transcripts 
were reviewed and coded independently, conceptual consistency of the themes was 
checked by the two coders and any differences resolved via discussion. Themes were 
developed and defined using an iterative process in order to capture a meaningful and 
rigorous account of the data relevant to the research questions.  Data management and 
analysis was done manually.   
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7.3 Results  
Phase 1 Quantitative Results 
During the study period, a total of 3,842 women with a singleton stillbirth were included in 
the analysis.  Of these women, 1356 (35.3%) had an autopsy for their baby following 
stillbirth.  Further, the autopsy rate over the study period was 25.1% and 36.3%, 
respectively among Indigenous and non-Indigenous women.  There was a non-statistically 
significant trend towards a 1% per annum increase in overall autopsy rates (OR 1.01, 95% 
CI 0.99-1.03; ptrend=0.205) over the study period. Likewise there was no statistically 
significant trend in autopsy rates among Indigenous (ptrend=0.363) and non-Indigenous 
women (ptrend=0.335). Assessing autopsy rates by gestational age groups, a significant 
increase of 9% per annum over the study period was found for stillbirths occurring at 24-27 
weeks (OR 1.09, 95% CI 103-1.15; ptrend=0.004). No significant trends were found for other 
gestational age groups.  Triennial autopsy rates for the whole population and by 
gestational age group are presented in Figures 7.3 and 7.4, respectively. 
 
Figure 7.3:  Triennial autopsy rates (per 100 singleton stillbirths), Queensland, mid 
2000-2011 
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Figure 7.4:  Triennial autopsy rates by gestational age group, Queensland, mid 2000-2011  
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The characteristics of the cohort of women and babies by autopsy status are given in 
Table 7.1.  Where an autopsy was performed for a stillborn baby, mothers were 
more likely to be primiparous (OR 1.47, 95% CI 1.28-1.70), aged 19-24 years (OR 
1.24, 95% CI 1.04-1.48), have been born in Europe (OR 1.43, 95% CI 1.02-2.01), 
have gestational diabetes (OR 1.47, 95% CI 1.03-2.09), pregnancy-induced 
hypertension (OR 1.61, 95% CI 1.01-2.57), have a baby with a congenital 
abnormality (OR 1.30, 95% CI 1.13-1.50) or have a small-for-gestational age baby 
(OR 1.28, 95% CI 1.11-1.48).  Conversely, where an autopsy was performed for a 
stillborn baby, mothers were less likely to be Indigenous (OR 0.59, 95% CI 0.46-
0.76), socioeconomically disadvantaged (OR 0.73, 95% CI 0.58-0.93), aged 35 
years or older (OR 0.81, 95% CI 0.67-0.98), live in a regional area (OR 0.84, 95% CI 
0.73-0.96), have been born in the Oceania region (OR 0.54, 95% CI 0.33-0.90), have 
antepartum haemorrhage (OR 0.70, 95% CI 0.58-0.83), have a very preterm baby 
(20-23 weeks) (OR 0.56, 95% CI 0.47-0.67), have an initially unexplained stillbirth 
(OR 0.83, 95% CI 0.72-0.95) or an intrapartum stillbirth (OR 0.55, 95% CI 0.46-
0.66)(Table 7.2). 
 
Table 7.1: Maternal and pregnancy characteristics by autopsy status for 3,842 
women with a singleton stillbirth, Queensland, mid 2000-2011 
Characteristics 
Autopsy 
(n=1 356) 
No Autopsy 
(n=2 486) 
p value 
Maternal age 
     ≤18 years 39 (2.9) 71 (2.9) 
0.001 
     19-24 years 368 (27.1) 558 (22.5) 
     25-30 years 422 (31.1) 794 (31.9) 
     31-34 years 279 (20.6) 489 (19.7) 
     35+ years 248 (18.3) 574 (23.1) 
Smoking status* 
     Non smoker 631 (46.5) 1 029 (41.4) 
0.234      Smoker 204 (15.0) 375 (15.1) 
     missing 521 (38.4) 1082 (43.5) 
Indigenous status 
     Indigenous 89 (6.6) 265 (10.7) 
<0.001 
     Non Indigenous 1 267 (93.4) 2 221 (89.3) 
Maternal region of birth 
     Africa 21 (1.5) 27 (1.1) 
0.057 
     Americas and Caribbean 13 (1.0) 20 (0.8) 
     Eastern Asia 16 (1.2) 40 (1.6) 
     Central, South and West Asia 22 (1.6) 36 (1.4) 
     South East Asia 33 (2.4) 63 (2.5) 
     Europe 63 (4.6) 81 (3.3) 
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Characteristics 
Autopsy 
(n=1 356) 
No Autopsy 
(n=2 486) 
p value 
     Australia and New Zealand 1 164 (85.8) 2 145 (86.3) 
     Oceania 20 (1.5) 68 (2.7) 
     missing 4 (0.3) 6 (0.2) 
Socioeconomic status 
     Highest ranked 20% 174 (12.8) 270 (10.9) 
0.038 
     Middle ranked 60% 926 (68.3) 1 679 (67.5) 
     Lowest ranked 20% 251 (18.5) 531 (21.4) 
     missing 5 (0.4) 6 (0.2) 
Substance Use 
     Yes 28 (2.1) 38 (1.5) 
0.221 
     No 1 328 (97.9) 2 448 (98.5) 
Primiparity 
     Yes 473 (34.9) 662 (26.6) 
<0.001      No 883 (65.1) 1 822 (73.3) 
     missing - 2 (0.1) 
Assisted Conception 
      Yes 51 (3.8) 96 (3.9) 
0.881      No 1 301 (95.9) 2 385 (95.9) 
     missing 4 (0.3) 5 (0.2) 
Hospital accommodation status 
     Public 1 113 (82.1) 2 020 (81.3) 
0.549      Private 241 (17.8) 461 (18.5) 
     missing 2 (0.1) 5 (0.2) 
Any pregnancy complications  
     Yes 1 336 (98.5) 2 445 (98.4) 
0.748      No 20 (1.5) 40 (1.6) 
     missing - 1 (0.0) 
Antepartum haemorrhage 
     Yes 201 (14.8) 497 (20.0) <0.001 
Pre-existing diabetes    
     Yes 35 (2.6) 52 (2.1) 0.330 
Gestational diabetes 
     Yes 56 (4.1) 71 (2.9) 0.035 
Any diabetes 
     Yes 91 (6.7) 123 (5.0) 0.023 
Pre-existing hypertension 
     Yes 28 (2.1) 52 (2.1) 0.956 
Pregnancy-induced hypertension 
     Yes 34 (2.5) 39 (1.6) 0.042 
Pre-eclampsia/Eclampsia 
     Yes 58 (4.3) 82 (3.3) 0.122 
Any hypertension 
     Yes 120 (8.9) 171 (6.9) 0.027 
Preterm birth 
     Yes 1 004 (74.0) 1 988 (80.0) 
<0.001      No 348 (25.1) 490 (19.7) 
     missing 4 (0.3) 8 (0.3) 
Gestational age group    
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Characteristics 
Autopsy 
(n=1 356) 
No Autopsy 
(n=2 486) 
p value 
     20-23 weeks 441 (32.5) 1 106 (44.5) 
<0.001 
     24-27 weeks 186 (13.7) 311 (12.5) 
     28-36 weeks 377 (27.8) 571 (23.0) 
     ≥ 37 weeks 348 (25.7) 490 (19.7) 
     missing 4 (0.3) 8 (0.3) 
Gender 
     Male 721 (53.2) 1 284 (51.6) 
0.283 
     Female 612 (45.1) 1 171 (47.1) 
     Undetermined 23 (1.7) 29 (1.2) 
     missing - 2 (0.1) 
Small for gestational age 
     Yes 460 (33.9) 716 (28.8) 
0.001      No 859 (63.3) 1 718 (69.1) 
     missing 37 (2.7) 52 (2.1) 
Congenital abnormality 
     Yes 483 (35.6) 741 (29.8) 
<0.001      No 871 (64.2) 1 742 (70.1) 
     missing 2 (0.1) 3 (0.1) 
Unexplained stillbirth** 
     Yes 523 (38.6) 1 071 (43.1) 
0.007 
     No 833 (61.4) 1 415 (56.9) 
Type of stillbirth    
     Antepartum 1 024 (75.5) 1 574 (63.3) 
<0.001      Intrapartum 179 (13.2) 501 (20.2) 
     Unknown 153 (11.3) 411 (16.5) 
Geographic location 
     Major city 803 (59.2) 1 358 (54.6) 
0.015 
     Regional 501 (36.9) 1 009 (40.6) 
     Remote 51 (3.8) 119 (4.8) 
     missing 1 (0.1) - 
Epoch  
     2000-2002 282 (20.8) 452 (18.2) 
<0.001 
     2003-2005 260 (19.2) 659 (26.5) 
     2006-2008 378 (27.9) 674 (27.1) 
     2009-2011 436 (32.2) 701 (28.2) 
Percentages may add up to greater than 100% due to rounding.      
Missing values omitted from Chi square and Fisher’s exact tests.   
*Data on maternal smoking collected from mid 2005 onwards.      
** Initially unexplained on death certificate (ICD10AM code: P95) before investigations performed 
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Table 7.2: Univariate association between maternal and pregnancy factors and 
stillbirth autopsy, mid 2000-2011 (n=3 842) 
Characteristics 
Odds Ratio 
(95% Confidence Interval) 
Maternal Age (Ref: 25-30 years) 
     ≤18 years 1.03 (0.69-1.55) 
     19-24 years 1.24 (1.04-1.48) 
     31-34 years 1.07 (0.89-1.30) 
     35+ years 0.81 (0.67-0.98) 
Smoking status (Ref: Non-smoker) 
     Smoker 0.89 (0.73-1.08) 
Indigenous status (Ref: Non Indigenous) 
     Indigenous 0.59 (0.46-0.76) 
Maternal Region of birth (Ref: Australia and New Zealand) 
     Africa 1.43 (0.81-2.55) 
     Americas and Caribbean 1.20 (0.59-2.42) 
     East Asia 0.74 (0.41-1.32) 
     Central, South and West Asia 1.13 (0.66-1.92) 
     South East Asia 0.97 (0.63-1.48) 
     Europe 1.43 (1.02-2.01) 
     Oceania 0.54 (0.33-0.90) 
Socioeconomic status (Ref: Highest ranked 20%) 
     Middle ranked 60% 0.86 (0.70-1.05) 
     Lowest ranked 20% 0.73 (0.58-0.93) 
Substance Use (Ref: No) 
     Yes 1.36 (0.83-2.22) 
Primiparity (Ref: No) 
     Yes 1.47 (1.28-1.70) 
Assisted Conception (Ref: No) 
      Yes 0.97 (0.69-1.38) 
Hospital accommodation status (Ref: Private) 
     Public 1.05 (0.89-1.25) 
Pregnancy complications (Ref: No) 
     Yes 1.09 (0.63-1.88) 
Antepartum haemorrhage (Ref: No)  
     Yes 0.70 (0.58-0.83) 
Pre-existing diabetes (Ref: No)  
     Yes 1.24 (0.80-1.91) 
Gestational diabetes (Ref: No)  
     Yes 1.47 (1.03-2.09) 
Any diabetes (Ref: No)  
     Yes 1.38 (1.05-1.83) 
Pre-existing hypertension (Ref: No)  
     Yes 0.99 (0.62-1.57) 
Pregnancy-induced hypertension (Ref: No)  
     Yes 1.61 (1.01-2.57) 
Pre-eclampsia/Eclampsia (Ref: No)  
     Yes 1.31 (0.93-1.85) 
Any hypertension (Ref: No)  
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Characteristics 
Odds Ratio 
(95% Confidence Interval) 
     Yes 1.31 (1.03-1.68) 
Preterm birth (Ref: ≥37 weeks) 
     20-23 weeks 0.56 (0.47-0.67) 
     24-27 weeks 0.84 (0.67-1.06) 
     28-36 weeks 0.93 (0.77-1.12) 
Gender (Ref: Female) 
     Male 1.07 (0.94-1.23) 
     Undetermined 1.52 (0.87-2.65) 
Small for gestational age (Ref: No) 
     Yes 1.28 (1.11-1.48) 
Congenital abnormality (Ref: No)  
     Yes 1.30 (1.13-1.50) 
Unexplained stillbirth (Ref: No)  
     Yes 0.83 (0.72-0.95) 
Type of stillbirth (Ref: Antepartum)  
     Intrapartum 0.55 (0.46-0.66) 
     Unknown 0.57 (0.47-0.70) 
Geographic location (Ref: Major City) 
     Regional 0.84 (0.73-0.96) 
     Remote 0.72 (0.52-1.02) 
Epoch (Ref: 2000-2002) 
     2003-2005 0.63 (0.51-0.78) 
     2006-2008 0.90 (0.74-1.09) 
     2009-2011 1.00 (0.82-1.21) 
Initially unexplained on death certificate (ICD10AM code: P95) before investigations performed 
 
 
Multivariate association between maternal/pregnancy characteristics and autopsy 
status 
Less than 24 weeks 
In the less than 24 week gestation group, women with a small-for-gestational age 
baby (aOR 1.49, 95% CI 1.15-1.95) or a baby with a congenital abnormality (aOR 
1.62, 95% CI 1.22-2.16) were more likely to have an autopsy performed for their 
stillborn baby. Maternal age of 35 years or older (aOR 0.70, 95% CI 0.49-0.99), 
Indigenous status (aOR 0.53, 95% CI 0.32-0.90), socioeconomic disadvantage (aOR 
0.57, 95% CI 0.36-0.89), intrapartum stillbirth (aOR 0.64, 95% CI 0.47-0.87) and 
stillbirths where it was unknown if they were antepartum or intrapartum (aOR 0.60, 
95% CI 0.43-0.82) were associated with decreased odds of having an autopsy 
performed (Table 7.3).  
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Table 7.3: Maternal and pregnancy factors associated with autopsy, less than 
24 weeks, mid 2000-2011 (n=1 547) 
Characteristics Adjusted Odds Ratios 
(95% Confidence 
Interval) 
Maternal Age (Ref: 25-30 years) 
     ≤18 years 1.23 (0.55-2.76) 
     19-24 years 1.25 (0.91-1.73) 
     31-34 years 0.92 (0.66-1.29) 
     35+ years 0.70 (0.49-0.99) 
Australian Indigenous status (Ref: Non Indigenous) 
     Indigenous 0.53 (0.32-0.90) 
Maternal region of birth (Ref: Australia and New Zealand) 
     Africa 1.40 (0.50-4.00) 
     Americas and Caribbean 0.60 (0.16-2.24) 
     East Asia 1.03 (0.43-2.47) 
     Central, South and West Asia 1.65 (0.69-3.95) 
     South East Asia 0.73 (0.30-1.80) 
     Europe 1.60 (0.89-2.89) 
     Oceania (excl Australia and New Zealand) 0.80 (0.26-2.49) 
Socioeconomic status (Ref: Highest ranked 20%) 
     Middle ranked 60% 0.70 (0.49-1.00) 
     Lowest ranked 20% 0.57 (0.36-0.89) 
Primiparity (Ref: No) 
     Yes 1.15 (0.88-1.52) 
Antepartum haemorrhage (Ref: No)  
     Yes 1.26 (0.90-1.76) 
Pregnancy-induced hypertension (Ref: No)  
     Yes 0.80 (0.08-7.69) 
Gestational diabetes (Ref: No)  
     Yes 2.33 (0.73-7.44) 
Small for gestational age (Ref: No) 
     Yes 1.49 (1.15-1.95) 
Unexplained fetal death (Ref: No)  
     Yes 0.86 (0.62-1.21) 
Congenital abnormality (Ref: No)  
     Yes 1.62 (1.22-2.16) 
Type of stillbirth (Ref: Antepartum)  
     Intrapartum 0.64 (0.47-0.87) 
     Unknown 0.60 (0.43-0.82) 
Remoteness (Ref: Major City) 
     Regional 0.97 (0.75-1.26) 
     Remote 1.82 (0.97-3.40) 
Epoch (Ref: 2000-2002) 
     2003-2005 0.57 (0.39-0.83) 
     2006-2008 0.85 (0.60-1.20) 
     2009-2011 0.80 (0.57-1.14) 
Initially unexplained on death certificate (ICD10AM code: P95)    Gestational age missing for 12 births  
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24 – 27 weeks 
Among those with a stillbirth in the 24-27 week gestational age group, women with a 
small-for-gestational age baby were more likely to have an autopsy performed for 
their stillborn baby (aOR 1.56, 95% CI 1.02-2.38).  Conversely, autopsy was less 
likely to be performed for a stillborn baby among women who had antepartum 
haemorrhage (aOR 0.53, 95% CI 0.31-0.89), an intrapartum stillbirth (aOR 0.38, 
95% CI 0.18-0.81) or where it was unknown if the stillbirth was antepartum or 
intrapartum (aOR 0.23, 95% CI 0.08-0.65) (Table 7.4). 
 
Table 7.4: Maternal and pregnancy factors associated with autopsy, 24-27 
weeks, mid 2000-2011 (n=497) 
Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
Maternal Age (Ref: 25-30 years) 
     ≤18 years 0.54 (0.15-1.96) 
     19-24 years 1.50 (0.83-2.70) 
     31-34 years 1.17 (0.66-2.07) 
     35+ years 0.67 (0.37-1.21) 
Australian Indigenous status (Ref: Non Indigenous) 
     Indigenous 0.44 (0.18-1.12) 
Maternal region of birth (Ref: Australia and New Zealand) 
     Africa 0.24 (0.04-1.38) 
     Americas and Caribbean 0.37 (0.03-4.66) 
     East Asia 0.25 (0.03-2.36) 
     Central, South and West Asia 0.43 (0.07-2.51) 
     South East Asia 0.26 (0.06-1.03) 
     Europe 0.96 (0.38-2.45) 
     Oceania (excl Australia and New Zealand) 0.80 (0.19-3.31) 
Socioeconomic status (Ref: Highest ranked 20%) 
     Middle ranked 60% 0.80 (0.41-1.55) 
     Lowest ranked 20% 0.59 (0.27-1.29) 
Primiparity (Ref: No) 
     Yes 1.15 (0.71-1.84) 
Antepartum haemorrhage (Ref: No)  
     Yes 0.53 (0.31-0.89) 
Pregnancy-induced hypertension (Ref: No)  
     Yes 2.43 (0.69-8.50) 
Gestational diabetes (Ref: No)  
     Yes 1.31 (0.39-4.37) 
Small for gestational age (Ref: No) 
     Yes 1.56 (1.02-2.38) 
Unexplained fetal death (Ref: No)  
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Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
     Yes 0.73 (0.46-1.16) 
Congenital abnormality (Ref: No)  
     Yes 1.02 (0.61-1.71) 
Type of stillbirth (Ref: Antepartum)  
     Intrapartum 0.38 (0.18-0.81) 
     Unknown 0.23 (0.08-0.65) 
Remoteness (Ref: Major City) 
     Regional 0.70 (0.45-1.09) 
     Remote 0.61 (0.20-1.83) 
Epoch (Ref: 2000-2002) 
     2003-2005 0.69 (0.35-1.35) 
     2006-2008 1.35 (0.70-2.59) 
     2009-2011 1.68 (0.90-3.13) 
Initially unexplained on death certificate (ICD10AM code: P95).   Gestational age missing for 12 births 
 
28-36 weeks 
Women aged 19-24 years (aOR 1.46, 95% CI 1.01-2.11) and primiparous women 
(aOR 1.45, 95% CI 1.06-1.98) were more likely to have an autopsy performed for 
their stillborn baby when stillbirth occurred at 28-36 weeks gestation.  In contrast, 
women who had an antepartum haemorrhage (aOR 0.68, 95% CI 0.48-0.95), an 
intrapartum stillbirth (aOR 0.35, 95% CI 0.17-0.74) or an initially unexplained stillbirth 
(aOR 0.64, 95% CI 0.47-0.87) were less likely to have an autopsy performed for their 
stillborn baby (Table 7.5). 
 
Table 7.5: Maternal and pregnancy factors associated with autopsy, 28-36 
weeks, mid 2000-2011 (n= 948) 
Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
Maternal Age (Ref: 25-30 years) 
     ≤18 years 0.92 (0.43-1.95) 
     19-24 years 1.46 (1.01-2.11) 
     31-34 years 1.05 (0.71-1.57) 
     35+ years 0.82 (0.55-1.23) 
Australian Indigenous status (Ref: Non Indigenous) 
     Indigenous 0.87 (0.50-1.52) 
Maternal region of birth (Ref: Australia and New Zealand) 
     Africa 1.58 (0.46-5.42) 
     Americas and Caribbean 2.52 (0.53-11.9) 
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Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
     East Asia 0.59 (0.18-1.96) 
     Central, South and West Asia 1.53 (0.55-4.23) 
     South East Asia 1.20 (0.55-2.64) 
     Europe 1.35 (0.66-2.75) 
     Oceania (excl Australia and New Zealand) 0.37 (0.14-1.02) 
Socioeconomic status (Ref: Highest ranked 20%) 
     Middle ranked 60% 1.22 (0.77-1.95) 
     Lowest ranked 20% 1.28 (0.74-2.21) 
Primiparity (Ref: No) 
     Yes 1.45 (1.06-1.98) 
Antepartum haemorrhage (Ref: No)  
     Yes 0.68 (0.48-0.95) 
Pregnancy-induced hypertension (Ref: No)  
     Yes 2.00 (0.86-4.65) 
Gestational diabetes (Ref: No)  
     Yes 0.83 (0.43-1.58) 
Small for gestational age (Ref: No) 
     Yes 0.84 (0.63-1.13) 
Unexplained fetal death (Ref: No)  
     Yes 0.64 (0.47-0.87) 
Congenital abnormality (Ref: No)  
     Yes 1.15 (0.81-1.63) 
Type of stillbirth (Ref: Antepartum)  
    Intrapartum 0.35 (0.17-0.74) 
    Unknown 0.60 (0.31-1.16) 
Remoteness (Ref: Major City) 
     Regional 0.88 (0.65-1.19) 
     Remote 0.95 (0.44-2.02) 
Epoch (Ref: 2000-2002) 
     2003-2005 0.78 (0.52-1.17) 
     2006-2008 0.88 (0.59-1.32) 
     2009-2011 1.22 (0.82-1.83) 
Initially unexplained on death certificate (ICD10AM code: P95)    Gestational age missing for 12 births 
 
37 weeks and older 
Among those women who had term stillbirths, primiparity (aOR 1.70, 95% CI 1.22-
2.39) and the presence of congenital abnormality (aOR 2.84, 95% CI 1.81-4.46) 
were associated with increased odds of having an autopsy performed.  In contrast, 
Indigenous status (aOR 0.53, 95% CI 0.29-0.96), antepartum haemorrhage (aOR 
0.59, 95% CI 0.36-0.97), remote residence (aOR 0.30, 95% CI 0.11-0.83) and 
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initially unexplained stillbirth (aOR 0.51, 95% CI 0.37-0.71) were associated with 
decreased odds of having an autopsy performed for a stillborn baby (Table 7.6). 
 
Table 7.6: Maternal and pregnancy factors associated with autopsy, ≥37 
weeks, mid 2000-2011  (n=838) 
Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
Maternal Age (Ref: 25-30 years) 
     ≤18 years 0.82 (0.23-2.88) 
     19-24 years 1.16 (0.77-1.76) 
     31-34 years 1.23 (0.80-1.90) 
     35+ years 0.93 (0.60-1.44) 
Australian Indigenous status (Ref: Non Indigenous) 
     Indigenous 0.53 (0.29-0.96) 
Maternal region of birth (Ref: Australia and New Zealand) 
     Africa 2.67 (0.58-12.3) 
     Americas and Caribbean 1.47 (0.32-6.80) 
     East Asia 1.37 (0.26-7.31) 
     Central, South and West Asia 0.20 (0.04-1.03) 
     South East Asia 1.29 (0.52-3.18) 
     Europe 1.68 (0.71-4.00) 
     Oceania (excl Australia and New Zealand) 0.40 (0.15-1.09) 
Socioeconomic status (Ref: Highest ranked 20%) 
     Middle ranked 60% 1.01 (0.61-1.68) 
     Lowest ranked 20% 0.84 (0.46-1.52) 
Primiparity (Ref: No) 
     Yes 1.70 (1.22-2.39) 
Antepartum haemorrhage (Ref: No)  
     Yes 0.59 (0.36-0.97) 
Pregnancy-induced hypertension (Ref: No)  
     Yes 0.80 (0.36-1.81) 
Gestational diabetes (Ref: No)  
     Yes 1.58 (0.84-2.98) 
Small for gestational age (Ref: No) 
     Yes 1.15 (0.82-1.62) 
Unexplained fetal death (Ref: No)  
     Yes 0.51 (0.37-0.71) 
Congenital abnormality (Ref: No)  
     Yes 2.84 (1.81-4.46) 
Type of stillbirth (Ref: Antepartum)  
     Intrapartum 1.03 (0.61-1.74) 
     Unknown 0.81 (0.47-1.39) 
Remoteness (Ref: Major City) 
     Regional 0.89 (0.64-1.23) 
     Remote 0.30 (0.11-0.83) 
Epoch (Ref: 2000-2002) 
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Characteristics 
Adjusted Odds Ratios 
(95% Confidence 
Interval) 
     2003-2005 0.60 (0.38-0.93) 
     2006-2008 1.06 (0.68-1.66) 
     2009-2011 0.95 (0.61-1.47) 
Initially unexplained on death certificate (ICD10AM code: P95)   Gestational age missing for 12 births 
 
Phase 2 Qualitative Results 
The results presented in the previous section show the maternal characteristics 
associated with consent for or decline of autopsy but not the lived experience of 
parents faced with the decision of whether or not to consent to autopsy for their 
stillborn baby.  In-depth qualitative interviews sought to include parents’ voices and 
perspectives on the autopsy consent process.  The interviews yielded rich data that 
illuminated the complexity of factors affecting parents’ decision making. 
Interviews were conducted with six parents (5 mothers and 1 father) of six babies 
during the study period.  The characteristics of the study participants are shown in 
Table 7.7.  Two of the stillbirths occurred during labour (intrapartum) and one of 
these was a termination of pregnancy.  Autopsy was performed for four babies.  
Although the small number of study participants precludes meaningful comparison 
across key characteristics, a range of experiences and views about the autopsy 
consent process were captured helping to bring to life and explain some of the 
associations found in the quantitative analysis.  
Direct quotations from parents are presented in italics with unique identifiers (A-F) to 
differentiate respondents and are used to illustrate the themes and subthemes. 
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Table 7.7: Characteristics of the participants in the in-depth interviews  
 Participant 
A 
Participant 
B 
Participant 
C 
Participant 
D 
Participant 
E 
Participant 
F 
Parent Characteristics 
Parent Mother Father Mother Mother Mother Mother 
Parent age 30-39 30-39 30-39 20-29 ≥40 20-29 
Residence Major city Major city Major city Major city Major city Remote 
Indigenous 
status 
Non 
Indigenous 
Non 
Indigenous 
Non 
Indigenous 
Non 
Indigenous 
Non 
Indigenous 
Non 
Indigenous 
Maternal 
region of birth 
Australia and 
New Zealand 
- Americas and 
Caribbean 
Australia and 
New Zealand 
Australia and 
New Zealand 
Australia and 
New Zealand 
Marital status married married married de facto married de facto 
Ethnicity/Race Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian 
Education Tertiary Secondary Tertiary Tertiary Tertiary Technical college 
Religion No religion No religion No religion Buddhist No religion No religion 
Primiparity Yes Yes No No Yes Yes 
Baby’s Characteristics 
Baby A C D E F G 
Type of 
stillbirth 
Antepartum Intrapartum Intrapartum 
(Termination) 
Antepartum Antepartum Antepartum 
Gestational 
age 
42 weeks 23 weeks 21 weeks 30 weeks 23 weeks 28 weeks 
Autopsy Yes No Yes No Yes Yes 
Hospital Characteristics 
Hospital A A B A B 
Hospital level Level 3 
referral 
Level 3 
referral 
Level 3 
referral 
Level 3 
referral 
Level 3 
referral 
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The distressing nature of the circumstances in which the decision making process around 
autopsy occurs and the need for parents to find answers were overarching themes.  There 
were a range of approaches to decision making; it is notable that three parents stated that 
the decision itself was “easy” as they knew this was the way to find answers and contribute 
to knowledge. Some parents had strong opinions either way while other parents struggled 
with a decision (Table 7.8). 
 
Table 7.8: Quotes from respondents showing the spectrum of approaches to 
decision making regarding consent to autopsy 
 
“Probably because they weren’t 100% sure what was actually wrong, 
for us it’s quite vital. So it wasn’t too hard of a decision for me” 
(Participant F, mother, consented to autopsy) 
 
 
“For me it wasn’t a hard decision. It was quite an easy decision 
because I wanted to know what had gone on. We had no idea.” 
(Participant B, father, consented to autopsy) 
 
 
“I’m a nurse so I know the importance of evidence-based research … 
I guess it wasn’t that big a decision compared to the other decisions 
we were having to make … if there was any way that we could find 
out what caused it or prevent any future pregnancies from ending like 
that, then we were going to take any available option to do that. So it 
wasn’t a significant decision on the scale of decisions that we had to 
make”. 
(Participant D, mother, consented to autopsy) 
 
 
“For me, it was much harder, you know, someone says autopsy and 
just the thought of them cutting up my little baby. That was awful and 
I really didn’t like the thought of that at all, [but] I wanted to know the 
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cause of death. So I said yes just … to discover why, really. That was 
more important to me than them not interfering with his body”. 
(Participant A, mother, consented to autopsy) 
 
 
“I felt like the autopsy wouldn’t answer the question for me about why 
the membranes broke and the other part to my decision I think was 
that if those results were going to be used in a study, I would have 
been more likely to decide to have an autopsy”.   
(Participant C, mother, declined consent to autopsy) 
 
 
“When we were told that she didn’t have a heart beat I think 
immediately I had already thought no autopsy at all. Like because I 
didn’t even know what the reasoning was why she had died but I 
honestly didn’t think that I could handle seeing, you know, feeling that 
they were cutting her up” 
(Participant E, mother, declined consent to autopsy) 
 
 
Four additional themes emerged relating to the context surrounding the decision making 
process and motivating factors for parents in relation to decisions regarding stillbirth 
autopsy.  These themes were: 1) a precious and time limited moment, 2) taking care of the 
body, 3) the need for an explanation, and 4) a station along the bereavement journey.  
 
A Precious and Time-limited moment 
The context within which parents were making decisions was described as “quite a 
precious and time-limited moment”. The notion of limited time featured prominently in 
comments from parents: the time they had with their baby was limited and the time they 
had to make numerous decisions that involved interactions with numerous staff was 
limited. The decision about autopsy was characterised by competing priorities for both 
parents and health care staff; including care of the mother, providing parents with 
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information and support, and providing space and time for parents and families to spend 
with the baby.  As one mother articulated: 
“There was quite a lot of things that they had to talk to us about in that 
period of time and it is quite a precious and time-limited moment in your 
life because from when the baby is born, their body is changing and so as 
the hours go by, you can see the baby change and you also know that 
you’re going to have to say goodbye.  So on the one hand it’s good to 
have information but on the other hand you really don’t want to spend a 
long time being caught up with all of this other stuff and I think that’s a 
really hard balance possibly for the staff to make because there’s lots of 
different people – I mean, I know that they were trying to give us time but 
on the other hand there’s a lot of different people coming in and out of the 
room and then they had to look after me as well as ask us about various 
things”   (Participant C, mother, declined consent for autopsy) 
The amount of time available before having to address a decision about autopsy was also 
important.  Two of the mothers had intrapartum stillbirths but in both cases they were 
aware that the baby would be unlikely to survive the birth. 
“We seemed to have what felt like a long time so I felt like that somehow 
made things easier.  It made us calmer just after birth and it wasn’t so 
much a shock …  I don’t know if relaxed is the right word but yeah, [we 
were] not in a really terrible state of shock.  I could imagine for families 
where everything happens much more quickly.”  (Participant C, mother, 
declined consent for autopsy) 
Time also meant parents were more likely to receive the information and support they 
needed and, ideally, the opportunity to develop a relationship with one or more care 
providers.  During this time, parents appreciated fore-warning of the discussion as well as 
having just one staff member go through the details of the information around stillbirth 
investigation. Continuity and rapport were important to parents. Parents reported preferring 
if the staff member discussing with them regarding autopsy consent had built rapport with 
them before initiating the discussion. 
“I had a bit of a relationship with the lady who organised the autopsy … it 
went fairly well and they gave you enough time, like I spoke to my partner 
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and that sort of thing about it. So they do give you time to talk about it” 
(Participant F, mother, consented to autopsy) 
Parents also appreciated receiving both written and verbal information as a number of 
parents interviewed described being overwhelmed by the situation and the amount of 
information being presented. 
“At that particular time you can’t think straight so there’s not a lot of 
information you can take in and retain through those pamphlets, where[as] 
someone sitting down and making sure that you understand it”   
(Participant F, mother, consented to autopsy) 
“The Registrar that was talking to us about the autopsy was someone that 
we had met – maybe not before I went into labour but we’d certainly talked 
to her a number of times and trusted her … I guess we liked her and she 
was very considerate towards us and what we needed at different times 
before the birth but also after the birth” (Participant C, mother, did not 
consent to autopsy) 
 
Taking care of the body 
Regardless of the decision parents ultimately made about autopsy, or of the degree of 
difficulty they experienced in making that decision, all expressed heartfelt concerns 
relating to the importance of taking care of their baby’s body. Parents comments related 
specifically to the autopsy procedure, for example, “cutting up”, concerns about the 
retention of body parts or tissue, “keeping the baby whole” and treating the baby with 
respect. Despite the death of the baby prior to birth, there was recognition of parents as 
parents; as protectors of their baby.  To this end, healthcare providers facilitated 
opportunities for parents to establish bonds with their infant through holding and memory 
creation activities such as taking photographs and inviting other family members to meet 
the baby; which may assist with grieving.  This was an acknowledgement of the 
uniqueness and preciousness of the limited amount of time parents had with their baby 
following birth.  
Given the role of parents as caregivers and protectors of their baby, being asked for 
consent to autopsy appears to be the antithesis of parenting.  As one parent expressed: 
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“I didn’t want to be separated from my baby.  If I could have kept him with 
me, I would have done that and keeping him whole would have been really 
important, not having bits of his brain taken that wouldn’t be returned.  I 
really didn’t like that notion at all.  That didn’t sit well.  I mean, the whole 
thing of autopsy is pretty terrible – you don't ever want to imagine 
someone you love having that procedure performed on their body”.   
(Participant D, mother, consented for autopsy) 
However, being asked for consent to autopsy was for parents another opportunity to 
demonstrate their role as protector and caregiver to their baby and to exercise some 
control in a situation where they felt somewhat powerless. 
“I can’t change the circumstances that she is gone but I still have control 
over how I want her to be treated in her death”  (Participant E, mother, 
declined consent for autopsy) 
In deciding for or against consent to an autopsy for their baby, parents described weighing 
up a number of competing factors.  The first of these was taking care of the body and not 
having it “cut”. This was particularly important to parents, as one mother expressed: 
“I still imagine it would be a very difficult decision just because of the 
physicality of what you imagine an autopsy to be, that you have this 
beautiful little baby and then to think that they would be cut or changed in 
a way – it would be difficult.  I think that was one thing very important for 
us, that we took care of his body and I imagine that would be very similar 
for many parents, that you really feel like you want to take care of the body 
even though the baby is not alive.”   (Participant C, mother, declined 
consent for autopsy) 
Parents who chose to have an autopsy examination of their baby described weighing up 
the need for an explanation and the physical reality of the autopsy examination against the 
need to protect the integrity of the baby’s body.  
“I wanted to know the cause of death and I knew that that [autopsy] would 
help in finding out what happened.  So I said yes… That was more 
important to me than them not interfering with his body.  I’m very grateful 
that we did actually because …he died of an infection and they wouldn’t 
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have known that had they not done an autopsy.”  (Participant A, mother, 
consented to autopsy) 
Also related to maintaining the integrity of the baby’s body was the subtheme of tissue 
retention.  This caused further distress to parents especially when they were unprepared 
for it. As one mother expressed: 
“We weren’t told at that point that he wasn’t whole, that he wasn’t all in 
there.  So then we had the funeral assuming that it was all there, didn’t 
even think that it wasn’t and he was cremated.  We got his ashes and then 
we came back eight weeks later and met with [bereavement midwives], 
the obstetrician and went over the results and it was then that they said, 
“Okay, so you know when we said that we can retain parts of him, we’ve 
actually kept his brain.  We’ve finished testing on it.  What do you want to 
do with it now?” and I was like, “What do you mean?  Where is it?  What 
are the options?”  That was a bit of a shock for me,… kind of traumatic… 
that he wasn’t all where I thought he was.  We had to kind of repeat the 
process, like they go, “Okay, do you want to take the brain?  You can bury 
it, you can get it cremated or we send it off with all of the other, you know, 
baby bits” and then they cremate it somewhere else and scatter the ashes.  
So yeah, that brought all that up again and I thought the funeral and the 
cremation was all done”. (Participant A, mother, consented to autopsy) 
Another aspect of taking care of the baby’s body was treating the body with respect.  This 
was evidenced by the distress caused when this was not done. 
“We went back the day after and they [babies] were brought into the room 
from the morgue still encased in plastic bags and everything.  I think it was 
an orderly who brought the babies in and I think it was probably just either 
lack of training or lack of understanding that there was someone actually 
in that room because I don’t think he even knew there was anyone in 
there”  (Participant F, mother, consented to autopsy) 
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The need for an explanation 
The need for an explanation was an important factor for parents regardless of whether 
they ultimately decided for or against an autopsy examination.  Parents who chose not to 
have an autopsy described having to come to terms with not having an explanation for 
what happened to their baby.   
“I think that’s probably one of the things that over time that you have to 
learn to accept in a way, that there isn’t always an explanation for things”  
(Participant C, mother, declined consent for autopsy) 
Likewise, among parents who chose to have an autopsy, some described concern that 
they would be left wondering if the results were inconclusive.  In contrast, having a clinical 
cause of death did not necessarily answer parents’ questions about what happened to 
their baby; parents were seeking answers to what initiated the chain of events that lead to 
their baby’s death and that might still be unknown. 
A subtheme within the need for an explanation was the value of an autopsy to find the 
cause of death.  This varied with clinical scenario and parents relied heavily on the 
professional opinion of their health care provider regarding the value of an autopsy 
examination.  The following quote highlights the importance of messages conveyed either 
implicitly or explicitly by health care providers. 
“The obstetricians and so on felt like it wouldn’t – I guess my impression 
was that they felt like it wouldn’t be able to explain why the membranes 
ruptured… So I felt like the autopsy wouldn’t really give information that 
would help answer our questions and maybe the test that I was more keen 
to have was this – some testing of the umbilical cord I think and the 
placenta, to look at that and that would then tell you about infection and so 
on.  That was more the kind of – I guess that was what they were 
suggesting, that maybe the membranes ruptured because of an infection 
or something”.   (Participant C, mother, declined consent for autopsy) 
Parents considered how the information from their child’s autopsy would be of benefit to 
them personally and to others when making their decision for or against autopsy.   
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“We certainly weren’t ever feeling like, “Oh no, that’s out of the question.”  
The decision-making was more around not seeing any real benefit either 
to us or to anyone else from going through that and that it’s not the kind of 
thing that you think, “Oh, we may as well just do it anyway” because it’s so 
invasive.”  (Participant C, mother, declined consent for autopsy) 
Some parents described consenting for autopsy as “making a sacrifice for science” and 
there was an expectation of reciprocal responsibility from healthcare providers particularly 
when the benefit to others was an important factor in their decision making.  
Numerous factors influenced parents’ decision making; their professional background was 
one such factor. In the scenario of a poor prognosis during the antenatal period, parents 
described seeking health information in relation to their baby’s diagnosis via online 
resources. 
The need for an explanation of what happened to the baby was important to parents as a 
means of dealing with feelings of guilt; as mothers did blame themselves and their bodies.   
“Was it good to know or not to know, being that listeria is something that’s 
transmitted through food. I always carry that guilt that I ate something that 
was the [cause of the] demise and I was so careful. I kind of always walk 
past something and think gosh was it that that caused it?”    (Participant E, 
mother, declined consent for autopsy) 
However, for some parents an explanation was helpful in alleviation feelings of guilt. 
“I’m very grateful that we did actually because it wasn’t that he was 
overdue or that my placenta had shut down.  He died of an infection and 
they wouldn’t have known that had they not done an autopsy.  So then I 
would have been left with all the questioning, the guilt, the uncertainty, the 
“there’s something wrong with me…”  So to actually get – it was a freak 
thing, completely undetectable and [midwife] says it’s one in a billion 
chance that that can happen, so very relieved we made that decision”  
(Participant A, mother, consented to autopsy) 
An explanation was also important for parents planning a future pregnancy, as shown in 
the following quote and as highlighted in the next section.   
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“I don’t want to have another pregnancy until I know those results … in 
case there’s something we could do to prevent it happening [again].”  
(Participant D, mother, consented to autopsy) 
 
A station along the bereavement journey 
A major theme was recognition that the autopsy consent process was not an endpoint in 
itself but rather a station along the bereavement journey.  This theme and the preceeding 
themes are represented visually in Figure 7.5. For parents, it was one decision among 
many decisions to be made – and the decision made also had significant ramifications for 
parents.  Ramifications included when and how they received autopsy results, whether the 
autopsy findings would be conclusive or inconclusive, and other possible unforseen 
outcomes from the autopsy process. 
Parents who consented to an autopsy described putting their lives on hold while waiting for 
autopsy results.  Some parents interviewed had lengthy and frustrating waits for autopsy 
results in excess of 6 and 12 months and suggested fast tracking of autopsy results for 
very young children. 
“I think it would help me to move on to get those results and put it to rest in 
my mind, that it wasn’t me that did something wrong or it wasn’t something 
that was likely to happen again with another pregnancy”  (Participant D, 
mother, consented to autopsy) 
“We received one result for one of the babies, we weren’t told that the 
other results weren’t there so that was a bit of a shock but you’d think 
they’d both come together but you only got one so like we’ve then got to 
go and ask again for the results of the other child”   (Participant F, mother, 
consented to autopsy) 
Of great importance to these parents was also the manner in which autopsy results were 
communicated to them.  As one parent expressed: 
“I don’t want a call at work or when I’m out telling me the results of my 
son’s autopsy.  How are they going to approach that?  Am I going to get a 
doctor’s appointment to talk about it sensitively?  There hasn’t really been 
discussion in that way.  I’d be pretty pissed off if I did get a call when I was 
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out and about to tell me those results because that would be an insensitive 
manner to do it but nor can I imagine them booking an appointment just to 
discuss that.”    (Participant D, mother, consented to autopsy) 
These parents have suggested ideally an appointment with their treating obstetrician with 
the opportunity to discuss autopsy results, allay fears and consider management options 
for the next pregnancy would be an appropriate manner to convey autopsy results.   
“I think when I received them [results] I was sitting there with a doctor, she 
went through it and explained it to me and that would be a lot better than 
receiving it say in the mail or something like that where you might read 
through it and a lot of the wording you won’t understand”   (Participant F, 
mother, consented to autopsy) 
Parents also commented on the limited availability of follow up support and care after 
leaving hospital. This was particularly so for parents living in remote areas. 
“When I was there [hospital], they give you all the pamphlets and the 
information or everything and it really is once you’ve left the hospital that 
there is absolutely no follow up care, there’s no offering of a counsellor, 
there was no counselling while I was in hospital even after the first child.  
Once you leave hospital, there is no aftercare … being in such an isolated 
area, having that contact or someone making contact or referral to a 
service out where you are but that doesn’t exist unfortunately”   
(Participant F, mother, consented to autopsy) 
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Figure 7.5: Journey map showing the interaction points between parents and health care providers in relation to the autopsy 
consent process.  
The solid purple-shaded boxes (below the winding path) indicate key events relating to the autopsy consent process.  The solid boxes (above the winding path) 
indicate processes triggered by the key events.  The dashed purple boxes (within the winding path) indicate the key themes from interviews with parents while the 
dashed green boxes indicate the key implications for clinical practice. 
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7.4 Discussion 
Main findings 
The objectives of this study were: to identify sociodemographic, pregnancy and medical 
factors which are associated with whether or not autopsy was performed following stillbirth 
and to gain an understanding of parents’ experiences of the autopsy consent process.  
This study found various sociodemographic, pregnancy and maternal factors were 
associated with autopsy after stillbirth and the associations varied with gestational age.  To 
our knowledge no recent studies have examined associations between stillbirth autopsy 
and maternal factors in a quantitative manner using population data.  This study also found 
that decision making around stillbirth autopsy for parents is influenced by various 
contextual and psychological factors. Four main themes relating to the context and 
motivation surrounding parents’ decision making were uncovered, namely: 1) a precious 
and time-limited moment, 2) taking care of the body, 3) the need for an explanation, and 4) 
a station along the bereavement journey.   
 
Interpretation of findings 
Perinatal autopsy has been shown to change diagnosis of cause of death or add important 
information in 22-76% of cases [308].  However the quality of autopsy varies [309]; and 
improved quality of autopsy as well as reporting and interpretation was found when 
performed by a perinatal pathologist [310, 311].  Furthermore, it is unclear which clinical 
scenario results in the highest yield of information for autopsy following stillbirth. It has 
been reported that autopsy together with placental examinations could contribute to 
decreasing the rate of unexplained stillbirths [312]. 
 
It was a paradoxical finding that stillbirths occurring at 28 weeks or more that were 
unexplained at the time of completing the death certificate were less likely to have an 
autopsy.  The reason for this was not immediately clear. We were unable to determine 
which investigations besides stillbirth autopsy were subsequently conducted. However, 
among stillbirths which were unexplained on the death certificate, the leading categories 
after subsequent investigation and classification according to PSANZ PDC were: 
unexplained antepartum fetal death (55.8%), spontaneous preterm (11.7%), antepartum 
haemorrhage (9.0%) and fetal growth restriction (5.5%). Classification to the latter three 
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categories were less likely to rely on autopsy findings [124]. Furthermore, these findings 
may reflect barriers to autopsy consent that have been observed in surveys of health care 
professionals’ view and practices, these include gaps in knowledge and training and an 
underestimation of the value of autopsy [126].  More broadly, an attitude of fatalism or 
“these things happen” is prevalent in relation to stillbirth [5] and combined with the 
message from some healthcare providers that the autopsy may not reveal an explanation 
for the cause of death may deter parents who are faced with this difficult decision. 
 
Indigenous women were less likely to have an autopsy, particularly for stillbirths occurring 
at 20-23 weeks and at term. These findings are particularly important as Indigenous 
women have higher rates and risk of stillbirth [4, 223], as well as higher rates of 
unexplained stillbirth [223].  There is very limited research into the views and experiences 
of Indigenous parents and families following stillbirth.  Further research is needed into the 
underlying factors affecting decision making in relation to autopsy consent for Indigenous 
parents and families. 
 
The presence of antepartum haemorrhage was associated with decreased odds of 
consenting to autopsy for stillbirths occurring at 24 weeks gestation or older.  This may 
reflect the ability of clinicians to discern cause of death from comprehensive maternal 
clinical history and evaluation in such instances [124, 313]; and that post mortem 
examination may not necessarily provide much additional information.    
 
We found intrapartum stillbirth was associated with decreased odds of autopsy particularly 
for stillbirths occurring at less than 37 weeks. These findings are supported by a qualitative 
study by Meaney and colleagues which showed that parents were more likely to have an 
autopsy for antepartum stillbirth than intrapartum stillbirth [314]. These findings may reflect 
the importance of having time to separate the autopsy decision from the immediate shock 
of the baby’s death.  Further analysis of these preterm intrapartum stillbirths showed that 
the leading categories of stillbirth based on the PSANZ PDC were: congenital abnormality 
(44.3%), spontaneous preterm (34%) and antepartum haemorrhage (8.0%).  Apart from 
congenital abnormality, classification to the latter two categories depend on information 
from clinical history and placental histopathology [124].   
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The concentration of specialist pathology services within larger urban centres requiring 
transportation of babies to these centres for investigation may explain the decreased 
likelihood of consent for autopsy for women living in remote areas.  Socioeconomic 
disadvantage was associated with decreased likelihood of consent to autopsy for stillbirths 
occurring at 20-23 weeks gestation. The driving factors for these findings are not clear, 
however, it is unlikely to be wholly financial.  Within the public health system, the financial 
cost to the parents and families associated with the autopsy itself or transfer of the baby to 
another facility is minimal [124, 128]. 
 
The presence of congenital abnormality was associated with increased odds of consenting 
to autopsy, particularly in stillbirths occurring around 20-23 weeks gestation and at term 
(≥37 weeks). This finding may reflect the value of autopsy to determine the cause of death 
in stillbirths where the suspected cause of death is congenital abnormality [7, 132].  We 
found increased odds of autopsy associated with small-for-gestational age (SGA) for 
stillbirths occurring at less than 28 weeks.  SGA is a proxy measure for fetal growth 
restriction which is an important risk factor for stillbirth [247]. It is determined from 
biometric measurements at autopsy or antenatal ultrasound evidence of growth restriction 
after excluding infection and congenital abnormality which are associated with SGA [124]. 
Information from autopsy may assist in management of subsequent pregnancies as there 
is evidence of increased risk of SGA recurrence [315]. 
 
This study found primiparity was associated with increased odds of consenting to autopsy 
where stillbirth occurred at 28 weeks gestation or older.  This may reflect parents’ 
concerns or need for reassurance about achieving a successful pregnancy outcome.  
Autopsy results may assist in determining cause of death and inform management of 
future pregnancies.  Contrasting results for maternal age and gestational age group were 
found.  Women aged 19-24 years were more likely to consent to autopsy for stillbirths 
occurring at 28-36 weeks; while women aged 35 years and older were less likely to 
consent to autopsy for stillbirths occurring at less than 24 weeks gestation. The latter 
findings may reflect early fetal deaths with a known or suspected probable cause of death. 
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What parents are saying following a stillbirth 
The qualitative study sought to explore the lived experiences of parents to gain an 
understanding of the autopsy consent process.  Despite only 6 interviews, the qualitative 
findings revealed a continuum of approaches to autopsy decision-making – from the three 
parents whose decision was relatively “easy” because for them autopsy had clear benefits 
including answers for themselves, subsequent pregnancies, and broader science. At the 
other end of the spectrum was the mother who, from the outset, was resolute in her 
decision not to proceed with autopsy to protect her baby from further harm.  For two other 
mothers making a decision about autopsy was less clear cut and followed much 
consideration of potential benefits, harms and reservation.  In one case, the need for an 
explanation (possibly also influenced by the views of her husband) was an overriding 
consideration.  In the second case, the parents declined autopsy for their baby after 
concluding that information gained would be of little use to themselves or broader scientific 
knowledge. 
Acknowledging and understanding the different ways parents may approach the decision-
making process is essential to providing a care environment that addresses parents’ 
concerns and supports them in making an informed decision. 
Regardless of the decision made, all parents acknowledged a number of salient factors 
that influence the decision making process. Our study found that parents took on the role 
of carer and protector for their infant and consequently respect for the infant’s body was an 
important consideration in the decision-making process.  Along a similar vein, Meaney and 
colleagues reported that parents who declined autopsy did so to protect their baby from 
further harm [314]. 
We found for some parents in our study, the need for an explanation was a more 
overriding consideration in their decision for autopsy. The importance for parents of having 
an explanation for what happened to their baby was a finding supported by various studies 
[123, 126, 134, 314]. In our study cohort, some mothers found the cause of death helpful 
in allaying their feelings of guilt, similar to findings reported by Meaney and colleagues 
[314]. Having information on the cause of death was also useful to parents for future 
pregnancies [134].  
An overarching theme from the qualitative analysis was the need for recognition of the 
significance and uniqueness of the death of a baby before birth. This had implications for 
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the various interactions between health care providers and parents during the counselling 
process for autopsy consent. 
 
Implications for clinical practice 
Implications for clinical practice are drawn from the study findings relating to interviews 
with parents.  Many of the implications for clinical practice are supported by the PSANZ 
Clinical Practice Guideline for Perinatal Mortality [124]. 
 
Counselling for autopsy 
Our study showed that parents relied heavily on the opinion of healthcare providers 
regarding the value of an autopsy and other investigations to provide information to 
determine the cause of death.  Studies have shown that the attitude of health care 
providers towards autopsy can influence whether parents are approached regarding 
autopsy and their parent’s ultimate decision regarding consent to autopsy [135, 316]. 
Health care providers should provide objective and realistic estimation of the usefulness of 
autopsy and other post mortem investigations to determine cause of death.  Health care 
providers should balance guidance with parental autonomy and ensure that their own 
values and opinions do not unduly influence parents [317].  In the provision of information, 
both verbal and parent-focussed printed materials are recommended [126, 317].  The re-
iteration of information could help to address parents questions and concerns about the 
autopsy process, what will happen to the baby’s body as well as the how the autopsy 
results will be conveyed. 
 
Conveying autopsy results 
The timeliness and manner of conveying autopsy results was an important aspect of the 
process for parents.  Horey and colleagues propose that autopsy results be conveyed to 
parents in a formal session (ie a designated appointment) in a manner that matches the 
gravity of the situation [318].  This recommendation was also confirmed within our study 
population and demonstrates an appreciation for the importance of the loss of the baby for 
parents.  Our finding that some parents had lengthy wait periods for autopsy results have 
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been confirmed in studies elsewhere [126, 317].  It was suggested that tests for very 
young children could be fast tracked; or at least healthcare providers could provide some 
estimate of the length of the waiting period with periodic communication to provide some 
indication of progress with results.  It was important to parents that their case was not 
forgotten and periodic communication was a suggested means to address this. 
 
Follow up care 
Parents who were planning for a subsequent pregnancy reported high levels of anxiety 
about the recurrence of stillbirth [319]. Parents indicated that they needed additional 
support during the management of the subsequent pregnancy. A recent qualitative meta 
analysis found parents’ need for support did not end immediately and highlighted the 
importance of follow up care [123]. This study also found that there was a gap in the 
provision of emotional support for parents following discharge from hospital, particularly for 
parents living in remote areas.  It is unclear who is best situated and equipped to provide 
such services.  
 
Study Limitations and strengths 
This large population study (quantitative component) is to our knowledge the first study 
exploring quantitatively the association between autopsy and maternal factors within an 
Australian context.  In this study, whether or not autopsy was performed was used as a 
proxy measure to indicate parental consent for autopsy, as consent is required for 
autopsy. However, there may be instances where consent was given but autopsy was not 
performed although we suspect this would have occurred in a very small number of cases 
with minimal effect on the study findings. Furthermore, data was unavailable on the 
proportion of parents who were approached for consent for autopsy. Another limitation of 
the quantitative component was that it was not possible to evaluate the 
comprehensiveness of stillbirth investigations as data was unavailable on the other tests or 
investigations performed. Moreover, a limitation of the qualitative component of this mixed 
methods study was the small number of interviews which did provide valuable insights, 
however, further qualitative interviews with a wider range of participants were needed. 
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7.5 Conclusion 
This study confirms that sociodemographic and pregnancy factors are associated with 
parental consent for autopsy post stillbirth. Of concern was the decreased likelihood of 
consent for autopsy where the stillbirth was initially unexplained on the death certificate.  It 
highlights the importance of ensuring that parents are provided with appropriate 
counselling and information regarding autopsy to ensure they make a fully informed 
decision. There is a need for further studies to explore the factors that drive decision-
making for parents, particularly among subgroups identified as being less likely to consent 
to autopsy, and how these factors can be addressed in order to potentially increase 
autopsy consent rates.  
The in-depth interviews highlight the factors that motivate parents in their decision making 
as well the context within which decisions are made.  The findings add important insights 
into the autopsy consent process for parents within a contemporary Australian setting.  
The findings of this study have direct implications for improving clinical practice including 
providing appropriate information to parents; and the timeliness and manner in which 
autopsy results are delivered to parents.   
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Chapter 8 
Synthesis of studies and findings 
 
This chapter presents a summary of the findings and limitations of the studies described in 
Chapters 3, 4, 5, 6 and 7.  Furthermore, the implications for public health policy are 
considered as well as directions for future research. 
 
8.1 Overview of the findings 
The primary aims of this Thesis were to better describe the epidemiology of stillbirth in an 
Australian context specifically among Aboriginal and Torres Strait Islander (Indigenous) 
and non-Indigenous women; and contribute to improving the quality of data through 
appropriate investigation of stillbirths.  The main objectives addressed were to: 
1. Examine trends in stillbirth by clinical classification of cause of death, Indigenous 
status and gestational age, to identify focal areas for preventive efforts (Chapter 3) 
2. Assess gestational age specific risk of stillbirth associated with four important 
contributors (diabetes, hypertension, antepartum haemorrhage and small-for-
gestational age) to higher stillbirth rates among Indigenous women in order to 
identify periods of increased risk (Chapter 4) 
3. Develop and validate a statistical model to predict the risk of antepartum stillbirth at 
term (≥37 weeks) using maternal and pregnancy factors as a potential decision-
making aid for clinicians and women (Chapter 5) 
4. Assess consistency in application of the Perinatal Society of Australia and New 
Zealand Perinatal Death Classification system between hospital committees and an 
independent expert panel, to identify areas for quality improvement (Chapter 6) 
5. Determine maternal and pregnancy factors associated with parental consent to 
autopsy following stillbirth and explore parents’ views and experiences of the 
autopsy consent process to inform clinical practice (Chapter 7) 
 
The population based Stillbirth trends analysis  (n=881,211 births) presented in Chapter 3 
assessed trends in stillbirth rates by geographic location, gestational age and clinical 
classification of cause of stillbirth to determine whether the gap in stillbirth rates between 
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Indigenous and non-Indigenous women was closing.  Although stillbirth rates among 
Indigenous women were consistently higher than non-Indigenous, the gap had narrowed 
over the period 1995 to 2011.  Indigenous women living in regional and remote areas 
experienced greater reductions in stillbirth rates than their urban counterparts.  There was 
little narrowing of the gap at term gestational ages (37 weeks and older).  The categories 
that contributed to higher overall stillbirth rates among Indigenous women included: 
perinatal infection, preterm birth, hypertension, antepartum haemorrhage, maternal 
conditions (mainly diabetes), fetal growth restriction and unexplained antepartum fetal 
death.  Many of these categories are potentially amenable to intervention in the pre-
pregnancy and antenatal periods using strategies addressing risk factors for adverse 
pregnancy outcomes. 
 
The population based Gestational age specific stillbirth risk analysis (n=360,987 births) 
presented in Chapter 4 advanced the line of enquiry from Chapter 3 and examined 
gestational age-specific risk of stillbirth associated with four conditions [diabetes, 
hypertension, antepartum haemorrhage and small-for-gestational age (SGA) (a proxy for 
fetal growth restriction)] highlighted in the previous study as important contributors to 
increased stillbirth rates among Indigenous women. After stratification by Indigenous 
status and controlling for sociodemographic, pregnancy and medical factors, increased 
risk of stillbirth associated with SGA and antepartum haemorrhage was found at all 
gestational ages assessed.  Diabetes was associated with increased risk of stillbirth during 
late preterm and term gestational ages and results were mixed for hypertensive disorders.  
Indigenous women had around twice the magnitude of stillbirth risk for pre-existing 
diabetes and SGA compared with non-Indigenous women. This study highlighted the 
disparity in stillbirth risk and the need to prioritise early detection and management of 
these conditions. 
 
Expanding on the findings from Chapter 3 and 4 regarding the sharp increase in risk at 
term and the lack of decrease in term stillbirth rates among Indigenous women, Chapter 5 
described a study that aimed to derive and validate a statistical model based on maternal 
clinical factors to predict the risk of antepartum stillbirth at term.  Despite strong 
association between maternal clinical factors and antepartum stillbirth risk, very little of the 
stillbirth risk was explained by the clinical factors in the model. The study findings are 
 
 
214 
 
supported by other reports of poor ability to predict stillbirth risk at term based on maternal 
clinical factors alone [230, 264] suggesting that factors which are predictive of antepartum 
stillbirth at term remain unknown at present. 
 
In Chapter 6, the focus of the Thesis was in exploring the quality of data on clinical causes 
of stillbirth.  The study aimed to assess consistency in application of the PSANZ perinatal 
death classification system between hospital committee and expert panel review of 217 
stillbirth cases in order to identify areas for quality improvement.  A substantial level of 
agreement was found overall; with high level of agreement for the categories of congenital 
abnormalities, spontaneous preterm and hypertension.  There were lower levels of 
agreement for the categories of antepartum haemorrhage and fetal growth restriction 
suggesting that improvements could be made to the category descriptions within the 
perinatal mortality audit guidelines as well as modules within the education program 
focussed on these categories.  
 
Chapter 7 continued the focus on data quality and the possibility of improving stillbirth 
autopsy rates. The study presented in Chapter 7 was a mixed methods study that aimed to 
gain an understanding of parents’ views and experiences of the autopsy consent process 
in order to inform clinical practice.  The quantitative component sought to identify maternal 
and pregnancy characteristics associated with parental consent or non-consent for 
autopsy following stillbirth; while the qualitative component explored parents lived 
experiences of the autopsy consent process. A number of overarching themes emerged 
from the in-depth interviews regarding the context and motivation around decision making 
for parents: 1) a precious and time-limited moment, 2) taking care of the body, 3) the need 
for an explanation, and 4) autopsy consent as a station along the bereavement journey. 
Timeliness and the manner in which autopsy results were communicated to parents was 
an important issue for parents who chose to have an autopsy. 
 
  
 
 
215 
 
8.2 Limitations of the studies and directions for future research 
 
Limitations of routinely collected data 
There were a number of limitations relating to the use of routinely collected data in the 
population based analyses presented in Chapters 3, 4, 5 and 7.  The population based 
studies utilised routinely collected data from the Queensland Perinatal Data Collection 
(QPDC). Data was unavailable for factors such as education level, coffee consumption, 
paternal age, previous small-for-gestational age and previous preterm birth; which have 
been identified by others as associated with increased risk of stillbirth [32]. Furthermore, 
ascertainment of factors such as previous stillbirth, alcohol use and previous caesarean 
section varied during the data collection period or was unreliable. 
Data for body mass index and gestational age at initiation of antenatal care were not 
routinely collected until July 2007 and July 2009, respectively. As a result, the direct effect 
of overweight/obesity and early initiation of antenatal care could not be assessed over the 
duration of the study period. However, in the analyses presented there was adjustment for 
maternal conditions associated with overweight and obesity such as diabetes and 
hypertension; likewise analyses including number of antenatal care visits were adjusted for 
gestational age.  Indices quantifying adequacy of antenatal care (which are derived from 
the number of antenatal care visits and gestational age at initiation of antenatal care) have 
been shown to introduce subtle biases depending on the method of calculation used [320]. 
The analyses presented in Chapters 3, 4 and 5 showed pre-existing diabetes to be a major 
risk factor for stillbirth within the Australian context.  However, data obtained from the 
QPDC was not sufficiently detailed to determine the type of pre-existing diabetes (whether 
Type I or Type II).  Further study could assess whether there was a differential in stillbirth 
risk between Type I and Type II diabetes. 
The QPDC is unique in its combination of population registry information with clinical 
cause of death assigned by a multidisciplinary committee at state level.  However, data 
collection systems were not equipped to capture detailed coding on terminations other 
than for maternal psychosocial reasons.  In Chapter 3, it would have been useful to 
examine trends in terminations for congenital abnormalities or for other medical conditions. 
Ethnicity is a complex construct which is difficult to measure and it is difficult to obtain 
detailed and nuanced data on ethnicity from routinely collected data. At present 
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Indigenous status and country of birth are the only ethnicity-related variables mandatorily 
collected across maternity centres [3].  While the level of accuracy of country of birth data 
in administrative data collections such as hospital admissions is generally high [321], it has 
been suggested that country of birth is not a reliable measure of ethnicity as women 
identify differently across and within country of birth groups [322]. 
Potential underestimation of the proportion of Indigenous women was a possibility if 
women did not identify as Aboriginal and/or Torres Strait Islander during clinical interview.  
Data was not available on the Indigenous status of the father or baby and so our studies 
were unable to identify Indigenous infants born to non-Indigenous mothers. However, 
Queensland birth registration data indicates that 30% of babies registered as Indigenous 
had an Indigenous father and a non-Indigenous mother and analyses of these data 
showed that maternal Indigenous status was a more significant predictor of adverse 
perinatal outcomes than the Indigenous status of the infant [323].  A limitation of the 
population based investigations in this Thesis was that rates and risk of stillbirth for Torres 
Strait Islander women and Aboriginal women were not examined separately as it has been 
suggested that perinatal outcome profiles are different between the two groups of women 
[324, 325].  
A substantial focus within this Thesis was on Aboriginal and Torres Strait Islander 
(Indigenous women) as a subgroup of the Australian population with higher rates and risk 
of stillbirth. However, reports suggest that overseas born women may have slightly higher 
stillbirth rates than Australian born women [3]; particularly women from the Indian 
subcontinent [25]. At present there is limited information about pregnancy outcomes for 
women of migrant or refugee backgrounds [273].  This presents an opportunity for further 
study.  In these groups, it would be important to consider the effects of length of stay in 
Australia, English language skills and acculturation.  
 
Term antepartum stillbirth risk prediction 
It was concluded from Chapter 5 that at present maternal factors explain only a small 
proportion of the risk of antepartum stillbirth risk at term; taken together with reports that 
up to 60% of stillbirths at term are unexplained [131], this is an area for further research.  
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The aetiology of stillbirth is varied, however, placental dysfunction has been suggested an 
important pathway [326] in the development of pre-eclampsia/eclampsia, fetal growth 
restriction and placental abruption [252].  Further research into the aetiology of placental 
dysfunction resulting in fetal death at later gestational ages could be useful in addressing 
the large proportion of term stillbirths with unknown cause of death. 
 
Stillbirth Classification Agreement Study 
This study was nested in the larger Stillbirth Investigation study which was to include all 
level 2 and level 3 hospitals with trained clinicians utilising the Perinatal Mortality Audit 
guidelines.  However, data had been received from a fraction of the participating hospitals.  
It is possible that there may have been “healthy volunteer” bias, whereby hospitals more 
likely to participate are also more likely to follow the guidelines.  This may result in overly 
optimistic estimates of agreement between hospital and expert panel reviews. It was 
difficult to estimate the extent of this bias as the data collection period was ongoing at the 
time of writing this Thesis. 
 
Parental Consent to Stillbirth Autopsy Study 
The quantitative component of the Parental Consent to Stillbirth Autopsy Study identified 
maternal and pregnancy characteristics associated with whether or not stillbirth autopsy 
was performed.  Whether or not autopsy was performed was used as a proxy measure of 
parental consent for autopsy, as consent was required for autopsy.  However, there may 
have been instances where consent was given but autopsy was not performed although 
we suspect this would have occurred in a very small number of cases with minimal effect 
on the study findings. Furthermore, it was unknown what proportion of parents was 
approached for consent for stillbirth autopsy.  Further study is needed into underlying 
factors that influence parent’s decisions, particularly for parents who decline autopsy. 
 
8.3 Public health implications 
The public health implications of the key findings of the studies have been reported in each 
of the respective chapters.  These implications fall into two broad categories, namely those 
relating to provision of primary health care and antenatal care and secondly those relating 
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to improving the quality of data available to inform stillbirth prevention strategies.  Many of 
the implications for antenatal care provision are addressed in the national antenatal care 
guidelines [273]. A number of the implications for improving the quality of data for stillbirth 
prevention can be addressed in future updates to the PSANZ Clinical Practice Guideline 
for Perinatal Mortality [124] and the IMPROVE education program [159].   These 
implications are summarised as follows: 
 
Figure 8.1: Public health implications of key study findings 
Public Health Implications 
Primary care services 
 Improving equity in access to primary 
care services 
 Education of primary care providers 
about assessing women’s risk of 
adverse pregnancy outcomes 
 Management of pre-existing medical 
conditions such as diabetes and 
hypertension before, during and 
between pregnancies 
 Follow up care for women following a 
stillbirth 
 
Antenatal care 
 Improving access to and utilisation of 
antenatal care through: 
o Appropriate and responsive care 
o Embedding cultural competence 
into mainstream services at the 
level of individual healthcare 
providers and at the 
organisational level 
 Provision of high quality antenatal care 
including: 
o Culturally appropriate service 
delivery models 
o Screening for risk factors of 
stillbirth and other adverse 
pregnancy outcomes 
o Diabetes management 
o Smoking cessation 
o Specialist assessment and 
support for substance-dependent 
pregnant women 
o STI screening and treatment 
o Folic acid supplementation 
o Fetal growth monitoring 
 
Improving the quality of data for stillbirth 
prevention 
 Updates to PSANZ Clinical Practice 
Guideline for Perinatal Mortality and its 
associated IMPROVE education 
program 
o Clear descriptions and case study 
examples for the categories of 
Antepartum Haemorrhage and 
Fetal Growth Restriction 
o Information for parents about 
autopsy (brochure) 
Tailoring information about autopsy 
to the needs of parents 
o Information for the health 
professional seeking consent 
(brochure) 
Communication of autopsy results to  
parents in a sensitive and respectful 
manner 
 
 Improving autopsy rates 
o Further research into underlying 
factors driving decision making for 
parents who decline autopsy 
o Interventions to reduce wait times 
for stillbirth autopsy results 
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8.4 Conclusions 
The primary aim of this Thesis was to improve the quality of data on stillbirths to inform 
interventions for prevention.  The research studies within this Thesis confirmed that 
although there was an overall decreasing trend in stillbirth rates among Indigenous 
women, there was disparity in stillbirth risk between Indigenous and non-Indigenous 
women due to potentially preventable conditions. The findings of the population based 
studies highlighted the importance of early detection and management of pre-existing 
conditions prior to, during and between pregnancies. However, it was also found that 
factors predictive of antepartum stillbirth at term remain largely unknown at present. 
In relation to the quality of data on causes and contributing factors for stillbirth, the 
research study found consistent application of the perinatal death classification system 
overall, however, there was scope to improve consistency in the classification to the 
categories of antepartum haemorrhage and fetal growth restriction.  Moreover, the studies 
identified maternal and pregnancy characteristics associated with whether or not stillbirth 
autopsy was performed; furthermore various factors affected parents’ decision making in 
relation to stillbirth autopsy. The findings from in-depth interviews with parents had 
implications for clinical practice including the manner in which autopsy results are 
communicated. 
A number of areas for future research were identified to address study limitations reported 
in this Thesis.  The study findings have the potential to inform interventions to optimise 
women’s health prior to, during and between pregnancies; as well as inform guidelines on 
perinatal mortality audit and the care of bereaved parents.  
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Appendix B 
Presented in this appendix are results relating to Chapter 4.   
 
Appendix B1: Significant interaction terms by Indigenous status  
Interaction terms 
Indigenous 
Hazard Ratio 
(95% CI) 
Non-Indigenous 
Hazard Ratio 
(95% CI) 
Smoking AND Small-for-gestational age 
     Smoking AND small-for-gestational age 
Relative to: No smoking AND No SGA 
 
0.61 (0.30-1.23) 
 
0.59 (0.45-0.77) 
Smoking AND Maternal age 
     Smoking AND 18 or younger 
     Smoking AND 19-24 years 
     Smoking AND 31-34 years 
     Smoking AND 35+ years 
Relative to: No smoking AND 25-30 years 
 
0.31 (0.08-1.26) 
1.15 (0.51-2.63) 
0.49 (0.14-1.70) 
0.32 (0.10-0.97) 
 
0.92 (0.47-1.80) 
0.74 (0.54-1.03) 
0.89 (0.61-1.31) 
1.05 (0.73-1.51) 
Marital status AND Maternal age 
     No partner AND 18 years or younger 
     No partner AND 19-24 years 
     No partner AND 31-34 years 
     No partner AND 35+ years 
Relative to: Domestic partner AND 25-30 years 
 
0.20 (0.05-0.77) 
0.58 (0.28-1.24) 
0.67 (0.18-2.43) 
0.08 (0.01-0.68) 
 
0.76 (0.37-1.54) 
0.71 (0.49-1.02) 
0.88 (0.54-1.44) 
0.97 (0.62-1.52) 
Accommodation AND Socioeconomic status 
     Public status AND Middle ranked 60% 
     Public status AND Lowest ranked 20% 
Relative to: Private status AND Highest ranked 
20% 
 
** 
0.95 (0.35-2.64) 
 
0.81 (0.59-1.13) 
1.27 (0.63-2.55) 
Geographic location AND Socioeconomic status 
     Regional area AND Middle ranked 60% 
     Regional area AND Lowest ranked 20% 
     Remote area AND Middle ranked 60% 
     Remote area AND Lowest ranked 20% 
Relative to: Major cities AND Highest ranked 20% 
 
1.13 (0.11-11.7) 
0.83 (0.08-9.17) 
** 
** 
 
1.12 (0.68-1.85) 
1.22 (0.69-2.15) 
1.68 (0.22-12.58) 
1.85 (0.23-14.98) 
Socioeconomic status AND Maternal age 
     Middle ranked 60% AND 18 or less 
     Middle ranked 60%AND 19-24 years 
     Middle ranked 60% AND 31-34 years 
     Middle ranked 60% AND 35+ years 
     Lowest ranked 20% AND 18 or less 
     Lowest ranked 20% AND 19-24 years 
     Lowest ranked 20% AND 31-34 years 
     Lowest ranked 20% AND 35+ years 
Relative to: Highest ranked 20% AND 25-30 years 
 
0.09 (0.00-1.93) 
** 
0.30 (0.02-5.52) 
0.81 (0.05-13.9) 
0.26 (0.01-4.93) 
** 
0.62 (0.03-11.42) 
0.48 (0.03-9.23) 
 
1.41 (0.33-6.04) 
0.83 (0.52-1.33) 
1.00 (0.67-1.49) 
1.40 (0.92-2.11) 
1.05 (0.22-5.06) 
0.65 (0.36-1.15) 
0.84 (0.47-1.49) 
1.55 (0.89-2.68) 
Bold estimates indicate significant interaction terms     ** unreliable estimates      
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Appendix B2: Univariate assessment of proportionality for conditions of interest 
Conditions 
Indigenous Non-Indigenous 
p value p value 
Antepartum haemorrhage 0.301 0.953 
Essential hypertension 0.709 0.042 
Pre-eclampsia/Eclampsia 0.199 0.030 
Pre-existing diabetes 0.001 <0.001 
Gestational diabetes 0.168 <0.001 
Small for gestational age 0.494 0.045 
Bold estimates indicate violation of proportionality 
 
Appendix B3: Univariate association between maternal and pregnancy factors and 
stillbirth by Indigenous status, Queensland, mid 2005-2011 
Characteristics 
Indigenous Non-Indigenous 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Maternal age (Ref: 25-30 years)   
     18 or younger 0.81 (0.41-1.60) 2.58 (1.88-3.54) 
     19-24 years 0.90 (0.62-1.30) 1.23 (1.07-1.43) 
     31-34 years 0.70 (0.38-1.26) 0.99 (0.85-1.15) 
     35 or older 1.32 (0.79-2.21) 1.29 (1.11-1.49) 
Geographic Location (Ref: Major city)   
     Regional area 1.30 (0.84-2.00) 1.07 (0.96-1.20) 
     Remote area 1.52 (0.93-2.50) 0.90 (0.63-1.30) 
Marital status (Ref: Domestic partner)   
    No domestic partner 1.04 (0.75-1.44) 1.63 (1.41-1.87) 
Relative socioeconomic disadvantage (Ref: Highest 20%)  
     Middle 60% 1.10 (0.41-3.00) 1.12 (0.97-1.31) 
     Lowest 20% 1.12 (0.41-3.08) 1.33 (1.09-1.62) 
Any smoking during pregnancy (Ref: No)   
     Yes 1.48 (1.07-2.06) 1.64 (1.45-1.86) 
Substance Use during pregnancy (Ref: No)  
     Yes 4.80 (2.60-8.86) 2.33 (1.40-3.87) 
Hospital accommodation status (Ref: Private)  
     Public 1.08 (0.35-3.39) 1.63 (1.43-1.85) 
Assisted Conception (Ref: No)   
     Yes 1.45 (0.21-10.6) 1.34 (1.05-1.72) 
Primiparity (Ref: No)   
      Yes 0.92 (0.64-1.33) 0.96 (0.86-1.08) 
Number of antenatal care visits (Ref: 8 or more visits)  
     Less than 2 16.4 (10.4-25.8) 46.9 (38.8-56.7) 
     2 – 4 5.94 (3.83-9.20) 18.3 (16.1-21.0) 
     5 – 7 1.34 (0.78-2.29) 3.81 (3.31-4.39) 
Baby’s gender (Ref: Female)   
     Male 1.33 (0.97-1.82) 1.01 (0.91-1.12) 
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Appendix B4: Univariate association between conditions of interest and stillbirth, by 
Indigenous status 
Characteristics 
Indigenous Non-Indigenous 
Hazard Ratio 
(95% CI) 
Hazard Ratio 
(95% CI) 
Pre-existing diabetes  8.03 (4.44-14.5) 3.63 (2.36-5.59) 
Gestational diabetes 0.41 (0.15-1.10) 0.84 (0.64-1.09) 
Pre-existing hypertension 5.58 (2.61-11.9) 3.84 (2.69-5.48) 
Pre-eclampsia/Eclampsia 1.31 (0.54-3.20) 3.09 (2.45-3.89) 
Antepartum Haemorrhage 22.7 (16.0-32.3) 13.7 (12.1-15.5) 
Small-for-gestational age 3.33 (2.41-4.61) 4.62 (4.12-5.19) 
 
 
Appendix B5: Adjusted hazard ratios for stillbirth by medical condition and 
Indigenous status, Queensland, mid 2005–2011 
Conditions 
Indigenousa Non-Indigenousb 
Adjusted HR 
(95% CI) 
p value Adjusted HR 
(95% CI) 
p value 
Antepartum haemorrhage^ 18.7 (12.9-27.3) <0.001 11.6 (10.2-13.2) <0.001 
Essential hypertension~ 2.82 (1.11-7.19) 0.030 3.67 (2.54-5.31) <0.001 
Pre-eclampsia/Eclampsia 1.35 (0.55-3.34) 0.514 2.67 (2.11-3.39) <0.001 
Pre-existing diabetes^ 7.28 (3.70-14.3) <0.001 4.20 (2.70-6.56) <0.001 
Gestational diabetes^ 0.43 (0.14-1.37) 0.154 1.22 (0.93-1.60) 0.145 
Small-for-gestational age 2.34 (1.65-3.30) <0.001 - - 
     Non-smoker - - 4.61 (4.00-5.30) <0.001 
     Smoker - - 2.68 (2.14-3.37) <0.001 
All models adjusted for maternal age, smoking status, parity, remoteness, substance use, gender, parity, 
hospital accommodation status, assisted conception use, socioeconomic status, marital status, number of 
antenatal care visits.  For Indigenous women, smoking status, number of antenatal care visits and 
prevalence of pre-existing diabetes mellitus varied with gestational age.  For non-Indigenous women, most 
variables in the models varied with gestational age. 
a
Indigenous models include the following interaction terms: smoking*maternal age and marital 
status*maternal age.   
b
 Non-Indigenous models include the following interaction term: smoke*FGR10.  ^These models additionally 
adjusted for pre-existing hypertension.   
^ These models additionally adjusted for pre-existing hypertension.  ~ These models additionally adjusted for 
pre-existing diabetes. 
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Appendix B6: Stillbirth risk for conditions of interest by geographic location, 
Indigenous women, Queensland, mid 2005-2011 
Conditions 
Indigenous 
Major City Regional Remote 
Prev 
(%) 
aHR 
(95% CI) 
Prev 
(%) 
aHR 
(95% CI) 
Prev 
(%) 
aHR 
(95% CI) 
Antepartum haemorrhage^ 2.76 1.00 2.06 1.58 (0.97-2.57) 2.29 1.69 (0.97-2.95) 
Essential hypertension* 0.72 1.00 0.96 1.47 (0.90-2.38) 1.24 1.83 (1.06-3.18) 
Pre-eclampsia/Eclampsia 2.01 1.00 2.73 1.49 (0.92-2.41) 4.06 1.88 (1.08-3.25) 
Pre-existing diabetes^ 0.94 1.00 1.25 1.47 (0.90-2.38) 1.72 1.83 (1.06-3.18) 
Gestational diabetes^ 4.85 1.00 6.54 1.49 (0.92-2.42) 8.27 1.88 (1.08-3.27) 
Small-for-gestational age 13.03 1.00 16.25 1.40 (0.87-2.27) 14.36 1.82 (1.05-3.15) 
Models adjusted for maternal age, smoking status, parity, remoteness, substance use, gender, hospital 
accommodation status, assisted conception use, socioeconomic status, marital status, number of antenatal 
care visits.  ^ These models additionally adjusted for pre-existing hypertension.  * These models additionally 
adjusted for pre-existing diabetes.  
 
Appendix B7: Stillbirth risk for conditions of interest by geographic location, non-
Indigenous women, Queensland, mid 2005-2011 
Conditions 
Non - Indigenous 
Major City Regional Remote 
Prev 
(%) 
aHR 
(95% CI) 
Prev 
(%) 
aHR 
(95% CI) 
Prev 
(%) 
aHR 
(95% CI) 
Antepartum haemorrhage^ 2.96 1.00 2.35 1.14 (1.01-1.28) 2.26 0.87 (0.60-1.27) 
Essential hypertension* 0.62 1.00 0.69 1.11 (0.99-1.25) 0.79 0.88 (0.60-1.29) 
Pre-eclampsia/Eclampsia 1.97 1.00 2.47 1.11 (0.99-1.25) 3.38 0.86 (0.59-1.26) 
Pre-existing diabetes^ 0.49 1.00 0.55 1.11 (0.99-1.25) 0.43 0.88 (0.60-1.29) 
Gestational diabetes^ 5.38 1.00 5.26 1.11 (0.99-1.25) 5.56 0.87 (0.60-1.28) 
Small-for-gestational age 8.30 1.00 8.61 1.10 (0.99-1.25) 7.82 0.89 (0.61-1.30) 
Models adjusted for maternal age, smoking status, parity, remoteness, substance use, gender, hospital 
accommodation status, assisted conception use, socioeconomic status, marital status, number of antenatal 
care visits.  ^ These models additionally adjusted for pre-existing hypertension.  * These models additionally 
adjusted for pre-existing diabetes.  
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Appendix C: Parent Information Sheet - Parental Consent to Stillbirth Autopsy Study 
 
 
 
PARENT INFORMATION SHEET 
 
Information and communication about autopsy following stillbirth: 
Meeting the needs of parents  
 
A Pilot Research Project 
 
 
 
Project Team Contacts: 
 
 Fran Boyle – The University of Queensland, Brisbane.  
Phone: 07 3346 4681, Mobile: 0402 099 556, email: f.boyle@sph.uq.edu.au 
 Vicki Flenady – Mater Medical Research Institute, Brisbane.  
Phone: 07 3163 1592, email: vflenady@mmri.mater.org.au 
 Trish Wilson – Mater Health Services, Brisbane.  
Phone: 07 3163 3467, email: Patricia.Wilson@mater.org.au 
 Paul Gardiner – Mater Medical Research Institute, Brisbane.  
Phone: 07 3163 2119, email: pgardiner@mmri.mater.org.au 
Thank you for thinking about taking part in this study about autopsy consent. We understand that 
this is a very difficult time for you and your family as you grieve the loss of your baby. The 
information you provide may help us to help other families in the future. This sheet explains 
important details about the project and is for you to keep.  
What is the purpose of this project? 
This study is being conducted by The University of Queensland and Mater Medical Research 
Institute. It is supported by Stillbirth and Neonatal Death Support Group (Sands), the Perinatal 
Society of Australia and New Zealand (PSANZ), and the Australian and New Zealand Stillbirth 
Alliance (ANZSA), with funding from the Stillbirth Foundation Australia (SFA). The purpose of the 
study is to learn more about parents’ decisions about autopsy (often referred to as perinatal 
autopsy) and whether parents are satisfied with the information given to them about autopsy. The 
lessons we learn from this pilot study will give us useful information that will help to improve care 
for parents at this difficult time. It will also help us develop a high quality nationwide survey. The 
nationwide survey will help: 
 
 develop appropriate information for parents 
 develop appropriate training for staff 
 increase parent satisfaction with the decision making process.  
 
This study and the planned national study will also explore how decisions about perinatal autopsy 
might be associated with parents’ grief. 
 
In order to achieve our best results we need to hear from parents who have been asked to decide 
about an autopsy for their baby. Even if you don’t think you have much to say, we would still very 
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much like to hear from you. We would like to hear from mothers and fathers. This information sheet 
describes the types of things we would like to learn from you.  
 
What information will be collected and why? 
We need some background information about you and how you felt about your pregnancy. This will 
assist in identifying the specific needs of parents as a result of pregnancy experiences. We also 
want to know about your experience and views of: 
 How the idea of an autopsy was first introduced and discussed 
 How you made your decision about whether to have an autopsy 
 Receiving the autopsy results if you had one performed 
 How you feel about your decision now. 
 
We would also like to know the ways in which your decision about whether or not to consent to an 
autopsy examination might have affected you.  In particular we want to understand its impact on 
the levels of grief in the months after the death of your baby.  
 
Finally, as this is a pilot project we would like your views on the questionnaire. For example, is it 
appropriate and user friendly for parents? 
 
How is the project being done? 
Six hospitals are taking part in the study. We will collect information and feedback from parents 
whose baby was stillborn at any of those hospitals.  
If you do choose to take part in the project you will be asked to complete a questionnaire. It will 
take about 30 minutes to complete. You will also be asked if you might be willing for one of the 
research team members to contact you again at a later time to learn more about your experience. 
The first questionnaire is at about 6-8 weeks after your baby died. You may choose to do this with 
the bereavement midwife at a return hospital visit, or it can be posted to you to complete and mail 
back in your own time.  
If we don’t receive your questionnaire within a couple of weeks, your midwife or another member of 
the research team will contact you by telephone or mail to see if you still want to be part of the 
study. 
For those parents who have agreed, we may contact you again about two months later to ask if 
you would be willing to tell us more about your experience. This would involve a telephone 
interview with a trained interviewer at a time that suits you. 
 
What does the project hope to gain? 
The goal of this project is to improve parents’ satisfaction with the process, information and 
decision-making around autopsy examination consent. There is unlikely to be any direct benefit to 
you but we know from other research that many grieving parents want to give feedback. Many 
people value doing so as they hope it will make a difference for others.  
 
Are there any costs in taking part?  
There are no costs to you or your family to take part in the project.   
 
Will parents receive feedback about the project? 
The results from this pilot study and the national study will be published and widely disseminated. If 
you are interested in the final results of this study and want a summary report to be sent to you, 
please let us know by marking this on the consent form.   
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Are there any risks? 
We are aware that the death of a baby is one of the most difficult times to endure. Our hope is that 
this study will not cause any additional distress to parents who take part.  We are aware that some 
parents may be upset by recounting events around the time that their baby died.  If this occurs and 
you need to talk to someone, please use the contact details on page one for the project team who 
can be contacted during office hours. In addition the Stillbirth and Neonatal Death Support (Sands) 
association and the Sudden Infant Death Syndrome (SIDS) organisation SIDS and KIDS provide 
bereavement support and/or counselling services to any family affected by the sudden or 
unexpected death of their baby. Their contact details are: 
SANDS: 13 000 SANDS (13 000 72637) 
SIDS and KIDS: 1800 628 648 
If any information that we collect indicates that you may be experiencing a form of grief that raises 
concern for your wellbeing or safety, you will be contacted by a bereavement research midwife.  
The midwife will recommend that you consult your GP or seek other appropriate care and support. 
Is participation in the study voluntary? 
You are free to decide whether or not to take part in the study. If you choose to not be involved in 
the project you will not be disadvantaged in any way.  All staff will provide you with the same care 
and support whatever you decide.  
Do you have any questions? 
The project team are available to answer any questions you may have about the project.  Please 
do not hesitate to contact the project team.  Contact details are on the first page of this information 
sheet. 
This project has been approved by the Mater Health Services Human Research Ethics Committee.  
If you have any complaints or concerns about the way the project is being conducted, you may 
contact the Research Ethics Coordinator at the coordinating centre on (07) 3163 1585. The 
Research Ethics Coordinator may decide to contact the Patient Representative or Hospital Ethicist 
at your local hospital if necessary.   
What if I do not want to be in the project? 
You are free to decide whether to participate or not. If you agree to take part you are also free to 
change your mind at any time, and you do not have to give a reason.  We will respect the 
decision as the right one for you.  If you wish to tell us why you have declined or want to withdraw 
during the project we would be grateful but it is not necessary.  This type of information helps us to 
be more sensitive to grieving parents approached to be involved in projects in the future.  Declining 
the project or withdrawing from the project will not affect the care and support you will be given 
during this time. 
 
This study is supported by the Stillbirth Foundation Australia  
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Appendix D: Interview Schedule - Parental Consent to Stillbirth Autopsy Study 
 
 
 
 
Qualitative Telephone Interviews 
 
Information and communication about autopsy following stillbirth: 
Meeting the needs of parents  
 
Draft interview schedule 
 
 
1. Introduction and preamble [standard script to be used by interviewers] 
2. Request for permission to record interview (and reminder that the participant can stop the 
interview at any time) 
3. Preliminary question 
How have things been for you since your baby died? (Ask if it’s okay to call the baby by his/her 
name during the interview) 
4. As you know, we want to find out how we might be able to improve care for parents, 
especially in relation to autopsy. That was probably one of the very difficult decisions you 
had to make … looking back now, can you tell me what it was like making that decision? 
5.  What were some of the things that worried or concerned you most? 
6. Can you think of anything – or anyone – that stands out as being particularly helpful? 
7. Anything that stands out as being particularly unhelpful? 
8. Looking back, can you think of any ways in which things might have been made a little 
easier for you? Are there things that you wish had been done differently? Is there anything 
you might want to say to other parents faced with the death of their baby and the decision 
about autopsy? 
9. Is there anything at all you would like to add? 
10. Thank you for your time and willingness to be involved in this study. 
 
Reminder about available sources of support -- SANDS: 13 000 SANDS (13 000 72637); SIDS and 
KIDS: 1800 628 648  
 
 
258 
 
Appendix E: Paper 1 - Final version of submitted manuscript (Published online 3 
Sep 2014) 
Title Page 
The disparity gap in Indigenous stillbirth in Queensland (Running title) 
 
Full title of the paper 
Stillbirth rates among Indigenous and non-Indigenous women in Queensland, Australia: Is the gap 
closing? 
 
Authors 
Miss Ibinabo Ibiebele 1,2 
A/Prof Michael Coory 3,4 
A/Prof Frances M. Boyle 2,5 
Prof Michael Humphrey 6 
Dr Susan Vlack 2,7 
A/Prof Vicki Flenady 1,5 
 
1 Translating Research Into Practice (TRIP) Centre, Mater Research Institute -University of 
Queensland (MRI-UQ), Brisbane, Australia 
2 School of Population Health, University of Queensland, Brisbane, Australia 
3 Murdoch Childrens Research Institute, Melbourne, Australia 
4 Department of Paediatrics, University of Melbourne, Melbourne, Australia 
5 Australia and New Zealand Stillbirth Alliance, Brisbane, Australia 
6 Queensland Maternal and Perinatal Quality Council, Brisbane, Australia 
7 Queensland Health Metro North Brisbane Public Health Unit, Brisbane, Australia 
 
Name and contact details (address, telephone number and email) of the corresponding author 
Correspondence: Ibinabo Ibiebele, Translating Research Into Practice (TRIP) Centre, Mater 
Research Institute – University of Queensland (MRI-UQ), Level 2 Aubigny Place, Raymond Terrace, 
South Brisbane, Queensland 4101, Australia 
+617 3163 2555  ibinabo.ibiebele@uqconnect.edu.au
 
 
259 
 
 Objective: To determine whether the disparity gap is closing between stillbirth rates for 
Indigenous and non-Indigenous women and to identify focal areas for future prevention efforts 
according to gestational age and geographic location 
Design: Population based retrospective cohort study 
Setting: Queensland, Australia 
Population: All singleton births of at least 20 weeks gestation or at least 400g birthweight 
Methods: Routinely collected data on births were obtained for the period 1995 to 2011.  
Indigenous and non-Indigenous stillbirth rates and percent reduction in the gap were compared 
over time and by geographic location and gestational age. 
Main Outcome Measures: All-cause and cause-specific stillbirth rates (per 1000 ongoing 
pregnancies) 
Results: Over the study period there was a 57.3% reduction in the disparity gap. While marked 
reductions in the gap were shown for women in regional (57.0%) and remote (56.1%) locations, 
these women remain at increased risk compared to those in urban regions. There was no 
reduction for term stillbirths. Major conditions contributing to the disparity were maternal 
conditions (diabetes) (RR 3.78, 95% CI 2.59-5.51), perinatal infection (RR 3.70, 95%CI 2.54-5.39), 
spontaneous preterm (RR 3.08, 95% CI 2.51-3.77), hypertension (RR 2.2, 95% CI 1.45-3.39), fetal 
growth restriction (RR 1.78, 95% CI 1.17-2.71) and antepartum haemorrhage (RR 1.58, 95% CI 
1.13-2.22).  
Conclusions: The gap in stillbirth rates between Indigenous and non-Indigenous women is closing, 
but Indigenous women continue to be at increased risk due to a number of potentially 
preventable conditions. There is little change in the gap at term gestational ages.  
 
Keywords 
Stillbirth; urban; fetal death; trends; cause of death; Aboriginal and Torres Strait Islander; 
Indigenous
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Introduction  
Stillbirth is devastating to families and remains a challenging problem globally, with an estimated 3 
million deaths occurring during the third trimester of pregnancy each year1. Applying the standard 
lower gestational age definition used in many high income countries, the numbers of stillbirths are 
likely to be at least double this estimate2.  Despite significant reductions in stillbirth rates in high 
income countries over the past 50 years,  reduction has slowed in recent times3.  National reports 
from Canada4 and Australia5, 6 indicate that stillbirth rates may be increasing.  In comparison, 
neonatal death rates in many of these countries have continued to decline.  In Australia5 and USA7, 
neonatal death rates declined at a faster pace than stillbirths. Between 1990 and 2000, the fetal 
and neonatal death rates in USA declined by an average of 1.3% and 2.4% per year, respectively7.  
Likewise in Australia during the same period, fetal and neonatal death rates declined by an annual 
average rate of 1.0% and 4.5%, respectively5, 8.  In Queensland during this period, fetal death rates 
increased by 0.14% per year while neonatal death rates decreased by 2.5% per year9. 
 
The need to address existing disparities across different population groups was recently 
highlighted as a priority in high income countries 10.  In Australia and other high income countries, 
marked disparity in stillbirth rates between Indigenous and non-Indigenous populations are 
evident6, 11 6, 11, 12.  A number of factors including physical and social environment, maternal 
behaviour, access to and quality of health care have been suggested as contributing to this 
disparity3, 13.  Geographic location (regional or remote residence) has been identified as an 
important risk factor for stillbirth in the Australian context14, 15.   
 
The study of temporal trends in rates and underlying cause of death is important to gaining an 
understanding of the scope for further reductions in stillbirth rates and to direct further clinical 
and research efforts16, 17.  The objective of this study was to assess the differences in stillbirth rates 
over time among Australian Aboriginal and Torres Strait Islander (Indigenous) and non-Indigenous 
women based on their geographic location and gestational age to determine whether the gap was 
closing. Additionally, this study aimed to assess cause-specific stillbirth rates to determine where 
the greatest disparities lie in order to identify focal areas for preventive efforts. 
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Methods  
Maternal demographic and pregnancy outcome data were obtained from the Queensland 
Perinatal Data Collection (QPDC) for singleton births occurring over the period 1995 to 2011. It is a 
requirement that all births of at least 20 weeks regardless of birthweight, and births of at least 
400g birthweight regardless of gestational age are registered in the QPDC.  During 1995 to 2011, 
881,654 singleton births were registered in Queensland.  Of these, a total of 443 births were 
excluded from the analysis for the following reasons: 148 terminations of pregnancy for maternal 
psychosocial reasons; 270 births with unknown maternal Indigenous status; 25 births occurred at 
less than 20 weeks gestation and were also less than 400g birthweight.   
 
Indigenous status was defined as whether or not the woman identified as Aboriginal and/or Torres 
Strait Islander.  Geographic location was based on postcodes of maternal usual place of residence 
according to the Australian Standard Geographical Classification (ASGC) Remoteness structure18, 
and was categorised as: urban (major cities), regional (inner and outer) and remote (remote and 
very remote). 
 
Causes of death were classified according to the Perinatal Society of Australia and New Zealand 
Perinatal Death Classification (PSANZ-PDC)19.  The classification of cause of death available from 
the QPDC dataset was assigned by a multidisciplinary perinatal mortality review committee as part 
of routine procedure. The overall autopsy rate during the study period was 37.6% (25.4% among 
Indigenous women and 38.9% among non-Indigenous women). Autopsy rates among Indigenous 
women were 28.7%, 27.4% and 18.6% among urban, regional and remote residents; while rates 
among their non-Indigenous counterparts were 40.0%, 36.9% and 42.7%, respectively.  Over the 
study period, there were four predecessors to the current PSANZ-PDC in use. These classification 
systems were mapped to the current PSANZ-PDC19 with minimal adjustment of subcategories to fit 
with the current system.  A full description of the system with instructions for use is available19.  A 
brief description of the intent of the PSANZ-PDC categories is provided in Table S1.   
 
Outcome Measures 
The primary outcome measures were stillbirth rate per 1000 ongoing pregnancies and cause- 
specific stillbirth rate per 1000 ongoing pregnancies by Indigenous status, geographic location and 
gestational age grouping. The gestational age groups used were “<24 weeks”, “24-27 weeks”, “28-
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36 weeks” and “≥37 weeks”.  These groups were chosen to reflect the commencement of active 
clinical management (≥24 weeks), for international comparison (≥28 weeks) and to distinguish 
between preterm and term births (≥37 weeks).  
 
Gestational age specific-stillbirth rate was calculated by dividing the number of stillbirths occurring 
within a specified gestational age window by the number of ongoing pregnancies at the start of 
the gestational age window20.  Cause and gestational age specific stillbirth rate was calculated 
using the number of stillbirths occurring within a specified gestational age window that were 
attributed to a specified cause as the numerator; and the number of ongoing pregnancies at the 
start of the gestational age window as the denominator. 
 
 
Statistical Analyses 
Descriptive statistics were used to characterise the population on a range of maternal 
sociodemographic and pregnancy attributes. All variables measured on a continuous scale were 
classified into categories and Chi square and Fisher’s exact tests were used to assess differences in 
proportions between groups.  Percentage differences in stillbirth rates were assessed in 2-3 year 
groupings and over the whole study period. Non-parametric test of trend was used to assess 
changes in stillbirth rates over the study period.  Relative risk and 95% confidence intervals were 
estimated for cause specific stillbirth rates for Indigenous women compared with non-Indigenous 
women by geographic location and gestational age grouping.  Relative risk and 95% confidence 
intervals for having an autopsy performed following a stillbirth were also estimated for Indigenous 
women compared with non-Indigenous women. Data analysis was undertaken using Stata 11.2 
(StataCorp LP 2009, Texas, USA). 
 
 
Results  
A total of 881,211 births (including 5425 stillbirths) were included in these analyses.  Of these, 
49,450 births (5.6%) were to Indigenous women and 831,761 births (94.4%) were to non-
Indigenous women.  The characteristics of the cohort are summarised in Table 1. During the study 
period, there were increases in the proportion of women birthing at 35 years or older among 
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Indigenous (5.5% to 10.1%, ptrend<0.001) and non-Indigenous women (12.9% to 20.4%, 
ptrend<0.001). 
 
Temporal trends in stillbirth rates by Indigenous status and geographic location 
Over the period 1995 to 2011, the stillbirth rate for all women birthing in Queensland was steady 
around 6.2/1000 ongoing pregnancies.  Trends in stillbirth rates by Indigenous status and 
geographic location are shown in Figure 1.  Indigenous stillbirth rates decreased 31.9% from 13.3 
to 9.1/1000 ongoing pregnancies (ptrend=0.014); while stillbirth rates among non-Indigenous 
women was steady around 5.9/1000 ongoing pregnancies. The difference in overall stillbirth rates 
between Indigenous and non-Indigenous women reduced by 57.3% from 7.5 to 3.2/1000 ongoing 
pregnancies over this period (Figure 1).  
 
Stillbirth rates among Indigenous women decreased by 10.2%, 29.2% and 49.9% for women living 
in urban, regional and remote areas, respectively.  In contrast, stillbirth rates among non-
Indigenous women increased by 0.9% and 11.4% for women living in urban and regional areas and 
decreased by 39.2% among non-Indigenous women living in remote areas (Figure 1).  The 
difference in stillbirth rates between Indigenous and non-Indigenous women decreased by 25.7%, 
57.0% and 56.1% for urban, regional and remote areas, respectively.   
 
Temporal trends in stillbirth rates by Indigenous status and gestational age 
Stillbirth rates were higher among Indigenous women for all gestational age groups assessed 
(Figure 2).  Among Indigenous women, stillbirth rates decreased by 9.5%, 29.3%, 69.1% and 7.1% 
for births at <24 weeks, 24-27 weeks, 28-36 weeks and ≥37 weeks, respectively.  Among non-
Indigenous women, there was a 36.3% increase in stillbirth rates at <24 weeks and decreases in 
the remaining groups of 9.0%, 12.4% and 21.7%, respectively (Figure 2). The difference in stillbirth 
rates reduced between Indigenous and non-Indigenous women birthing at all gestational age 
groups except ≥37 weeks, where the difference increased by 18.0%. Between 2001 and 2011, the 
gap was steady around 1.2/1000 ongoing pregnancies (Figure 2).  
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Temporal trends in cause-specific stillbirth rates by Indigenous status 
Among Indigenous women, decreasing rates of stillbirth due to perinatal infection (ptrend<0.001) 
and conversely, increasing rates of stillbirth due to fetal growth restriction (ptrend=0.040) were 
shown over the study period. (Table S2).  Among non-Indigenous women, significant increases in 
the rates of stillbirth due to congenital abnormality (ptrend<0.001) and spontaneous preterm birth 
(ptrend=0.013) were shown concurrent with decreases in the rates of stillbirth due to hypertension 
(ptrend<0.001), antepartum haemorrhage (ptrend<0.001), perinatal infection (ptrend=0.029), maternal 
conditions (ptrend=0.044) and unexplained antepartum fetal death (ptrend=0.011) (Table S3).  The 
increases in rates of congenital abnormality among non-Indigenous women may be due to higher 
proportions of older mothers among this population. Presented in Table S4 are trends in cause-
specific relative risk for Indigenous women relative to non-Indigenous women. 
 
Comparison of cause-specific stillbirth rates 
The overall stillbirth rate for the 17 year study period among Indigenous women was higher than 
for non-Indigenous women (RR 1.81, 95%CI 1.66-1.98)(Table 2).  The major PSANZ-PDC categories 
contributing to the disparity were: maternal conditions, perinatal infection, no obstetric 
antecedent, spontaneous preterm, hypertension, fetal growth restriction, unexplained 
antepartum fetal death and antepartum haemorrhage (Table 2). 
 
Overall, Indigenous women had a nearly four-fold increased risk of stillbirth due to maternal 
conditions (RR 3.78, 95%CI 2.59-5.51) and perinatal infection (RR 3.70, 95% CI 2.54-5.39).  Pre-
existing and gestational diabetes constituted a large component (42.2%) of maternal conditions; 
and Indigenous women had over a six-fold increased risk of stillbirth due to diabetes (RR 6.42, 95% 
3.89-10.62).  Perinatal infections were comprised of bacterial infections (53.0%), viral and other 
(fungal and protozoal) infections. While numbers were small, there was a significantly increased 
risk of stillbirth due to syphilis infection among Indigenous women (Table 2).   
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More than half (56.0% Indigenous and 56.3% non-Indigenous) of all stillbirths assigned to the 
category of spontaneous preterm had evidence of chorioamnionitis on placental histopathology 
and a further 7.6% (6.7% Indigenous and 7.8% non-Indigenous) had clinical chorioamnionitis (i.e. 
without placental confirmation).  Indigenous women had a three-fold increased risk of stillbirth 
due to spontaneous preterm birth (RR 3.08, 95% CI 2.51-3.77).  
 
The majority of stillbirths (65.5%) attributed to hypertension were due to pre-eclampsia with or 
without superimposed chronic hypertension.  The risk of stillbirth due to hypertension was 
significantly higher for Indigenous compared to non-Indigenous women (RR 2.22, 95% CI 1.45-
3.39). Indigenous women had an increased risk of stillbirth due to fetal growth restriction (RR 1.78, 
95% CI 1.17-2.71) and antepartum haemorrhage (RR 1.58, 95% CI 1.13-2.22). Placental abruption 
accounted for 86.0% of all stillbirths attributed to antepartum haemorrhage. 
 
The risk of unexplained antepartum fetal death was higher for Indigenous women (RR 1.61, 95% CI 
1.37-1.90), further, there were 69 stillbirths classified as having no obstetric antecedent identified 
and births to Indigenous women were over-represented within this category (RR 3.19, 95% CI 
1.67-6.08). 
 
No increased risk of stillbirth was evident for the main categories of congenital abnormality, 
hypoxic peripartum death or stillbirth due to specific perinatal conditions (including antenatal cord 
complication and feto-maternal haemorrhage) among Indigenous women compared with non-
Indigenous women (Table 2). However, within subgroups an increased risk of stillbirth due to 
central nervous system (CNS) abnormality (RR 1.84, 95% CI 1.27-2.66) and uterine abnormalities 
(including cervical incompetence) (RR 2.59, 95% CI 1.10-6.11) was observed. 
 
Cause-specific stillbirth rates by geographic location  
In urban areas, Indigenous women had increased risk of stillbirth due to perinatal infection and 
spontaneous preterm; while Indigenous women living in remote areas had increased risk of 
stillbirth due to central nervous system abnormality (RR 3.38, 95% CI 1.31-8.72), maternal 
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conditions, spontaneous preterm birth and unexplained antepartum fetal death.  Indigenous 
women living in regional areas had increased risk of stillbirth due to perinatal infection 
[particularly syphilis and non GBS bacterial infection], hypertension including gestational 
hypertension and pre-eclampsia with or without chronic hypertension (RR 2.26, 95% CI 1.14-4.48), 
maternal conditions including diabetes (RR 6.38, 95% CI 3.12-13.05), fetal growth restriction, 
spontaneous preterm and unexplained antepartum fetal death (Table 3, subcategory data not 
shown). 
 
Cause-specific stillbirth rates by gestational age   
No change was shown in all-cause stillbirth risk for Indigenous women as gestational age 
increased.  However, Indigenous women had increased risk of stillbirth due to perinatal infection 
and spontaneous preterm at all gestational ages assessed (Table 4).  
 
Discussion 
Main Findings  
We found that although Indigenous stillbirth rates were consistently higher than non-Indigenous 
rates, the gap had narrowed.  These findings mirror national reports of declining Australian 
Indigenous stillbirth rates over the period 1991-200421 and US reports among American Indian and 
Alaskan Native women  (7.5 to 6.2/1000 births between 1990 and 2005)22.  Our study found that 
Indigenous women living in regional and remote areas experienced greater reductions in stillbirth 
rates than their urban counterparts. 
 
There was little narrowing of the stillbirth rate gap at gestational ages of 37 weeks or more largely 
due to preventable conditions of diabetes, infection and fetal growth restriction.  These findings 
highlight the opportunity for further reductions in term stillbirths among the Indigenous 
population.   
Overall, we found an increased risk of stillbirth due to maternal conditions, perinatal infection, 
spontaneous preterm birth, hypertension, fetal growth restriction, antepartum haemorrhage and 
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unexplained antepartum fetal death among Indigenous women compared with non-Indigenous 
women.  Most of these categories of stillbirth are potentially amenable to interventions in the pre-
pregnancy and antenatal periods3.  Similar findings were reported among Inuit and First Nation 
women in Canada, where excess stillbirths compared with non-Aboriginal women were attributed 
to fetal growth restriction, placental disorders and congenital anomalies among Inuit women and 
diabetes and hypertension among First Nation women11.  In New Zealand, Māori women had 
increased risk for all PSANZ-PDC categories compared with New Zealand European women except 
hypoxic peripartum death and specific perinatal conditions, although the differences were not 
statistically significant23.  
 
Strengths and Limitations 
Consistent allocation of cause of death to a large population based vital registry by a 
multidisciplinary expert panel using clinical practice guidelines is a major strength of this study. 
One limitation is the possible underestimation of the proportion of Indigenous women which 
could be the case if Indigenous women did not identify themselves at clinical interview. This may 
have resulted in an underestimation of the disparity gap in stillbirth rates between Indigenous and 
non-Indigenous women.  Secondly, stillbirth rates for Torres Strait Islander women and Aboriginal 
women were not examined separately as reports suggest that perinatal outcome profiles are 
different between the two groups24, 25. Thirdly, trends in terminations of pregnancy for reasons 
other than maternal psychosocial reasons could not be assessed, as they were not routinely 
collected in the QPDC. Therefore, disparity in cause-specific stillbirth rates may be underestimated 
if there are lower rates of terminations among Indigenous women.  Lastly, the autopsy rate from 
our study was low and data were unavailable on the rates of other stillbirth investigations 
undertaken, including placental pathology investigation an important investigation for 
determining cause of death3. Therefore, misclassification of cause of death as a result of 
suboptimal investigations cannot be ruled out. Furthermore, it is possible that increased rates of 
unexplained antepartum fetal death and stillbirths with no obstetric antecedent observed among 
Indigenous women may reflect differing autopsy rates.   
 
Interpretation of findings 
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Antenatal Care 
Differentials in the rates of attendance and early initiation of antenatal care have been reported 
between Indigenous and non-Indigenous women6.  In addition, significant variation in the quality 
of antenatal care received by Indigenous women has been reported including low rates of 
morphology ultrasound and screening for gestational diabetes and infection26.  Service delivery 
models incorporating community-based or controlled services, respect for Indigenous people and 
culture, continuity of care, integrated spectrum of services, and consideration of logistic issues 
have been shown to be successful in improving maternal and child health outcomes for women in 
Indigenous communities27. 
 
Maternal smoking 
Smoking during pregnancy is an important modifiable risk factor for Indigenous women requiring 
urgent attention through effective policy and guidelines for smoking cessation interventions 
tailored and targeted to Indigenous women. Smoking rates among Indigenous women in our study 
(53.0%) were over 3 times that of non-Indigenous women;  similar to national rates (50.0% versus 
11.7% in 2011)6 . The population attributable risk for stillbirth has been estimated at 6.2%2.  
Furthermore, smoking quit rates during pregnancy among Indigenous women are lower than for 
non-Indigenous women6.  While there is evidence to show that psychosocial interventions can 
increase smoking cessation rates in late pregnancy and decrease rates of preterm birth and low 
birthweight28 overall, little research has focussed on interventions specific to Indigenous women. 
The role of nicotine replacement therapy in pregnancy is unclear, but may hold some promise29.  
 
Diabetes 
There was a six-fold increased risk of stillbirth due to diabetes among Indigenous mothers.  These 
findings are consistent with national reports that Indigenous women have disproportionally higher 
rates of pre-existing and gestational diabetes in pregnancy than non-Indigenous women30.  At 
present there is little evidence for or against pre-conception care for women with pre-existing 
diabetes31, although lower rates of congenital abnormalities have been reported among women 
with Type 1 diabetes receiving pre-conception care compared to those who did not32.  Likewise, 
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lifestyle modifications in combination with insulin were found to improve birth outcomes for 
women with mild gestational diabetes33.  However, interventions to prevent or manage diabetes 
have not had the same magnitude of impact within the Indigenous population and not enough 
clinical focus on women at risk or women with diabetes has been given as a possible explanation 
for this27.   
 
Congenital abnormalities 
Our study suggested an increased risk of stillbirth due to CNS abnormalities among Indigenous 
women, especially those living in remote areas.  These findings are supported by national reports 
of higher rates of neural tube defects (NTDs), the most common CNS abnormalities, among 
Indigenous women and women living in remote areas34. The association between folate and 
reduced risk of NTDs has been well established.  Lifestyle factors such as low fruit and vegetable 
intake, smoking and high levels of alcohol consumption have been associated with folate 
deficiency35.  Peri-conceptual folic acid supplementation, smoking cessation and avoidance of 
alcohol consumption during pregnancy are recommended as part of antenatal care practices36.  
 
Perinatal Infection 
The results indicate a disproportionately high burden of stillbirth due to perinatal infection among 
Indigenous women. This finding is somewhat consistent with several studies that found high rates 
of sexually transmitted infections (STIs) among Indigenous women of reproductive age living in 
rural communities37, 38 and pregnant Indigenous women living in urban areas39.  Early diagnosis 
and treatment of syphilis has been shown to be associated with similar risk of stillbirth as the 
general uninfected population40.  A number of programs which demonstrated sustained 
reductions in rates of STIs in Aboriginal and Torres Strait Islander communities have highlighted 
the need for STI screening to be incorporated into antenatal care protocols for Indigenous 
women27. 
 
Preterm birth 
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Spontaneous preterm labour and birth is linked with socioeconomic disadvantage, infection, 
chronic diseases (diabetes and hypertension), genetic influence; however many are idiopathic 41. 
We found higher rates of preterm birth overall and higher risk of stillbirth following idiopathic 
spontaneous onset of preterm labour among Indigenous compared with non-Indigenous women.    
Evidence for strategies to reduce preterm birth is limited and a better understanding of the 
mechanisms and causes of preterm to enable focused intervention studies is required41, 42 . 
 
 
Conclusion 
The gap in stillbirth rates between Indigenous and non-Indigenous women is narrowing, but 
Indigenous women continue to be at increased risk of stillbirth due to a number of potentially 
preventable causes.  There has been little reduction in the gap between Indigenous and non-
Indigenous women in relation to term stillbirth rates and this presents an area of focus for further 
preventive efforts.  At term, Indigenous women had increased risk of stillbirth due to maternal 
conditions (mainly diabetes), perinatal infection, fetal growth restriction and unexplained 
antepartum fetal death.  High quality antenatal care at all levels using culturally appropriate 
service delivery models which incorporate diabetes management, smoking cessation, STI 
screening and treatment, folic acid and fetal growth monitoring hold some promise of helping to 
improve pregnancy outcomes for Indigenous women.  
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Table 1: Comparison of sociodemographic characteristics of Indigenous versus non-Indigenous 
mothers and babies, Queensland, 1995-2011 
Characteristics 
Indigenous 
n(%) 
Non-Indigenous 
n(%) 
 
All births 49 450 (5.6) 831 761 (94.4)  
Maternal age (years) 
     ≤ 20 12 888 (26.1) 66 171 (8.0)  
     21-34 32 577 (65.9) 623 301 (74.9)  
     ≥ 35 3 985 (8.1) 142 289 (17.1)  
Primiparous 
     Yes 11 624 (23.5) 250 877 (30.2)  
Baby sex^ 
     Male 25 548 (51.7) 428 092 (51.5)  
Gestational age at birth (weeks) 
     <24 weeks 355 (0.7) 2 646 (0.3)  
     24-27 weeks 386 (0.8) 2 701 (0.3)  
     28-36 weeks 4 913 (9.9) 48 605 (5.8)  
     37-41 weeks 43 044 (87.1) 767 101 (92.2)  
     42+ weeks 723 (1.5) 10 654 (1.3)  
Birthweight     
     Less than 10th centile~ 7 995 (16.2) 76 024 (9.1)  
Index of relative socioeconomic disadvantage* 
     Highest 20% 1 110 (2.3) 110 013 (13.3)  
     Middle 60% 28 727 (58.4) 585 074 (70.6)  
     Lowest 20% 19 340 (39.3) 133 460 (16.1)  
Accommodation status 
     Private 1 127 (2.3) 255 685 (30.7)  
     Public 48 322 (97.7) 576 056 (69.3)  
Smoker^^ 
     Yes 11 140 (53.0) 59 680 (16.8)  
Substance Use 
     Yes 785 (1.6) 4 514 (0.5)  
Pregnancy complications** 
     Yes 19 903 (61.6) 344 075 (63.4)  
Remoteness 
     Urban 10 281 (20.8) 503 085 (60.5)  
     Regional 28 820 (58.3) 306 402 (36.8)  
     Remote 10 347 (20.9) 22 255 (2.7)  
Stillbirth    
     Yes 527 (1.1) 4 898 (0.6)  
^Data was missing for 4 births and sex was indeterminate for 108 births (97 non-Indigenous and 11 Indigenous).  
~Australian population birthweight centile.  *Index of relative socioeconomic disadvantage was based on postcode of 
maternal place of residence.   ^^Data on smoking was collected from July 2005, smoking status was unknown for 504 
307 births (28 404 Indigenous and 475 903 non-Indigenous births).  **pregnancy complication data consistently 
collected from July 2001    
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Figure 1: Stillbirth rates by Indigenous status and geographic location, singleton births, 
Queensland, 1995-2011 
 
 
 
Figure 2: Stillbirth rates by Indigenous status and gestational age grouping, singleton births, 
Queensland, 1995-2011 
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Table 2: Comparison of cause specific stillbirth rates by Indigenous status, singleton births, 
Queensland, 1995-2011 
PSANZ Perinatal Death Classification 
Category 
Indigenous Non-Indigenous Total 
(n=49,450) (n=831,761) (n=881,211) 
n rate n rate n Rate RR 
All cause* 527 10.7 4898 5.9 5425 6.2 1.81 (1.66-1.98) 
Congenital Abnormality 75 1.5 1138 1.4 1213 1.4 1.11 (0.88-1.40) 
   Central nervous system 31 0.6 284 0.3 315 0.4 1.84 (1.27-2.66) 
   Cardiovascular system 5 0.1 122 0.1 127 0.1 0.69 (0.28-1.69) 
   Chromosomal 13 0.3 352 0.4 365 0.4 0.62 (0.36-1.08) 
   Multiple 13 0.3 161 0.2 174 0.2 1.36 (0.77-2.39) 
   Other 13 0.3 219 0.3 232 0.3 1.00 (0.57-1.75) 
Perinatal Infection 33 0.7 150 0.2 183 0.2 3.70 (2.54-5.39) 
   GBS 3 0.1 30 0.0 33 0.0 1.68 (0.51-5.51) 
   Syphilis 15 0.3 1 0.0 16 0.0 252 (33-1910) 
   Other bacterial 7 0.1 41 0.0 48 0.1 2.87 (1.29-6.40) 
   Viral 1 0.0 43 0.1 44 0.0 0.39 (0.05-2.84) 
   Fungal/Protozoal/other 7 0.1 35 0.0 42 0.0 3.36 (1.49-7.57) 
Hypertension 24 0.5 182 0.2 206 0.2 2.22 (1.45-3.39) 
   Pre-existing 9 0.2 53 0.1 62 0.1 2.86 (1.41-5.79) 
   Pregnancy induced/Pre-eclampsia 14 0.3 127 0.2 141 0.2 1.85 (1.07-3.22) 
   Unspecified 1 0.0 2 0.0 3 0.0 8.41 (0.76-92.7) 
Antepartum Haemorrhage 37 0.7 393 0.5 430 0.5 1.58 (1.13-2.22) 
   Abruption 31 0.6 339 0.4 370 0.4 1.54 (1.06-2.22) 
   Other 6 0.1 54 0.1 60 0.1 1.87 (0.80-4.34) 
Maternal conditions 33 0.7 147 0.2 180 0.2 3.78 (2.59-5.51) 
   Diabetes 21 0.4 55 0.1 76 0.1 6.42 (3.88-10.62) 
   Autoimmune (lupus) 3 0.1 7 0.0 10 0.0 7.21 (1.86-27.9) 
   Other 9 0.2 85 0.1 94 0.1 1.78 (0.90-3.54) 
Specific Perinatal conditions 16 0.3 261 0.3 277 0.3 1.03 (0.62-1.71) 
   Fetomaternal haemorrhage 4 0.1 49 0.1 53 0.1 1.37 (0.50-3.80) 
   Antenatal cord complication 3 0.1 83 0.1 86 0.1 0.61 (0.19-1.92) 
   Uterine abnormalities 6 0.1 39 0.0 45 0.1 2.59 (1.10-6.11) 
   Other 3 0.1 90 0.1 93 0.1 0.56 (0.18-1.77) 
Hypoxic peripartum death 6 0.1 103 0.1 109 0.1 0.98 (0.43-2.23) 
   With intrapartum complications 2 0.0 49 0.1 51 0.1 0.69 (0.17-2.82) 
   No/Unspecified intrapartum complications 4 0.1 54 0.1 58 0.1 1.25 (0.45-3.44) 
Fetal growth restriction 24 0.5 227 0.3 251 0.3 1.78 (1.17-2.71) 
   Reduced vascular perfusion 13 0.3 128 0.2 141 0.2 1.71 (0.97-3.02) 
   Other 11 0.2 99 0.1 110 0.1 1.87 (1.00-3.48) 
Spontaneous preterm 110 2.2 601 0.7 711 0.8 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 157 3.2 1638 2.0 1795 2.0 1.61 (1.37-1.90) 
No obstetric antecedent 11 0.2 58 0.1 69 0.1 3.19 (1.67-6.08) 
* Clinical classification data missing for 1 stillbirth (Indigenous).  “Other” category consists of combinations of subcategories. 
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Table 3: Relative risk of stillbirth for Indigenous versus non-Indigenous women by geographic location, Queensland, 1995-2011 
PSANZ Perinatal Death Classification Category 
Relative Risk 
Indigenous versus Non Indigenous 
Urban Regional Remote Total 
Congenital abnormality 1.02 (0.60-1.73) 1.06 (0.78-1.45) 1.11 (0.63-1.95) 1.11 (0.88-1.40) 
Perinatal Infection 3.09 (1.35-7.05) 3.67 (2.18-6.19) - 3.70 (2.54-5.39) 
Hypertension 0.81 (0.20-3.27) 3.17 (1.85-5.45) 2.69 (0.72-10.01) 2.22 (1.45-3.39) 
Antepartum haemorrhage 1.75 (0.82-3.71) 1.31 (0.85-2.03) 1.37 (0.53-3.52) 1.58 (1.13-2.22) 
Maternal conditions 2.15 (0.79-5.85) 4.38 (2.63-7.28) 3.44 (1.13-10.52) 3.78 (2.59-5.51) 
Specific perinatal conditions 0.63 (0.16-2.53) 0.87 (0.42-1.78) 1.84 (0.62-5.48) 1.03 (0.62-1.71) 
Hypoxic peripartum death 0.78 (0.11-5.60) 1.22 (0.43-3.42) 0.43 (0.05-3.68) 0.98 (0.43-2.23) 
Fetal growth restriction 1.31 (0.49-3.55) 2.70 (1.61-4.52) 0.61 (0.13-2.96) 1.78 (1.17-2.71) 
Spontaneous preterm 2.45 (1.54-3.88) 2.99 (2.24-3.99) 6.26 (3.16-12.41) 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 1.39 (0.95-2.03) 1.50 (1.20-1.86) 2.64 (1.64-4.23) 1.61 (1.37-1.90) 
No obstetric antecedent 1.69 (0.23-12.39) 2.28 (0.94-5.50) 8.60 (0.96-76.96) 3.19 (1.67-6.08) 
All cause 1.47 (1.18-1.81) 1.76 (1.56-1.98) 2.37 (1.84-3.04) 1.81 (1.66-1.98) 
Autopsy rate (Indigenous,  Non-Indigenous) 
Relative Risk (95% CI) 
28.7%, 40.0% 
0.72 (0.51-1.00) 
27.4%, 36.9% 
0.74 (0.61-0.90) 
18.6%, 42.7% 
0.44 (0.29-0.66) 
25.5%, 38.9% 
0.65 (0.56-0.76) 
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Table 4: Causes specific relative risk of stillbirth, Indigenous versus non-Indigenous mothers by gestational age grouping, Queensland, 1995-
2011 
PSANZ Perinatal Death Classification Category 
Relative Risk (95% CI) 
Indigenous versus Non Indigenous 
< 24 weeks 24 - 27 weeks 28 – 36 weeks ≥ 37 weeks Total 
Congenital abnormality 1.03 (0.77-1.38) 0.99 (0.46-2.13) 1.63 (1.00-2.64) 0.85 (0.27-2.69) 1.11 (0.88-1.40) 
Perinatal Infection 2.63 (1.35-5.12) 4.22 (1.85-9.67) 6.79 (3.26-14.14) 3.23 (1.35-7.71) 3.70 (2.54-5.40) 
Hypertension 2.99 (1.41-6.35) 2.41 (1.09-5.33) 1.67 (0.77-3.64) 1.05 (0.14-7.85) 2.22 (1.45-3.40) 
Antepartum haemorrhage 2.24 (1.33-3.78) 1.88 (0.81-4.36) 0.88 (0.43-1.79) 1.64 (0.71-3.79) 1.58 (1.13-2.22) 
Maternal conditions 5.89 (2.49-13.93) 1.69 (0.52-5.54) 2.83 (1.40-5.73) 5.79 (3.17-10.57) 3.78 (2.59-5.51) 
Specific perinatal conditions 1.55 (0.71-3.36) - 2.06 (0.99-4.29) 0.21 (0.03-1.54) 1.03 (0.62-1.71) 
Hypoxic peripartum death - - 1.13 (0.15-8.57) 1.08 (0.44-2.67) 0.98 (0.43-2.23) 
Fetal growth restriction - 1.69 (0.60-4.72) 2.12 (1.13-3.97) 2.86 (1.41-5.77) 1.78 (1.17-2.71) 
Spontaneous preterm 3.01 (2.40-3.79) 3.26 (1.94-5.49) 3.40 (1.41-8.16) - 3.08 (2.51-3.77) 
Unexplained antepartum fetal death 1.53 (0.98-2.39) 1.81 (1.19-2.76) 1.63 (1.23-2.16) 1.67 (1.28-2.17) 1.61 (1.37-1.90) 
No obstetric antecedent 4.39 (1.79-10.78) - 6.17 (1.97-19.39) 1.11 (0.15-8.37) 3.19 (1.68-6.08) 
All cause 1.87 (1.62-2.16) 1.87 (1.47-2.37) 1.83 (1.53-2.18) 1.71 (1.40-2.09) 1.81 (1.65-1.98) 
Autopsy rates (Indigenous, Non-Indigenous) 
Relative Risk (95% CI) 
19.71%, 31.07% 
0.63 (0.48-0.84) 
22.67%, 42.71% 
0.53 (0.35-0.81) 
31.34%, 43.09% 
0.73 (0.56-0.94) 
30.19%, 45.05% 
0.67 (0.50-0.90) 
25.48%, 38.87% 
0.66 (0.56-0.76) 
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Abstract 
Background 
In Australia, significant disparity persists in stillbirth rates between Aboriginal and Torres Strait 
Islander (Indigenous Australian) and non-Indigenous women.  Diabetes, hypertension, antepartum 
haemorrhage and small-for-gestational age (SGA) have been identified as important contributors 
to higher rates among Indigenous women.  The objective of this study was to examine gestational 
age specific risk of stillbirth associated with these conditions among Indigenous and non-
Indigenous women. 
 
Methods 
Retrospective population-based study of all singleton births of at least 20 weeks gestation or at 
least 400 grams birthweight in Queensland between July 2005 and December 2011 using data 
from the Queensland Perinatal Data Collection, which is a routinely-maintained database that 
collects data on all births in Queensland.  Multivariate logistic regression was used to calculate 
adjusted odds ratios (aOR) and 95% confidence intervals, adjusting for maternal demographic and 
pregnancy factors. 
 
Results 
Of 360987 births analysed, 20273 (5.6%) were to Indigenous women and 340714 (94.4%) were to 
non-Indigenous women. Stillbirth rates were 7.9 (95% CI 6.8-9.2) and 4.1 (95% CI 3.9-4.3) per 1000 
births, respectively.  For both Indigenous and non-Indigenous women across most gestational age 
groups, antepartum haemorrhage, SGA, pre-existing diabetes and pre-existing hypertension were 
associated with increased risk of stillbirth.  There were mixed results for pre-eclampsia and 
eclampsia and a consistently raised risk of stillbirth was not seen for gestational diabetes. 
 
Conclusion 
This study highlights gestational age specific stillbirth risk for Indigenous and non-Indigenous 
women; and disparity in risk at term gestations.  Improving access to and utilisation of appropriate 
and responsive healthcare may help to address disparities in stillbirth risk for Indigenous women. 
 
Keywords: 
Aboriginal and Torres Strait Islander Australians, Indigenous, fetal death, stillbirth, risk, diabetes, 
hypertension, antepartum haemorrhage, small for gestational age 
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Background 
Stillbirth rates in Australia have failed to improve over the past two decades.  Marked disparity in 
stillbirth rates persist between Aboriginal and Torres Strait Islander (Indigenous Australian) and 
non-Indigenous women [1-3]. In 2012, national stillbirth rates among Indigenous women were one 
and a half times higher (10.8 vs 7.1/1000) than among non-Indigenous women [2]. Moreover, this 
disparity persists in the rate of term stillbirths (RR 1.71, 95% CI 1.40-2.09) with little change over 
time [1]. 
Diabetes, hypertension, antepartum haemorrhage and small-for-gestational age are important 
contributors to the higher stillbirth rates observed among Indigenous women [1].  In Queensland, 
pre-existing and gestational diabetes affected approximately 0.6% and 6.7% of pregnancies [2]; 
while Australian national estimates are 0.6% and 4.7%, respectively [4]. There is evidence of 
increasing prevalence of pre-existing and gestational diabetes within Queensland[2, 5]; with 
consistently higher rates of diabetes for Indigenous women compared with non-Indigenous 
women [4].  However, larger increases in the prevalence of gestational diabetes have been 
reported for non-Indigenous women [6].  Hypertensive disorders of pregnancy (including pre-
existing and pregnancy-induced hypertension) affects around 0.6% and 4.4% of pregnancies in 
Queensland [2].  Antepartum haemorrhage (including placenta praevia and abruption) is 
associated with up to 20% of very preterm births [7] and affects 2.4% of pregnancies in 
Queensland [2].  Indigenous women have higher rates of small-for-gestational age births than non-
Indigenous women [8].   
Given the contribution of these conditions to stillbirth rates and the disproportionate burden 
among disadvantaged groups, determining the specific periods of increased risk of stillbirth 
associated with these conditions is important for clinical management and potential further 
reductions in stillbirth rates.  The objective of this study was to examine the gestational age-
specific risk of stillbirth associated with antepartum haemorrhage, hypertension, diabetes and 
small-for-gestational age among Indigenous and non-Indigenous women in Queensland to 
determine if there are differential effects of risk factors.  
 
Methods  
We conducted a population-based study utilising data from the Queensland Perinatal Data 
Collection (QPDC) for the period July 2005 to December 2011.  The QPDC is an administrative 
database which holds data on all births occurring in Queensland.  It is a requirement that all births 
in Queensland are registered in the QPDC for administrative purposes [9].  
Demographic factors assessed included maternal Indigenous status, age, marital status, 
socioeconomic status and geographic location.  Indigenous status was based on maternal self-
identification as Aboriginal or Torres Strait Islander or not.  Relative socioeconomic disadvantage 
(based on residential postcode) was defined as residing in the lowest ranked 20% of 
neighbourhoods.  Geographic location (based on residential postcode) was classified as major city, 
regional or remote.  Pregnancy factors assessed included smoking status, substance use, hospital 
accommodation status, assisted conception use, primiparity, number of antenatal care visits, 
gestational age at birth, baby’s sex and small-for-gestational age (SGA).  SGA was defined as 
birthweight less than the 10th Australian population percentile by gestational age, plurality and sex 
[10]. 
 
 
283 
 
Medical conditions of interest included: antepartum haemorrhage, essential hypertension, pre-
eclampsia/eclampsia, gestational and pre-existing diabetes. Unfortunately, we were unable to 
assess the effect of overweight/obesity over the study duration. Midwives, who are directly 
involved in the clinical care of the individual mothers, provide the data to the QPDC. Data audits 
completed in other Australian states show that false positives and false negatives are generally 
<5% for diabetes, hypertensive disorders and antepartum haemorrhage [11]. Stillbirth was defined 
as fetal death of at least 20 weeks gestation or 400g birthweight.  Stillbirths as a result of 
terminations of pregnancy for maternal psychosocial reasons, births of unknown maternal 
Indigenous status or gestational age, births less than 20 weeks and less than 400g birthweight, and 
births with a congenital anomaly were excluded.  
Statistical Analysis 
The all-cause conditional probability of stillbirth occurring at each gestational age interval was 
calculated using the number of stillbirths occurring within each gestational age interval as the 
numerator and the number of ongoing pregnancies minus half the number of births occurring 
within the gestational age interval as the denominator [12]. 
Risk ratios were used to quantify the unadjusted risk of stillbirth relative to livebirth associated 
with the conditions of interest (diabetes, hypertension, antepartum haemorrhage and small-for-
gestational age).  The adjusted stillbirth risk for each of the conditions of interest was assessed in 
four gestational age intervals of four weeks and an interval of 37 weeks or more using multivariate 
logistic regression. Regression models were adjusted for the previously listed demographic and 
pregnancy factors.  The denominator was adjusted to reflect the population-at-risk (i.e. the 
number of ongoing pregnancies at the start of the gestational age interval of interest).  Analysis 
was stratified by maternal Indigenous status, as we hypothesised that differences would be 
observed in stillbirth risk between Indigenous and non-Indigenous women, furthermore, both 
groups of women differed significantly on a number of demographic and pregnancy factors. 
Similar patterns in stillbirth risk were found across strata of antepartum/intrapartum and 
unknown stillbirth, therefore, to maintain sample size results are presented for all stillbirths 
combined. Secondary analysis was undertaken on the whole population (Indigenous and non-
Indigenous women combined) to assess stillbirth risk among Indigenous women relative to non-
Indigenous women.  Statistical analyses were performed using Stata/SE for Windows 13.1 
(StataCorp LP, College Station, TX, USA 2013).  Ethics approval was obtained from the Queensland 
Health Central Office (Ref: HREC/05/QHC/009), University of Queensland School of Public Health 
(Ref: II180313) and Mater Health Services (Ref: HREC/15/MHS/36/AM07) Human Research Ethics 
Committees. 
 
Results 
The characteristics of the study population are summarised in Table 1. A total of 360,987 births 
were included in the analyses.  Of these, 20,273 (5.6%) births were to Indigenous women and 
340,714 (94.4%) were to non-Indigenous women.  The stillbirth rates were 7.9 (95% CI 6.8-9.2) and 
4.1 (95% CI 3.9-4.3) per 1000 births, respectively; giving a risk ratio of 1.9 (95% CI 1.6-2.3).  For 
Indigenous and non-Indigenous women, there were higher rates of smoking, substance use, 
preterm birth and fewer than 8 antenatal care visits among women with a stillbirth compared to 
women with a live birth (Supplementary Table 1).  Among non-Indigenous women, there were 
 
 
284 
 
higher rates of socioeconomic disadvantage (risk ratio 1.18, 95% CI 1.03-1.35) for women with a 
stillbirth (Supplementary Table 1). 
Table 2 shows birth outcomes for the study population.  For Indigenous and non-Indigenous 
women, there were higher rates of pre-existing diabetes, pre-existing hypertension, antepartum 
haemorrhage and SGA among women with a stillbirth compared to women with a live birth (Table 
2).  However, there were significant differences in the prevalence of the conditions of interest 
between Indigenous and non-Indigenous women, respectively as follows:  pre-existing diabetes 
(1.3% vs 0.5%, p<0.001), gestational diabetes (6.6% vs 5.3%, p<0.001), pre-existing hypertension 
(1.0% vs 0.7%, p<0.001), pre-eclampsia/eclampsia (2.9% vs 2.2%, p<0.001), antepartum 
haemorrhage (2.3% vs 2.7%, p<0.001) and small-for-gestational age (15.2% vs 8.4%, p<0.001).  
The all-cause stillbirth risk profile for Indigenous and non-Indigenous women was characterised by 
lower rates of stillbirth at gestational ages before 38 weeks (0.2 to 0.6/1000 and 0.1 to 0.3/1000 
ongoing pregnancies for Indigenous and non-Indigenous women, respectively).  A marked increase 
in risk was then observed from 39 weeks onwards, with a two-fold or higher risk for Indigenous 
women compared with non-Indigenous women (Figure 1).  
Overall, women with a stillbirth were more likely to have: pre-existing diabetes (2.1% vs 0.5%, risk 
ratio 3.92, 95% CI 2.79-5.51), pre-existing hypertension (2.5% vs 0.7%, risk ratio 3.70, 95% CI 2.70-
5.08), pre-eclampsia/eclampsia (5.3% vs 2.2%, risk ratio 2.39, 95% CI 1.94-2.96), antepartum 
haemorrhage (24.6% vs 2.6%, risk ratio 9.43, 95% CI 8.62-10.3) and a small for gestational age 
infant (30.5% vs 8.7%, risk ratio 3.47, 95% CI 3.21-3.75), while women with gestational diabetes 
(4.0% vs 5.4%, risk ratio 0.74, 95% CI 0.58-0.94) or pregnancy-induced hypertension (1.8% vs 2.9%, 
risk ratio 0.62, 95% CI 0.43-0.90) were less likely to have a stillbirth.   
Gestational age-specific odds of stillbirth are presented by condition for Indigenous and non-
Indigenous women separately in Table 3; and for the whole population in Supplementary Table 2. 
Supplementary Table 3 shows the odds of stillbirth by condition of interest for Indigenous women 
relative to non-Indigenous women.   
 
Diabetes 
There were significantly increased odds of stillbirth associated with pre-existing diabetes from 33 
weeks onwards for both groups of women. Among Indigenous women, the odds of stillbirth at 33-
36 and 37+ weeks were aOR 19.0 (95% CI 5.3-68) and aOR 15.4 (95% CI 4.8-49), respectively.  
Among non-Indigenous women, the adjusted odds ratios for the equivalent gestational ages were 
7.7 (95% CI 3.4-17.6) and 6.8 (95% CI 3.5-13.2) (Table 3). There was a suggestion of increased odds 
of stillbirth associated with gestational diabetes from 33 weeks onwards among non-Indigenous 
women. There were decreased odds of stillbirth associated with diabetes at gestational ages less 
than 28 weeks for Indigenous women, but increased odds at term (Supplementary Table 3). 
 
Hypertension 
There was a suggestion of increased odds of stillbirth associated with pre-existing hypertension at 
all gestational ages assessed.  Pre-eclampsia/eclampsia was likely to be associated with increased 
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odds of stillbirth for both groups of women, although numbers were too small in some instances 
to reach conventional statistical significance of 0.05.  As with diabetes, there were decreased odds 
of stillbirth associated with hypertensive disorders at gestational ages less than 28 weeks for 
Indigenous women, and increased odds at term (Supplementary Table 3). 
 
Antepartum haemorrhage 
Antepartum haemorrhage was strongly associated with stillbirth for most gestational age groups 
and for both Indigenous and non-Indigenous women.  Among non-Indigenous women, odds of 
stillbirth for antepartum haemorrhage was higher at 33-36 weeks (aOR 17.9, 95% CI 13.1-24.4) 
compared to odds at less than 28 weeks or at term (Table 3). Compared to non-Indigenous 
women, there were decreased odds of stillbirth at 24-27 weeks (aOR 0.56, 95% CI 0.33-0.96) but 
increased odds of stillbirth at 37+ weeks (aOR 1.53, 95% CI 1.07-2.21)(Supplementary Table 3). 
 
Small-for-gestational age (SGA) 
There were significantly increased odds of stillbirth associated with SGA from 24 weeks gestation 
onwards for Indigenous women; and at all gestational age groups for non-Indigenous women 
(Table 3). Indigenous women had decreased odds of stillbirth associated with SGA at gestational 
ages less than 28 weeks compared with non-Indigenous women, but there was no difference in 
stillbirth risk at 28 weeks or older (Supplementary Table 3).  
 
Discussion  
Main findings 
This study found increased odds of stillbirth associated with pre-existing diabetes, pre-existing 
hypertension, antepartum haemorrhage and SGA across most gestational age groups for both 
Indigenous and non-Indigenous women after adjusting for potential confounders. There were 
mixed results for pre-eclampsia/eclampsia and gestational diabetes. At less than 27 weeks, there 
were decreased odds of stillbirth associated with diabetes, pre-existing hypertension and SGA for 
Indigenous compared with non-Indigenous women. Conversely, the odds of stillbirth for diabetes, 
hypertension and antepartum haemorrhage were 1 ½ times higher at term for Indigenous women 
as non-Indigenous women. The protective effect observed at lower gestational ages may be due to 
detection bias or differing causes of stillbirth; higher rates of spontaneous preterm birth have 
been reported for Indigenous women [13].  Likewise, the increased odds of stillbirth may reflect 
the impact of lower levels of antenatal care such as decreased detection of SGA and suboptimal 
diabetes management.  Few studies have assessed gestational age-specific stillbirth risk using the 
population-at-risk approach within this study population [14]. The profile of all-cause stillbirth risk 
for both groups of women was similar to profiles reported in populations in USA [15]. However, 
the overall magnitude of risk for Indigenous women was about twice that of non-Indigenous 
women.  
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We acknowledge that the study was underpowered to detect interactions between Indigenous 
status and stillbirth risk factors which may have indicated differential effects of risk factors within 
the two groups of women.   
 
Diabetes 
We found increased odds of stillbirth associated with pre-existing diabetes from 33 weeks 
onwards for both groups of women.  Similar findings of increased risk of stillbirth due to pre-
existing diabetes from 32 weeks onwards have been reported elsewhere [16, 17].  The one and a 
half fold disparity in the magnitude of stillbirth risk between Indigenous and non-Indigenous 
women at term mirrors higher rates of pre-existing diabetes among Indigenous women in our 
study (1.3% versus 0.5%). Similarly, our finding of increased odds of stillbirth due to gestational 
diabetes from 28 weeks onwards among non-Indigenous women concurs with Hutcheon and 
colleagues [18]. While the prevalence of gestational diabetes have been reported to be higher 
among Indigenous women, the rate of increase of gestational diabetes over time was found to be 
greater among non-Indigenous women [4].  
 
Current management for pre-existing diabetes includes strict glycaemic control, pre-conceptual 
folate supplementation, cessation of oral hypoglycaemic agents, diabetes complication review, 
periodic ultrasound scans for fetal morphology (18-20 weeks), cardiac views (24 weeks), fetal 
growth (28-30 and 34-36 weeks)[19].  The International Association of Diabetes and Pregnancy 
Study Group recommend screening all women at their first antenatal visit for gestational diabetes 
or previously undiagnosed pre-existing diabetes [20]; however, a tiered approach with early 
screening of women at high risk or with multiple risk factors is recommended in Australia [21].  
Perinatal mortality audits in high income countries have identified poor glycaemic control [22, 23] 
and inadequate screening among women at risk [24] as contributing to stillbirth. Conversely, pre-
pregnancy counselling has been found to significantly lower the risk of major congenital anomalies 
associated with diabetes during pregnancy (RR 0.36, 95% CI 0.22-0.59; absolute risk 2.1% versus 
6.5%) [21].  Pre-conception care was found to reduce perinatal mortality while optimal vs 
suboptimal serum blood glucose control was associated with reduced perinatal mortality (RR 0.40, 
95% CI 0.25-0.63) but not stillbirth (RR 0.51 95% CI 0.14-1.88)[25].  Our findings highlight the need 
for early initiation of monitoring of women with pre-existing diabetes, especially for Indigenous 
women; and early identification and management of gestational diabetes. 
 
Antepartum haemorrhage 
We found increased risk of stillbirth associated with antepartum haemorrhage at all gestational 
age groups assessed; and the magnitude of risk for Indigenous women was 1 ½ times higher than 
for non-Indigenous women at term.  Despite differences in methodology, similar magnitude of risk 
has been reported in population based studies from Canada and USA with adjusted odds ratios 
ranging from 11.40-18.90 for stillbirth associated with placental abruption in births of at least 20 
weeks [26, 27].  The disparity in risk seen between Indigenous and non-Indigenous women may be 
a reflection of higher prevalence of risk factors for placenta praevia and abruption such as 
maternal smoking (52.7% vs 16.6%), substance use (1.7% vs 0.5%) and small for gestational age 
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(15.2% vs 8.4%).  At present, there is limited evidence for the prediction or prevention of 
abruption; and antepartum haemorrhage usually constitutes a sudden obstetric emergency.  The 
mainstay of management for antepartum haemorrhage includes: assessment of maternal and 
fetal condition, prompt resuscitation if required and early delivery if there is fetal distress or the 
baby is suitably mature [28, 29]. It is estimated that up to 70% of antepartum haemorrhage cases 
occur in apparently low risk pregnancies [30]. 
 
Small-for-gestational age (SGA) 
We found increased odds of stillbirth associated with SGA from 24 weeks onwards for both 
Indigenous and non-Indigenous women; and similar findings have been reported elsewhere [16].  
Although not reflected in the stillbirth odds, there was a higher prevalence of SGA among 
Indigenous women in this study (15.2% vs 8.4%), similar to reports from the Northern Territory 
(Indigenous 11.9% vs non-Indigenous 5.0%) [31].  
SGA has been used as a proxy for fetal growth restriction and undetected fetal growth restriction 
has been identified as a significant potentially modifiable risk factor for stillbirth [32].  There are 
currently no antenatal interventions to treat fetal growth restriction and the mainstay of 
management is fetal monitoring to determine the optimal timing for delivery (balancing risks and 
benefits of adverse fetal outcomes against morbidity and mortality associated with early delivery 
at a given gestational age) [33].  Management for SGA involves accurate determination of 
gestational age and serial monitoring of fetal growth (using symphysis-fundal height measurement 
or ultrasound biometry).  However, controversy exists over the accuracy of symphysis-fundal 
height measurement especially in obese women [34] and the use of customised growth charts due 
to lack of high level evidence [35].  A number of interventions have been found to be effective in 
the prevention of SGA among women at increased risk, including: antiplatelet agents, smoking 
cessation, progesterone therapy, anti-thrombotic therapy and interventionist care in severe pre-
eclampsia [36].  Further studies are needed into preventive strategies for SGA that also include 
pre-eclampsia and preterm birth [36], as well as investigating the serious adverse effects of 
antenatal antithrombotic therapies [37]. 
 
Equity in access to antenatal care 
Overall, this study highlights the importance of optimal maternal health prior to pregnancy as well 
as early initiation of high quality antenatal care in the context of continued disparity in risk of 
stillbirth among Indigenous and non-Indigenous women.  Equity in access to antenatal care 
services and their utilisation is important to addressing disparities in health outcomes for all 
women, particularly Indigenous women [38].  Indigenous women in our study were more likely to 
have fewer antenatal care visits, a finding supported by others [2, 13].  Limited availability of 
culturally appropriate services may affect attendance for antenatal care; for example there were 
on average 5.5 antenatal care visits within mainstream services versus 10.5 visits within 
community controlled service settings for Indigenous women [39].  Active efforts to ensure 
appropriate and responsive care in the clinical environment both at the level of the individual 
health practitioner and within mainstream health care services are essential to reduce or eliminate 
social barriers to accessing health care. Embedding cultural competence in continuing 
organisational quality improvement processes has been shown to enhance health outcomes for 
 
 
288 
 
Indigenous people [40]. This is especially important for Indigenous women who seek care within 
mainstream health services.   
The Australian government has recognised the importance of maternal and child health to the 
“Closing the Gap” initiative and has prioritised maternal and child health [41]. It has been shown 
that an investment in stillbirth prevention provides a three-fold return in terms of maternal, 
neonatal and child health [42].  While there has been continued support for Aboriginal and Torres 
Strait Islander community controlled health centres and their Mums and Bubs centres, many 
health and lifestyle modification programs have been defunded.  Declines seen in smoking and 
under-5 child mortality rates are further evidence for the need to maintain funding for successful 
lifestyle modification programs and antenatal care services operated by the community controlled 
health services [41].  More broadly, access to primary care services is critical to reducing health 
inequity and policies that undermine universal health care pose a significant threat to this goal by 
presenting further financial barriers that are likely to disproportionately affect the most vulnerable 
[43].  
 
Conclusions 
This study highlights the gestational age specific stillbirth risk associated with diabetes, 
hypertension, antepartum haemorrhage and small for gestational age.  It also highlights the 
disparity in stillbirth risk between Indigenous and non-Indigenous women at term and the need to 
prioritise early detection and management of these conditions and to work with women before, 
during and between pregnancies. Improving access to and utilisation of appropriate and 
responsive healthcare may help to address disparities in stillbirth risk for Indigenous women. 
Larger population-based studies are needed to re-evaluate whether there are differences in the 
effect of risk factors on stillbirth risk among Indigenous and non-Indigenous women.  
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Figure 1: Gestational age specific risk of stillbirth by Indigenous status  
Numerator = the number of stillbirths occurring at each week of gestational age.   
Denominator = the number of ongoing pregnancies at each gestational age week minus half the number of 
births occurring within the gestational age week 
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Table 1: Maternal and pregnancy characteristics by livebirth or stillbirth and Indigenous 
status 
Characteristics 
Indigenous 
(n=20 273) 
Non-Indigenous 
(n=340 714) 
Maternal age (years)   
     ≤18 years 1 454 (7.2) 4 402 (1.3) 
     19-24 years 8 765 (43.2) 67 896 (19.9) 
     25-30 years 5 693 (28.1) 119 253 (35.0) 
     31-34 years 2 427 (12.0) 81 322 (23.9) 
     ≥35 years 1 934 (9.5) 67 841 (19.9) 
Geographic Location   
     Major City 4 169 (20.6) 209 778 (61.6) 
     Regional area 11 920 (58.8) 122 590 (36.0) 
     Remote area 4 184 (20.6) 8 334 (2.5) 
Marital Status   
     Domestic partner 13 033 (64.3) 302 212 (88.7) 
     No domestic partner 7 232 (35.7) 38 452 (11.3) 
Relative socioeconomic disadvantage   
     Lowest 20%  7 422 (36.7) 39 503 (11.6) 
Any smoking during pregnancy   
     Yes 10 692 (53.1) 56 720 (16.7) 
Substance Use during pregnancy   
     Yes 343 (1.7) 1 705 (0.5) 
Hospital accommodation status   
     Public 19 853 (97.9) 229 717 (67.4) 
Assisted Conception   
     Yes 92 (0.5) 12 909 (3.8) 
Primiparity   
     Yes 4 834 (23.8) 102 091 (30.0) 
Number of antenatal care visits   
     Less than 2 1 102 (5.4) 2 291 (0.7) 
     2 – 4 3 405 (16.8) 17 349 (5.1) 
     5 – 7 5 828 (28.8) 63 386 (18.6) 
     8 or more 9 911 (49.0) 257 496 (75.6) 
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Table 2: Maternal medical and pregnancy conditions by livebirth or stillbirth and Indigenous status 
Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Risk Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Risk Ratio 
(95% CI) 
Preterm birth 56 (35.0) 53 (0.3) 132 (94.3-187) 451 (32.4) 243 (0.1) 453 (391-525) 
Pre-existing diabetes 12 (7.5) 248 (1.2) 6.08 (3.48-10.6) 21 (1.5) 1 702 (0.5) 3.01 (1.96-4.61) 
Gestational diabetes ^ 1 324 (6.6) 0.38 (0.14-1.00) 58 (4.2) 18 135 (5.3) 0.78 (0.61-1.00) 
Pre-existing 
hypertension 
7 (4.4) 190 (0.9) 
4.63 (2.21-9.69) 
31 (2.2) 2 189 (0.7) 
3.45 (2.43-4.90) 
Pre-eclampsia/Eclampsia ^ 574 (2.9) 1.10 (0.46-2.60) 77 (5.5) 7 359 (2.2) 2.55 (2.05-3.17) 
Pregnancy induced 
hypertension 
^ 488 (2.4) 
0.26 (0.04-1.82) 
27 (1.9) 9 897 (2.9) 
0.67 (0.46-0.97) 
Antepartum 
haemorrhage 
44 (27.5) 412 (2.0) 
13.4 (10.3-17.6) 
337 (24.2) 8 948 (2.6) 
9.18 (8.35-10.1) 
Small-for-gestational age 58 (36.3) 3 021 (15.0) 2.46 (2.00-3.02) 410 (29.5) 28 214 (8.3) 3.58 (3.30-3.89) 
^Numbers and percentages not displayed for cells with 5 or less observations to protect participant privacy.    
ICD10-AM codes: Antepartum haemorrhage (O44.1, O45-O46), Pre-existing hypertension (O10.0, O10.2-10.4, O10.9, O11), Pregnancy Induced hypertension (O13), Pre-
eclampsia/Eclampsia (O14, O15), Pre-existing diabetes (O24.0, O24.1, O24.3, O24.8), Gestational diabetes (O24.4, O24.9).   
Small-for-gestational age = birthweight less than the 10
th
 Australian population percentile by gestational age, plurality and sex 
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Table 3: Gestational age-specific risk of stillbirth by medical condition and Indigenous status  
Conditions 
Indigenous (n=20,273 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes
a,c
 1.42 (0.17-11.6) 3.15 (0.31-31.7) 7.81 (1.28-47.8) 19.0 (5.30-68.4) 15.4 (4.79-49.2) 
Gestational diabetesa,c - - - 0.68 (0.09-5.32) 0.93 (0.22-4.01) 
Pre-existing hypertension
 b,c
 2.27 (0.27-18.8) 5.62 (0.55-57.7) 13.2 (2.07-84.5) 1.35 (0.14-12.8) 1.49 (0.15-14.8) 
Pre-Eclampsia/Eclampsia c 0.70 (0.09-5.14) 1.59 (0.21-12.2) - 1.92 (0.24-15.2) 3.32 (0.79-14.0) 
Antepartum haemorrhage
a
 18.1 (9.91-33.1) 14.2 (5.14-39.4) 31.2 (11.9-81.6) 2.53 (0.31-20.3) 17.1 (7.28-40.0) 
Small-for-gestational age 1.30 (0.67-2.52) 3.32 (1.31-8.44) 7.04 (2.70-18.4) 3.05 (1.16-8.02) 2.10 (1.08-4.08) 
Conditions 
Non-Indigenous (n=340,714 births) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes
a
 0.90 (0.21-3.94) 3.23 (0.98-10.7) 1.33 (0.18-9.64) 7.68 (3.36-17.6) 6.77 (3.47-13.2) 
Gestational diabetesa 0.47 (0.21-1.06) 0.76 (0.31-1.87) 1.25 (0.61-2.56) 1.94 (1.14-3.32) 1.29 (0.84-1.97) 
Pre-existing hypertension
 b
 7.27 (4.18-12.6) 6.59 (2.99-14.6) 3.35 (1.05-10.7) 2.54 (0.80-8.11) 1.29 (0.41-4.04) 
Pre-eclampsia/Eclampsia 0.99 (0.51-1.94) 6.40 (4.14-9.91) 5.55 (3.43-8.99) 2.00 (0.94-4.26) 2.77 (1.65-4.66) 
Antepartum haemorrhage
a
 9.03 (7.21-11.3) 7.99 (5.67-11.3) 12.8 (9.25-17.9) 17.9 (13.1-24.4) 7.95 (5.85-10.8) 
Small-for-gestational age 3.73 (3.00-4.64) 6.43 (4.78-8.67) 3.85 (2.77-5.33) 3.49 (2.50-4.87) 3.72 (2.91-4.74) 
Regression models adjusted for maternal age, smoking status, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception use, 
socioeconomic status, marital status, number of antenatal care visits.   
a
Models additionally adjusted for pre-existing hypertension.   
b
 These models additionally adjusted for pre-existing diabetes.    
c
 Exact logistic regression model 
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Supplementary Table 1: Maternal and pregnancy characteristics by livebirth or stillbirth and Indigenous status 
Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Risk Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Risk Ratio 
(95% CI) 
Maternal age (years)       
     ≤18 years 10 (6.3) 1 444 (7.2) 0.87 (0.48-1.59) 42 (3.0) 4 360 (1.3) 2.35 (1.74-3.17) 
     19-24 years 67 (41.9) 8 698 (43.3) 0.97 (0.81-1.16) 313 (22.5) 67 583 (19.9) 1.13 (1.02-1.24) 
     25-30 years 48 (30.0) 5 645 (28.1) 1.07 (0.84-1.36) 437 (31.4) 118 816 (35.0) 0.90 (0.83-0.97) 
     31-34 years 14 (8.8) 2 413 (12.0) 0.73 (0.44-1.20) 290 (20.8) 81 032 (23.9) 0.87 (0.79-0.97) 
     ≥35 years 21 (13.1) 1 913 (9.5) 1.38 (0.92-2.06) 310 (22.3) 67 531 (19.9) 1.12 (1.01-1.23) 
Geographic Location       
     Major City 26 (16.3) 4 143 (20.6) 0.79 (0.55-1.12) 835 (60.0) 208 943 (61.6) 0.97 (0.93-1.02) 
     Regional area 95 (59.4) 11 825 (58.8) 1.01 (0.89-1.15) 525 (37.7) 122 065 (36.0) 1.05 (0.98-1.12) 
     Remote area 39 (24.4) 4 145 (20.6) 1.18 (0.90-1.56) 31 (2.2) 8 303 (2.5) 0.91 (0.64-1.29) 
Marital Status       
     Domestic partner 102 (63.8) 12 931 (64.3) 0.99 (0.88-1.11) 1 148 (82.5) 301 064 (88.7) 0.93 (0.91-0.95) 
     No domestic partner 58 (36.3) 7 174 (35.7) 1.02 (0.83-1.25) 241 (17.3) 38 211 (11.3) 1.54 (1.37-1.73) 
Relative socioeconomic disadvantage 
     Lowest 20%  59 (36.9) 7 363 (36.6) 1.01 (0.82-1.23) 190 (13.6) 39 313 (11.6) 1.18 (1.03-1.35) 
Any smoking during pregnancy 
     Yes 95 (59.4) 10 597 (52.7) 1.17 (1.03-1.33) 332 (23.9) 56 388 (16.6) 1.47 (1.34-1.62) 
Substance Use during pregnancy 
     Yes 11 (6.9) 332 (1.7) 4.17 (2.33-7.44) 15 (1.1) 1 690 (0.5) 2.16 (1.31-3.59) 
Hospital accommodation status 
     Public 157 (98.1) 19 696 (97.9) 1.00 (0.98-1.02) 1 084 (77.9) 228 633 (67.4) 1.16 (1.13-1.19) 
Assisted Conception       
     Yes ^ 91 (0.5) 1.38 (0.19-9.85) 66 (4.7) 12 843 (3.8) 1.26 (0.99-1.59) 
Primiparity       
     Yes 37 (23.1) 4 797 (23.9) 0.97 (0.73-1.29) 418 (30.0) 101 673 (30.0) 1.00 (0.93-1.09) 
Number of antenatal care visits 
     Less than 2 47 (29.4) 1 055 (5.2) 5.66 (4.43-7.25) 147 (10.6) 2 144 (0.6) 16.8 (14.4-19.7) 
     2 – 4 57 (35.6) 3 348 (16.6) 2.16 (1.75-2.67) 459 (33.0) 16 890 (5.0) 6.68 (6.19-7.21) 
     5 – 7 23 (14.4) 5 805 (28.9) 0.50 (0.35-0.74) 367 (26.4) 63 019 (18.6) 1.43 (1.31-1.56) 
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Characteristics 
Indigenous (n=20273) Non-Indigenous (n=340714) 
Stillbirth 
(n=160) 
Livebirth 
(n=20113) 
Risk Ratio 
(95% CI) 
Stillbirth 
(n=1392) 
Livebirth 
(n=339322) 
Risk Ratio 
(95% CI) 
     8 or more 31 (19.4) 9 880 (49.1) 0.40 (0.29-0.55) 407 (29.2) 257 089 (75.8) 0.39 (0.36-0.42) 
^Numbers and percentages not displayed for cells with 5 observations or less 
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Supplementary Table 2: Gestational age-specific risk of stillbirth associated with diabetes, hypertension, antepartum haemorrhage and 
SGA, combined Indigenous and non-Indigenous women, Queensland, mid 2005-2011   
Conditions 
All births (n=360 987) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetes
a
 1.02 (0.31-3.37) 3.34 (1.17-9.57) 3.00 (0.92-9.78) 7.28 (3.35-15.8) 8.26 (4.70-14.5) 
Gestational diabetesa 0.41 (0.18-0.91) 0.68 (0.28-1.67) 1.12 (0.55-2.28) 1.80 (1.07-3.02) 1.24 (0.82-1.87) 
Pre-existing hypertension
 b
 6.30 (3.70-10.7) 6.29 (2.97-13.3) 4.39 (1.75-11.0) 2.76 (1.00-7.64) 1.36 (0.50-3.70) 
Pre-Eclampsia/Eclampsia 0.92 (0.49-1.73) 5.50 (3.57-8.46) 4.47 (2.76-7.26) 2.10 (1.03-4.27) 2.63 (1.61-4.30) 
Antepartum haemorrhagea 9.68 (7.85-12.0) 8.49 (6.14-11.7) 13.8 (10.1-18.6) 16.4 (12.1-22.2) 8.44 (6.32-11.3) 
Small-for-gestational age 3.26 (2.64-4.02) 5.95 (4.47-7.93) 3.98 (2.93-5.40) 3.51 (2.56-4.81) 3.35 (2.66-4.22) 
Regression models adjusted for maternal age, smoking status, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception use, 
socioeconomic status, marital status, number of antenatal care visits.   
a
Models additionally adjusted for pre-existing hypertension.   
b
 These models additionally adjusted for pre-existing diabetes.    
 
Supplementary Table 3: Effect of Indigenous status on gestational age specific stillbirth risk (Indigenous relative to non-Indigenous) 
Conditions 
All births (n=360 987) 
Adjusted Odds Ratios (95% Confidence Intervals) 
20-23 weeks 24-27 weeks 28-32 weeks 33-36 weeks 37-42+ weeks 
Pre-existing diabetesa 0.71 (0.51-0.98) 0.51 (0.30-0.86) 0.66 (0.39-1.11) 0.86 (0.51-1.46) 1.45 (1.01-2.09) 
Gestational diabetesa 0.71 (0.51-0.99) 0.53 (0.31-0.89) 0.67 (0.40-1.12) 0.89 (0.52-1.51) 1.49 (1.04-2.15) 
Pre-existing hypertension
 b
 0.71 (0.51-0.98) 0.51 (0.30-0.86) 0.66 (0.39-1.11) 0.86 (0.51-1.46) 1.45 (1.01-2.09) 
Pre-Eclampsia/Eclampsia 0.72 (0.52-1.00) 0.53 (0.31-0.89) 0.67 (0.40-1.12) 0.90 (0.53-1.53) 1.50 (1.04-2.15) 
Antepartum haemorrhage
a
 0.77 (0.55-1.08) 0.56 (0.33-0.96) 0.73 (0.43-1.23) 0.99 (0.58-1.69) 1.53 (1.07-2.21) 
Small-for-gestational age 0.68 (0.49-0.95) 0.49 (0.29-0.83) 0.58 (0.34-0.99) 0.85 (0.50-1.45) 1.42 (0.98-2.04) 
Regression models adjusted for maternal age, smoking status, remoteness, substance use, gender, parity, hospital accommodation status, assisted conception use, 
socioeconomic status, marital status, number of antenatal care visits.   
a
Models additionally adjusted for pre-existing hypertension.   
b
 These models additionally adjusted for pre-existing diabetes.    
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Figure 1: Gestational age specific risk of stillbirth by Indigenous status  
 
 
Numerator = the number of stillbirths occurring at each week of gestational age.   
Denominator = the number of ongoing pregnancies at each gestational age week minus half the number of 
births occurring within the gestational age week 
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Appendix G Conference Abstracts 
Appendix G1: Predictors of autopsy following stillbirth 
 
Ibinabo Ibiebele1,2, Fran Boyle1,2, Dell Horey3, Patricia Wilson4, Michael Coory5,6, Vicki 
Flenady1,2 
1 Mater Research Institute-University of Queensland, Brisbane, Australia  2 School of 
Population Health, University of Queensland, Brisbane, Australia  3 Department of Public 
Health, La Trobe University, Melbourne, Australia  4 Mater Mothers’ Hospital, Mater Health 
Services, Brisbane, Australia  5 Murdoch Childrens Research Institute, Melbourne, 
Australia  6 Department of Paediatrics, University of Melbourne, Melbourne, Australia 
Email: Ibinabo.ibiebele@uqconnect.edu.au 
 
Background: The stillbirth rate in Australia has not improved for over two decades. 
Accurate determination of causes of these deaths are critical to effective prevention. In 
Queensland, nearly 60% of stillbirths at term are “unexplained” with unexplained stillbirth 
more common for Indigenous women (3.2 vs 2.0/1000). However with low autopsy rates, 
many stillbirths are “unexplored” rather than “ unexplained”. This study aims to determine 
factors associated with autopsy following stillbirth.   
 
Method:  Routinely collected population-based data on all singleton stillbirths of at least 
400g birthweight or 20 weeks gestation in Queensland between July 2000 and December 
2011 were examined.  Adjusted odds ratios (aOR, 95%CI) were calculated.  Analysis was 
stratified by gestational age group (<24, 24-27, 28-36 and ≥37 weeks).  
 
Results: Of 3842 women included in these analyses, 1356 (35.3%) consented to autopsy.  
Factors associated with increased odds of autopsy consent differed across the gestational 
age groups as follows: fetal growth restriction (aOR ranged from 1.53-1.55, for gestational 
ages <28 week), primiparity (aOR 1.46-1.60, ≥28 weeks) and maternal age (19-24 
years)(aOR 1.45, 28-36 weeks).  Factors associated with decreased odds were: 
intrapartum stillbirth (aOR 0.36-0.65, <37 weeks), antepartum haemorrhage (aOR 0.52-
0.67, ≥24 weeks), Indigenous status (aOR 0.50-0.52, 20-23 and ≥37 weeks), initially 
unexplained stillbirth (aOR 0.42-0.62, ≥28 weeks) and remote residence (aOR 0.27, ≥37 
weeks).  
 
Conclusions: Sociodemographic and pregnancy factors are associated with whether or 
not autopsy is performed following stillbirth. Of concern are associations between no 
autopsy examination with Indigenous status, and with an initial diagnosis of unexplained 
stillbirth.  Culturally appropriate information and consultation for Indigenous women after 
stillbirth is warranted.  
 
Citation: 
Ibiebele I, Boyle F, Horey D, Wilson P, Coory M, Flenady V. Predictors of autopsy 
following stillbirth. Perinatal Society of Australia and New Zealand 19th Annual Conference: 
Discoveries – Improving Perinatal Care, Melbourne, April 19-22 2015.  Journal of 
Paediatrics and Child Health, 2015. 51 (Suppl. 1): p. 28. 
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Appendix G2: Autopsy consent process: what parents are saying following a 
stillbirth 
 
Ibinabo Ibiebele1,2 , Vicki Flenady1,2, Dell Horey3, Patricia Wilson4, Michael Coory5,6, Fran 
Boyle1,2 
1 School of Population Health, University of Queensland, Brisbane, Australia   2 Mater 
Research Institute-University of Queensland, Brisbane, Australia  3 Department of Public 
Health, La Trobe University, Melbourne, Australia  4 Mater Mothers’ Hospital, Mater Health 
Services, Brisbane, Australia  5 Murdoch Childrens Research Institute, Melbourne, 
Australia  6 Department of Paediatrics, University of Melbourne, Melbourne, Australia.  
Email: ibinabo.ibiebele@uqconnect.edu.au  
 
Background: Stillbirth is a devastating pregnancy outcome.  There has been little 
reduction in stillbirth rates in recent times.  Autopsy is the gold standard investigation for 
determining cause of death but rates are declining and parental consent is a major factor. 
It is unclear how healthcare professionals can support parents in this difficult decision.  
This study aims to provide a detailed understanding of parents’ views and experiences in 
relation to autopsy following stillbirth.   
 
Method:  This qualitative study is nested in a larger prospective study involving 5 
Queensland hospitals.  Parents complete a questionnaire 6-8 weeks following stillbirth; 
and semi-structured telephone interviews with a purposive sample of 10 participants 2-3 
months later aiming to explore their decision-making process in greater depth. Thematic 
analysis of interview transcripts is used to identify patterns in the data.   
 
Results: Preliminary analysis confirms the distressing nature of decision-making during 
the autopsy consent process and highlights three emerging themes : the need for an 
explanation (importance, value of autopsy, managing feelings of guilt, planning for the 
future), respecting/honouring the baby (taking care of the baby), and altruism (value of 
information to others).  An important sub-theme within respect for the baby was tissue 
retention which can invoke further distress especially when parents are unprepared for 
this.   
 
Conclusions: These preliminary results support findings from other studies into reasons 
parents decline consent for autopsy and add further important insights into the autopsy 
consent process for parents in the contemporary Australian setting. The findings have 
direct implications for improving clinical practice including providing appropriate 
information to parents. 
 
Citation:  
Ibiebele I, Flenady V, Horey D, Wilson P, Coory M, Boyle F. Autopsy consent process: 
what parents are saying following a stillbirth. Perinatal Society of Australia and New 
Zealand 19th Annual Conference: Discoveries – Improving Perinatal Care, Melbourne, April 
19-22 2015.  Journal of Paediatrics and Child Health, 2015. 51 (Suppl. 1): p. 28. 
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Appendix G3: Gestational age specific risk of stillbirth among Indigenous and non-
Indigenous women in Queensland 
 
Ibinabo Ibiebele1,2, Vicki Flenady1,2, Michael Coory3,4, Fran Boyle1,2, Sue Vlack2,5, Philippa 
Middleton6, Yvette Roe7, Gordon Smith8 
1 Mater Research Institute-University of Queensland, Brisbane, Australia  2 School of 
Population Health, University of Queensland, Brisbane, Australia  3 Murdoch Childrens 
Research Institute, Melbourne, Australia  4 Department of Paediatrics, University of 
Melbourne, Melbourne, Australia  5 Queensland Health Metro North Brisbane Public 
Health Unit, Brisbane, Australia  6 Robinson Institute, University of Adelaide, Adelaide, 
Australia  7 Institute for Urban Indigenous Health, Brisbane, Australia  8 Department of 
Obstetrics and Gynaecology, Cambridge University, Cambridge, United Kingdom.   
Email: ibinabo.ibiebele@uqconnect.edu.au 
 
Background: In Australia, significant disparity persists in stillbirth rates between 
Aboriginal and Torres Strait Islander (Indigenous) and non-Indigenous women.  Diabetes, 
hypertension, fetal growth restriction and antepartum haemorrhage have been identified as 
important contributors to higher rates among Indigenous women.  The objective of this 
study was to examine gestational age specific risk of stillbirth associated with these 
conditions among Indigenous and non-Indigenous women.  
 
Methods: Population-based retrospective study involving all singleton livebirths and 
stillbirth of at least 400g birthweight or 20 weeks gestation in Queensland between July 
2005 and December 2011.  Stillbirth risk was assessed in five gestational age intervals 
(<24, 24-27, 28-32, 33-36 and ≥37 weeks). Analysis was stratified by maternal Indigenous 
status.  
 
Results: Of 360988 births analysed, 20273 (5.6%) were to Indigenous women and 
340714 (94.4%) were to non-Indigenous women. Stillbirth rates were 7.9 and 4.1 per 1000 
births, respectively.  Increased risk of stillbirth associated with fetal growth restriction and 
antepartum haemorrhage was found throughout the gestational age groups. Diabetes was 
associated with increased stillbirth risk at later gestational ages. There were differences in 
the profile and magnitude of stillbirth risk between Indigenous and non-Indigenous women 
respectively as follows: pre-existing diabetes (adjusted odds ratios ranged from 16.45-
18.75 versus 3.32-8.10); antepartum haemorrhage (adjusted odds ratios ranged from 
15.40-38.05 versus 7.90-17.86).  
 
Conclusion: This study highlights disparities in stillbirth risk between Indigenous and non-
Indigenous women and the need to prioritise prevention and management of diabetes, 
hypertension, fetal growth restriction and antepartum haemorrhage.  
Citation: 
Ibiebele I, Flenady V, Coory M, Boyle F, Vlack S, Middleton P, Roe Y, Smith G. 
Gestational age specific risk of stillbirth among Indigenous and non-Indigenous women in 
Queensland. Perinatal Society of Australia and New Zealand 19th Annual Conference: 
Discoveries – Improving Perinatal Care, Melbourne, April 19-22 2015.  Journal of 
Paediatrics and Child Health, 2015. 51 (Suppl. 1): p. 126. 
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Appendix G4: Temporal trends and causes of stillbirth among Indigenous and non-
Indigenous women in Australia by gestational age: Is the gap closing? 
 
Ibinabo Ibiebele 1,2, Michael Coory 3,4, Frances M. Boyle 2,5, Michael Humphrey 6, Susan 
Vlack 2,7, Vicki Flenady 1,5 
1 Translating Research Into Practice (TRIP) Centre, Mater Research Institute -University of 
Queensland (MRI-UQ), Brisbane, Australia  2 School of Population Health, University of 
Queensland, Brisbane, Australia  3 Murdoch Childrens Research Institute, Melbourne, 
Australia   4 Department of Paediatrics, University of Melbourne, Melbourne, Australia   5 
Australia and New Zealand Stillbirth Alliance, Brisbane, Australia   6 Queensland Maternal 
and Perinatal Quality Council, Brisbane, Australia   7 Queensland Health Metro North 
Brisbane Public Health Unit, Brisbane, Australia 
 
Background:   Progress with reduction in stillbirth rates has slowed in recent times in 
many high income countries and Australian national reports suggest rates may be 
increasing.  The Lancet Stillbirth series highlighted the need to address disparity across 
population subgroups as a means of further reducing rates in these countries.  It has been 
established that Indigenous women in Australia have higher rates of stillbirth than non-
Indigenous women.  Examination of temporal trends in rates and underlying cause of 
death is important to gaining an understanding of the scope for further reductions and to 
direct further clinical and research efforts. 
 
Objectives:   To assess whether the disparity gap is closing in stillbirth rates between 
Indigenous and non-Indigenous women; and to assess cause-specific stillbirth rates to 
determine where the greatest disparities lie in order to identify focal areas for future 
prevention efforts. 
 
Methods:   Data on singleton livebirths and stillbirths of at least 400g birthweight and/or 20 
weeks gestation in Queensland, Australia (a region of approximately 50,00 births each 
year)  between 1995 and 2011 were obtained.  Prospective stillbirth rates (i.e., stillbirths 
per 1000 ongoing pregnancies) by gestational age (≥24, ≥28 and ≥37 weeks) were 
calculated for Indigenous and non-Indigenous women.  Cause-specific prospective 
stillbirth rates using the Perinatal Society of Australia and New Zealand Perinatal Death 
Classification (PSANZ-PDC), relative risk and 95% confidence intervals were also 
calculated for Indigenous women relative to non-Indigenous women by gestational age.   
 
Results:   Over the study period, prospective stillbirth rates for Indigenous women 
decreased from 13.3 to 9.1/1000 while rates remained steady at 5.9/1000 for non-
Indigenous women.  There was a 57.3% reduction in the disparity gap between Indigenous 
and non-Indigenous women. These reductions were more pronounced for women birthing 
at ≥24 weeks (66.9%) and ≥28 weeks (76.6%), while at term (≥37 weeks), there was an 
18.0% increase in the disparity gap. Between 2001 and 2011, the disparity gap at term 
was steady around 1.2/1000 ongoing pregnancies.  Major conditions contributing to the 
disparity in stillbirth rates at term were: maternal conditions (diabetes), perinatal infection, 
fetal growth restriction and unexplained antepartum fetal death.  Higher rates of 
undetermined causes may have been driven by lower autopsy rates.  
 
Conclusion:   The gap in stillbirth rates between Indigenous and non-Indigenous women 
is closing; however, Indigenous women continue to be at increased risk of stillbirth due to 
a number of potentially preventable conditions.  High quality antenatal care at all levels 
using culturally appropriate service delivery models which incorporate diabetes 
management, smoking cessation, STI screening and treatment, folic acid and fetal growth 
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monitoring hold some promise of helping to improve pregnancy outcomes for Indigenous 
women. 
 
Presented at: 
ISA/ISPID International Conference on Stillbirth, SIDS and Baby Survival, Amsterdam, 
September 18-21 2014  
Australian Society for Medical Research Postgraduate Student Conference, Brisbane, May 
28 2014 
 
  
 
 
304 
 
Appendix G5: Closing the gap: stillbirth among Indigenous and non-Indigenous 
women in Queensland by gestation and geographic location, 1995-2011 
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Background: Progress with reduction in stillbirth rates has slowed in recent times in many 
high income countries prompting the need to address disparity across population 
subgroups. Australian Indigenous women have higher rates of stillbirth than non-
Indigenous women and geographic location has been identified as an important risk factor. 
The objective of this study was to examine differences in prospective stillbirth rates 
between Indigenous and non-Indigenous women according to gestational age group and 
geographic location. 
 
Method:  Data on singleton livebirths and stillbirths of at least 400g birthweight and/or 20 
weeks gestation in Queensland between 1995 and 2011 were obtained.  Prospective 
stillbirth rates (i.e., stillbirths per 1000 ongoing-pregnancies) by gestational age (≥24, ≥28 
and ≥37 weeks) and geographic location (urban, regional and remote) were calculated for 
Indigenous and non-Indigenous women. 
 
Results: Over the study period, prospective stillbirth rates for Indigenous women 
decreased from 13.3 to 9.1/1000 while rates remained steady at 5.9/1000 for non-
Indigenous women. Rates varied significantly for Indigenous women by geographic 
location (urban 8.5/1000 versus regional 10.8/1000 versus remote 12.5/1000 ongoing 
pregnancies, p=0.019).  The difference in rates between Indigenous and non-Indigenous 
women decreased by 57.3% overall.  These reductions were more pronounced for women 
living in regional (57.0%) and remote areas (56.1%) than urban (25.7%) areas. Likewise 
reductions were observed for rates at ≥24 and ≥28 weeks’ gestation. 
 
Conclusions: The gap in stillbirth rates between Indigenous and non-Indigenous women 
is reducing; however, substantial inequities remain especially for Indigenous mothers who 
live in regional and remote areas. 
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Appendix G6: Causes of stillbirth in Queensland among Indigenous and non-
Indigenous women by gestation and geographic location, 1995-2011 
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Background: Reductions in stillbirth rates in many high income countries have slowed or 
stalled prompting the need to address disparity across population subgroups.  In Australia, 
Indigenous women have higher rates of stillbirth and other adverse pregnancy outcomes 
compared with non-Indigenous women.  Geographic location has also been identified as 
an important risk factor in the Australian context. The objective of this study was to 
determine disparity in cause-specific prospective stillbirth rates in order to identify focal 
areas for preventive efforts. 
 
Method:  Data on singleton livebirths and stillbirths of at least 400g birthweight and/or 20 
weeks gestation in Queensland between 1995 and 2011 were obtained.  Cause-specific 
prospective stillbirth rates using PSANZ Perinatal Death Classification, relative risk and 
95% confidence intervals were calculated for Indigenous women relative to non-
Indigenous women by gestational age (≥24, ≥28 and ≥37 weeks) and geographic location 
(urban, regional and remote).   
 
Results: The all-cause risk of stillbirth was 81% higher for Indigenous women compared 
with non-Indigenous women and varied by geographic location [urban (RR 1.47, 95%CI 
1.18-1.81);  regional (RR 1.76, 95%CI 1.56-1.98) and remote (RR 2.37, 95%CI 1.84-
3.04)]. Overall, Indigenous women had increased risk of stillbirth categorised as:  maternal 
conditions (mainly diabetes), perinatal infection, spontaneous preterm birth, hypertension, 
fetal growth restriction, antepartum haemorrhage and unexplained antepartum fetal death. 
The risk of stillbirth due to fetal growth restriction and maternal conditions increased with 
gestational age. 
 
Conclusions: Indigenous women remain at increased risk of stillbirth due to a number of 
potentially preventable causes.  These findings identify focal areas for preventative 
strategies such as improving the quality of care for Indigenous women throughout the 
reproductive lifespan. 
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